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Abstract 
The desire to monitor important neurotransmitters in the in vivo environment, in real-
time and in conscious subjects has been the driving force behind the continued 
development over the last 40 years of a range of biosensor devices. This is a none too 
difficult task considering the milieu of substances that are present in vivo, particularly in 
the brain where there also exists a wide range of electroactive species, and where 
foreign objects are treated as hostile and subject to severe biological strain. 
Nevertheless, the rewards for developing a selective and sensitive biosensor are worth 
the effort. Today they are used, have been used and will increasingly be used for 
extremely important medical processes, including developing an understanding of 
disease etiology, determination of key intercession points in these pathologies, 
preclinical and clinical testing of proposed new treatments, and earlier diagnosis of 
medical conditions. With this in mind this thesis focused on the development and 
characterisation of a ᴅ-serine biosensor based around the flavin enzyme ᴅ-amino acid 
oxidase. In the recent past ᴅ-serine has been elevated from an “unnatural” amino acid to 
be recognised as a very important neurotransmitter that could be responsible for the 
regulation of a large portion of glutamate signalling in the forebrain. It has been highly 
implicated in a number a severe and widely occurring neurodegenerative diseases, 
ranging from schizophrenia to amyotrophic lateral sclerosis. 
Initial groundwork and development of a biosensor was underway when this thesis 
began. Extensive investigation and characterisation of this sensor, conducted at the start 
of this thesis, found that the biosensor displayed satisfactory sensitivity and selectivity 
properties. However, for the purposes of this project, to develop a biosensor suitable for 
chronic in vivo monitoring of ᴅ-serine, it was deemed unfit. This was due to an 
uneconomical and difficult to reproduce production methodology. Thus, from a solid 
starting point, from which much useful information had been gleamed, an entirely new 
biosensor was designed with the underlining principal of reproducibility and economic 
viability added to the need for sensitivity and selectivity. The final design involved the 
use of the cross-linking agent glutaraldehyde in conjunction with methyl methacrylate 
to immobilise the ᴅ-amino acid oxidase on to the surface of the electrode. To achieve 
effective interference rejection the dual use of Nafion
®
 followed by an 
electropolymerised layer of poly-o-phenylenediamine was utilised. The electrode 
surface was a 125 µm Pt/Ir wire that was 0.5 mm in length. 
 iii 
The design achieved a sensitivity of 16.47 ± 0.18 µA.cm
-2
.mM
-1
. It was found that the 
response was oxygen independent up to 100 µM ᴅ-serine. The limit of detection was 
determined to be 0.425 ± 0.005 µM and the biosensor has a response time of 5.95 ± 0.75 
s. In the in vivo environment it was demonstrated that the biosensor could detect both 
increases and decreases in the endogenous concentration of ᴅ-serine, particularly in 
response to typical and traditional N-methyl-ᴅ-aspartate receptor antagonists like MK-
801.  
Our device will make it possible to monitor, in vivo in real-time and without 
interference, the concentration of, and changes that occur in ᴅ-serine in a conscious 
subject. This could have a major impact on medical processes, both normal and 
pathological, whereby the metabolism of ᴅ-serine is of interest, including the 
development and testing of potential new drugs. 
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2 
1.1 Introduction 
The primary aim of this thesis is the development of a sensor that can detect, with 
appropriate sensitivity and selectivity, the excitatory amino-acid ᴅ-serine, which is both 
a neurotransmitter and a gliotransmitter, in a physiological environment. It is hoped that 
such a device will be an invaluable tool to help bring some clarity to the major 
discussions ongoing at present in the field of neuroscience about the role of ᴅ-serine in 
some of the major degenerative diseases that are increasingly afflicting the human race. 
It is only in the last 20 years that ᴅ-serine (ᴅ-ser) has become interesting to the 
neuroscience community. This occurred as evidence mounted that it could act as a 
coagonist, with glutamate, at the “glycine”-site of an N-methyl-ᴅ-aspartate receptor 
(NMDAr) (Fadda et al., 1988; Wood et al., 1989). Since then a large body of evidence 
has grown to suggest that many important neuromodulatory processes are controlled by 
the presence of ᴅ-ser and not glycine. Indeed, had these discoveries been made 10 or 20 
years earlier the glycine-site would possibly be named the ᴅ-serine-site. 
The human brain, while only responsible for 2% of body weight, consumes 20% of 
oxygen and 25% of glucose used overall in the body. It is larger, when compared to 
body weight, than that of any other mammal. The brain is comprised of two different 
types of matter, grey and white, and two types of cells, neurons and glial cells. Neurons 
are the cells that conduct signalling and are the main working units, numbering ~10
11
 in 
a human brain. The neurons could not function without the glial cells which insulate, 
physically support, provide nutrition and oxygen, destroy pathogens, and remove dead 
neurons. In other words the glial cells maintain homeostasis for the neurons. Both of 
these cells form the grey matter of the brain. White matter consists of the dendrites and 
axons which connect the neurons to each other. A schematic diagram of neuron is 
shown in Figure 1-1: 
  Chapter 1: Introduction 
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Figure 1-1 
A neuron. 
The release of neurotransmitters at a synapse is triggered by an action potential. This 
action potential is created when an initial stimulus causes an electrical impulse, 
consisting of K
+
 or Na
+
, to form. This impulse travels down the axon of a neuron to the 
dendrites at the axon terminal where neurotransmitters are released from the pre-
synaptic neurons. The neurotransmitters diffuse across the synaptic cleft where they 
stimulate action from either surrounding astrocytes or a post-synaptic neuron. This 
stimulation can lead to the creation of an action potential in the post-synaptic neuron or 
be inhibitory and prevent any further signal transmission. 
The largest component of the brain is the cerebrum, or the telencephalon. Together with 
the diencephalon it forms the forebrain or prosencephalon. The midbrain 
(mesencephalon) and hindbrain (rhombencephalon) form the brain stem. The cerebrum 
is divided into four areas; frontal lobe, parietal lobe, temporal lobe and occipital lobe. It 
is these areas which have evolved massively over time to be responsible for the many 
higher order functions that distinguish humans from other mammals.  
  Chapter 1: Introduction 
4 
 
Figure 1-2 
The lobes of the cerebrum. 
The cerebral cortex is the general term for all of the grey matter of the cerebrum. 
Underneath the grey matter exists the white matter and basal ganglia. It is in the basal 
ganglia that the striatum is found (see Section 7.1). With glutamate being an excitatory 
neurotransmitter at over 90% of synapses in grey matter, and the NMDAr the most 
dominant device for controlling synaptic plasticity and memory, the study of a 
coagonist of glutamate, which not only has a greater affinity than glycine for the glycine 
site, but also increases the affinity of the glutamate site towards glutamate (Fuchs et al., 
2011), is vitally important to better understand the functioning of the signalling 
processes taking place at synapses. 
1.2 In Vivo Neurochemical Analysis 
As it became clear that the brain could not be treated as a uniform unit, with different 
processes occurring in different areas, different localisations of cells and specific areas 
being responsible for different tasks, methodologies for analysing neurochemicals in 
vivo evolved to allow determination and closer examination of these features. This has 
lead to the development of a wide range of techniques.  
Electroencephalography (EEG) measures, using a series of electrodes placed on the 
outside of the scalp, the voltage changes that occur in the cerebral cortex due to activity 
or ion flow. It measures the summation of the synchronous activity of millions of 
neurons at any one point, and while it has poor spatial resolution it has good temporal 
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resolution. Magnetoencephalography (MEG) works in much the same way as EEG but 
it monitors the changing magnetic flux created in the brain by the flow of ions. While it 
has similar temporal resolution as EEG, MEG has a superior spatial resolution. It has 
the disadvantage however of only being able to monitor the fields produced by dendrites 
that are orientated in a certain way due to technological limitations.  
Techniques that measure the three-dimensional changes in blood flow began with 
single-photon emission computed tomography (SPECT) and positron emission 
tomography (PET). Both techniques require the injection of a radionuclide containing 
substance into the bloodstream. X-ray computed tomography (CT) can also involve the 
use of a contrast agent but it is not necessary. All three of these techniques provide good 
spatial resolution but very poor temporal resolution. An important technological 
advance came with the advent of 3-D magnetic resonance imaging (MRI), which 
utilises the principals of NMR (nuclear magnetic resonance). Unlike CT it does not use 
ionising radiation and provides better resolution than the previously mentioned 
techniques, especially in relation to slight variation in tissue types. Contrast agents can 
be used in MRI to further enhance its identification of features. The most recent 
advancement in this technology has been the advent of functional magnetic resonance 
imaging, fMRI. This is a very important technique developed to elucidate functional 
variations in the brain. It utilises blood-oxygen-level-dependant (BOLD) contrast to 
determine the difference between arterial and venous blood, and hence map activity. It 
is by far the most widely used brain imaging technique as it does not require injection of 
radiomarkers or contrast agents or involve exposure to radiation. 
Alongside the development of these non-invasive techniques has also been the 
development of two very important surgically invasive techniques – microdialysis and 
in vivo voltammetry (IVV). With a lot of the processes that are interesting to 
neuroscientists occurring in the synaptic cleft these two methods allow sampling of 
chemicals in the extracellular fluid (ECF) of the brain (microdialysis) or real-time 
monitoring of the concentration of particular analytes (IVV). Recently, certain IVV 
techniques have even been likened to, or developed to be analogous to fMRI, an 
important advance which increases the variety of experiments (i.e. behavioural and 
freely moving) that can be conducted as bulky machinery and anaesthetics (for rodent 
work) are not required (Lowry et al., 2010).  
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Microdialysis is a technique whereby a probe with a semi-permeable membrane is 
surgically implanted into a region of interest. The membrane allows the diffusion of 
molecules, small enough to pass through the pores, from the ECF into the fluid being 
pumped through the probe (called the perfusate when it is pumped into the probe and 
dialysate when it is collected) or the diffusion of molecules from the perfusate into the 
brain, a targeted method of delivery know as retrodialysis. Substances collected in the 
dialysate can then be analysed post-collection and quantisation of a large variety of 
substances is possible by high-performance liquid chromatography and mass 
spectrometry. A full discussion of the microdialysis method can be found in Section 2.6.  
First demonstrated as feasible method of monitoring oxygen and ascorbic acid by Clark 
(Clark et al., 1953; Clark et al., 1958; Clark & Lyons, 1965) IVV, as it is currently 
understood, did not become a mainstream neuroanalytical technique until 1973 when 
pioneering work by Adams et al. established modern methodologies for its use 
(Kissinger et al., 1973). This is despite this fact that Clark demonstrated its efficacy 
during surgical procedures (Clark & Lyons, 1962), and indeed a lot of modern sensors 
are based on the platinum electrode that Clark first described. The general principal 
behind IVV is the application of a suitable potential, or potential profile, to an electrode 
and the monitoring of the current produced as species of interest are reduced or oxidised 
on the surface of the transducer. Potentials applied can vary greatly; fixed pulse 
amplitude and time intervals of chronoamperometry, continually changing the applied 
voltage which is swept between two voltages (linear sweep voltammetry), away from 
and back to the starting voltage at a slow (cyclic voltammetry) or fast scan rate (e.g. fast 
cyclic voltammetry, FCV). Voltages can be stepped between two points by fixed 
amounts at fixed intervals (staircase voltammetry), and techniques can be combined, 
like differential pulse voltammetry which is a combination of chronoamperometry and 
the sweep technique, or double pulse amperometry which is like chronoamperometry 
also but with two voltages used in each pulse. There is also constant potential 
amperometry (CPA) where the voltage is held constant at a level which causes continual 
reaction. Amperometry is a subset of IVV techniques.  
Sensors have been developed which when used with IVV are capable of detecting a 
myriad of different, interesting substances found in the ECF. These include ascorbic 
acid (AA) (O'Neill et al., 1984; Hasebe et al., 1998), oxygen (Bolger & Lowry, 2005; 
Bazzu et al., 2009; Bolger et al., 2011), nitric oxide (Bedioui et al., 1997; Chang et al., 
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2005; Brown et al., 2009), dopamine and/or serotonin and/or homovanillic acid (O'Neill 
et al., 1982; Forni & Nieoullon, 1984; Crespi et al., 1989; Rice et al., 1994; Kulagina et 
al., 2001; Al Mulla et al., 2009), noradrenaline, uric acid (O'Neill & Lowry, 1995), and 
many others (O'Neill, 1994). However, all of these substances are electroactive at 
various potentials. Thus, the difficult part in producing a selective sensor is developing 
a technique which blocks or selectively removes the other electroactive species by the 
addition of choice thin films and choice of a potential profile. What happens though 
when it is a non-electroactive substance, like an amino-acid neurotransmitter, that is the 
target molecule for detection by electrochemical methods? 
1.3 IVV Biosensors 
When the target molecule of interest for a sensor is not electroactive, it becomes 
necessary to include a substance which produces an electroactive species or a current in 
response to the presence of this non-electroactive species. This sensor is then known as 
a biosensor, as the recognition element takes the form of a biomolecule. This 
biorecognition element can have many forms – enzyme, tissue, organelle, microbes and 
antibodies – and be mounted on a multitude of transducers (O'Neill et al., 1998; Cooper 
& Cass, 2004). Clark and Lyons were again pioneers in the field of biosensors, utilising 
glucose oxidase to detect glucose in the first reported fabrication and utilisation of a 
biosensor (Clark & Lyons, 1962). Subsequently, biosensors have been designed for 
glutamate (Belay et al., 1999; Karyakin et al., 2000; Burmeister & Gerhardt, 2001; 
McMahon et al., 2006; Pauliukaite et al., 2006; Qin et al., 2008; Tian et al., 2009), 
glucose (Boutelle et al., 1986; Lowry et al., 1994; Karyakin et al., 1995; Hu & Wilson, 
1997a; Lowry et al., 1998; Garjonyte & Malinauskas, 1999), lactate (Hu & Wilson, 
1997b; de Keijzer et al., 1999; Yang et al., 1999), choline and/or acetylcholine (Kano et 
al., 1994; Garguilo & Michael, 1995b; Tsafack et al., 2000; Burmeister et al., 2008), 
aspartate (Haughton, pending publication), hydrogen peroxide (Kulagina & Michael, 
2003; O'Brien et al., 2007), pyruvate and ascorbate (Fernandes et al., 1999; Chauhan et 
al., 2011). 
Two important components of a biosensor are the biological element which responds to 
the desired substrate and how this recognition event is converted into a current in the 
transducer. The bio-recognition element can be bound by a number of processes 
including physical adsorption, cross-linking, entrapment in or under a membrane, 
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covalent bonding, or a combination of these processes (O'Neill et al., 1998). However, 
it is the method of transferring the information of the biological event occurring to the 
surface of the transducer that has led to the general classification system for 
voltammetric biosensors. First generation biosensors are of the type first developed by 
Clark in the 50’s and 60’s. They monitor substrate concentration by observing the 
consumption of O2 or the production of H2O2 (Clark & Lyons, 1962; Updike & Hicks, 
1967). This is achieved by the use of a large over-current in the case of H2O2, which 
creates interference from species such as ascorbic acid (AA), or a negative potential for 
O2. A constant drawback for first generation biosensors is that they suffer from variable 
oxygen tension in vivo (see Section 6.9), yet they remain the most common type. 
Second generation biosensors utilise a mediator as an electron transfer agent. This 
removes the need for a large current to successfully operate the biosensor, and removes 
oxygen from the reaction mechanism. A problem is created however in that a lot of 
mediators are highly toxic and have the potential of leeching from the surface (Gründig 
& Krabisch, 1989) and causing unknown quantities of damage in the in vivo 
environment (Beh et al., 1991), as well as reactivity towards organic molecules (Wilson 
& Turner, 1992). Third generation biosensors are based on the principle of direct 
electron transfer between the redox site in the enzyme and the transducer, achieved 
using organic salts such as tetrathiafulvalene (TTF) and tetracyanoquinodimethane 
(TCNQ) (Albery et al., 1985), although these have been shown to be quasi-second 
generation in function utilising charged species (e.g. TCNQ
-
) to transfer charge 
(Centonze et al., 1997). Development of “wired” third generation biosensors, utilising 
functionalised surfaces with electron transfer arrays (Heller, 1990), remains the most 
promising in overcoming the problems highlighted. First-generation biosensors are the 
area of interest to our group and work. 
Regardless of the generation of biosensor a constant issue is that of electroactive 
interference from endogenous molecules. Even in second generation biosensors, with 
their lower operating potential, this problem is not totally mitigated (Lowry & O'Neill, 
1992b) Many methods have been utilised to overcome this issue, which is particularly 
important in the physiological environment (Wilson & Gifford, 2005). Generally, the 
methodology involves the deposition of a thin-film of a polymeric substance onto the 
surface of the transducer which is thick enough to reject interference species from the 
surface, but also thin enough so as not to hinder the arrival of the H2O2 or O2 molecule, 
in the case of first generation biosensors, at the reactive surface. The use of Nafion
® 
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(which also repels species by electrostatic interaction) and poly-amines are quite 
common in this regard (Kunimura et al., 1988; Malitesta et al., 1990; Lowry & O'Neill, 
1992a; Lowry et al., 1994; Garguilo & Michael, 1995a; Friedemann et al., 1996; 
Jezkova et al., 1997; Malinauskas et al., 1998; Brown & Lowry, 2003; Craig & O'Neill, 
2003; Dai et al., 2006; Kirwan et al., 2007; McMahon et al., 2007; Brown et al., 2009; 
Rothwell et al., 2009; Rothwell et al., 2010; Bilal et al., 2011), and both are discussed 
further in this thesis (see Sections 2.8.4, 4.4 and 6.4). 
1.4 ᴅ-Serine in the Brain 
Although they were known to be present in bacteria for several decades, ᴅ-amino acids 
have only recently become interesting. The initial discovery of high levels of ᴅ-aspartate 
(ᴅ-asp) in both rat and human brains (Dunlop et al., 1986) led to further investigations 
by other groups. The discovery of unusually high quantities of ᴅ-ser (Hashimoto et al., 
1992) and ᴅ-aspartate (ᴅ-asp) (Hashimoto et al., 1993c) has led to a whole new 
direction in neuroscientific research, with growing implications for several complex 
disease states.  
This interest began due to the discovery that ᴅ-ser has an identical or higher affinity for 
the historical “glycine-site” of the NMDAr (Danysz et al., 1990; Matsui et al., 1995; 
Priestley et al., 1995). This increased affinity is possibly explained by the ability of ᴅ-
ser to displace water from the binding pocket of NR1 and form three additional 
hydrogen bonds in comparison to glycine (Furukawa & Gouaux, 2003) The glycine-site 
is situated on the NR1 subunit (Johnson & Ascher, 1987), one of four components of 
the NMDAr.  Thus, it was proposed that ᴅ-ser is an endogenous ligand of the NMDAr 
(Hashimoto et al., 1993b), which is released by glutamate to work in the synapse with 
glutamate (Cull-Candy, 1995). In order to test this hypothesis several groups began to 
look at the distribution of NMDAr’s, ᴅ-ser and glycine in the brain. It was discovered 
that ᴅ-ser was found to be most concentrated in astrocytes in the grey matter and white 
matter (Schell et al., 1995; Schell et al., 1997) with the highest levels found in the 
forebrain, in the cerebral cortex, the hippocampus and the striatum in particular 
(Chouinard et al., 1993; Hashimoto et al., 1993b; Hashimoto et al., 1995b). There is no 
reported difference between concentrations in the grey and white matter (Kumashiro et 
al., 1995). The concentration decreases as one travels from the telencephalon to the 
diencephalon, to the midbrain and finally the brain stem and cerebellum in the 
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hindbrain. More interesting still is the fact that this distribution pattern is almost the 
exact same as NMDAr’s and the opposite of glycine distribution (Schell et al., 1997). 
Furthermore because of a strong uptake and transporter system the concentration of 
glycine at the synapse is well below the saturation level and ᴅ-ser is up to 100 times 
more efficient at moderating NMDAr synaptic currents (Berger et al., 1998; Bergeron et 
al., 1998).  
With all of this physical evidence mounting more in-depth studies of the relationship 
between ᴅ-ser and the NMDAr were inevitable, and they added to a growing body of 
evidence that ᴅ-ser is very important in neurotransmission. This includes the discovery 
of ᴅ-ser immunoreactivity in neurons (Yasuda et al., 2001b; Kartvelishvily et al., 2006; 
Rosenberg et al., 2010), dendrites  and axons (Yasuda et al., 2001b) and microglia 
(Williams et al., 2006). Glutamate released from neurons is found to stimulate AMPA 
and/or kainite receptors on glial cells and neurons (Ribeiro et al., 2002; Mothet et al., 
2005; Kartvelishvily et al., 2006; Martineau et al., 2008), which in turn releases ᴅ-ser 
into the synaptic cleft. Recent reports all appear to favour ᴅ-ser as the favoured 
coagonist and not glycine (Shleper et al., 2005; Panatier et al., 2006; Stevens et al., 
2010a) at NMDAr’s, with blockade of the glycine GlyT1 transporter leading to full 
occupancy of binding sites, and blockade of GlyT2 having no effect on NMDAr 
currents or sensitivity to exogenous ᴅ-ser (Stevens et al., 2010a; Stevens et al., 2010b). 
Locally high concentrations of GlyT1 around NMDAr’s thus serves to demonstrate that 
glycine content is kept low allowing ᴅ-ser to regulate the majority of activity.  
It has also been shown that glutamate and NMDAr elicited neurotoxicity is regulated by 
ᴅ-ser and not gly (Shleper et al., 2005). Perhaps some of the strongest evidence of this 
link is provided by a study which shows that selective degradation of ᴅ-ser and not gly 
adversely affects NMDAr mediated neurotransmission (Mothet et al., 2000) A 
hypothesis has also been offered that both glutamate and ᴅ-ser are stored in astrocytic 
vesicles allowing for the release of a potent NMDAr activating cocktail (Oliet & 
Mothet, 2009). It has been shown that neuronal ᴅ-ser mediates NMDAr activation and 
controls its extracellular concentration (Rosenberg et al., 2010), and that serine 
racemase protein and mRNA is higher in neurons than in astrocytes (Takeyama et al., 
2006; Yoshikawa et al., 2007). This and other evidence points to different roles for glial 
and neuronal ᴅ-ser (Wolosker, 2007), especially in development as relative 
concentrations change over time (Hashimoto et al., 1993a; Hashimoto et al., 1993d; 
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Schell et al., 1997; Koike & Ninomiya, 2000; Wang & Zhu, 2003; Balu & Coyle, 
2012).  
A general requirement for the classification of a substance is that it must have a 
transport mechanism. Although two transporters capable of transporting ᴅ-ser have been 
identified, the alanine-serine-cysteine transporter (ASCT2) and a general amino acid 
transporter (Asc-1) (Helboe et al., 2003; Matsuo et al., 2004; Sikka et al., 2010), no ᴅ-
ser specific transporter has been identified. A final twist in the complicated, and still not 
fully understood, pathway has come with the very recent elucidation of differing 
activation methods for NMDAr’s in different locations. It now appears that synaptic 
NMDAr’s are potentiated by ᴅ-ser, while extrasynaptic NMDAr’s are activated by gly 
(Papouin et al., 2012).  
1.4.1 Serine Racemase and the Metabolism of ᴅ-serine 
All of this theorising around the function of ᴅ-ser would be purely speculative without a 
method to synthesise it, an important property for any putative neurotransmitter to 
possess. For many years it was believed that ᴅ-amino acids did not have a synthetic 
pathway in mammals. The synthesis of ᴅ-ser was first reported in 1965 in eukaryotes 
and 33 years later in silkworms, where serine racemase was found to synthesise ᴅ-ser 
from ʟ-serine (ʟ-ser) (Srinivasan et al., 1965; Uo et al., 1998).  
Further developments were to follow rapidly, particularly from Wolosker et al. who 
discovered enriched quantities of serine racemase (SR) in glial cells, and that it is 
responsible for endogenous ᴅ-ser and thus activation of the NMDAr (Wolosker et al., 
1999a; Wolosker et al., 1999b; Wolosker et al., 2002; Xia et al., 2004). Combining this 
information with evidence that ʟ-ser concentration changes affects the levels of ᴅ-ser 
(Dunlop & Neidle, 1997; Takahashi et al., 1997), and the similar to ᴅ-ser glial 
distribution of ʟ-ser and the mechanism to synthesise ʟ-ser (Yamasaki et al., 2001; 
Yasuda et al., 2001a) provided a strong case for the presentation of ᴅ-ser as a 
neurotransmitter. This information also cleared up the debate on whether gly or ʟ-ser 
was the precursor for ᴅ-ser (Iwama et al., 1997). More recently it has been established 
that SR is found predominantly in neurons and not glia (Yoshikawa et al., 2007; Miya et 
al., 2008). With an increasing number of neurotransmitter criteria being fulfilled by ᴅ-
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ser investigations into the functionality of SR and the metabolism of ᴅ-ser were 
conducted.  
Early on it was established that mammalian SR requires the cofactor pyridoxal 5ʹ-
phosphate (serine/threonine dehydratases also require this cofactor) and is highly 
selective for ʟ-ser, it does not racemise any other amino acids (Wolosker et al., 1999b; 
de Miranda et al., 2000). The fact that SR could also degrade ʟ-ser and ᴅ-ser by an α,β-
elimination reaction (de Miranda et al., 2002; Foltyn et al., 2005) into pyruvate and 
water was unexpected but provides a local mechanism for the degradation and control 
of ᴅ-ser levels, and indeed approximately three times more pyruvate is synthesised 
compared to ᴅ-ser under normal conditions. Cofactors for the improved activation of SR 
were determined to be Mg
2+
, Ca
2+
 and an Mg.ATP complex, although ADP and AMP 
work just as well (Cook et al., 2002; de Miranda et al., 2002).  
Physiologically SR is found to be regulated in many different ways. Mainly this occurs 
through two proteins, positively via a glutamate receptor interacting protein GRIP-1 
(Kim et al., 2005; Baumgart et al., 2007) and negatively by Golga3 (Dumin et al., 
2006). Another protein, the scaffold protein interacting with C-kinase-1 (PICK1) is also 
implicated in, but not directly responsible for, the activation of SR (Fujii et al., 2006; 
Hikida et al., 2008). The association of SR with Golga3 has also shown that SR is often 
bound to intracellular and dendritic membranes, which inactivates it towards ᴅ-ser 
production (Dumin et al., 2006). This mechanism is regulated by phosphatidylinostitol-
(4,5)-biphosphate (PIP2) and a feedback mechanism initiated by the activation of 
NMDAr’s which is responsible for the translocation of SR (Balan et al., 2009; Mustafa 
et al., 2009). Phosphorylation of SR in general is also required for effective production 
of ᴅ-ser (Foltyn et al., 2010), and a second feedback mechanism, also instigated by 
NMDAr activation, via neuronally derived nitric oxide (NO) also inhibits the action of 
SR. These two feedback mechanisms have lead to the theory that it is actually tight 
regulation of ᴅ-ser levels, the coagonist, which prevents glutamatergic over-potentiation 
and neurotoxicity. This complex metabolic pathway is summarised below in Figure 1-3; 
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Figure 1-3 
The proposed, simplified metabolic pathways of ᴅ-serine. 
The debate around neuronal and astrocytic ᴅ-ser and SR and which is more important 
functionally, or even which one carries out what role, continues. What is clear is that the 
highest levels of SR are found in neurons, keeping a strict control on levels of ᴅ-ser 
there. On the other hand the highest levels of ᴅ-ser are found in the extracellular space 
where only two low affinity transporters are present resulting in its relatively long half 
life of 16 hours. The release of ᴅ-ser from both neurons and glia is stimulated by AMPA 
receptor activation. Glial release has been shown to be both vesicular (Mothet et al., 
2005) and non-vesicular in origin (Ribeiro et al., 2002), whereas neuronal release and 
not glial release is stimulated by KCl and N-methyl-ᴅ-aspartate (Kartvelishvily et al., 
2006). What appears to be happening though is that there is a ‘serine-shuttle’ in 
operation whereby neurons are supplied with ʟ-ser by astrocytes (Verleysdonk & 
Hamprecht, 2000; Wolosker, 2011). Whatever the case, the two now appear to be 
inextricably linked, and whether it is astrocytic or neuronal ᴅ-ser that is responsible for 
NMDAr activation the case for ᴅ-ser as this coagonist is almost beyond doubt. 
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1.4.2 The Relevance of ᴅ-serine to Schizophrenia 
Aside from its role in basic neurotransmission processes, ᴅ-ser has been a target of 
much research in relation to schizophrenia. Traditionally there are two hypotheses that 
describe the pathology of schizophrenia, the GABA/dopaminergic hypofunction theory 
and the NMDAr/glutamatergic theory (Lisman et al., 2008). The NMDAr model has 
particular relevance for ᴅ-ser, especially when considered in the now evolving context 
of ᴅ-ser being the primary control mechanism of glutamatergic neurotransmission. 
Affecting approximately 1% of the population worldwide, schizophrenia is a severely 
debilitating disease with three classes of symptoms; positive, negative and cognitive. 
Modern medical interventions are not particularly efficacious in treating the negative 
and cognitive symptoms, illustrating that the diseases etiology is still not particularly 
well understood. Thus, further investigation and identification of new treatment points 
is very important. 
There is a lot of pathophysiological evidence for the involvement of ᴅ-ser in 
schizophrenia (Javitt, 2012; Labrie et al., 2012). Genetic risk factors for schizophrenia 
are difficult to identify and there is only a tentative link between the genealogy of ᴅ-ser 
(specifically for SR and ᴅAAO) and schizophrenia. Not disregarding this, NMDAr 
antagonists produce schizophrenic like symptoms without further deterioration by 
dopaminergic agonists (Javitt & Zukin, 1991; Krystal et al., 1994; Krystal et al., 2005). 
A reduced ᴅ-ser to total serine ratio has been found when drug naive schizophrenic 
patients were examined (Hashimoto et al., 2005b; Bendikov et al., 2007), there are 
reduced levels of ᴅ-ser in the serum of patients (Hashimoto et al., 2003; Yamada et al., 
2005) and there is a correlation between improved symptoms and increased plasma ᴅ-
ser levels (Ohnuma et al., 2008). There is also strong evidence for increased ᴅAAO 
expression in the cerebellum (Kapoor et al., 2006; Verrall et al., 2007; Burnet et al., 
2008; Madeira et al., 2008; Ono et al., 2009) with more unclear results in other parts of 
the brain. 
Perhaps the more compelling arguments are found when animal models of 
schizophrenia are considered. Animal models are created using specific drugs, genetic 
alterations or through the isolation model. Pharmacological models whereby NMDAr 
antagonists, and modulation of their effects, are used have been shown to cause in 
particular the negative and cognitive symptoms (Lipina et al., 2005; Almond et al., 
2006; Takeyama et al., 2006; Hashimoto et al., 2007a; Gozzi et al., 2008; Hashimoto et 
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al., 2008b; Labrie et al., 2008; Hashimoto et al., 2009; Abou El-Magd et al., 2010; 
Vardigan et al., 2010). Genetically altered animals, where SR or ᴅAAO has been 
removed or been made inactive also show many promising results in terms of 
characterisation of schizophrenic behaviours (Hashimoto et al., 2005a; Almond et al., 
2006; Hashimoto et al., 2008a; Labrie et al., 2009a; Labrie et al., 2009b; Konno et al., 
2010; Labrie et al., 2010). Finally, ᴅ-ser has been shown to be effective in the 
attenuation of schizophrenic symptoms both as an add-on and individual therapy  
1.4.3 ᴅ-Serine in Relation to other Disease States 
The interest in ᴅ-ser is not only limited to schizophrenia. It is implicated in many other 
important and prevalent diseases. These implications begin at the most basic level, 
memory formation, synaptic plasticity and long-term-potentiation (LTP). Here it has 
been shown that ᴅ-ser and neuronal SR are essential for LTP to occur, particularly in the 
hippocampus and medial prefrontal cortex (Turpin et al., 2011; Fossat et al., 2012), and 
how age related deficits and spatial learning and recall are mediated by these two 
substances (Maekawa et al., 2005; Turpin et al., 2011; Benneyworth et al., 2012). Both 
LTP and long-term-depression (LTD) are very important targets for pharmaceutical 
treatment (Zhang et al., 2008; Collingridge et al., 2013). ᴅ-aspartate, another highly 
prevalent ᴅ-amino acid, has also been shown to have a link to LTD and schizophrenia in 
a drug model of the disease (Errico et al., 2008). On the other side of this coin, 
abnormalities in levels of ᴅ-ser have been shown to be highly implicated in cell death, 
both in the brain and in peripheral organs. Global ischemia and perinatal asphyxia are 
both mediated by increased levels of ᴅ-ser and glutamate which leads to over-activation 
of NMDAr’s and thus excitotoxicity (Katsuki et al., 2004; Katsuki et al., 2007; Dhawan 
et al., 2011; Fuchs et al., 2012). Excitotoxicity induced by ᴅ-ser can occur anywhere 
from the hippocampus to the kidney (Shleper et al., 2005; Soto et al., 2008). 
Strong links have also been found between increased ᴅ-ser and glutamate levels and 
bipolar disorder and major depression, with ᴅ-ser also shown to block the effect of 
common anti-depressants (Hashimoto et al., 2007b; Wlaz et al., 2011). Drug addictions 
are also linked to the glutamatergic pathway, with ᴅ-ser reducing drug-seeking 
behaviour in cocaine addiction treatment (Hammond et al., 2013), the NMDAr being 
linking to µ-opioid receptor systems and morphine shown to increase SR and ᴅ-ser 
levels (Yoshikawa et al., 2008). There is tentative evidence for a link between the 
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NMDAr and neurodegenerative disorders such as Alzheimer’s, Parkinson’s and 
vascular dementia, all of which have been extensively reviewed (Danysz & Parsons, 
2012; Malinow, 2012; Olivares et al., 2012). Finally, the most common adult-onset 
neuromuscular disease, motor neuron disease or amyotrophic lateral sclerosis (ALS) has 
been extensively reviewed and examined in the context of the involvement of ᴅAAO, 
SR and ᴅ-ser (Crow et al., 2012; Paul & de Belleroche, 2012). 
1.5 ᴅ-Amino Acid Oxidase 
A flavin dependant oxidase enzyme, ᴅAAO was first discovered in 1935 by Hans Krebs 
(Krebs, 1935) and has become a model FAD-dependant oxidase for study, as indicated 
by a nine paper study of its various properties which was undertaken in the 60’s and 
70’s (Yagi et al., 1967; Yagi et al., 1975). Much of this work has occurred in relation to 
ᴅAAO derived from pig kidney, as with Yagi et al., or the yeast Rhodotorula Gracilis 
(Pilone, 2000), as until recently it has been very difficult to express human ᴅAAO and 
thus has only recently been characterised (Molla et al., 2006). It has a very broad 
substrate specificity producing the relevant imino acid and hydrogen peroxide from the 
metabolism of a number of neutral, hydrophobic, polar and basic ᴅ-amino acids. The 
reaction occurs at the centralised FAD moiety (see Figure 1-4) and is discussed further 
in Section 2.8.2.  
 
Figure 1-4 
A human ᴅAAO dimer, showing the position of the FAD units in the interior. The FAD unit is 
complexed to benzoic acid. Source : (Kawazoe et al., 2006) 
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Although the presence of enriched ᴅAAO in mammalian brains has been acknowledged 
for nearly 50 years (Neims et al., 1966), it was not until large quantities of ᴅ-amino 
acids such as ᴅ-ser, ᴅ-ala and ᴅ-proline were detected that its purpose began to become 
clear. The distribution of ᴅAAO tells a story of its own, it is inversely correlated with 
the distribution of ᴅ-ser (Horiike et al., 1987; Horiike et al., 1994), where it is highly 
concentrated in the hindbrain and midbrain and virtually absent in the forebrain. It also 
undergoes development changes in distribution with its levels in the cerebellum 
(hindbrain), medulla and pons (midbrain) only beginning to increase at postnatal day 10 
in rodents, about the time that ᴅ-ser levels significantly decrease in these regions 
(Weimar & Neims, 1977; Hashimoto et al., 1995a). This indicates that it has a role in 
the metabolism of ᴅ-ser, and that the two have a developmental regulative role. Indeed, 
ᴅAAO protein and presence is detected in the forebrain (Bendikov et al., 2007; Verrall 
et al., 2007; Sacchi et al., 2008), but it appears that its activity is down-regulated by 
some negative effector (Molla et al., 2006). This lends further strength to the case for ᴅ-
ser as an important neurotransmitter in the forebrain; its main degrading mechanism is 
disabled in this region.  
In relation to disease states there are several important links which have been drawn. 
ᴅAAO inhibitors have been strongly linked to the attenuation of psychotic and 
schizophrenic symptoms (Adage et al., 2008; Hashimoto et al., 2009; Smith et al., 
2009; Abou El-Magd et al., 2010; Smith et al., 2010) through the induced alteration of 
ᴅ-ser levels. Furthermore, mice lacking ᴅAAO activity have been shown to exhibit 
schizophrenic-like behaviours (Almond et al., 2006; Labrie et al., 2009a; Labrie et al., 
2010). The gene G72 has been tentatively linked to schizophrenia and one of its spliced 
isoforms pLG72 is responsible for the inactivation of ᴅAAO (Sacchi et al., 2008).  
ᴅAAO is used in this thesis as a means to detect the presence of ᴅ-ser. This is based/due 
in part to the success of other work carried out in using this enzyme for this purpose, 
and also because in our area of interest, the forebrain, there are many interesting ways to 
manipulate the levels of ᴅ-ser without impacting on the activity of ᴅAAO. This is in 
direct contrast to the hind and midbrain where ᴅAAO activity is the primary route for 
the metabolism of ᴅ-ser. 
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1.6 Existing Work 
To our knowledge there have been two published electrochemical ᴅ-ser biosensors 
designed before which could be suitable for in vivo use. The first published biosensor 
(Pernot et al., 2008) utilised yeast ᴅAAO, which was recombined and purified to a 
concentration of 55 U/mg before utilisation. It achieved a detection limit of 16 nM and a 
response time of 2 seconds and a sensitivity of 9.2 pA.mM
-1
. Using a poly-m-
phenylenediamine layer it achieved an interference rejection rate of 97%. The biosensor 
was constructed on a platinum fibre 25 µm in diameter and 150 µm long.  
The second biosensor, designed by Z.M. Zain and based on the same Pt/Ir 125 µm 
diameter wire that this thesis is based on is discussed in further detail in Chapter 4. It is 
the basis on which this body of work was conducted and provided a solid foundation for 
the development described later in this thesis. It reports a detection limit of 20 nM and a 
response time of 0.7 seconds with sensitivity of 61 ± 7 µA.cm
-2
.mM
-1
. 
Previous to the development of biosensors ᴅ-ser content has been detected in a number 
of ways. These include HPLC and gas chromatography in combination with 
microdialysis (Hashimoto et al., 1992; Hashimoto et al., 1995b). Capillary 
electrophoresis (CE) has also been utilised (Zhao et al., 2005) and expanded on in the 
form of microdialysis-CE-laser induced fluorescence (Ciriacks & Bowser, 2006). Both 
ᴅ-ser immunoreactivity staining (Schell et al., 1997) and monitoring via an enzymatic 
array constructed using ᴅ-ser dehydratase have also been reported (Ito et al., 2007). 
Finally, in the food industry ᴅ- and ʟ- amino acids are key indicators of nutritional value 
and ripeness and as such general ᴅ-amino acid biosensors have been developed to aid 
their use in this area (Rosini et al., 2008). 
1.7 Thesis Overview 
This thesis begins with a brief outline of some of the theoretical aspects utilised in the 
body of research and a description of the experiment conditions and process utilised 
during the work in Chapters 2 and 3 respectively. Chapter 4 will take an in depth look at 
the biosensor designed by Zain as discussed in Section 1.6 and explore its construction 
and component parts. This information will feed into Chapter 5 where the design of a 
new ᴅ-ser biosensor will begin. This design process will be concluded in the early part 
of Chapter 6, with the rest of the chapter dedicated to the further in vitro 
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characterisation of the new biosensor’s properties. A brief in vivo investigation into the 
correct functioning and validation of the operation of the biosensor will be explored in 
Chapter 7, before final conclusions are drawn in Chapter 8.  
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2.1 Introduction 
The in vitro development and characterisation of a ᴅ-ser biosensor which is suitable for 
in vivo characterisation and use is the primary goal of this thesis. Two voltammetric 
electrochemical techniques were utilised in this work and their theories will be 
described in this chapter. The first, constant potential amperometry is discussed in 
Section 2.4, and the second, cyclic voltammetry is discussed in Section 2.5.  
The effectiveness and suitability of the various electrode designs are described and 
compared by their response to the target substrate and interferent species using current 
density (J, µA.cm
-2
) and other statistical analyses described in Section 2.9. The theory 
of Michaelis-Menten kinetics, and the important parameters KM and Jmax, which are 
used to describe the activity of enzymes towards a substrate, is detailed in Section 2.7. 
Microdialysis, an analytical method which is both complementary to and an alternative 
of biosensor technology, is detailed in Section 2.6. This technique was used in the 
modified format of retrodialysis to carry out preliminary in vivo characterisation and 
verification of the final biosensor design.  
The theory of mass transport governs a major parameter in all of these techniques, the 
motion of reactants and products to and from the active surface of the electrode. This 
theory details the processes which take place in the bulk liquid medium; it is described 
in Section 2.3.  
A second process which underlies all electrochemical techniques is the electron transfer 
which takes places as a species is oxidised or reduced at the active surface. The general 
reaction for this process is detailed in Equation 2-1. 
         
Equation 2-1 
 
O and R are the oxidised and reduced species respectively and n is the number of 
electrons transferred in the reaction. Distribution of charge on the active surface of the 
electrode and its interaction with the bulk media also play a role, as it is the applied 
potential which drives this process, and are detailed briefly in Section 2.2. 
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2.2 Charge Distribution at the Active Surface 
Voltammetry involves the application of an electric potential (e.m.f.), with respect to a 
fixed potential, to an electrode in order for the desired reduction or oxidation processes 
to take place at its surface. It is well known that due to electrostatic repulsion all charge 
in a conductor resides on its outside surface. This charge on the surface of the electrode 
will induce a charge distribution in the electrolyte. The distribution of charge within the 
electrolyte is complex, depending on several factors including electrode potential and 
background electrolyte concentration among other things.  
There are three classical models to describe how the space-charge region behaves; the 
Helmholtz model, the Gouy-Chapman model and the Stern model. In all of these 
models the interface between the electrode and the electrolyte may be considered as a 
two dimensional space, regardless of the geometry of the interface. The following is a 
brief description of more detailed discussions (Brett & Brett, 1993; Bard & Faulkner, 
2001; Monk, 2001; Gileadi & Urbakh, 2003). 
The Helmholtz model envisages the interface region as planes of charge containing the 
electrons of the applied potential and the counter-ions in the electrolyte separated by an 
ion-free solvent layer. This is sometimes called the ‘compact layer’ or Helmholtz layer 
and is indicative of the closest distance of approach by surface-inactive ions. It does 
however not take into account electrolyte concentration which can have profound 
effects at lower concentrations. 
Gouy and Chapmann independently proposed a treatment based on a non-linear 
distribution of charge extending into the electrolyte, based around the Poisson-
Boltzmann equation for a system of electric charges. This ‘diffuse’ model took into 
account applied potential and electrolyte concentration, however experimental results 
and its predictions varied greatly.  
Stern proposed a combination of both of these models. This model had a compact layer 
of charge and a diffusion of charge into the electrolyte. It is most commonly used in a 
form later proposed by Grahame which describes the potential drop across the interface 
as a sum of the compact and diffuse layer. This is most successful in experimental 
prediction as it treats the compact layer as independent of the concentration of the 
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inactive electrolyte layer while the diffuse layer is dependent on the background 
electrolyte concentration. 
For the purposes of the experiments described within this thesis the background 
electrolyte concentration was kept as a sufficiently high level (> 100 mM, (Brett & 
Brett, 1993)) so as to negate the predictive inaccuracies of the Helmholtz model. Thus, 
all charge transfer processes can be treated as taking place at the outer Helmholtz plane. 
The diffuse layer is considered negligible and the potential drop occurs in a linear 
fashion across the Helmholtz layer. 
2.3 Mass Transport 
As a particular reduction or oxidation reaction occurs, at the Helmholtz plane, a 
concentration differential is created. This is due to the formation of products and usage 
of reactants which produces a spatial concentration difference with the bulk solution. 
The solution will act to address this concentration imbalance, and three different 
transport mechanisms can be effected, which are summarised in the following 
discussion (Brett & Brett, 1993; Bard & Faulkner, 2001; Monk, 2001; Calvo, 2003). 
Expanding Equation 2-1 and examining the expression for the rate of an electrode 
reaction (Equation 2-5) we can see the importance of this imbalance and the transport 
mechanisms.  
                  
Equation 2-2 
 
              
              
Equation 2-3 
 
                   
Equation 2-4 
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Equation 2-5 
 
The transport mechanisms are diffusion, convection and migration. Diffusion is the 
movement of species down a concentration gradient, convection is the bulk movement 
of the solution due to an applied mechanical force or thermodynamic effect, and 
migration is the movement of ions down a potential gradient. Migration was negated for 
this work due to the presence of a large amount of background electrolyte and can thus 
be discounted. All measurements, unless otherwise specified were taken in quiescent 
solutions and this convection effects were also negligible. This leaves diffusion as the 
primary means of transport of species within the bulk solution. 
2.3.1 Diffusion 
Diffusion is a natural movement of species from an area of high concentration to an area 
of low concentration and applies to neutral or charged species. The phenomenon of 
diffusion is described by Fick’s 1st Law (see Equation 2-6). This states that the flux of 
the species, J, is proportional to the change in the concentration, c, with respect to the 
direction x, which is also called the concentration gradient, 
  
  
. They are related by the 
proportionality constant D, the diffusion coefficient, and this can be determined 
experimentally or estimated by using a variety of relations. 
      
  
  
 
Equation 2-6 
 
 
Figure 2-1 
A volume segment dx of solution with a concentration gradient, where a flux J is flowing from the 
area of higher concentration to the area of lower concentration.  
dx 
J(x,t) J(x+dx,t) 
x+dx x 
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By considering Fick’s 1st Law (Equation 2-6) and Figure 2-1 we can derive Fick’s 2nd 
Law (see Equation 2-7) which elucidates the change in concentration with respect to 
time. 
  
  
  
   
   
 
Equation 2-7 
 
As a reaction proceeds it is usual for the concentration of the reactants to decrease in 
time. However, in the case of microelectrodes (diameters in the range 5 to 300 µm) 
where only minimal substrate is consumed and currents are small a steady state 
response is achieved and there is no change in concentration over time, i.e. 
  
  
    
(O'Neill et al., 1998). However, the microelectrodes used in this project were not of the 
size, 0.1 to 50 µm, where their diffusion properties were altered and planar diffusion 
became mixed with hemispherical diffusion.  
Thus, for the purposes of calculating the variation of current with time, the disk 
electrodes may be considered to be planar and uniformly accessible to the bulk solution. 
This results, from Fick’s 2nd Law, in the Cottrell equation (see Equation 2-8) 
        
    
 
   
    
 
 
 
Equation 2-8 
 
where I is the current measured at time t at the electrode of surface area A, n is the 
number of electrons, F is the Faraday constant, J is the flux and D is the diffusion 
coefficient. I is directly proportional to the concentration of the substrate in the bulk 
solution c∞. 
When considering cylinder electrodes it is necessary to change the coordinate system 
from the simple one dimensional system previously considered for planar electrode 
surfaces. To do this Fick’s 1st Law is altered, allowing inclusion of the Laplacian 
Operator,  (see Equation 2-9). This operator, in the appropriate form, allows one to 
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change coordinate systems freely. As a consequence Fick’s second law is also altered to 
the form shown in Equation 2-10.  
         
Equation 2-9 
 
  
  
      
Equation 2-10 
 
For an electrode of a cylindrical shape with a diameter greater than 50 µm the Laplacian 
Operator takes the form of (Brett & Brett, 1993) 
 
  
   
 
 
  
 
  
   
 
  
 
Equation 2-11 
 
In order to solve Fick’s 2nd Law, and thus find the flux variation in time and the 
diffusion limited current, it is necessary to define conditions for the system to obey. 
These conditions specify concentration and/or spatial characteristics, and are defined in 
relation to time, i.e. at t=0. 
Solving Fick’s 1st Law for a species R at the surface of an electrode it is found that the 
flux, JR(0,t), is proportional to the current density, 
 
 
. This is because the total number of 
electrons transferred per unit time must be proportional to the quantity of R reaching the 
surface in that time t, i.e. 
     ,     
 
   
     
     ,   
  
     
Equation 2-12 
 
A is the surface area of the electrode, F is the Faraday constant, n is the number of 
electrons transferred per molecule that reacts at the surface and i is the current. 
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The solutions to Equation 2-12 and Equation 2-10 can determine the current flowing 
across the electrode-solution interface as a function of time, concentration or other 
parameters for any electrode geometry. 
2.4 Amperometry 
The most frequently utilised electrochemical method in this project, constant potential 
amperometry (CPA) is the recording of the current produced by the oxidation or 
reduction of an analyte under the conditions of a fixed applied potential. Diffusion is the 
only form of mass transport considered to be occurring within the system (see Section 
2.3). After the initial application of a fixed voltage the capacitance currents associated 
with the setup of the charged layers at the active surface (see Section 2.2) decay to 
almost zero, resulting in steady-state currents. The potentials used in the project were 
chosen such that all substrate reaching the surface was oxidised, also known as 
overpotential. Thus, the amperometric current measured is directly proportional to 
analyte concentration at all times. This current is the sum of two different contributing 
factors; see Equation 2-13, the Cottrell current and the steady-state current.  
                 
Equation 2-13 
 
The Cottrell component disappears for large values of time, t, and the steady-state 
current predominates. It is these diffusion-limited steady-state currents which are 
reported in this work and for a reversible or irreversible reaction they are given by 
Equation 2-14 (Forster, 1994) 
     
     
 
 
Equation 2-14 
 
where n is the number of electrons transferred, F is the Faraday constant, A is the 
surface area, D is the diffusion coefficient, c is the concentration and r is the radius of 
the electrode. 
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However, iss is influenced by many subtleties of the system (Dayton et al., 1980) 
including, for instance, the thickness of insulation. As such a geometric correction 
factor, G, is included to take account of these influences resulting in the modified 
Equation 2-15 
     
     
 
 
Equation 2-15 
 
Despite theoretical reports of true steady-state behaviour not being reached by 
microelectrodes, a quasi-steady-state is achieved (Aoki, 1993). This is dependent on, 
and proportional to, the radius of the electrode. The results reported in this thesis 
demonstrate effective steady-state currents within a certain time frame. 
2.5 Cyclic Voltammetry 
Cyclic voltammetry (CV) involves the application of a triangular waveform potential 
profile (see Figure 2-2). Starting at an initial potential, Ei, where no oxidation occurs the 
potential is increased at a constant rate, v, to a maximum value, Emax, before being 
decreased at the same rate until the initial potential is reached. 
 
Figure 2-2 
A cyclic voltammogram potential waveform. 
As the potential is decreased back to the initial starting potential any species that was 
oxidised on the forward sweep is reduced. There is a delay between scans to prevent the 
Applied  
Potential 
Time, t 
Emax 
Ei 
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previous scan influencing the next scan and measurements are performed in quiescent 
solution meaning, as with CPA, all mass transport is diffusion controlled. 
Similar to CPA, CV produces two kinds of current at the active surface. However, in the 
case of CV the capacitance current never dissipates as the applied e.m.f. is continuously 
varied. This results in constant changes to the double layer charge. As a result it is 
necessary to subtract the background current, taken before addition of an analyte to the 
solution, from the overall current. This enables observation of the Faradaic current 
resultant from any electrochemical processes and the characteristic CV of a particular 
analyte.  
Figure 2-2 describes a reversible system, which when applied to CV results in a current-
potential profile similar to that illustrated in Figure 2-3. At Ei only R is present in the 
system and no electron transfer is taking place. As the potential is swept forward 
electron transfer is induced once appropriate potential values are reached. Initially the 
rate of transfer, or the rate of oxidation, is limited by the potential. Once a sufficient 
potential is reached then all R reaching the surface is oxidised to O. Further increases in 
potential from this point do not result in an increased rate of reaction, and hence larger 
currents, as the process is now being controlled by diffusion. This is the case until the 
point is reached where potential inversion begins. The maximum anodic current, ipa, is a 
balance between the increasing electrochemical rate constant, kox, and decreasing 
surface concentration of R. Before Epa is reached a rapidly increasing kox controls i, and 
at potentials higher than Epa diffusion controls the rate of reaction.  
 
Figure 2-3 
A typical current-potential profile for a CV of a reversible redox substrate. 
Epa 
ipa 
ipc 
Epc 
Potential 
Current 
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On the reverse sweep, the electroactive species is reduced from O back to R in a manner 
similar to the oxidation process. 
2.6 Microdialysis 
A technique first carried out by Prof. Urban Ungerstedt in the Karolinska Institut in 
Sweden (Ungerstedt & Pycock, 1974), microdialysis involves the implantation of a 
probe into the living brain or tissue. Based on dialysis theory the probe has a semi-
permeable membrane at its tip. The membrane is manufactured to allow passage of 
water and small solutes up to a specified cut-off point, usually 10 – 30 kD molecular 
weight. The passage of molecules through the membrane allows sampling of 
metabolites, neurotransmitters and other analytes of interest from the living brain. 
Perfused with artificial cerebrospinal fluid (aCSF), designed to mimic the ionic 
concentration of the brain, the perfusate equilibrates with the extracellular fluid (ECF) 
by osmotic diffusion across the membrane. The dialysate can then be collected and 
analysed using, for example, high performance liquid chromatography (HPLC). 
 
Figure 2-4 
A microdialysis probe, showing the flow of molecules out of the perfusate into the ECF and vice versa. 
The most important use of microdialysis has been its employment in preclinical 
neuropyschopharmacology, which has been extensively reviewed (Darvesh et al., 2011; 
Zhang et al., 2012), where it has been used widely in rodents. It is used to study the 
  Chapter 2: Theory 
53 
concentration of neurotransmitters and transporter molecules, and consequent changes 
following the delivery of drugs of interest to the brain environment. Of particular 
interest is the study of monoamines, like dopamine, norepinepherine and serotonin, and 
amino acids, including glutamate and acetylcholine. The study of the altered 
concentrations of these molecules following treatment with psychostimulants and 
potential/existing treatments for diseases such as AD, PD and schizophrenia has become 
an industry of its own. 
Microdialysis is utilised in the measurement of various analytes where brain trauma has 
occurred (Hillered & Persson, 1999) in order to monitor surgical procedures (Bhatia et 
al., 2006), recovery and post incident changes in certain analytes (Feuerstein et al., 
2010) which can indicate secondary ischemia and deterioration in the patient’s 
condition. However, it does have disadvantages, the primary one being damage caused 
to tissues peripheral to the probe as a result of fibrosis (Mathy et al., 2003) and damage 
to the blood brain barrier (Grabb et al., 1998; Groothuis et al., 1998). Attempts are 
being made to incorporate sensor technology in-line with microdialysis in order to 
remove the need for coupled HPLC monitoring as this means analysis is often several 
minutes behind the real-time events which sensors would be able to detect (Rogers et 
al., 2011). 
For this project microdialysis was used for the delivery of substances into the 
environment of a biosensor. The two devices were co-implanted with proximity of less 
than 1 mm (Yang et al., 1998). As explained in Section 1.2, this distance is normally 
required to ensure the electrode was not enveloped in the region of brain injury caused 
by the probe (Kadota et al., 1994). However for the purposes of the experiments carried 
out within this project there was little interest in the natural response of analyte levels 
and the brain to the procedures carried out. Rather perfusions were carried out in order 
to elicit a response indicative of a correctly functioning biosensor. Requiring only this 
ability to create a change in response did not require normal probe-electrode spacing to 
be adhered to as saturation of the area around the electrode was generally sufficient for 
the experiments performed. 
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2.7 Enzymes 
2.7.1 Introduction 
Enzymes are biological catalysts; they increase the rate of reaction without themselves 
being used up in the reaction. They achieve this by lowering the activation energy of the 
particular reaction of interest, but they do not change the position of equilibrium. Highly 
complex in nature and structure, enzymes are usually highly specific, reacting with 
generally only one substrate and having minimal affinity for other species. Due to this 
specificity they are extremely desirable substances for incorporation into biosensor 
designs. The immobilisation of a stable enzyme on a biosensor allows its corresponding 
substrates concentration to be monitored indirectly by electrochemical means. The use 
of the enzyme ᴅ-amino acid oxidase is central to this thesis and the fabrication of a ᴅ-ser 
biosensor. 
Enzymes are constructed from long chains of amino acids which are folded into 
complex structures to produce the active site where the substrate specific reaction takes 
place. The combination of their size and multiple amino acid segments enable an 
enzyme to bind very specifically, via multiple active sites, to its particular substrate. It is 
the flavin moiety which binds molecular oxygen and converts the enzyme back to its 
original form so that it may interact with another molecule of substrate. ᴅ-amino acid 
oxidase, as already discussed, is an oxidoreductase enzyme which incorporates a flavin 
moiety, FAD, acts on the CH-NH2 group and must have O2 present as an accepting 
group. The general scheme of an oxidase enzyme reaction process at the surface of a 
first generation biosensor is illustrated in Figure 2-5. Hydrogen peroxide, produced 
when the FAD is oxidised, reacts at the electrode surface to produce a current and is 
thus called the signalling molecule. 
 
Figure 2-5 
Generalised reaction mechanism of an oxidase enzyme on a first generation biosensor. The green 
arrows represent reduction and blue arrows indicate oxidation. 
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O2 
Enzyme/FAD 
Enzyme/FADH2 
Substrate 
Product 
Electrode  
  surface 
  Chapter 2: Theory 
55 
2.7.2 Enzyme Kinetics 
The highly complex nature of the active site of an enzyme is what allows it to 
selectively react with only one or a limited number of substrates. The complex structure 
leads to complex reaction mechanisms with many variables. It is, however, possible to 
treat these reactions in a generalised fashion in order to determine the overall kinetic 
parameters of a specific reaction.  
      
  
 
   
       
  
 
   
      
Equation 2-16 
 
Equation 2-16 is the general enzymatic kinetic equation, where E is the enzyme, S is the 
substrate, ES is the enzyme-substrate complex, P is the product and k represents the rate 
constant for each of the reactions.  
Initially it is found in a reaction that the concentration of the product is low and thus the 
reverse reaction of product to the enzyme-substrate complex, indicated by k-2 is 
negligible. This yields the result shown in Equation 2-17: 
      
  
 
   
        
  
       
Equation 2-17 
 
It was in 1913 that Michaelis and his student Menten formulated a method of applying 
the steady-state approximation to the formation and destruction of ES, and subsequently 
derive a rate equation for an enzymatic catalysis process (Michaelis & Menten, 1913). 
The rate of change of ES is of primary importance to this process. This rate and an 
expression for the total enzyme concentration, [E]0, are indicated in Equation 2-18 and 
Equation 2-19 respectively: 
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Equation 2-18 
 
                
Equation 2-19 
 
where [ ] indicates concentration. Combining these two equations and applying the 
steady-state approximation, where 
     
  
  , it is found: 
                                        
Equation 2-20 
 
From Equation 2-20 it is possible to isolate the concentration of the enzyme-substrate 
complex, giving Equation 2-21: 
      
       
     
      
  
 
Equation 2-21 
 
Michaelis and Menten replaced the constants, 
      
  
, with the Michaelis constant KM to 
further simplify the equation to: 
      
       
       
 
Equation 2-22 
 
But the overall rate of reaction, v, is solely dependent on the concentration of the 
enzyme-substrate complex and the rate of formation of products, k2, thus: 
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Equation 2-23 
and therefore, 
   
         
       
 
Equation 2-24 
 
If the concentration of the substrate is very high compared to the enzyme then the 
enzyme will only exist as the complex ES and the rate of reaction can reach its maximal 
initial velocity, Vmax. Thus since [S] >> KM  
            
Equation 2-25 
 
Further assuming that substrate is actually present in much higher concentration than 
the enzyme, then the initial substrate concentration, [S]0, is much greater than the initial 
enzyme concentration, [E]0, and therefore we can say         . All together, 
combining this assumption with Equation 2-24 and Equation 2-25 we arrive at the 
Michaelis-Menten equation: 
  
        
       
 
Equation 2-26 
 
where v is the rate of reaction, Vmax is the maximal rate of reaction, [S]0 is the initial 
substrate concentration and KM is the Michaelis constant. 
When experimental values of v are plotted against [S]0, as shown in Figure 2-6, we 
observe a rectangular hyperbola. From this graph both Vmax and KM can be obtained as 
shown, with KM being [S] where    
    
 
. 
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Figure 2-6 
Graph of the reaction rate, v, against substrate concentration, [S]0, for an enzyme concentration, [E]0 
for a single substrate enzyme catalysed reaction resulting from the Michaelis-Menten equation 
(Equation 2-26). 
While Michaelis-Menten kinetics (M-M) is a very useful tool, in its simplicity and 
approximations it does fail to take account of certain circumstances that do occur. One 
of these situations is where more than one molecule of substrate binds to a single 
molecule of enzyme. Where all enzyme sites are similar and independent the response 
will still be the hyperbolic curve illustrated. However, in circumstances where the 
phenomenon of cooperativity is present, the binding of a substrate to one active site on 
the enzyme increases the affinity of other sites on the enzyme to bind more molecules of 
substrate (Ricard & Cornish-Bowden, 1987). In this case an altered version of the 
Michaelis-Menten equation is used to quantify the deviation from hyperbolic, idealised 
kinetics. This constant α was introduced following the work of Hill on the aggregation 
of hæmoglobin and oxygen (Hill, 1910; Stryer, 1988). The new form of the equation is 
called Michaelis-Menten Hill-type kinetics (M-M-H) and is described as follows: 
   
    
     
   
  
 
Equation 2-27 
 
Here i indicates the current observed from the oxidation of hydrogen peroxide at the 
surface of the electrode. Values of α that are smaller than 1 indicates negative 
cooperativity. Conversely an α value >1 means there is positive cooperativity which 
means a larger change in rate of reaction with [S] and thus increased sensitivity, if only 
over a particular range of [S].  
v     
 
 
     
KM 
[S]0 
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2.8 Structures and Reactions 
2.8.1 ᴅ-Serine 
ᴅ-amino acids are oxidised by ᴅ-amino acid oxidase into the corresponding imino acid. 
The imino acid then reacts with a water molecule to produce an α-keto acid and 
ammonia. In the case of ᴅ-ser the imino acid produced is imino-pyruvic acid, and the α-
keto acid is β-hydroxypyruvic acid. The reaction is illustrated in Figure 2-7: 
 
Figure 2-7 
Mechanism for the oxidation of ᴅ-ser to A  its imino acid and B  further to its correspond α-keto acid 
with the production of ammonia. The FAD moiety attached to ᴅ-amino acid oxidase is also reduced to 
FADH2 in the first step. 
2.8.2 Flavin Adenine Dinucleotide 
A large molecule (Figure 2-8) located at the heart of the structure ᴅ-amino acid oxidase, 
it is actually the FAD unit which is reduced as a ᴅ-ser molecule is oxidised. The FAD is 
then re-oxidised by molecular oxygen with accompanying production of hydrogen 
peroxide, see Figure 2-9: 
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Figure 2-8 
Structure of the entire FAD molecule, showing the flavin mononucleotide (FMN) unit in green and the 
adenine monophosphate (AMP) group in blue (Stryer, 1988). 
 
Figure 2-9 
Structures of the reactive parts of the FAD and FADH2 moieties (Stryer, 1988). 
2.8.3 Hydrogen Peroxide 
First generation biosensors utilising enzymes produce stoichiometrically equivalent 
amounts of hydrogen peroxide as substrates react with the enzyme. The electrode 
material widely used for the detection of this hydrogen peroxide is platinum (Hall et al., 
1998a). The process is well known and characterised as a two-electron transfer that was 
first proposed by Hickling and Wilson and then backed up with further evidence by 
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Lingane and Lingane. (Hickling & Wilson, 1951; Lingane et al., 1963). It is based on a 
thin oxide film forming on the surface of the platinum, with which the H2O2 interacts, 
similar to that proposed for palladium (Gorton, 1985). The mechanism for the oxidation 
is outlined below in three equations (Hall et al., 1998b): 
                             
Equation 2-28 
 
                            
Equation 2-29 
 
                     
       
Equation 2-30 
 
The complex formation between the oxide film and hydrogen peroxide is described in 
Equation 2-28. Equation 2-29 describes the breakdown of this complex releasing water 
and oxygen and leaving behind an unoxidised metal surface. Finally in Equation 2-30 it 
is seen that the water recombines with the platinum surface to release two protons and 
two electrons. It is these electrons which produce the current that is measured and 
related directly to the concentration of substrate in solution. 
2.8.4 Electropolymerisation of o-Phenylenediamine 
o-phenylenediamine is the most widely studied polymer, of the phenylenediamine 
derivatives, for use as an interference rejection layer in biosensor design (Rothwell et 
al., 2010). It functions on a size exclusion principle whereby the pores within its 
structure are small enough for H2O2 and gaseous molecules can pass freely through the 
pores but electroactive substances are blocked because of their substantially larger size. 
Yet despite extensive research (Li et al., 2002) little is still known about the structure of 
poly-o-phenylenediamine (PPD) and the mechanism by which it occurs, particularly 
under neutral conditions as in this work. However, two proposed structures have 
emerged which appear to be dependent on the conditions the polymerisation is carried 
out under. Under conditions of low pH (<1) it is believed that the structure is a 
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phenazine-like ‘ladder’ structure, see Figure 2-10. This is the most commonly reported 
structure, supported by work on infrared, Raman and UV-Vis spectroscopy, quartz 
microcrystal balance studies, radiometry and electrochemical techniques (Bilal et al., 
2011). 
        
 
Figure 2-10 
Proposed phenazine “ladder” like structures of PPD where A is the oxidised form (Sayyah et al., 2009) 
and B has not been oxidised at all (Bilal et al., 2011). 
With increasing pH the extent of conjugation decreases as more free amino groups are 
detected on the surface (Losito et al., 2003). The presence of these ‘defects’ in the 
phenazine-like structure possibly as main repeating units could give an indication of the 
material produced under slightly acidic or neutral condition, although there is no or very 
limited information available (Losito et al., 2001). The more ‘open’ or polyaniline-like 
1,4-substituted benzenoid-quinoid structure (Yano, 1995) can be seen in Figure 2-11. 
 
Figure 2-11 
Proposed 1,4-substituted benzenoid-quinoid structure of PPD, ‘open’ structure (Losito et al., 2001). 
A mechanism for the polymerisation of o-PD to PPD with the ‘open’ structure has been 
proposed (Sayyah et al., 2009) and it is illustrated below in Figure 2-12: 
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Figure 2-12 
The proposed mechanism of formation of the PANI or ‘open’ structure of PPD  
PPD grown in acidic electrolytes produces a conducting polymer (‘ladder’ structure), 
where the layer thickness can be controlled (Chiba et al., 1987). An ‘open’ polymer that 
self-insulates as it polymerises producing a film of ca.10 nm (Malitesta et al., 1990) is 
hypothesised to be produced under neutral pH conditions. In this project only self-
insulating polymers were grown. 
2.8.5 Ascorbic Acid 
The oxidation of ascorbic acid (AA) at the surface of a platinum electrode involves a 
2H
+
 2e
-
 mechanism with the accompanying production of ʟ-dehydroascorbic acid. This 
then rapidly hydrolyses in an irreversible reaction to the electro-inactive open chain ʟ-
2,3-diketogulonic acid. As the major electroactive species present in ECF (Grunewald et 
al., 1983) it is readily oxidised with an E½ in the range -100 to +400 mV vs. SCE 
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(O'Neill et al., 1998). As such it is used as a model interferent species in biosensor 
design. The reaction mechanism is described in Figure 2-12. 
 Figure 2-13 
Reaction mechanism for the oxidation of AA to the electro-inactive product L-2,3-diketogulonic acid 
2.9 Data Analysis 
Experimental calibrations in this project were carried out using CPA. Analysis of the 
data collected began with the smoothing of data using an in-built function in LabChart 
6. This function used a Bartlett Triangular Window method to filter the data and reduce 
noise which was inherent in the system. The triangular window is resultant from the 
convolution of two rectangular sinc
 
windows, and is an apodisation function.  Thus, the 
Bartlett window is a sinc
2
 function which reduces an interferogram smoothly to zero at 
the edges of the sampled region. The width of the window that the function was applied 
to was 2n+1, where n was the number of readings taken per second during the 
calibration. 
Post smoothing a time averaged response was extracted using LabChart 6. This sample 
was taken from a steady-state response period over a time period of ca. 20 seconds. The 
extracted data samples were then brought into GraphPad Prism 5 for further analysis. 
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2.9.1 Linear and Non-Linear Regression 
Regression fitting involves finding a line or a curve which minimises the sum of the 
squares of the perpendicular distances of the points to the fitted line or curve. Linear 
regression fits were applied to calibrations for response to AA and H2O2. Non-linear 
regression fits taking the form of the Michaelis-Menten equation and the modified Hill-
Type equation (see Section 2.7.2) were applied to enzymatic calibrations for response to 
ᴅ-ser. Upon fitting of a regression to a particular set of data various other forms of 
statistical analyses were used to gleam further information from the data and to enable 
comparisons to be drawn. 
2.9.2 Statistical Analysis 
2.9.2.1 t-Tests 
Parametric t-tests allow the comparison of two pieces of information with a quantitative 
examination of the statistical difference between the results. Two types of t-test were 
used during this work. Where possible it was favourable to use paired t-tests, which 
examined electrodes that differed only by post production intervention, for example 
time or protein treatment. Otherwise unpaired t-tests were used for electrodes which 
differed by production treatment, for example the application of different substances or 
layers. When conducting unpaired t-tests Welch correction was used where deemed 
necessary. GraphPad InStat was used for all t-tests. 
2.9.2.2 P-values 
The assigned P-value is a probability, thus its value is 0 ≤ P ≤ 1. It describes the 
statistical difference between two values and allows one to decide whether or not it is 
significantly different. The smaller the P-value the more likely it is to be significantly 
different, small values indicate that the sampled values have a difference that is unlikely 
due to chance. A confidence interval of 95 % was used throughout this project meaning 
a p-value of < 0.0500 was required to indicate a significant difference between the two 
data sets involved. It was denoted graphically by *. However, confidence values of 99 
%, p < 0.0100** and 99.9 %, p < 0.0010***, were also used in various instances to 
indicate differences of even greater significance. 
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2.9.2.3 R2 values 
Known as the coefficient of correlation, the R
2
 value is a measure of the goodness of fit 
of a data set to a regression (linear and non-linear). Like the P-value it is a unit-less 
value with the range 0 ≤ R2 ≤ 1. A value of 1 indicates a perfect fit, where all points lie 
directly on the line or curve which is proposed as the fit. A value of 0 indicates that 
there is no relationship between the X and Y values in the data set and that it is not 
possible to ascribe the chosen trend, linear or non-linear, to them. 
2.9.2.4 One-Way ANOVA 
One-way Analysis of Variance (ANOVA) with standard Tukey-Kramer Multiple 
Comparison tests was used to compare results of treatment. In this case the electrodes 
have not been modified since fabrication save a ‘treatment’ of time, being stored in a 
particular substance, or multiple calibrations. The multiple calibrations could be 
conducted as per normal (see Section 3.6) or with, for instance, an altered temperature 
or pH. This is a better form of analysis as it takes into account that the same electrodes 
are being examined and each result is dependent on previous results and the ‘treatments’ 
applied. Results analysed by this method will only be displayed as p > 0.0500, p < 
0.0500*, p < 0.0100** and p < 0.0010***. 
2.9.3 Current Density 
In this project electrodes of varying sizes and geometries are used and it is important to 
be able to compare them on an equal footing. In order to do that in this thesis all current 
values were converted to current densities, J. This is a process of normalising the 
currents to the surface area of the electrode from which these currents were attained, see 
Equation 2-31: 
   
 
 
 
Equation 2-31 
 
where J is the current density, I is the current flowing and A is the active surface area of 
the electrode. Thus current per unit area, J (µA.cm
-2
), were compared across electrode 
types and allow comparison to other work. 
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2.9.4 Linear Region Slope 
Sensitivity to a particular analyte is an important characteristic to define for a biosensor. 
Calculation of the linear region slope was the method used to determine sensitivity 
within this project. The linear region of the response to an analyte is generally 
considered to extend as far as 
  
 
. For a substrate like ᴅ-ser, whose concentration in vivo 
is low, the extent of the linear region is not of particular importance, rather high 
sensitivity within the linear region is critical. The linear region slope (LRS) is 
approximately equal to 
    
  
, see Equation 2-32 (O'Neill et al., 2008) which is derived 
from Equation 2-26: 
   
     
     
    
     
   
  
       
       
  
    
  
    
Equation 2-32 
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3.1 Chemicals 
3.1.1 Enzymes 
ᴅ-Amino Acid Oxidase (porcine kidney) (ᴅAAO) BBI Enzymes Ltd. 
ᴅ-Amino Acid Oxidase (porcine kidney) Fluka Chemie GmbH. 
ᴅ-Amino Acid Oxidase (porcine kidney) Sigma Chemical Co. 
3.1.2 Interferent Species 
Ascorbic Acid (AA) Sigma-Aldrich Chemical Co. 
3-Hydroxytyramine (Dopamine), (DA) Sigma Chemical Co. 
Uric Acid (UA)  Sigma Chemical Co. 
ʟ-Tryptophan (ʟ-trp) Aldrich Chemical Co. 
5-Hydroxyindole 3-Acetic Acid (5-HIAA) Sigma Chemical Co. 
Dehydroascorbic Acid (DHAA) Aldrich Chemical Co. 
3,4-Dihydroxyphenyl-acetic Acid (DOPAC) Aldrich Chemical Co. 
ʟ-Glutathione, oxidised form 90% (ʟ-gluta) Aldrich Chemical Co. 
Homovanillic Acid (HVA) BioChemika Ltd. 
ʟ-Tyroseine (ʟ-tyr) Aldrich Chemical Co. 
ʟ-Cysteine (ʟ-cys) Aldrich Chemical Co. 
5-Hydroxytryptamine (Serotonin), (5-HT) Sigma Chemical Co. 
3.1.3 Amino-Acids 
ᴅ-Serine (ᴅ-ser) Sigma Chemical Co. 
ᴅ-Aspartic Acid (ᴅ-asp) Aldrich Chemical Co. 
ᴅ-Alanine (ᴅ-ala) Aldrich Chemical Co. 
ᴅ-Proline (ᴅ-pro) Fluka Chemie GmbH 
ᴅ-Phenylalanine (ᴅ-phe) Aldrich Chemical Co. 
ᴅ-Tyrosine (ᴅ-tyr) Aldrich Chemical Co. 
ᴅ-Glutamic Acid (ᴅ-glu) Lancaster Synthesis Ltd. 
ᴅ-Arginine (ᴅ-arg) Fluka Chemie GmbH 
ᴅ-Histidine (ᴅ-his) Fluka Chemie GmbH 
ᴅ-Lysine (ᴅ-lys) Aldrich Chemical Co. 
Glycine (gly) Alpha Aesar Ltd. 
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ʟ-Serine (ʟ-ser) Aldrich Chemical Co. 
ʟ-Aspartic Acid (ʟ-asp) Sigma Chemical Co. 
ʟ-Alanine (ʟ-ala) Aldrich Chemical Co. 
ʟ-Proline (ʟ-pro) Lancaster Synthesis Ltd. 
ʟ-Phenylalanine (ʟ-phe) Aldrich Chemical Co. 
ʟ-Glutamic Acid (ʟ-glu) Sigma Chemical Co. 
ʟ-Arginine (ʟ-arg) Sigma Chemical Co. 
ʟ-Histidine (ʟ-his) Fluka BioChemika 
3.1.4 Electrode Fabrication Chemicals 
Bovine Serum Albumin (Fraction V) (BSA) Sigma Chemical Co. 
Flavin Adenine Dinucleotide (FAD) Sigma Chemical Co. 
Glutaraldehyde, Grade I, 25% solution (GA) Sigma-Aldrich Chemical Co. 
Nafion
®
, 5% in Aliphatic Alcohol (Naf) Aldrich Chemical Co. 
Polyethylenimine, 80% ethoxylated (PEI) Aldrich Chemical Co. 
Styrene (Sty) Aldrich Chemical Co. 
Methyl Methacrylate (MMA) Aldrich Chemical Co. 
o-Phenylenediamine (o-PD) Sigma Chemical Co. 
Glycerol Aldrich Chemical Co. 
3.1.5 In Vitro Chemicals 
Oxygen Gas (Medical Grade) BOC Gases 
Nitrogen Gas BOC Gases 
Acetone Sigma Chemical Co. 
Ethanol Sigma Chemical Co. 
Hydrogen Peroxide 30% w/w ACS reagent Sigma Chemical Co. 
3-sn-phosphatidylethanolamine (PEA) Sigma Chemical Co. 
Sodium Hydroxide Sigma-Aldrich Chemical Co. 
Sodium Chloride Sigma-Aldrich Chemical Co. 
Sodium Phosphate Monohydrate Sigma-Aldrich Chemical Co. 
3.1.6 In Vivo chemicals 
Ethylenediaminetetraacetic acid (EDTA) BDH Chemicals Ltd. 
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Veratridine Sigma Chemical Co. 
Magnesium Chloride Sigma Chemical Co. 
Calcium Chloride Sigma Chemical Co. 
Potassium Chloride Sigma Chemical Co. 
Adenosine 5’-triphosphate Magnesium salt (ATP.Mg) Sigma Chemical Co. 
Nω-Nitro-ʟ-arginine methyl ester hydrochloride(L-NAME) Sigma Chemical Co. 
(+)-MK-801 Sigma Chemical Co. 
ʟ-Arginine (ʟ-arg) Sigma Chemical Co. 
3.2 Solutions 
All solutions were prepared with doubly distilled water which was deionised using a 
Milli-RO water purification system, or water from a Milli-Q Q-Pod, Millipore Integral 3 
(A10) system unless otherwise stated. Both systems were supplied by Millipore Ireland 
BV, Tullagreen, Carrigtwohill, Co. Cork. Solutions that could be kept for more than 12 
hours were stored at 4 ºC or -18 ºC in a Hotpoint FF220E fridge-freezer. 
3.2.1 Enzyme Solutions 
ᴅ-Amino Acid Oxidase (porcine kidney) (ᴅAAO) (BBI Enzymes Ltd.) 
A 600 U.mL
-1
 solution was made by dissolving 0.00201 g of the 7.46 U.mg
-1
 solid in 
250 µL of water, PBS pH 8.5, PBS pH 7.6 or PBS pH 8.0. Alternately PBS pH 8.5 with 
25 mg.mL
-1
 BSA and 1% glycerol (w/v) was used to dissolve the enzyme. 
ᴅ-Amino Acid Oxidase (porcine kidney) (Fluka Chemie GmbH.) 
A 200 U.mL
-1
 solution was made by dissolving 0.00263 g of the 1.9 U.mg
-1
 solid in 250 
µL of water. 
ᴅ-Amino Acid Oxidase (porcine kidney) (Sigma Chemical Co.) 
100 U.mL
-1
, 250 U.mL
-1
 and 600 U.mL
-1
 solutions of the 2.3 U.mg
-1
 solid were obtain 
by dissolving 0.00109 g, 0.00272 g or 0.00652 g in 250 µL of water respectively. 
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3.2.2 Electrode Fabrication Solutions 
o-Phenylenediamine (o-PD) 
A 300 mM super saturated solution of o-PD was prepared under strict conditions of N2 
saturation by dissolving 0.324 g of monomer in 10 mL of PBS. The solution was 
sonicated for 2 minutes to aid dissolution. Care was taken to ensure at all times that air 
was excluded from the process as oxygen in solution can oxidise the monomer to 
varying degrees reducing the uniformity of the polymer obtained. 
Bovine Serum Albumin 1% (BSA) 
A 1% w/v solution was prepared by dissolving 0.01 g in 1 mL H2O. 
Glutaraldehyde solutions (GA) 
A 1 % v/v solution was prepared by dissolving 40 µL 25% GA in 1 mL H2O. 
Alternately 0.1, 0.2, 0.5, 1.5, 2.0, 2.5, 5 and 10 % solutions were prepared by dissolving 
4, 8, 20, 60, 80, 100, 200 or 400 µL respectively in 1 mL H2O. 
1% BSA in 1% GA (BSAGA) 
This solution was prepared by dissolving 0.01 g of BSA in 0.5 mL water. To this 40 µL 
of 25% GA was added to the resulting solution and was made up to 1 ml with water to 
yield a 1% w/v BSA and 1% v/v GA solution. The solution was prepared in this way to 
limit the amount of cross-linking of the BSA and GA. This solution was altered by 
using 4, 8, 20, 60 or 80 µL of 25 % GA to produce a solution with 1 % BSA and 0.1 %, 
0.2 %, 0.5 %, 1.5 % and 2 % GA respectively. 
Flavin Adenine Dinucleotide (FAD) 
Two concentrations of FAD solution were used. A 0.08 mM solution of FAD was 
produced by dissolving 0.00314 g in 50 mL H2O. A 0.02 mM solution was produced 
from this by diluting 12.5 mL of the 0.08 mM solution in 50 mL of H2O. 
Nafion
® 
solutions (Naf) 
This was used as a 5 % solution obtained from the manufacturer or diluted to 1% by 
making 200 µL of the 5 % solution up to 1 mL using a 50 : 25 : 25 mixture of water : 
methanol : ethanol. 
  Chapter 3: Experimental 
77 
Polyethylenimine (PEI) 
Three solutions of 0.1 %, 1 % and 5 % were prepared from an 80 % ethoxylated PEI (35 
– 40 % solution in water) solution by dissolving 0.00313g, 0.03125 g or 0.15625 g 
respectively in 1 mL of water. 
Styrene (Sty) 
Styrene was used as pure 99% monomer, as received from the manufacturer. 
Methyl Methacrylate (MMA) 
MMA was used in its pure 99% monomer form from the manufacturer. 
3.2.3 In Vivo Solutions 
Artificial Cerebro-Spinal Fluid (aCSF) 
aCSF was prepared with 8.766 g sodium chloride (0.15 M), 0.178 g calcium chloride 
(0.0016 M), 0.204 g magnesium chloride (0.0021 M) and 0.298 g potassium chloride 
(0.004 M) dissolved in 1L of water. 
Normal Saline Solution 
0.9% normal saline solution was prepared by dissolving 0.9 g NaCl in 100 mL of water. 
Veratridine 
A 100 µM solution of Veratridine was prepared by dissolving 0.00034 g in 5 mL of 
aCSF. 
Nitric Oxide Solution (NO) 
NO was synthesised by a well characterised and highly reproducible method previously 
described (Brown et al., 2005). 
Ethylenediaminetetraacetic Acid (EDTA) 
A 1000µM solution of EDTA was prepared by dissolving 0.00146 g in 5 mL of aCSF. 
Adenosine Triphosphate (ATP) 
The ATP.Mg salt was certified as containing 8% w/w Mg
2+
 on average. Thus 0.00278 g 
was dissolved in 5 mL water. 
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ʟ-Serine and ᴅ-Serine 
100 mM solutions were prepared by dissolving 0.2627g in 25 mL aCSF. From this two 
1000 µM solutions were formulated by diluting 50 µL of the 100 mM solutions in 5 mL 
of aCSF. Further serial dilutions of ᴅ-ser were prepared by diluting 500, 200, 100, 50, 
25, 10 and 5 µL of the 1000 µM solution in 5 mL aCSF to produce 100, 40, 20, 10, 5, 2 
and 1 µM solutions respectively.  
ᴅ-Serine and EDTA 
A combined 1000 µM ᴅ-ser and 1000 µM EDTA solution was prepared by dissolving 
0.00372 g EDTA in 100 µL of 100 mM ᴅ-ser solution, and making the combined 
solution up to 10 mL with aCSF. 
ʟ-Serine and ATP 
A combined 1000 µM ʟ-ser and 1000 µM ATP solution was prepared by dissolving 
0.00556 g ATP in 100 µL of 100 mM ʟ-ser solution, and making the combined solution 
up to 10 mL with aCSF. 
Nω-Nitro-ʟ-arginine methyl ester hydrochloride (ʟ-NAME) 
A 100 µM solution was prepared by dissolving 0.0013 g in 5 mL of aCSF. 
Ascorbic Acid (AA) 
A 1000 µM solution was prepared by freshly dissolving 0.00088 g in 5 mL of N2 
saturated aCSF and used immediately. 
MK-801 
A 0.3 mg/kg solution of MK-801 was prepared in 1 mL of normal saline solution based 
on the weight of the animal. 
3.3 Computer – Based Instrumentation and Software 
The use of computers was essential to the process of carrying out any experiment, be 
that a polymerisation or calibration. They allow the accurate collection, storage and 
analysis of vast quantities of information, and are now an integral part of bioanalytical 
science. 
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3.3.1 Potentiostat, Data Acquisition Hardware and CPU 
All experiments were carried out using a low-noise potentiostat from ACM Instruments. 
This was connected to a PowerLab 400 data acquisition device from ADInstruments 
Ltd. (Oxford, UK) via a U2SCX cable, which allows SCSI to USB connectivity, 
supplied by Ratoc Systems International, California. The PowerLab was connected to a 
Dell Inspiron 6000 (Intel
®
 Pentium Centrino
®
 M 1.60 GHz processor) which stored the 
data and displayed it in real-time. The experimental equipment setup is displayed in 
Figure 3-1 and was protected by a Masterplug PowerCut surge protection device. 
 
Figure 3-1 
A picture of the experimental equipment setup. A Dell Inspiron 6000 sits on top of a PowerLab 400. 
Beneath both of these is the ACM Potentiostat. To the left can be seen an electrochemical cell. 
All data generated was copied onto and analysed on an Acer Aspire 5610 (Intel
®
 Core 
Duo
®
 T2300 processor). 
3.3.2 Computer Software 
All potentiostatic experimental procedures (e.g. CPA) were carried out using Chart4 
(Chart for Windows Version 4.2.3) from ADInstruments Ltd, Oxford, UK. They were 
then analysed using LabChart6, Version 6.1.1 also supplied by ADInstruments Ltd. 
Potentiodynamic protocols (e.g. CV) were carried out and analysed using EChem 
(EChem for Windows Version 1.5.2) also from ADInstruments Ltd. UK. 
Graphical analysis and display of data, including the fitting of linear and non-linear 
regressions, was undertaken using GraphPad Prism Version 5.01 from GraphPad 
Dell Inspiron 
PowerLab 400 
Potentiostat 
Electrochemical 
Cell 
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Software Inc., California, U.S.A. This software package was also used to graph raw data 
obtained from in vivo experiments. Statistical analyses including paired and unpaired t-
tests were performed using GraphPad InStat, Version 3.05, also from GraphPad 
Software Inc.  
3.4 Ancillary Equipment 
3.4.1 Cylinder Electrode Spinner 
In order to assist with the fabrication of cylinder electrodes devices were designed to 
rotate the electrodes in a horizontal plane. Initially an electric hotplate with a magnetic 
stirring mechanism was modified to allow fixing of electrodes to the rotating magnet. 
However after initial experiments a more suitable design was required as the rotation 
speed of the hotplate device was difficult to control and erratic. Thus a design was 
constructed using Lego
®
 TECHNIC which was powered by a 12 V DC geared 
instrument motor, supplied by Mclennon Servo Supplies Ltd. UK, and a R95 12V 
500mA DC power supply adapter, model number MC120S050,  supplied by Mean Well 
Europe BV. There were two versions of this device, as shown in Figure 3-2; 
 
Figure 3-2 
Pictures of the electrode spinning devices created primarily from Lego® TECHNIC. A was the first 
version and B was the second version. 
where design A was the initial construction capable of handling 8 electrodes, 4 on either 
side, and design B had the capacity to spin the 8 electrodes all on the same side. 
 B A 
A 
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3.4.2 Other Equipment 
Two types of microscope were used to carry out microscopic observations. An SM22 
microscope was used in conjunction with a stereo heatless FLQ 150 light source, both 
manufactured by Hund
®
 Wetzler, Germany. An Olympus SZ51 utilising a stereo Schott 
EasyLED RL+ light source, both supplied by Mason Technology, Dublin 8, was the 
second microscopy tool used.  
The pH meters used were; a SevenEasy
TM
 pH Meter S20, supplied by Mettler Toledo 
AG, Analytical, Sonnenbergstrasse 74, CH-8603 Schwerzenbach and a PerpHecT LogR 
350 meter, from Orion Research Inc., Boston, MA, U.S.A. They were calibrated using 
Buffer Solution pH 4.00 with fungicide and Buffer Solution pH 7.00 with fungicide, 
both supplied by Riedel-de-Haën, Sigma-Aldrich Laborchemikalien GmbH. 
Homogenisation of solutions were carried out using a Fisherbrand
®
 FB11002 Sonicator, 
manufactured by Elma
®
, Germany, an ULTRAsonik
TM
 57X Cleaner from Ney Dental 
Inc., supplied by AGB Ireland, and a REAX Top vortex, supplied by Heidolph, 
Germany. 
A Sartorious LA230S electronic balance, accurate to ± 0.1 mg, was used to weigh out 
most compounds. A Sartorius CP225D electronic balance, accurate to ± 0.01 mg, was 
used to weigh compounds where a greater degree of accuracy was required, for example 
ᴅAAO. A Sartorius BP310P, accurate to ±1mg, was used to weigh out o-PD. All 
balances were supplied by Sartorius AG, Göttingen, Germany.  
Three models of stirring magnetic stirring plate were utilised, a Yellowline MST mini, a 
Yellowline MSH basic S2 and a Yellowline MST basic C. The MST basic C model was 
also used in conjunction with a TC1 temperature probe and controller. All were 
supplied by IKA-Werke GmbH, Staufen, Germany. 
Air pumps used during this project were the Stellar 110 Series II, from Aqua One
®
, UK, 
and the Air 100, from Rena
®
, France. 
To accurately measure aliquots of solutions a series (1, 10, 20, 100, 1000 µL) of 
Hamilton MICROLITER
TM
 Syringes were used. They were sourced from Hamilton 
Bonaduz AG, Switzerland. 
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3.5 Electrode Preparation 
Working electrodes used in this work were all platinum based. This was due to the high 
sensitivity of platinum to H2O2 (O'Neill et al., 2004). They were manufactured using 
Teflon
®
 coated Platinum/Iridium (90%/10%) wire (125 µm bare diameter, 160 µm 
coated diameter (5T), Advent Research Materials, Suffolk, UK), herein referred to as 
Pt/Ir. Approximately a 6 cm length of Pt/Ir was cut and 4 mm of Teflon
®
 was gently 
removed from one end. This end was then soldered (Sn-Pb-Ag low melting point solder, 
Multicore, Henkel AG, Germany; Weller
®
 WTCP51 soldering station and iron, Apex 
Tool Group GmbH & Co., Germany; Xytronic 426 DLX fume extractor, Xytronic 
Industries, Taiwan) into a gold clip (Fine Science Tools GmbH, Germany) which 
provided rigidity and good electrical contact for subsequent connection to a potentiostat 
via a flexible, screened, six-core cable (Plastics One Inc., U.S.A.). These were the basic 
production steps for an electrode before the disc or cylinder surfaces were produced. 
3.5.1 In vitro Electrodes 
Two types of in vitro electrodes were fabricated during this project. These were disc and 
cylinder working electrodes. The auxiliary electrode was a solid strand of pure Pt wire 1 
mm in diameter and the reference electrode was a saturated calomel electrode. 
3.5.1.1 Disc Working Electrodes 
Disc electrodes were used during this project for the completion of the first two sections 
of work. A disc electrode was formed by cutting the end of the electrode transversely 
through the Teflon
®
 and the metal wire inside to produce a flat surface perpendicular to 
the axis of the length of the wire. It is illustrated in Figure 3-3 
 
Figure 3-3 
A diagram of a disc electrode 
3.5.1.2 Cylinder Working Electrodes 
Cylinder electrodes were used in the latter half of this project for reasons outlined in 
Section 6.1. All cylinder electrodes used were 0.5 mm in length. They were fabricated 
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by taking the basic electrode described above (Section 3.5) and very carefully removing 
1 mm of Teflon
®
 from the end of the wire. The electrode was then placed under a 
microscope and the freshly exposed cylindrical surface was trimmed back to 0.5 mm 
guided by marks created immediately prior using a digital Vernier callipers. 
Figure 3-4 
A schematic of a 0.5 mm cylinder electrode. 
3.5.2 In vivo Electrodes 
3.5.2.1 Working Electrodes 
Electrodes for use in vivo were prepared in the same manner as the in vitro electrodes, 
with two minor changes. Firstly, the in vitro gold clip was replaced with a smaller in 
vivo gold clip, which was better suited to fitting the pedestal required for making the 
connection between the animal and the potentiostat (see Section 3.7.4). The connection 
between the wire and the clip was also covered in a thin layer of 2-part-epoxy (Sigma 
Aldrich Co.) to ensure a secure connection and prevent the Teflon
®
 coating from 
moving whilst being handled during surgery. 
3.5.2.2 Auxiliary Electrode 
The auxiliary electrode was prepared from Teflon
®
 coated Silver wire (200 µm bare 
diameter, 250 µm coated diameter (5T), Advent Research Materials, Suffolk, UK). 
From one end of the 4.5 cm electrode 5 mm of Teflon
®
 was removed. This was then 
soldered into an in vivo gold clip and the joint sealed with 2-part-epoxy. 1 cm of 
Teflon
®
 was removed from the opposing end and this exposed surface was then tightly 
wrapped around a stainless steel surgical screw (Plastics One, VA, USA). The contact 
of the silver wire and screw was then ensured by application of a small quantity of 
solder, see Figure 3-5. This also ensured that the electrode would not move during 
surgery. 
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Figure 3-5 
Diagram of in vivo electrodes, both are made from silver wire, soldered into a gold clip and sealed 
with epoxy resin. A represents a reference electrode and B is an auxiliary electrode. 
3.5.2.3 Reference Electrode 
The reference electrode for surgical procedures was prepared in the same manner as the 
auxiliary electrode. However, the 1 cm of exposed silver was not attached to a screw - 
instead it was bent, first at 90 º to the electrode axis, then in a semi-circle and finally 
back along the electrode axis, as shown in Figure 3-5. This bent shape allowed the 
electrode to make contact with tissue but prevented it from moving around or changing 
its depth into the tissue. 
3.5.3 Electropolymerisation of o-PD 
o-PD was polymerised by two methods. The principal one was by CPA where the 
electrodes were held at +700 mV vs. SCE in a 300 mM solution of monomer for 30 
minutes. The second method of preparation was by using CV. Here the electrodes were 
cycled between 0 V and +1 V vs. SCE at a scan rate of 100 mVs
-1
 for 15 cycles, again in 
a 300 mM solution of monomeric o-PD. After polymerisation was completed the 
electrodes were washed with water and allowed to dry at 4 ºC before further use. 
3.5.4 Dipping Procedures 
The dipping procedure involved the immersion of a prepared electrode into the desired 
solution for ~ 1 second. This constituted a dip. There was often more than one dip in a 
layer. Dips in a single layer were separated by the minimal amount of time possible. 
Each layer was allowed to air dry for 5 minutes before addition of the next layer. 
Usually there were ten layers in a single application but there could be as many as 
twenty and as few as five. Applications were allowed to dry for 1 hour at 4 ºC. An 
application could then be repeated in order to achieve a complete protocol. 
A 
B 
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3.5.5 Structured Naming of Designs 
The multitude of designs tested in this thesis required a logical reusable naming 
procedure which could instantly elucidate the differences in a particular protocol. An 
example of this is as follows: 
PtD – Naf – PPD – {MMA – [600UPBS x2 – GA2%] x5 – FAD(5) } x2 
Here { } indicate a complete application and the x2 proceeding it indicates the 
application was applied twice to complete the protocol.  
The [ ] indicates layers that were repeated within the application, in this case a dip of 
600 U ᴅAAO in PBS pH 8.5 (this was the standard pH utilised as described later in 
Section 4.7.1, solutions with other pH values will be indicated within the text with 
appropriate naming labels) was applied on layer one and on layer two the dip into 
ᴅAAO was followed by a dip of GA 2%. This process was repeated 5 times as shown 
by the x5.  
The ( ) indicates a dip that was applied once on a particular layer within the application. 
The particular layer is indicated by the number enclosed within the brackets. Here it was 
a dip of FAD on the fifth layer only.  
A detailed layout of the dipping procedure is described below in Table 3-1; 
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Application Layer Dip Substance 
1 
1 
1 MMA 
2 600U pH 8.5 
2 
1 600U 8.5 
2 GA 2% 
3 1 600U 8.5 
4 
1 600U 8.5 
2 GA 2% 
5 
1 600U 8.5 
2 FAD 
6 
1 600U 8.5 
2 GA 2% 
7 1 600U 8.5 
8 
1 600U 8.5 
2 GA 2% 
9 1 600U 8.5 
10 
1 600U 8.5 
2 GA 2% 
Table 3-1 
Complete detailed description of the dipping procedure followed for Application 1 for the protocol 
described by PtD – Naf – PPD – { MMA – [600UPBS x2 – GA2%] x5 – FAD(5) }x2. 
Within the application the first dip into MMA was proceeded directly by the first dip of 
600UPBS constituting the first complete layer. PtD indicates the electrodes were 
prepared as a Pt/Ir disc.  
Naf indicates the application of Nafion layers, unless otherwise specified it was 5 layers 
of Nafion 5% following by drying at 4 ºC for twelve hours.  
PPD indicates that o-PD was polymerised onto the surface by CPA unless otherwise 
specified.  
3.6 In Vitro Experimental Cell 
In vitro calibrations were carried out in a cell, constructed in-house, at room 
temperature and under normal atmospheric calibrations. The cell consisted of a 25 mL 
glass vial to which was fitted a custom designed Teflon
®
 lid. A standard 3-electrode set-
up was used to carry out experiments. The lid had several ports to allow the insertion of 
these three electrode types: an auxiliary, a reference and working electrodes. There were 
also inlets to allow the injection of solutions into the cell and control of the gaseous 
atmosphere within the cell. A diagram of the experimental cell and the Teflon
®
 cap are 
shown in Figure 3-6:  
  Chapter 3: Experimental 
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 Figure 3-6 
Schematic of: A the 3-electrode experimental cell, and B the Teflon® cap used with the cell. 
The saturated calomel electrode provided a reference background potential against 
which the current flowing in the working electrodes was measured. The Pt auxiliary 
electrode provided a ‘well’ or ‘sink’ of electrons for the electrolyte, which ensured the 
electrochemical phenomena could take place at the working electrodes. 
3.6.1 General Calibration Method 
To carry out a calibration 20 mL of PBS, pH 7.4, was inserted into this cell. The 
reference, auxiliary and working electrodes were inserted and connected to the 
potentiostat. Subsequently, aliquots of substrate solution (for example 10 µL of 100 mM 
ᴅ-ser solution) were injected into the cell using an appropriate syringe. Resultant current 
changes were monitored until a steady-state was achieved, see Section 2.4. The next 
aliquot of substrate was then injected. The aliquot sizes were calculated to increase the 
overall concentration of the solution in the cell to a predetermined level. 
3.6.2 Repeated Calibrations Methodology 
Short-term repeated calibrations were conducted by fabricating the biosensors and 
calibrating six times in quick succession. Between each calibration the electrodes were 
dried in the air for five minutes before being placed into a fresh solution of PBS for 
calibration again. The entire process took 2 days per set, with the electrodes being 
stored overnight at 4 ºC between calibration 3 and 4. 
Pt/Ir working 
electrodes 
Stirring Bead 
Gas Supply 
Tubing Saturated Calomel 
Reference Electrode 
Pt auxiliary 
electrode 
Phosphate Buffered 
Saline (PBS) 
Working Electrode 
Inlet 
Gas Inlet 
Auxiliary Electrode 
Port 
Reference Electrode 
Port 
Solution Injection 
Port 
Teflon® Cap 
A B 
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Long-term repeated calibrations were conducted over a four week period. There were to 
be three calibrations at the start, Day 0, Day 1 and Day 3, and three calibrations spread 
out over the rest of the time period, Day 7, Day 21 and Day 28. Between each 
calibration the electrodes were stored at 4 ºC. 
Shelf-life tests were conducted on Day 0 and either Day 21 or Day 28. Between the Day 
0 and the second calibration the electrodes were again stored at 4 ºC 
3.6.3 Full-Scope Amino Acid and Electroactive Interferent Calibration 
Methods 
These calibrations were carried out by setting up the experimental cell as per normal 
(under N2 saturation for electroactive interferents). Once the electrodes had settled the 
calibration began with the injection of substrate into the cell. Each injection brought the 
level of that substrate to 10 µM in the cell. After a ten minute settling period, the next 
substrate was injected. This continued until all of the substrates had been added. 
3.6.4 Oxygen Dependence Calibration Method 
An experimental method was devised to elucidate the effect that changing oxygen levels 
would have on the response of the sensor to ᴅ-ser. Three working electrodes and one 
bare Pt/Ir disk electrode, at –650 mV to monitor oxygen levels (Bolger et al., 2011), 
were placed into a cell, setup as normal but with air being bubbled directly into the 
PBS. Then an aliquot of ᴅ-ser was added to the solution and allowed to settle with the 
air bubbling through the solution. Next, with care being taken to maintain a constant 
level of bubbling (to keep convective effects constant), N2 was bubbled into the solution 
and the air was removed. Once the signals had stabilised again the process was reversed, 
with the N2 supply being removed and the air supply being reinstated. This process was 
continued with the level of ᴅ-ser being increased with each cycle of decreasing and 
increasing the dissolved O2 content. This method of calibration was devised to best 
replicate the short term changes in dissolved oxygen that might occur in the 
physiological environment. 
  Chapter 3: Experimental 
89 
3.7 Surgical Procedures 
3.7.1 Animal Subjects 
Out-bred Wistar rats (an albino strain of the species Rattus norvegicus) were acquired 
from Charles River UK Ltd. (Kent, UK), weighing between 200 and 250 g at the time of 
delivery. Animals were house in a temperature, (17 - 23 ºC), humidity and light (08:00 
on and 20:00 off cycle) controlled environment. They were supplied with water and 
food ad libitum. All animals were regularly handled prior to surgery and subsequently 
commencement of the experimental procedures. In this period they were group housed, 
with a maximum of 3 animals per cage. 
3.7.2 Surgery Setup and Equipment 
Prior to the surgical procedure a number of items of equipment had to be setup and 
checked. The first checks and setup procedures were conducted on the anaesthetic units. 
Pre-operative anaesthesia was provided by a vaporiser for induction (Univentor 400 
Anaesthesia Unit) with a Stellar S3 air pump (both supplied by Agnthos, Sweden) and a 
1.4 L capacity Induction Chamber. Anaesthesia during the surgery was provided by the 
same vaporising system and a stereotaxic inhalation mask, again supplied by Agnthos. 
The stereotaxic frame was sourced from Kopf, CA, USA. The frame was located in a 
bench-top laminar flow unit, and a surgical drill was setup. An incubation chamber, 
Thermacage MKII, supplied by Datesand Ltd, UK, was turned on and set to 27 ºC. A 
thermal plate was also placed in the stereotaxic frame, for the rat to be placed on and a 
steady body temperature maintained throughout the procedure. 
Surgical screws and Teflon
®
 pedestals were supplied by Plastics One Inc., VA, USA 
and were used in conjunction with dental acrylate cement (Sigma Aldrich) to secure the 
biosensors and a microdialysis probe (CMA Microdialysis, Sweden) to the skull of the 
subject. Previous to this, all electrodes were prepared. Biosensors were made according 
to the in vivo protocols in Section 3.5.2, and then pre-calibrated for response to AA and 
ᴅ-ser. A reference and auxiliary electrode were also fabricated. One biosensor was 
attached to the microdialysis probe with the active surface of the biosensor positioned 
less than 1 mm to the side of and centrally to the dialysis membrane (see Section 2.6).  
Attachment was achieved using the two part epoxy along most of the length of the 
insulated part of the biosensor and the probe shaft.  
  Chapter 3: Experimental 
90 
3.7.3 Surgery Protocol 
Rats were anaesthetised by volatile anaesthetic, Isoflurane (using the vaporiser and 
induction chamber), at a flow rate of 700 – 800 mL.min-1 and a concentration of 4%. 
Upon attaining successful anaesthesia the animal was weighed and had its hair removed 
from the skull using an electric razor. The animal was then secured in the stereotaxic 
frame where anaesthesia was maintained using the inhalation mask under a flow rate of 
400 – 500 mL.min-1 and a concentration of 3% initially to ensure complete anaesthesia 
post transfer but then reduced to 1.8 – 2.2% for the duration of the procedure, 
depending on the weight of the rat. During the incision and drilling phases the 
concentration was raised to 2.5 – 3.0% but lowered again once these procedures were 
completed. Within the stereotaxic frame the skull was held level between lambda and 
bregma. Lambda is where the sagittal and lambdoidal sutures intersect. Bregma is the 
point where the sagittal and coronal sutures intersect and is anterior to lambda. Their 
locations can be confirmed by applying pressure to the different skull plates and 
observing the junctions. Bregma was used as the zero point for calculation of 
coordinates for implantation.  
A rectal temperature probe was inserted into the rat, to maintain a body temperature of 
37 ºC throughout the procedure in conjunction with the heating plate positioned 
underneath the subject. The animal’s body and face were covered in sterile drapes and 
the incision area cleaned with tincture of iodine. An incision was made in the centre of 
the skull, along the anterior-posterior plane, from just behind the eyes to the back of the 
ears. The scalp was manoeuvred to the sides and held using a combination of forceps 
and small surgical bull clamps. This exposed the maximum surface area for the 
procedure to be carried out. The lipid periosteum layers were also removed and clamped 
to the sides, as these would prevent secure adhesion of the cement and hinder the 
procedure. Epidural haemorrhages were eliminated by cauterising, to prevent excessive 
bleeding. 
The stereotaxic coordinates used were determined from the Paxinos and Watson rat 
atlas (Paxinos & Watson, 2007). The anterior-posterior (A-P) and medial-lateral (M-L) 
coordinates were referenced with respect to the zero-point (bregma), with A-P positive 
in the anterior and M-L positive lateral to medial on the right hemisphere. Dorsal-
ventral (D-V) coordinates were calculated from the dura mater. The dura is the first of 
three meninges that surround the brain and spinal cord. Increasing negative coordinates 
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in this case indicated greater distance into the brain, i.e. ventral to the dura. Only one 
location was used for the entirety of the in vivo characterisation, that of the Striatum. 
The coordinates used were; A-P ± 1.0 mm, M-L ± 2.5 mm, D-V – 5 mm. 
 
Figure 3-7 
A representative diagram of the exposed area of the skull during surgery and placement of the 
various points of interest. 
With bregma determined and the stereotaxic equipment zeroed the skull was drilled at 
the relevant working electrode sites. The combined microdialysis probe and biosensor 
were facilitated by the drilling of a 1 mm bore hole at the right hemisphere coordinates. 
A hole was also drilled for the reference electrode (in the cortex), the combined 
auxiliary electrode and screw, and the three other surgical screws. A diagram of the 
approximate placement of these items is shown in Figure 3-7. The surgical screws were 
inserted. Their main purpose was to aid the securing of the dental cement to the skull 
(except for the combined screw and auxiliary electrode), hence they were placed at the 
extremities of the procedure area. The dura mater, arachnoid and pia mater meninges 
were penetrated using a hypodermic needle for 5 seconds to ensure safe passage of the 
probe and biosensors. They were then stereotaxically inserted to the correct depth. The 
reference electrode was placed into its correct position and whilst all the electrodes were 
still attached to the stereotaxic frame a layer of dental cement was applied to the skull to 
secure them. With all components parts secured against ‘moving about’, they were 
detached from the stereotaxic frame and the electrode clips were inserted into the 
Teflon
®
 headpiece according to the diagram in Figure 3-8; 
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Figure 3-8 
Map of the Teflon® headpiece which the electrodes were cemented into (bottom side) and to which 
the shielded cable screws onto (top side) to connect the subject to the potentiostat. The holes on the 
bottom side are larger to hold the female pins which are attached to the electrodes. The smaller holes 
on top accommodate the male ends of the cable. The working electrodes are numbered 1 – 4 and with 
the reference in R and the auxiliary A. 
The electrodes were then secured into the headpiece using dental cement, taking care to 
ensure only the bottom few threads of the headpiece were secured in the cement and no 
cement got into the top of the headpiece or electrode clips. The excess wire was then 
folded down carefully onto the skull, the headpiece pushed down as close to the skull as 
possible and all exposed wires and parts of the microdialysis probe cemented over 
completely to ensure that they could not be damaged by scratching. Care was taken to 
ensure the scalp was not trapped in the cement, this would allow air to circulate around 
the wound better when the procedure was completed, and thus provide better healing. 
Once the cement had dried completely the surgical incision was closed using a suture so 
that the scalp came up over the bottom of the dental cement and closed around it below 
the headpiece. The surgical procedure was then completed and the animal was removed 
from the stereotaxic frame. 
3.7.4 Post-Operative Care 
Following conclusion of the surgery and prior to the placement of the rat within the 
incubation chamber to recover, it was administered 1.0 mL of saline containing 0.1 
mg.kg
-1
 of Tamgesic (buprenorphine hydrochloride) by subcutaneous injection (s.c.). 
This provided post-operative analgesia and aided the recovery of the subject while in 
the incubation chamber. After at least one hour recovery in the incubation chamber, and 
when the animal was beginning to move about again, it was transferred to its home 
bowl in the experimental procedure room, where it would remain until termination. It 
was provided with water and food ad libitum and allowed to recover for at least 12 
hours before being connected to the potentiostat. No experiments were conducted until 
at least 24 hours after the conclusion of the surgical procedures and 12 hours after the 
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potentiostat had been connected and switched on. A photograph of the home bowl setup 
is shown below in Figure 3-9; 
 
Figure 3-9 
The setup of the home bowl where subjects were housed post-operatively and throughout all 
experimental procedures. 
All animals were housed individually post-operatively to ensure the best possible 
protection of the electrode-containing headpiece and microdialysis probe. The housing 
consisted of a home bowl, with side door and lid, mounted on a Raturn system (BASi, 
Bioanalytical Systems Inc, Indiana, U.S.A.) which rotated automatically to prevent 
entanglement and to allow the animal to move around freely. The implanted electrodes 
were connected to the potentiostat via an insulated, flexible, screened six-core cable 
(supplied by Plastics One Inc., VA, USA). The animal was tethered with the cable 
passing through the swivel mount of the tether (positioned in the centre of the bowl 
above the rats head) to ensure free movement around the home bowl. The animal’s 
health, food and drink consumption, and weight was continuously monitored and scored 
each day. 
3.8 In Vivo Experimental Procedures 
Microdialysis solutions were prepared in aCSF, except NO which was prepared in 
water, and all subcutaneous (s.c.) injection solutions made up in normal saline solution. 
Previous to the commencement of experiments a steady baseline was observed for at 
least 5 minutes. At least 3 hours was left between the end of one procedure and the 
commencement of the next, with up to 24 hours between the more ‘stressful’ 
experiments, details within each section to follow. All solutions were freshly prepared 
before use. 
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At the beginning of each microdialysis experiment the lines were purged with 0.5 mL of 
biocide followed by 1 mL aCSF. Then 0.5 mL of the solution to be used was purged 
through the lines and connected to a syringe of the appropriate solution, being careful to 
avoid getting air bubbles in the tubing. The syringe was then placed into the Univentor. 
A flow rate of 2 µL.min
-1
 was used for all experiments. The Univentor was turned on 
until solution was flowing freely from the end of the tube. It was then rapidly connected 
to the inlet of the probe in the subject’s headpiece. The dialysate was not collected for 
further analysis, and allowed to flow out the outlet, with the appearance of the first drop 
marking the beginning of the experiment. 
When the signal was judged to have reached a stable new baseline the Univentor was 
turned off and the flow of solution discontinued. The tubing was disconnected from the 
outlet valve. In other experiments a liquid swivel was used to alternate between two 
solutions. Once each solution had been used, in the predetermined order, with each 
reaching its own response level, all tubing as disconnected and the syringe pump was 
turned off. The signal response was allowed time to recover and the new baseline noted. 
During all of this time the animal was free to move, eat and drink. All experiments were 
conducted during the ‘day’ period of the light cycle, beginning at least one hour after 
the changeover from ‘night’ and finished at least one hour before the next ‘night’. 
The specific subject which will be reported on had a full day recovery before 
experiments commenced. The experimental period lasted for 21 days. Termination was 
carried out by a lethal s.c. injection of 1 mL Euthatal. All graphs will display the 
biosensor with the microdialysis probe in the right striatum as a green trace. The lone 
biosensor in the left striatum will be a green trace and red arrows will indicate the start 
and end of a perfusion. All values presented in table format are gathered from the mean 
value of 30 second samples of the signal at each level. 
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4.1 Introduction 
The project began based on work carried out by Z. M. Zain, later published (Zain et al., 
2010), which started the search for a sensitive and selective biosensor for ᴅ-ser using 
porcine ᴅ-amino acid oxidase as the bio-recognition unit. At the beginning of this 
project it was hoped that a suitable, stable configuration had been achieved and that 
after in vitro characterisation and reproducibility testing that the sensor already designed 
could be taken to the in vivo environment for further detailed characterisation. To be 
successful as a chronic in vivo biosensor it was deemed that a limit of detection (LOD) 
of less than 1 µM and a KM which is larger than 100 µM and less than 1000 µM were 
necessary. The biosensor would not have to be reusable after implantation, but would 
need to retain its sensitivity for the two calibrations that would be required to 
characterise the biosensor before implantation. However, shortly into the project it was 
determined that the sensor designed, while functional and producing satisfactory results, 
was quite difficult to reproduce. An investigation was then conducted into the design to 
study the various components in an attempt to determine the contributions of each 
element and if it was possible to reproduce, or enhance the reproducibility of the design. 
It was found that the biosensor could be fabricated, but it did not meet all of the 
requirements necessary for a chronic in vivo biosensor. This chapter will describe the 
investigation that took place and the results produced in attempting to improve the 
robustness of the biosensor. 
Results presented in this chapter and subsequent chapter will be presented in three 
formats. A table presenting the calibration points used within individual calibration of a 
group of electrodes can be found in Appendix 1. This data will be a sample of the raw 
data recorded during the calibration which has undergone a simple transformation to a 
current density value appropriate for the particular geometry of the electrodes utilised. 
Secondly, within the following chapters there will be a table of the kinetic data 
calculated, in Prism, based on the raw data presented in the relevant calibration data 
table. The kinetic parameters are a statistical comparison for best fit between M-M and 
M-M-H kinetics, see Section 2.7.2, where p < 0.05 is significant and indicates M-M-H 
kinetics. In a case where one model did not converge, denoted by n/c, the other kinetic 
fit was chosen. The R
2
, Jmax, KM, α and LRS are the values obtained from the best fit 
kinetic model. R
2
 indicates goodness of fit of the chosen kinetic model. Finally this 
information will be graphically represented with the raw data plotted as individual 
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points with error bars indicating the SEM. These points are then overlaid with a curve 
of the calculated best fit kinetic model. 
The basic configuration, of most biosensors discussed within this chapter, is as depicted 
in Figure 4-1. All alterations discussed in this chapter centre on this design with various 
layers being omitted or modified or added as detailed in each section. 
 
Figure 4-1 
The basic configuration of biosensors discussed within Chapter 4. 
4.2 Biosensor Configuration 
At the onset of this project the working electrode design was detailed as being; 
PtD – PPD – Naf 1% x3 (5 sec dip) – GA 25% x3 (5 sec dip) – ᴅAAO (600 U H2O) 
By the time of the publication of the design the procedure changed, by Zain, without 
change in the sensitivity (LRS), whereby the PPD growth was carried out using CV and 
the dipping regime altered. 
PtD – PPDcv – Naf 1% x5 (5 sec dip) – GA 25% (5 min dip) – ᴅAAO (600 U H2O) 
This second design reported a current-density (see Section2.9.3) transformed 
Michaelis–Menten non-linear regression with a Jmax of 91 ± 2 µM.cm
-2
 and a KM of 
1300 ± 100 µM.  The linear region displayed a sensitivity of 63 ± 2 µA.cm
-2
.mM
–1
 (n = 
4), R
2
 = 0.996. This can be seen below in Figure 4-2:  
Pt/Ir Disk Surface 
ᴅAAO 
Glutaraldehyde (GA) 
Nafion (Naf) 
PPD 
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Figure 4-2 
Current density – concentration plot for PtD-PPD-Naf-GA-DAAO biosensor designed by Z.M. Zain. 
These reported values were the benchmark for sensitivity with which this project began, 
with good sensor characteristics of a high Jmax, low KM and thus a high LRS. 
4.3 Circumstantial Functioning of the Biosensor 
Initial attempts to reproduce the biosensor designed by Z. M. Zain yielded poor results, 
as typified by the calibration data shown in Table 9-1 and displayed in Figure 4-3. 
These three initial designs were chosen as they matched most closely the methods 
previously described in Section 4.2. The designs were; 
 PtD-PPD-Naf1%x5-GA25%-600UH2Ox10,  
PtD-PPD-Naf1%x3-GA25%x3-600UH2Ox10  
and PtD-PPD-Naf1%x3-GA25%x3-600UH2Ox5. 
It can be seen in Table 4-1 that the Jmax, KM and LRS were all inferior to the reported 
values. PtD-PPD-Naf1%x3-GA25%x3-600UH2Ox10 provides the highest Jmax, PtD-
PPD-Naf1%x3-GA25%x3-600UH2Ox5 the lowest Km and PtD-PPD-Naf1%x3-
GA25%x3-600UH2Ox10 the highest LRS, yet all are significantly different (p < 
0.0001***, p = 0.0030** and p < 0.0001*** respectively) and unfavourable compared 
to the reported values, see Section 4.2. 
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Electrode Design 
PtD-PPD-Naf1%x5-
GA25%x1-
600UH2Ox10, n=13 
PtD-PPD-Naf1%x3-
GA25%x3-
600UH2Ox10, n=7 
PtD-PPD-Naf1%x3-
GA25%x3-
600UH2Ox5, n=4 
Kinetics M-M, p = 0.6972 M-M, p = 0.7593 M-M, p = 0.2311 
R
2
 0.9992 0.9999 0.9940 
Jmax, µA.cm
-2
 29.03 ± 0.98 34.72 ± 0.35 18.02 ± 1.35 
KM, µM 5936 ± 351 5486 ± 100 4409 ± 641 
LRS, uA.cm
-2
.mM
-1 4.89 ± 0.13 6.33±0.05 4.09 ± 0.31 
Table 4-1 
Kinetic parameters, fit, Jmax and KM values calculated from the calibration data in Table 9-1. Jmax, KM 
and LRS are presented as Mean ± SEM. 
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Figure 4-3 
J – concentration profile of replications of sensor designed by Zain, Mean ± SEM. Green trace PtD-
PPD-Naf1%x3-GA25%x3-600UH2Ox10, n = 13; red trace PtD-PPD-Naf1%x5-GA25%x1-600UH2Ox10, 
n = 7; blue trace PtD-PPD-Naf1%x3-GA25%x3-600UH2Ox5, n = 4. 
Further investigation of the reported design and consultation with Z. M. Zain provided a 
clue as to the reason why efforts to reproduce reported sensitivity were unsuccessful. 
Zain’s electrodes were made with solutions newly prepared before production of each 
set of 4 electrodes. This improved the sensitivities of the biosensors but did not ensure 
the desired sensitivity was achieved every time. 
To investigate this further two sets of 4 electrodes were prepared simultaneously from 
freshly prepared solutions according to recipe PtD-PPD-Naf1%x3-GA25%x3-
600UH2Ox10. The electrodes were produced/dipped in the sequence E1, E2, E3.....E8. 
The individual response of these electrodes to ᴅ-ser is displayed in Figure 4-4. Also 
depicted is the grouped response of E2 - E4 and E5 - E8. 
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Electrodes E1 E2 - E4 E5 - E8 
Kinetics M-M-H, p = 0.0070 M-M, p = 0.8127 M-M, n/c 
R
2
 0.9781 0.9854 0.9957 
Jmax, µA.cm
-2
 40.97 ± 1.60 32.98 ± 2.47 26.63 ± 1.30 
KM, µM 456.3 ± 59.1 3464 ± 635 4724 ± 502 
α 1.980 ± 0.430   
Table 4-2 
Kinetic parameters, fit, Jmax and KM values calculated from the calibration data in Table 9-2. Jmax, KM 
and α are presented as Mean ± SEM. 
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Figure 4-4 
J-concentration plot for PtD-PPD-Naf1%x3-GA25%x3-600UH2Ox10 obtained when all solutions are 
freshly prepared immediately prior to the dipping process. Depicted are the responses of an 
individual electrodes, which was the first electrode prepared from the new solutions, and calibrated 
once the fabrication process was complete. The Mean ± SEM of electrodes 2, 3 & 4 is indicated by 
black squares and of electrodes 5, 6, 7 & 8 by the black triangles. 
Cursory inspection of the responses in Figure 4-4 immediately shows a discrepancy 
between the 1
st
 electrode, E1, prepared in the fresh solutions and all other electrodes 
prepared subsequently. Examining the data presented in Table 9-2 and Table 4-2 it can 
be seen that E1 has a different kinetic model, M-M-H, to the rest of the electrodes, M-
M. This difference was illustrated best by disparity in the KM values. E1 has an ideal KM 
of 456.3 ± 59.1 µM, which is much smaller than the E2 – E4 value of 3464 ± 635 µM, 
which increases again to 4724 ± 502 µM for E5 – E8. Contrastingly the Jmax is seen to 
be decreasing, from 40.97 ± 1.60, to 32.98 ± 2.47, to 26.63 ± 1.30 µA.cm
-2
, for the same 
electrodes respectively. 
As a further effort to quantify these differences and observe changes that might take 
place over time, the electrodes were stored at 4 ºC for 7 days and then calibrated for 
response to ᴅ-ser again. The results are illustrated in Figure 4-5 and listed in Table 4-3; 
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Figure 4-5  
J-concentration plot for PtD-PPD-Naf1%x3-GA25%x3-600UH2Ox10 as in Figure 4-4. Depicted are the 
responses 7 days after that initial calibration. The Mean ± SEM of electrodes 2, 3 & 4 is indicated by 
black squares and of electrodes 5, 6, 7 & 8 by the black triangles. 
Electrodes E1 E2 - E4 E5 - E8 
Kinetics M-M, p = 0.1452 M-M, n/c M-M, p = 0.2066 
R
2
 0.9927 0.9920 0.9952 
Jmax, µA.cm
-2
 50.12 ± 1.94 26.74 ± 1.25 29.97 ± 4.20 
KM, µM 1955 ± 229 9405 ± 757 16878 ± 3383 
Table 4-3 
Kinetic parameters, fit, Jmax and KM values calculated from the responses elicited after the biosensors 
in Table 4-2 were stored for 7 days, see Table 9-3. Jmax and KM are presented as Mean ± SEM. 
The Jmax of E2 – E4 and E5 – E8 is not significantly different after 7 days, p = 0.0872 
and p = 0.4762 respectively. However the KM values are significantly different for both 
E2 – E4, p = 0.0039**, and E5 – E8, p = 0.0120*. These two sets of statistics combine 
to illustrate an enzymatic response which has become linear, indeed the KM for E2 – E4 
is almost outside the calibration range and the KM for E5 – E8 is well beyond the 
calibrated range and is an extrapolated value. The KM of E1 has increased by a factor of 
~ 4 after 7 days and the kinetic model has changed from M-M-H to M-M, also 
indicating a more linear response to ᴅ-ser. It was felt that this was due to a continuing 
slow interaction between the enzyme and the high concentration of GA which was 
altering the activity of the enzyme. 
From the data in Table 4-1 it was decided to continue forward with 10 dips of 600 U/ml 
of ᴅAAO from this point forward as PtD-PPD-Naf1%x3-GA25%x3-600UH2Ox10 and 
PtD-PPD-Naf1%x5-GA25%x1-600UH2Ox10 provided a higher Jmax (p < 0.0001*** and 
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p < 0.0001***) and LRS value (p < 0.0001*** and p = 0.0139*)  than the lower number 
of 5 dips. Between the two 10 enzyme dip recipes there was also a significant difference 
in the Jmax values (p = 0.0006***) and LRS (p < 0.0001***). There was no significant 
difference between their KM values (p = 0.3703). It was the large KM value (~ 5000 µM) 
which was seen as the main obstacle to a successful biosensor as it determined the LRS. 
Maintaining a large Jmax and reducing the KM to between the 456 µM of E1 and 1300 
µM reported by Zain was seen as a fundamental objective. 
Taking all of the above data into account it was decided to embark on an exploration of 
the different components of the sensor recipe to elucidate what effect each had on the 
sensitivity. The results of these explorations are detailed in Sections 4.4 to 4.10. For 
these experiments the “freshly” prepared enzyme solution that had been utilised for the 
experiments in Figure 4-4 and Figure 4-5 was used throughout. It was not envisaged 
that fresh solutions of enzyme should have to be used each time for the sensor to be 
reproducible (Ryan et al., 1997; O'Brien et al., 2007). 
4.4 Nafion® interactions and Effect on Biosensor Sensitivity 
The inclusion of Nafion
®
 (Naf) in the recipe was one which was considered a little 
unusual and different. It has been documented that it has a detrimental effect on PPD 
films, possibly due to the presence of the alcohols in the Naf solution degrading the film 
(Friedemann et al., 1996). In that study it was shown that the interferent rejection layer 
had less selectivity to NO (similar in size to H2O2, the signal molecule in this project) 
over AA, DA and nitrite when the Naf layer was applied after the PPD film compared to 
when the Naf layer was applied before the PPD layer.  
The proceeding work was carried out previous to discovery and use of the second 
formulation by Zain, and so followed the general formulation of PtD-PPD-Naf1%x3-
GA25%x3-600UH2Ox5. The first alterations involved the removal of the PPD film 
(yellow trace in Figure 4-6) and the removal of the PPD and Naf 1% dips (green trace). 
In order to aid further understanding of the interactions of the constituents’, in the 
sensor design, a further recipe was produced. This recipe had the PPD and GA 25% dips 
removed (blue trace). 
The ᴅ-ser calibrations of these four new electrode recipes are presented in Table 9-4 and 
Table 4-4. The collected data is also graphed in Figure 4-6 along with the calibration 
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curve of PtD-PPD-Naf1%x3-GA25%x3-600UH2Ox5, originally described in Table 4-1 
and depicted in Figure 4-3 (blue trace). This sensor recipe is represented by the red trace 
in Figure 4-6. 
The removal of the PPD film (yellow trace in Figure 4-6) had a significant effect on the 
sensitivity of the biosensor. The Jmax is significantly increased from 18.02 ± 1.35 to 
69.23 ± 6.04 µA.cm
-2
, p = 0.0002***, whereas the KM changed to 5246 ± 836.4 from 
4409 ± 641 µM, a non-significant change, p = 0.4573. Absence of the PPD layer and the 
3xNaf1% dips (green trace) returns the Jmax and KM to levels that are not significantly 
different from the starting recipe, p = 0.1259 and p = 0.0511 respectively. Conversely 
removal of the PPD and 3xGA25% dips (blue trace) meant that the Jmax remained 
elevated at 74.27 ± 4.29 µA.cm
-2
. This is significantly higher, p < 0.0001***, than the 
original recipe but similar to the value where only the PPD film was absent, p = 0.5217. 
The KM values were not significantly different, p = 0.0908 and p = 0.3942, for the same 
comparisons. 
Examination of the designs Jmax and LRS values lead to a few conclusions being drawn 
(the differences in the KM being largely insignificant does not allow conclusions to be 
drawn). The first one is that the function of the GA appears to be the tight binding of the 
ᴅAAO. This is seen clearly by observing that in both PtD-PPD-Naf1%x3-GA25%x3-
600UH2Ox5 and PtD-GA25%x3-600UH2Ox5 the Jmax and LRS are significantly lower 
than the other two recipes lowest. This indicates the strength of the GA has restrictively 
bound the ᴅAAO, inhibiting its function and reducing turnover of ᴅ-ser. It is also 
possible to speculate that the Naf and PPD have also combined in a manner which has 
rendered it impossible for the GA to interact with. The chemical combination produced 
could provide a surface which is inert to both of the amine interactive carbonyl groups 
on the GA. At best the combination of PPD film and Naf dip layers is no different than 
the bare metal surface at a base surface for the GA and enzyme linking to occur on. 
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Figure 4-6 
J-concentration plot for PtD-PPD-Naf1%x3-GA25%x3-600UH2Ox5 (red trace) and the 3 variations 
fabricated to elucidate the role of the Naf1%x3 dips. PtD-Naf1%x3-GA25%x3-600UH2Ox5 is the 
yellow trace, PtD-GA25%x3-600UH2Ox5 is the green trace, PtD-Naf1%x3-600UH2Ox5 is the blue trace. 
All traces are plotted as Mean J ± SEM with fitted kinetic curve. 
Electrode 
Design 
PtD-Naf1%x3-
GA25%x3-600UH2Ox5, 
n=4 
PtD-GA25%x3-
600UH2Ox5, n=4 
PtD-Naf1%x3-
600UH2Ox5, n=4 
Kinetics M-M, p = 0.4354 M-M, n/c M-M, p = 0.3559 
R
2
 0.9938 0.9974 0.9978 
Jmax, µA.cm
-2
 69.23 ± 6.04 21.54 ± 1.45 74.27 ± 4.29 
KM, µM 5246 ± 836.4 6844 ± 770.1 6200 ± 617.3 
LRS, µA.cm
-
2
.mM
-1
 
13.20 ± 1.01 3.148 ± 0.151 11.98 ± 0.53 
Table 4-4 
Kinetic parameters, fit, Jmax and KM values calculated from the calibration data in Table 9-4. Jmax, KM 
and LRS are presented as Mean ± SEM.  
This is further borne out by the data provided by PtD-Naf1%x3-600UH2Ox5 (blue 
trace). Here the removal of the GA25%x3 dips has resulted in a Jmax significantly higher 
than the first two examples discussed. Interestingly the Jmax and LRS of PtD-Naf1%x3-
GA25%x3-600UH2Ox5 (yellow trace) is statistically the same as PtD-Naf1%x3-
600UH2Ox5. This could indicate that with the removal of the PPD film and the 
subsequent loss of any interaction between the PPD and Naf has changed how binding 
occurs within the recipe. Here it appears that the GA now primarily binds to the Naf and 
that there are only a limited number of carbonyl groups remaining to interact with the 
GA. It may be that one carbonyl group is bound to the Naf and one group is free to bind 
a ᴅAAO or even that the majority of all groups are bound to the Naf. Either way it 
certainly appears that the cross-linking of ᴅAAO to each other and even the binding of a 
 Chapter 4: Immobilisation Matrix Free Biosensor Designs 
106 
single GA to two sites on the same ᴅAAO is severely reduced when Naf and GA are 
combined without the presence of PPD. In the presence of PPD or without PPD and Naf 
it appears that the GA serves to restrict the shape, movement and functioning of the 
enzyme. 
Thus it is possible to say that the Naf contributes little to the design of the sensor. It 
interacts, most probably in a detrimental way, with the PPD film. The GA does not 
appear to bind effectively to the Naf in the formulation and thus results in a recipe with 
two separate entities. The first is a PPD-Naf film on top of which is resting a heavily 
cross-linked GA-ᴅAAO complex. The degree of cross-linking appears to be detrimental 
to the full function of the enzyme, inhibiting turnover of substrate. 
4.5 Contribution of Glutaraldehyde to Biosensor Sensitivity 
Having demonstrated that the GA-ᴅAAO complex was possibly denaturing the enzyme 
and reducing its ability to turnover substrate, investigating its role within the biosensor 
recipe was the next component to be examined. It was a component which had drawn 
attention of its own accord, as the use of GA at 25% concentration is unusual. It would 
be more typical to see GA used at concentration levels similar to 2.5% (Wang et al., 
1997), 1% (O'Brien et al., 2007), 0.5% (Hu & Wilson, 1997)  0.13% (Burmeister & 
Gerhardt, 2001) and 0.01% (Sanford et al., 2010). Where GA had been used as a 25% 
solution it was used in the context of holding the electrode in close proximity of the 
solution and allowing the vapours released to form the cross-links (McMahon et al., 
2005) and not dipping the electrode directly into the solution. Glutaraldehyde, 0.5%, has 
been used previously in conjunction with ᴅAAO to immobilise the enzyme onto 
aminated beads, and thus providing the most stable configuration (López-Gallego et al., 
2005b) 
A further alteration was also considered across all of the biosensors fabricated. The PPD 
film was formed by CV rather than CPA. This yielded a PPDcv layer. The reasons for 
this change are found in Section 4.2 where it was stated that Zain had also utilised a CV 
method to form the polymer layer. Thus by forming the PPDcv layer not only is a 
comparison enabled between the various GA percentages but also an insight might be 
gained into the effect of the type of polymer formed on the biosensor sensitivity. An in-
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depth examination of different polymer formation methods (in conjunction with 2% 
GA) and resultant effects on sensitivity are detailed in Section 4.7.2. 
Thus to explore the influence of the GA on the properties of the biosensor, electrodes 
were prepared according to the general recipe PtD-PPDcv-Naf1x3%-GA25%x3-
600UH2Ox5 but with the GA 25% replaced by concentrations of 0.5%, 1.0%, 2.0%, 
5.0% and 10.0% GA. The results obtained for these electrodes are listed in Table 9-5 
and Table 4-5. 
The results obtained are also graphically represented in Figure 4-7 and Figure 4-8. The 
large variation in the observed sensitivities with corresponding change in % of GA used 
is very apparent when considering these two diagrams.  
Use of 0.5 % GA produced a biosensor with minimal response to increases in substrate 
concentration (red trace, Figure 4-7) with a Jmax of 0.279 ± 0.014 µA.cm
-2
 and KM of 
4312 ± 508 µM. These were significantly different when compared to 1%, 2%, 5%, 
10% and 25% GA respectively. The lower value of Jmax (p = 0.0003***, p < 0.0001***, 
p = 0.0004***, p = 0.0007***, p = 0.0007***) was unfavourable. However, the lower 
KM value (p = 0.0058**, p = 0.0383*, p = 0.0009***, p = 0.0048**, p = 0.0222*) was 
desirable. While the lower KM is beneficial the very small Jmax renders this recipe 
untenable. 
The changes in sensitivity show the combined effect of the Jmax and KM changes. The 
2% GA recipe has a significantly higher LRS than the 0.5%, 5% and 10% GA recipes, p 
< 0.0001*** for all three comparisons. The LRS of the 25% recipes is significantly 
larger than that of the 2% recipe, p = 0.0042**. 
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%GA used 0.5%, n = 4 1.0%, n = 3 2.0%, n = 8 
Kinetics M-M, n/c M-M, p = 0.9107 M-M, p = 0.3781 
R
2
 0.9942 0.9997 0.9956 
Jmax, µA.cm
-2
 0.2794 ± 0.0146 81.26 ± 1.51 22.33 ± 1.61 
KM, µM 4312 ± 508.6 7251 ± 252.1 7993 ± 1039 
LRS, µA.cm
-2
.mM
-1
 0.0648 ± 0.0046 11.21 ± 0.19 0.9537 ± 0.0355 
%GA used 5%, n = 3 10%, n = 3 25%, n = 4 
Kinetics M-M, n/c M-M, n/c M-M, n/c 
R
2
 0.9997 0.9995 0.9957 
Jmax, µA.cm
-2
 5.914 ± 0.115 3.671 ± 0.087 14.25 ± 0.95 
KM, µM 8853 ± 299.7 7500 ± 325.9 7548 ± 926.4 
LRS, µA.cm
-2
.mM
-1
 0.6680 ± 0.0102 0.4895 ± 0.0103 1.888 ± 0.112 
Table 4-5 
Kinetic parameters, fit, Jmax and KM values calculated from the calibration data in Table 9-5. Jmax and 
KM are presented as Mean ± SEM. 
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Figure 4-7 
J-concentration plot for PtD-PPDcv-Naf1%x3-GA25%x3-600UH2Ox5 (purple trace) and 4 of the 5 
variations fabricated to elucidate the role of the GA25%x3 dips. The blue trace is GA10%x3, GA5%x3 
is the green trace, GA2%x3 is the yellow trace and GA0.5%x3 is represented by the red trace. All 
traces are plotted as Mean J ± SEM with fitted kinetic curve. 
Interestingly the 1% GA (orange trace in Figure 4-8) recipe produced a significantly 
higher Jmax, 81.26 ± 1.51 µA.cm
-2
, than either 2%, 5%, 10% or 25%, p < 0.0001*** for 
all. The Jmax decreases to 22.33 ± 1.61 µA.cm
-2
 for 2% GA, and continues to decrease 
significantly, p < 0.0001***, for 5% GA to 5.914 ± 0.115 µA.cm
-2
, and significantly 
further to 3.671 ± 0.087 µA.cm
-2
, p < 0.0001***. Increasing the GA concentration used 
to 25% increases the Jmax to 14.25 ± 0.95 µA.cm
-2
, which is significantly higher than 
10% GA, p = 0.0016** but significantly lower than 2% GA, p = 0.0075**. 
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Examining the KM values there is no significant difference between 1% and 2%, p = 
0.6832, 1% and 10% GA, p = 0.5782, or 1% and 25% GA, p = 0.8008. There is also no 
difference between 2% and 10%, p = 0.7862, 2% and 25%, p = 0.7903, or between 10% 
and 25% GA, p = 0.9677. The 5% KM values are significantly higher than 1% and 10%, 
p = 0.0150* and p = 0.0378*, but not 2% or 25%, p = 0.6372 and p = 0.2982 
respectively. 
The comparison, of the LRS of the 1% GA recipes to the other five recipes, illustrates 
the degree of change which occurs with the use of this particular concentration of GA. It 
is significantly larger than all the other sensitivity values, p < 0.0001*** for all values. 
Numerically it is an order of magnitude more sensitive than the other GA recipes. 
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Figure 4-8 
J-concentration plot for PtD-PPDcv-Naf1%x3-GA25%x3-600UH2Ox5 (purple trace) and its variation 
with GA1%x3, represented by the orange trace. All traces are plotted as Mean J ± SEM with fitted 
kinetic curve. 
Taken together these results indicate that the Jmax and KM values change in a radical 
way, particularly over small changes in the % of GA used when the % of GA is kept 
low. Both KM and Jmax appear to settle into a particular range once the GA % reaches 
and exceeds 5%. Below this value, particularly between 0.5% and 2% GA there does 
seem to be an important and radical interplay between the two kinetic parameters. This 
was demonstrated most obviously by the biosensors fabricated with 1% GA in the 
recipe. They obtained a Jmax ~ 5 times higher than the 2% and 25% GA recipes and ~ 
300 times higher than the 0.5% recipe, however its KM is the same as that of the 25% 
and 2%, slightly lower than 5% and almost twice the value obtained for 0.5% GA. This 
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complex interplay is summarised in Figure 4-9. From the plot it is quite clear that 
possibly the most interesting area, in terms of GA% used, for further study could be that 
between 0.5% and 2%. Within this region it appears that the interplay between KM and 
Jmax is most complex and could provide the solution to a biosensor with a high Jmax and 
a low KM. It also most certainly appears that using GA as a 25% solution is unlikely to 
provide the best solution as above 5% concentration the KM remains high and the Jmax 
low. 
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Figure 4-9 
A plot of the KM values (red points) and Jmax (green points) obtained when the % concentration of GA 
used in the recipe PtD-PPDcv-Naf1%x3-GA25%x3-600UH2Ox5 was varied between 0.5% and 25%. 
Larger concentrations of GA are either distorting the active site of the enzyme, 
rendering it inactive, providing an increased diffusional barrier or distorting the 
underlying films. Individually or in combination these three processes are limiting the 
Jmax and increasing the KM resulting in significantly lower sensitivities for 
concentrations of GA over 2%. 
Briefly, turning to the difference caused by the change in polymerisation method it is 
necessary to compare the results here for PtD-PPDcv-3xNaf1%-3xGA25%-5x600UH2O 
with the results for PtD-PPD-3xNaf1%-3xGA25%-5x600UH2O as obtained in Section 
4.3. It is seen that there is no significant difference between the Jmax values, p = 0.0625, 
but that the KM is increased significantly for PPDcv, p = 0.0317*. Further comparisons 
like this are examined in Section 4.7.2. 
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4.6 Variations of the Enzyme Solution 
4.6.1 Different Suppliers of ᴅAAO 
Previous to work commencing on the biosensor recipe provided by Z. M. Zain 
preliminary methodology work had been carried out on a sample of ᴅAAO obtained 
from Fluka Chemie. It was noticed that this enzyme produced differing results to the 
enzyme obtained from BBI Enzymes. As a result it was decided to examine the effect 
different enzyme samples from different suppliers would have on the sensitivity of the 
biosensor. Each of three suppliers, Fluka, Sigma and BBI, provided the enzyme with 
differing ratios of enzyme and protein, 1.9 U.g
-1
, 2.3 U.g
-1
 and 7.46 U.g
-1
 (units per 
gram of solid) respectively. 
Thus different solutions were prepared from the Fluka and Sigma enzyme samples and 
compared to the BBI enzyme which was being used as a standard. A 200 U.mL
-1
 
solution was prepared from the Fluka 1.9 U.g
-1
 enzyme. From the Sigma 2.3 U.g
-1
 
enzyme 100 U.mL
-1
, 250 U.mL
-1
 and 600 U.mL
-1
 solutions were prepared. These 
solutions were then used to fabricate biosensors according to the recipe PtD-PPD-
Naf1%x5-GA25%-Enzymex10 and were subsequently calibrated for their response to 
ᴅ-ser. The results of these calibrations are detailed in Table 9-6 and are directly 
comparable to the PtD-PPD-Naf1%x5-GA25%-600UH2Ox10 results detailed in Table 
4-1. 
It is interesting to note that electrodes fabricated with the 600 U.mL
-1
 solution, 
formulated from the 2.3 U.g
-1
 Sigma ᴅAAO, could only be made with 5 dips into the 
enzyme solution and not 10 as per the other recipes. This was due to the very viscous 
nature of the solution at this high concentration and the formation of clumps of material 
on the electrode surface rather than a smooth film. It was for this same reason that the 
Fluka enzyme was only prepared in a solution of 200 U.mL
-1
. This solution and the 
Sigma 250 U.ml
-1
 solution were found to be the optimum high concentration before 
clumping became an issue. 
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Electrode Design 
200U.mL
-1
 soln, 
1.9U.g
-1
 solid 
Fluka, n = 8 
100U.mL
-1
 soln, 
2.3U.g
-1
 solid 
Sigma, n = 8 
250U.mL
-1
 soln, 
2.3U.g
-1
 solid 
Sigma, n = 8 
600U.mL
-1
 soln, 
2.3U.g
-1
 solid 
Sigma, n = 3 
Kinetics M-M, p = 0.4354 M-M, n/c M-M, p = 0.3559 
M-M-
H,p=0.0214 
R
2
 0.9978 0.9970 0.9981 0.9981 
Jmax, µA.cm
-2
 30.27 ± 1.40 29.46 ± 1.65 64.08 ± 4.36 33.69 ± 2.80 
KM, µM 3929 ± 314 8881 ± 844 10274 ± 1019 3735 ± 573 
α    1.273 ± 0.098 
LRS, µA.cm
-2
.mM
-1 7.706 ± 0.280 3.317 ± 0.137 6.238 ± 0.207 9.020 ± 0.649 
Table 4-6 
Kinetic parameters, fit, Jmax and KM values calculated from the calibration data in Table 9-6. The values 
for PtD-PPD-Naf1%x5-GA25%-600UH2Ox10 have been omitted but can be found in Table 4-1. Jmax, KM, 
α and LRS are presented as Mean ± SEM.  
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Figure 4-10 
J-concentration plot for the PtD-PPD-Naf1%x5-GA25%-Enzymex10 recipes presented in Table 9-6. 
100 U.ml-1 2.3 U.g-1 is the yellow trace, 250 U.ml-1 2.3 U.g-1 is the green trace and 600 U.ml-1 2.3 U.g-1 is 
the blue trace. Kinetic curve fits are those described in Table 4-6 and Table 4-1. All traces are plotted 
as Mean J ± SEM with fitted kinetic curve. 
It is interesting to observe from Table 4-6 and Table 4-1 that  the 600 U.mL
-1
 Sigma 
solution is the only one of the 5 solutions considered that conformed to Michaelis-
Menten Hill-Type kinetics, a more desirable kinetic model as will produce a higher LRS 
and lower KM than Michaelis-Menten kinetics for the same Jmax.  Indeed it can be seen 
that its KM is significantly lower than the 100 U.mL
-1
 and 250 U.mL
-1
 solutions made 
with the Sigma enzyme, p = 0.0065** and p = 0.0046** respectively, and significantly 
lower than the 600 U.mL
-1
 solution made with the BBI enzyme, p = 0.0145*. It is not 
significantly different from the 200 U.mL
-1
 solution made from the Fluka enzyme, p = 
0.7609. The benefit of this M-M-H kinetics can be seen visually in Figure 4-10 where 
the 250 U.ml
-1
 2.3 U.g
-1
 is the green trace and 600 U.ml
-1
 2.3 U.g
-1
 is the blue trace. It 
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can be seen that the M-M-H kinetics mean a more linear initial region of increasing J 
with increasing concentration of ᴅ-ser and also a more marked turning point as the 
enzyme reaches the limit of its ability to turn-over substrate. 
The Jmax of various solutions are non-significantly different, except for that of the 250 
U.mL
-1
 solution formulated from the 2.3 U.g
-1
 Sigma enzyme. This is significantly 
higher than the other solutions, p < 0.0001*** for all solutions expect the 600 U.mL
-1
 
2.3 U.g
-1
 solution where p = 0.0027**.  
The LRS of the 600 U.mL
-1
 2.3 U.g
-1
 Sigma solution is significantly higher than the 
other solutions, p < 0.0001*** for 100 U.mL
-1
 2.3 U.g
-1
 solution, p < 0.0004*** for 250 
U.mL
-1
 2.3 U.g
-1
 solution and p < 0.0001*** for 600 U.mL
-1
 7.46 U.g
-1
 solution. The 
exception to this is the 200 U.mL
-1
 1.9 U.g
-1
 solution, which is not significantly lower, p 
= 0.0539. 
Increasing the enzyme concentration for the 2.3 U.g
-1
 solution from 250 U.ml
-1
 to 600 
U.ml
-1 
changes the kinetics to a Hill-type which may indicate that the increasing 
quantity of enzyme and protein on the surface is changing the diffusional properties of 
the biosensor. 
From Figure 4-10 it can be seen that obtaining as high a concentration of enzyme in 
solution can be beneficial. It appears that increased enzyme loading on the electrode 
surface not only increases the Jmax but also possibly decreases the KM and can change 
the kinetic model to the more favourable M-M-H. Figure 4-11 (comparison of the 
highest concentration solutions before “clumps” appear on the electrode surface) 
elucidates the possibility that the environment the enzyme is trapped within is also 
important to consider. Here the ratio of active enzyme to protein as supplied 
demonstrates the capability of providing a more favourable environment for optimum 
activity. It is also possible to relate this back to the information in Sections 4.4 and 4.5 
and deduce that all components of the biosensor impact its operation and need to be 
tuned to each other in order to obtain the most sensitive functioning possible.  
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Figure 4-11 
J-concentration plot for the PtD-PPD-Naf1%x5-GA25%-Enzymex10 recipes presented in Table 9-6 
where the enzyme solutions have reached maximum useable concentration. 200 U.ml-1 1.9 U.g-1 is the 
red trace and 250 U.ml-1 2.3 U.g-1 is the green trace. Also included is the PtD-PPD-Naf1%x5-GA25%-
10x 600 U.ml-1 7.46 U.g-1 recipe from Table 4-1 (purple trace).  Kinetic curve fits are those described 
in Table 4-6 and Table 4-1. All traces are plotted as Mean J ± SEM with fitted kinetic curve. 
The lower sensitivity of the 600 U.ml
-1 
7.46 U.g
-1 
biosensor in comparison to the 600 
U.ml
-1 
2.3
 
U.g
-1
 design is particularly indicative of the importance of the delicate 
balance between enzyme, protein and cross-linking agent. This is further backed up by 
the similar Jmax of 200 U.ml
-1
 1.9 U.g
-1 
and 100 U.ml
-1
 2.3 Ug
-1
 with differing KM and 
the same KM but differing Jmax of the 100 U.ml
-1
 and  250 U.ml
-1
 2.3 U.g
-1
 biosensor 
designs.    
4.6.2 Effect of Additives in the Enzyme Solution on Biosensor Sensitivity 
Consideration was also given to the method of formulating the enzyme solution. It was 
noted that previous reports of working with ᴅAAO in a biosensor has reported using it 
with 25 mg.mL
-1
 BSA and 1% glycerol in 0.02M PBS with a pH 8.5 (Pernot et al., 
2008). Thus an enzyme solution containing these substances was formulated with 
enzyme concentration remaining at 600 U.mL
-1
 (symbolised by 600U+A in recipes). 
Three electrode types were initially prepared with this enzyme solution. These were 
analogous to those prepared initially in Section 4.3 to investigate the original reported 
biosensor design. 
The calibration data obtained from the three PtD-PPD-Naf1%-GA25%-600U+A 
electrodes is displayed in Table 9-7, and the kinetic parameters in Table 4-7. All 
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formulations of the 600U+A display M-M kinetics. There is no significant difference 
between PtD-PPD-Naf1%x3-GA25%x3-600U+Ax5 and PtD-PPD-Naf1%x5-GA25%-
600U+Ax10 in either KM or Jmax, p = 0.5655 and p = 0.1295 respectively. Both curves 
are also M-M fit with no significant difference in the LRS value, p = 0.2830. The extra 
quantity of Naf in the latter appears to be counteracted by the extra quantity of 600U+A 
utilised and the different method of application of GA. 
Electrode Design 
Naf1%x5-GA25%-
600U+Ax10, n=4 
Naf1%x3-GA25%x3-
600U+Ax10, n=3 
Naf1%x3-GA25%x3-
600U+Ax5, n=7 
Kinetics M-M, p = 0.3170 M-M, p = 0.9431 M-M, n/c 
R
2
 0.9984 0.9979 0.9994 
Jmax, µA.cm
-2
 29.27 ± 1.69 53.50 ± 1.49 32.08 ± 0.86 
KM, µM 6126 ± 534 3215 ± 219 6453 ± 287 
LRS, µA.cm
-2
.mM
-1 4.778 ± 0.152 16.64 ± 0.74 4.971 ± 0.09 
Table 4-7 
Kinetic parameters, fit, Jmax and KM values calculated from the calibration data in Table 9-7. The values 
are comparable to those found in Table 4-1, where the same designs are discussed excepting the 
enzyme solution which is made up in water. Jmax, KM and LRS are presented as Mean ± SEM. 
There is a significant difference however between PtD-PPD-Naf1%x3-GA25%x3-
600U+Ax10 and PtD-PPD-Naf1%x5-GA25%-600U+Ax10 or PtD-PPD-Naf1%x3-
GA25%x3-600U+Ax5. Its KM is significantly lower, p = 0.0069** and p = 0.0001*** 
respectively. Its Jmax is significantly higher, p = 0.0001*** and p < 0.0001*** 
respectively, as is the LRS, p < 0.0040** and p = 0.0040** respectively. Here the 
higher amount of 600U+A, the lower quantity of Naf and the layering of the GA 
application has influenced all parameters favourably. 
Thus even though it has the same number of enzyme dips as PtD-PPD-Naf1%x5-
GA25%-600U+Ax10 or the same other components as PtD-PPD-Naf1%x3-GA25%x3-
600U+Ax5, the results for PtD-PPD-Naf1%x3-GA25%x3-600U+Ax10 are very 
significantly different, with all kinetic parameters significantly higher. Despite their 
difference in component and enzyme dips PtD-PPD-Naf1%x5-GA25%-600U+Ax10 and 
PtD-PPD-Naf1%x3-GA25%x3-600U+Ax5 show no statistical differences. 
Graphed above in Figure 4-12 is a comparison of the 600UH2O and the 600U+A 
enzyme solution formulations of the PtD-PPD-Naf1%x5-GA25%-Enzymex10 recipes. It 
can clearly be seen that there is a non-significant difference between the KM values, p = 
0.7907, Jmax values, p = 0.9063, and LRS values, p = 0.5900. The different formulation 
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of the enzyme solution has no effect on the response obtained from this biosensor 
recipe. 
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Figure 4-12 
J-concentration plot for the comparison of PtD-PPD-Naf1%x5-GA25%-Enzymex10. The orange trace 
represents the 600U+A recipe from and Table 4-7. The red trace represents the original 600UH2O 
recipe from and Table 4-1. Traces are plotted as Mean J ± SEM with fitted kinetic curve. 
Contrastingly, there are significant differences seen in Figure 4-13 between the 
600UH2O and the 600U+A enzyme solution formulations of the PtD-PPD-Naf1%x3-
GA25%x3-Enzymex10 recipes. The 600U+A solution produces a KM that is 
significantly lower, p < 0.0001***, a higher Jmax, p = 0.0062**, and a higher LRS, p = 
0.0051**. This is a far superior result as it has increased the Jmax, lowered the KM and 
thus increased the LRS, which are all results that this exploration was attempting to 
achieve. 
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Figure 4-13 
J-concentration plot comparing the PtD-PPD-Naf1%x3-GA25%x3-Enzymex10 recipes. The dark green 
trace is the 600U+A recipe in Table 4-7. The bright green trace is the original 600UH2O recipe in 
Table 4-1. Traces are plotted as Mean J ± SEM with fitted kinetic curve. 
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Figure 4-14 
J-concentration plot comparing the PtD-PPD-Naf1%x3-GA25%x3-Enzymex5 recipes. The light blue 
trace is the 600U+A recipe in Table 4-7. The royal blue trace is the original 600UH2O recipe in Table 
4-1. Traces are plotted as Mean J ± SEM with fitted kinetic curve. 
Above in Figure 4-14 a further variance in results is seen between the 600U+A and 
600UH2O solutions. In this instance, applied to the PtD-PPD-Naf1%x3-GA25%x3-
Enzymex5 recipe, observed is a non-significant decrease in the KM, p = 0.0960, a 
significant decrease in the Jmax, p < 0.0001***, and a corresponding significant decrease 
in the LRS, p < 0.0001***.  
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The dramatic difference between the results obtained for PtD-PPD-Naf1%x3-
GA25%x3-600U+Ax5 and PtD-PPD-Naf1%x3-GA25%x3-600U+Ax10, in comparison 
to their 600UH2O counterparts, demonstrates further that all changes to the biosensor 
recipe must be made in the context of all the component parts. Producing a significant 
change with one recipe by making a particular alteration will not necessarily produce a 
similar result even in closely related recipes. Initially, it was found that there was no 
difference between the water and additive solutions (Figure 4-12) when the recipe 
contained 5 dips into Naf and 1 dip into GA with 10 dips of enzyme solution, this could 
be due to the single layer of GA which allows for a finite amount of cross-linking with 
substances in the enzyme solution.  
Next, with three dips of Naf and GA and ten dips of the enzyme solution it is found that 
the additive solution produces a much more sensitive biosensor than the water based 
enzyme solution (Figure 4-13). Upon reduction of the enzyme dips to five, in 
conjunction with the three dips of Naf and GA, the sensitivities are reversed with the 
water solution now displaying the larger LRS (Figure 4-14). This suggests that the 
larger number of GA dips are beneficial to the retention of the additive enzyme and 
resultant sensitivity increases, although this effect is lost with a reduced number of 
enzyme dips. 
In order to further explore how slight changes to a biosensor recipe would affect the 
sensitivity a two further sets of electrodes were prepared with 600U+A and 600UH2O. 
These electrodes followed the general recipe PtD-PPD-Naf1%x3-GA25%x3-Enzymex3. 
The calibration data obtained is displayed in Table 9-8 and the subsequently determined 
kinetic parameters are listed in Table 4-8 and graphed in Figure 4-15.  
Initially it is necessary to note that the 600UH2O biosensor produced a significantly 
higher KM than PtD-PPD-Naf1%x3-GA25%x3-600UH2Ox5, the lowest KM from 
Section 4.3, p = 0.0005***. It has a significantly lower Jmax than PtD-PPD-Naf1%x3-
GA25%x3-600UH2Ox10, the highest Jmax from Section 4.3, p < 0.0001***. Finally its 
LRS is significantly lower than PtD-PPD-Naf1%x3-GA25%x3-600UH2Ox10, the 
highest LRS from Section 4.3, p < 0.0001***. 
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Figure 4-15 
J-concentration plot for the comparison of  PtD-PPD-Naf1%x3-GA25%x3-Enzymex3. The pink trace 
represents the 600U+A recipe, and the purple trace represents the 600UH2O recipe. Both sets of data 
are taken from Table 9-8 and Table 4-8. Traces are plotted as Mean J ± SEM with fitted kinetic curve. 
Electrode Design 
PtD-PPD-Naf1%x3-GA25%x3-
600H2Ox3 n = 4 
PtD-PPD-Naf1%x3-GA25%x3-
600U+Ax3 n = 4 
Kinetics M-M, p = 0.1476 M-M, n/c 
R
2
 0.9997 0.9989 
Jmax, µA.cm
-2
 27.79 ± 0.43 6.080 ± 0.306 
KM, µM 6509 ± 194 6463 ± 485 
LRS, µA.cm
-2
.mM
-1 4.269 ± 0.066 4.971 ± 0.09 
Table 4-8 
Kinetic parameters, fit, Jmax and KM values calculated from the calibration data in Table 9-8. Jmax, KM 
and LRS are presented as Mean ± SEM. 
The results between the 600U+A and 600UH2O for PtD-PPD-Naf1%x3-GA25%x3-
Enzymex3 are comparatively similar to those obtained for PtD-PPD-Naf1%x3-
GA25%x3-Enzymex5. The KM is not different, p = 0.9327. The Jmax and LRS are 
however significantly lower, both p < 0.0001***. This results further bears out the 
results seen with the previous three recipes whereby the beneficial effect of the 
increased number of GA dips in relation to the additive enhanced enzyme solution is 
lost when the number of enzyme dips is also reduced, and the water based enzyme 
solution then becomes more efficient. 
This collected and complex set of interplays for the recipe is graphically summarised in 
Figure 4-16. Here, as in Figure 4-9, the KM values are represented by red points and 
error bars. The Jmax values are displayed by green points and error bars. In an added 
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level of complexity though, the values obtained using the 600UH2O solution are 
connected using blue lines and the purple lines connect the 600U+A solution results. 
2 4 6 8 10
0
2000
4000
6000
8000
0
20
40
60
80
100
KM (+A)
Jmax (+A)
KM (H2O)
Jmax (H2O)
No. of dips into enzyme solution
K
M
,

M
J
m
a
x ,

A
.cm
-2
Figure 4-16 
A plot of the KM values (red points) and Jmax (green points) obtained when the number of enzyme dips 
used in the recipe PtD-PPD-Naf1%x3-GA25%x3-Enzymex? were varied. The enzyme solution used 
was also changed with the purple line connecting results obtained using a 600U+A solution and the 
blue line connecting results from a 600UH2O solution. 
It is interesting to note, and easier to observe, that the observed KM appears to reduce as 
dips of enzyme are increased for both solutions. However, the Jmax tends to also 
decrease, except in the case of the 600U+A solution. This could point to a beneficial 
effect whereby if the enzyme is tempered or stabilised by an appropriate set of other 
components increasing number of dips could allow a continued decrease in KM and 
increase in Jmax. 
Although the additives showed the possibility for potential benefits in biosensor design 
they were not found to have a pronounced effect over a large range of recipes for them 
to be considered for all future designs. This is especially true when one considers that 
the solution of ᴅAAO, PBS, glycerol and BSA “went off” after three days. Black lumps, 
of an undetermined nature, most likely a mould or fungus, were discovered to appear in 
the solution after this length of time. These lumps were also found in the PBS, glycerol 
and BSA solution which was prepared previous to the addition of the ᴅAAO. Taking 
this into account it was decided that this combination of additives was unsuitable for 
long term, multiple uses because of the limited shelf life of the solution and the 
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uncertainty in what was occurring and what effect it was having on the 
solution/enzyme. 
4.7 Combined Alterations to the Biosensor Recipe 
All the results from the preceding sections and experiments (from Section 4.2 to Section 
4.6.2) indicated that changing one component of a biosensor recipe in isolation 
produced varying and unpredictable changes in sensitivity. Thus it was decided that a 
compound approach whereby one or more aspects of the recipe were changed 
simultaneously should be examined. These compound changes related to changes in; the 
PPD layer formed, the GA % used and the enzyme solution. 
4.7.1 Enzyme Solution pH Changes Combined with GA Changes 
The first combined change to be examined involved the alteration of the ᴅAAO solution 
between 600UH2O and a 600 U.mL
-1
 solution made up in PBS pH 8.5 (600UPBS). 
These solutions were used in a PtD-PPD-Naf1%x3-GAx3-Enzymex5 recipe where the 
GA % used was 2% and 25%. GA 2% was chosen as it was the percentage which 
showed the most similar results to 25% in previous testing, see Figure 4-7 in Section 
4.5. Yet, 2% is a much lower concentration and hopefully would not have a detrimental 
effect on the enzyme solution over time. The decision to use PBS at pH 8.5 was 
influenced by its use in the additives described previously in Section 4.6.2.  
The results of these combined changes provide some interesting information. The first 
and possibly most important point is that the biosensors made with the 600UPBS 
solution provide significant enhancement of desired properties in the case of both 2% 
GA and 25% GA. This can be seen in Table 4-9 and Figure 4-17 where, in the case of 
2% GA, the 600UPBS Jmax is increased over the 600UH2O, p = 0.0002***, and the KM 
is not significantly different, p = 0.6604. When 25% GA was used the Jmax increased 
significantly, p = 0.0012**, and the KM again was not significantly changed, p = 
0.6345. Combined this meant that there was a significant increase in the LRS of both 
sets, p < 0.0001*** for 2% GA and p = 0.0031** for 25% GA. 
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Electrode Design 
GA 2%, 
600UH2O, n = 4 
GA 2%, 
600UPBS, n = 3 
GA 25%, 
600UH2O, n = 4 
GA 25%, 
600UPBS, n = 7 
Kinetics M-M, p = 0.0569 
M-M-H, 
p=0.0026 
M-M, p = 0.2311 M-M, p = 0.3782 
R
2
 0.9979 1.000 0.9940 0.9932 
Jmax, µA.cm
-2
 20.70 ± 1.18 36.05 ± 0.84 18.02 ± 1.35 29.13 ± 1.60 
KM, µM 9506 ± 919 10045 ± 463 4409 ± 641 3999 ± 511 
α  0.9588 ± 0.0101   
LRS,µA.cm
-2
.mM
-
1
 
2.177 ± 0.092 3.589 ± 0.083 4.086 ± 0.307 7.284 ± 0.568 
Table 4-9 
Kinetic parameters, fit, Jmax, KM and A values calculated from the calibration data in Table 9-9. Jmax, KM, 
LRS and α are presented as Mean ± SEM. 
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Figure 4-17 
J-concentration plot for the comparison of PtD-PPD-Naf1%x3-GAx3-Enzymex5. The purple trace 
represents biosensors formulated with 25% GA and 600UPBS, and the pink trace 25% GA and 
600UH2O. Biosensors made with 2% GA and 600UPBS are depicted in red and the orange trace plots 
2% GA and 600UH2O. Both sets of data are taken from Table 9-9 and Table 4-9. Traces are plotted as 
Mean J ± SEM with fitted kinetic curve. 
Comparing the 2% GA 600UPBS and the 25% GA 600UPBS it is seen that the 2% GA 
has a significantly higher Jmax value, p = 0.0281*, but that the 2% GA has a significantly 
higher KM, p = 0.0001***. This results in the 25% GA 600UPBS still having 
significantly higher LRS than the 2% GA equivalent, p = 0.0034**.  
The 2% 600UPBS biosensors have a significantly higher Jmax compared to the 25% GA 
600UH2O, p = 0.0001***, although the KM is significantly higher, p = 0.0012**. This 
combination results in LRS values that are non-significantly different, p = 0.2372. Thus 
formulation the enzyme solution with PBS pH 8.5 rather than neutral deionised water 
appears to increase the sensitivity of the biosensors.  
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Noteworthy too is the fact that the 2% GA 600UPBS is the only formulation displaying 
M-M-H kinetics. While this is a positive indication it is however offset by the fact that it 
also has the largest KM value of the four designs. So despite this design having the 
largest Jmax combined with M-M-H kinetics, it was not the result that was being 
searched for, as demonstrated by its poor LRS. 
4.7.2 Different Polymer Growth Methods Combined with an Altered GA % 
and Enzyme Solution Changes 
Continuing with the PtD-PPD-Naf1%x3-GAx3-Enzymex5 recipe which utilised now 2% 
GA and not 25%, a further set of changes was examined. These changes involved the 
continuing examination of the 600UH2O and 600UPBS enzyme solutions. Further 
alterations now included examination of the PPD layer. Initial reports from Z.M. Zain 
discussed the use of CPA to grow the PPD layer, however as previously noted (see 
Section 4.2) by the time of publication (Zain et al., 2010) this had changed to a CV 
growth method. Both methods are described in Section 3.5.3. 
The polymer alterations were thus; the use of the CPA technique (PPD), the use of the 
CV technique (PPDcv) and a variant of the CPA technique (PPDa). This variant involved 
a less stringent application of the completely N2 saturated process that would be 
normally followed. Once polymerisation had begun the solution was exposed to the 
atmosphere (as denoted by the a in the nomenclature) allowing a certain degree of 
‘oxidised’ polymer formation to occur (see Section 2.8.4). The reason for this was that, 
as previously stated, the type of polymerisation that occurs and the structure of the 
polymer is still greatly disputed and while previous research by the group indicates that 
complete nitrogen saturation provides a more selective membrane, the effect of nitrogen 
saturation during polymerisation on sensitivity was one which was desirable to explore. 
It is also impossible to compare the degree of nitrogen saturation achieved by different 
studies and groups. Thus by comparing different controlled polymerisation methods 
within this study it was considered possible to discover useful comparisons. Thus four 
new sensor designs were created, using PPDcv/PPDa, 2% GA and 600UPBS/600UH2O. 
These were compared to the PPD, 2% GA, 600UPBS/600UH2O examined previously, 
in Section 4.7.1. Examining the data in Table 4-10 and Table 4-9 we see the 
continuation of the trend whereby the use of 600UPBS either increases the Jmax or 
decreases the KM substantially. This further leads to an improvement in the LRS across 
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the three different polymerisation methods utilised when compared to the 600UH2O 
alternative. 
Electrode Design 
PPDa, 2% GA, 
600UH2O, n = 
4 
PPDa, 2% GA, 
600UPBS, n = 
4 
PPDcv, 2% GA, 
600UH2O, n = 
8 
PPDcv, 2% GA, 
600UPBS, n = 
4 
Kinetics 
M-M-H, 
p < 0.0001 
M-M, 
p = 0.6136 
M-M, 
p = 0.3781 
M-M-H, 
p = 0.0001 
R
2
 1.000 0.9995 0.9956 0.9999 
Jmax, µA.cm
-2
 42.09 ± 1.18 36.05 ± 0.62 22.33 ± 1.61 58.98 ± 2.74 
KM, µM 11974 ± 663 5177 ± 188 7993 ± 1039 12741 ± 1195 
α  0.9323 ± 0.0104  0.9244 ± 0.0242 
LRS, µA.cm
-2
.mM
-
1
 
3.515 ± 0.096 6.964 ± 0.143 2.794 ± 0.172 4.629 ± 0.220 
Table 4-10 
Kinetic parameters, fit, Jmax and KM values calculated from the calibration data in Table 9-10. Jmax, KM, 
α and LRS are presented as Mean ± SEM. 
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Figure 4-18 
J-concentration plot for the comparison of PtD-PPD-Naf1%x3-GA2%x3-600UH2Ox5. The orange trace 
signifies PPD (taken from Figure 4-17). The green trace represents PPDa. The blue trace represents 
PPDcv. Both sets of data are taken from Table 9-10 and Table 4-10. Traces are plotted as Mean J ± 
SEM with fitted kinetic curve. 
Firstly it is necessary to analyse the 600UH2O recipes collectively. In Figure 4-18 can 
be seen the composite J-concentration plot for the three 2% GA and 600UH2O recipes. 
The most noticeable difference between the recipes is that the PPD recipe (orange trace, 
in keeping with that of Figure 4-17) and the PPDcv recipe (blue trace) produce 
significantly lower sensitivities than the PPDa alternative. This is interesting as the 
former PPD layers are polymerised under strict conditions of N2 saturation, whereas 
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PPDa is exposed to the atmosphere during the polymerisation process, while all 
solutions were prepared under the same conditions of N2 saturation. 
Comparing PPDa to PPD and PPDcv it can be seen that its Jmax is significantly higher, 
both p < 0.0001***, and the KM is unchanged, p = 0.3743 and p = 0.0534 respectively, 
leading to and LRS value which is also significantly higher, p < 0.0001*** and p = 
0.0186* respectively. The differences between PPD and PPDcv are minimal. The Jmax of 
PPD is not significantly different, p = 0.5233, and neither is the KM, p = 0.2176. 
However the LRS of PPD is significantly lower, p = 0.0368. 
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Figure 4-19 
J-concentration plot for the comparison of PtD-PPD-Naf1%x3-GA2%x3-600UPBSx5. The red trace 
signifies PPD (taken from Figure 4-17). The green trace represents PPDa. The blue trace represents 
PPDcv. Both sets of data are taken from Table 9-10 and Table 4-10. Traces are plotted as Mean J ± 
SEM with fitted kinetic curve. 
Turning now to look at the three 600UPBS recipes collectively in Figure 4-19 it is 
possible to see similar trends. Again, it is observed that the PPD recipe (red trace as in 
Figure 4-17) has a lower sensitivity than the PPDa (green trace) and PPDcv (blue trace). 
Its Jmax is non-significantly different from PPDa, p > 0.9999, and significantly lower 
than PPDcv, p = 0.0010**. The KM is significantly higher than that of PPDa, p = 
0.0001***, and non-significantly different from the PPDcv value, p = 0.1253. As with 
600UH2O this leads the PPD 600UPBS to have a significantly lower LRS than either 
PPDa or PPDcv, p < 0.0001*** and p = 0.0119* respectively.  
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As in the case of the PPD with 600UPBS and 600UH2O (see Section 4.7.1) the use of 
the 600UPBS with PPDa and PPDcv improves at least one kinetic parameter and thus the 
LRS. For PPDa it is seen that the Jmax is decreased for 600UPBS, p = 0.0040**, however 
the KM is also drastically reduced, p < 0.0001***, leading to an overall increase in LRS, 
p < 0.0001***. The Jmax of PPDcv is increased, p < 0.0001***, the KM is increased also, 
p = 0.0193*, but together, again, they lead to a significant increase in the LRS, p < 
0.0001***, when 600UPBS is utilised in the recipe. 
The percentage error in each of the sensors using different polymerisation method is 
also noted to decrease with the use of 600UPBS. For example, consider the Jmax values, 
as a percentage of the mean the SEM decreases in all cases. The PPD error reduces from 
5.70% to 2.33%, the PPDa error reduces from 2.80% to 1.72%, and for PPDcv it reduces 
from 7.21% to 4.65%. Similar results are found for KM and LRS values. Thus it also 
appears that 600UPBS produces more consistent biosensors, as it may be reducing 
variation in the enzyme solutions – water solutions being unbuffered are subject to pH 
variations. 
Finally noteworthy also is the enzymatic fit differences. Unfortunately although some 
recipes do display a better M-M-H fit, they are blighted by high KM values and thus no 
advantage is gained. 
4.8 Variations to the Biosensor Formulation Based on Previously 
Designed Biosensors 
Lastly of interest in this exploration was whether any techniques or chemicals used 
previously could enhance the sensitivity of the sensors or provide any useful 
information. This included examining different binding techniques, stabilisers and bio-
molecules. 
The use of PEI was one of particular interest in this broadening of parameters 
investigated. This is an interesting molecule as it is a polymeric substance which has 
polycationic structure and has been used widely in sensors before (Belay et al., 1999; 
Patel et al., 2000). It has been used to secure and stabilise substances to the surface of 
an electrode (Jezkova et al., 1997; Cox et al., 2003) and to increase efficiency of 
enzymes after other substances have reduced it (McMahon et al., 2006; Bolger, 2007; 
Haughton, pending publication). 
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Widely used also has been either BSA on its own (Ryan et al., 1997; Pernot et al., 2008) 
or in a solution combined with glutaraldehyde, BSAGA (Hu & Wilson, 1997; 
Burmeister & Gerhardt, 2001; O'Brien et al., 2007). 
Of interest also was the FAD moiety. This molecule is the actual site within the ᴅAAO 
structure where the electron transfer processes take place. Addition of further quantities 
of FAD to biosensor designs is an approach that has been examined before with some 
degree of success (Haughton, pending publication) 
4.8.1 Alternative Methods for Primary Binding of ᴅAAO 
Thus it was decided to try alternative methods of binding the ᴅAAO to the surface. 
These methods constituted the use of both PEI and BSAGA as binding elements. In 
addition to this a duplication of the GA and ᴅAAO layering from the standard recipe 
was also considered. 
4.8.1.1 Duplication of Layering 
It was hoped that a repetition of the layers of the cross-linking agent, GA, and the 
enzyme, 600UH2O could improve the sensitivity or kinetics parameters of the sensor. 
This effect had been observed before within the group (Haughton, pending publication). 
Thus the PtD-PPD-Naf1%x3-GA2%-600UH2Ox5 recipe was altered to take the form 
PtD-PPD-Naf1%x3-[GA2%x3-600UH2Ox5]x2. 2% GA was chosen as it was hoped to 
provide a good level of cross-linking without the detrimental effects of 25% GA as 
discussed previously (Section 4.3). 
The data for PtD-PPD-Naf1%x3-GA2%x3-600UH2Ox5 was previously presented in 
Section 4.7.1 and depicted as the orange trace in Figure 4-17. It is restated here for 
clarity and easier comparison. It was seen previously that its sensitivity could be 
improved by using 600UPBS, but it was decided to utilise 600UH2O to retain 
consistency with the original recipes. 
It is quite clear from examining the data in Table 4-11 that there is an advantage to be 
gained from doubling the layers of GA and 600UH2O. The Jmax has doubled in value, a 
significant difference, p = 0.0003***, however the KM has also increased, p = 0.0298*. 
Overall this does lead to an improved LRS, p = 0.0001***.  
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Electrode Design 
PtD-PPD-Naf1%x3-[GA2%x3-
600UH2Ox5]x2, n = 4 
PtD-PPD-Naf1%x3-GA2%-
600UH2Ox5, n = 4 
Kinetics M-M, p = 0.1964 M-M, p = 0.0569 
R
2
 0.9996 0.9979 
Jmax, µA.cm
-2
 42.94 ± 2.738 20.70 ± 1.18 
KM, µM 13578 ± 1104 9506 ± 919 
LRS,µA.cm
-2
.mM
-
1
 
3.162 ± 0.058 2.177 ± 0.092 
Table 4-11 
Kinetic parameters, fit, Jmax and KM values calculated from the calibration data in Table 9-11. Jmax, KM 
and LRS are presented as Mean ± SEM. 
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Figure 4-20 
J-concentration plot for the comparison of PtD-PPD-Naf1%x3-GA2%x3-600UH2Ox5 (yellow trace) 
and PtD-PPD-Naf1%x3-[GA2%x3-600UH2Ox5]x2 (red trace). Both sets of data are taken from Table 
9-11 and Table 4-11. Traces are plotted as Mean J ± SEM with fitted kinetic curve. 
Although this was a positive result, the increased size of the linear region as denoted by 
the larger KM was not a desired outcome. It is also worth noticing that the Jmax of the 
double layered biosensors is not significantly different, p = 0.529, than the single 
layered 600UPBS biosensors in Section 4.7.1, which also has a lower KM, p = 0.0256*, 
and a better LRS, p = 0.0056**. 
4.8.1.2 Use of PEI as a Binding Agent 
As a preliminary examination of the usefulness of PEI as binding agent in combination 
with the original recipe, 1 layer of 1% PEI was included before the enzyme dips. This 
resulted in the biosensor recipe PtD-PPD-Naf1%x3-GA25%x3-PEI1%-600UH2Ox5. 
The hope was that the positive charges in the PEI structure would interact favourably 
with negatively charged groups (amino acid residues) on the outside of the enzyme. The 
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use of aminated molecules and PEI in particular has been shown to substantially 
increase the stability of not only ᴅAAO but glucose oxidase and other enzymes (Alonso 
et al., 2005; López-Gallego et al., 2005a; López-Gallego et al., 2005c). This was hoped 
would lead to a better orientation of the enzyme or a more secure binding to the surface 
without compromising functionality. 25% GA was used in order to keep comparisons 
true to the original recipe. 
The calibration data for PtD-PPD-Naf1%x3-GA25%x3-PEI1%-600UH2Ox5 is presented 
in Table 9-12 and Table 4-12 and displayed in Figure 4-21.  
What is immediately clear from examining the data obtained above is that the use of 
PEI has had a hugely detrimental effect on all kinetic aspects of the biosensors. The Jmax 
calculated is not significantly different, p = 0.0919, however the LRS is significantly 
worse than the original recipe, p < 0.0001***. The KM value is difficult to consider, it is 
extremely large, well outside of the calibrated range and the error calculated for it is so 
large that, despite the mean value being nearly eight times larger than the original, there 
is no significant difference in the values, p = 0.0654.  
Electrode Design 
PtD-PPD-Naf1%x3-GA25%x3-
PEI1%-600UH2Ox5, n = 4 
PtD-PPD-Naf1%x3-GA25%x3-
600UH2Ox5, n = 4 
Kinetics M-M-H, p < 0.0001 M-M, p = 0.2311 
R
2
 0.9998 0.9940 
Jmax, µA.cm
-2
 11.77 ± 2.811 18.02 ± 1.35 
KM, µM 73601 ± 30744 4409 ± 641 
α 0.7815 ± 0.0209  
LRS,µA.cm
-2
.mM
-1
 0.1599 ± 0.0287 4.086 ± 0.307 
Table 4-12 
Kinetic parameters, fit, Jmax, A and KM values calculated from the calibration data in Table 9-12. Jmax, α 
and KM are presented as Mean ± SEM. 
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Figure 4-21 
J-concentration plot of PtD-PPD-Naf1%x3-GA25%x3-PEI1%-600UH2Ox5 (green trace), the data is 
taken from Table 9-12 and Table 4-12. PtD-PPD-Naf1%x3-GA25%x3-600UH2Ox5 (yellow trace) is 
taken from Table 9-11 and Table 4-11. Traces are plotted as Mean J ± SEM with fitted kinetic curve. 
Taken together, these parameters appear to indicate, according to best data, that there is 
a very large initial linear range, before the levelling off as per M-M-H kinetics. But in 
the linear region the current increases only very slowly. It was quite clear that adding 
PEI to the recipe without incorporating any other compounds was not likely to lead to a 
beneficial outcome; indeed incorporating it appears that the positive charges could be 
repelling ᴅAAO, preventing it from binding to the surface. Furthermore it appears the 
PEI is preventing ᴅ-ser from reaching the enzyme in the normal diffusion-controlled 
manner, possibly due to its interaction with the charges which are present on ᴅ-ser, 
which has a zwitterionic from at neutral pH. 
4.8.1.3 Binding ᴅAAO using PEI and BSAGA 
Having realised that PEI on its own was not likely to enhance the sensitivity of the 
biosensors it was decided to consider it in conjunction with other additions to the recipe. 
The first of these to be examined was the BSAGA combined solution (see Section 
3.2.2). This solution, as previously stated at the start of Section 4.8.1, is a particular 
formulation of two substances that are widely used in the production of biosensors. It 
combines the cross-linking agent GA and the protein BSA which can serve to provide a 
non-severe, natural environment for an enzyme to function. This is because BSA is rich 
in lysine residues, residing primarily on the outside of the protein, and these are the 
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most favourable bonding sites for GA. Thus this solution can be a very successful 
stabilising agent when immobilising enzymes onto a surface. 
It was decided to examine two variants of the original recipe that would incorporate PEI 
and BSAGA. Having previously seen that the addition of PEI before the enzyme layers 
had drastically reduced the efficiency of the biosensor it was decided to add it after the 
enzyme layers had been applied. The BSAGA solution used was made with 1% v/v GA 
and 1% w/v BSA. The recipes devised were PtD-PPD-Naf1%x3-GA25%x3-
600UH2Ox5-PEI1%-BSAGA and PtD-PPD-Naf1%x3-600UH2O-PEI1%-BSAGA. It 
was hoped these would elucidate better the binding potential of both the PEI and 
BSAGA, whether using PEI after the enzyme layers could positively affect the 
sensitivity, and whether in combination they could securely bind the enzyme to the 
surface with or without the use of GA. 
Upon examining the calibration data in Table 9-13 and Table 4-13 it is easy to see there 
is a large difference between the two recipes. Looking at the graphic in Figure 4-22 this 
difference becomes even more apparent. The recipe without the GA dip (red trace) is 
vastly inferior to the recipe with the GA included (PtD-PPD-Naf1%x3-GA25%x3-
600UH2Ox5-PEI1%-BSAGA, green trace). 
Comparing the two recipes it can be seen that the Jmax of the recipe including GA (green 
trace) is significantly higher than that without GA (red trace), p = 0.0019**. Similar to 
the PEI recipe discussed just previously it can be seen again that the KM value has 
increased hugely, to a mean value that is four times the maximum concentration 
calibrated for an error which is twice as large. Thus statistically there is no significant 
difference in the KM values, p = 0.2475.  
Electrode Design 
PtD-PPD-Naf1%x3-600UH2Ox5-
PEI1%-BSAGA, n = 4 
PtD-PPD-Naf1%x3-GA25%-
600UH2Ox5-PEI1%-BSAGA, n = 
4 
Kinetics M-M-H, p = 0.0001 M-M, p = 0.9353 
R
2
 0.9991 0.9901 
Jmax, µA.cm
-2
 3.306 ± 0.876 36.75 ± 3.13 
KM, µM 30178 ± 16880 5956 ± 1014 
α 0.7257 ± 0.0374  
LRS,µA.cm
-2
.mM
-
1
 
0.110 ± 0.032 6.170 ± 0.560 
Table 4-13 
Kinetic parameters, fit, Jmax and KM values calculated from the calibration data in Table 9-13. Jmax, α, 
KM and LRS are presented as Mean ± SEM. 
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Figure 4-22 
J-concentration plot of PtD-PPD-Naf1%x3-GA25%x3-600UH2Ox5-PEI1%-BSAGA (green trace) and 
PtD-PPD-Naf1%x3-600UH2Ox5-PEI1%-BSAGA (red trace). The data plotted is taken from Table 9-13 
and Table 4-13. Traces are plotted as Mean J ± SEM with fitted kinetic curve. 
There is a significant difference in the LRS values with the GA recipe being 
significantly higher, p < 0.0001***. It appears that with sufficient quantities of GA the 
ᴅAAO will not be negatively influenced by Naf, as previously seen in the case of PtD-
PPDcv-Naf1x3%-GA0.5%x3-600UH2Ox5 in Section 4.5. It is possible that the exterior 
layer of BSAGA is not affecting the enzyme at all and that in fact it is cross-linking the 
PEI. As such for the green trace the first layer of GA is functioning to retain the enzyme 
and the PEI is interacting minimally with the ᴅAAO and mainly with the BSAGA. In 
the recipe without an initial GA layer (red trace) it is probable that the ᴅAAO will 
absorb onto the Naf, as seen in Section 4.4, but that the PEI layer on top of this is 
detrimental to the activity of the enzyme without it being stabilised by the first GA 
layer. 
If consideration is given to the original starting recipe of PtD-PPD-Naf1%x3-GA25%x3-
600UH2Ox5, as examined in Section 4.3, and PtD-PPD-Naf1%x3-GA25%x3-
600UH2Ox5-PEI1%-BSAGA some significant changes are observed. The Jmax is 
increased, p = 0.0015**, the KM is non-significantly different, p = 0.2446. Combined, 
this produces a significantly higher LRS, p = 0.0006***. Thus the inclusion of PEI and 
BSAGA can produce a significant improvement in the kinetic parameters, although it is 
likely to only affect diffusion of substrates and provide a further protective and retention 
layer on top of the ᴅAAO.  
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When comparing PtD-PPD-Naf1%x3-GA25%x3-600UH2Ox5-PEI1%-BSAGA to the 
un-modified PtD-PPD-Naf1%x3-GA25%x3-600UPBSx5 there are some differences to 
observe. The Jmax of the PEI-BSAGA biosensors is significantly higher, p = 0.0380*. 
However the KM is non-significantly different with the PEI and BSAGA added, p = 
0.0843. Overall this yields a lower, but not significantly lower LRS of 6.170 ± 0.560 
µA.cm
-2
.mM
-1
, p = 0.1012. The inclusion of the PEI and BSAGA can be considered a 
significant improvement yielding approximately the same benefit as the change from 
600UH2O to 600UPBS. 
4.8.2 Further Alterations Including FAD 
As discussed in Section 2.8.2 the FAD unit which lies at the heart of the ᴅAAO 
structure is the component part which undergoes reduction as the amino acid is oxidised 
to an imino acid. This unit is then re-oxidised by molecular oxygen. Therefore it was of 
interest to discover could provision of extra quantities of this unit increase the turnover 
rate of the enzyme and thus increase the sensitivity of the biosensors. 
Two recipes were devised which were hoped would provide some indication of whether 
FAD could be incorporated with a beneficial effect. These recipes were PtD-PPD-
Naf1%x3-PEI1%-600UPBSx5-FAD and PtD-PPD-Naf1%x3-GA25%x3-PEI1%-
600UPBSx5-FAD. These two recipes put the PEI before the ᴅAAO again to examine 
would the FAD increase the sensitivities and at the GA primary binding layer. 
Electrode Design 
PtD-PPD-Naf1%x3-GA25%-
PEI1%-600UH2Ox5-FAD, n = 4 
PtD-PPD-Naf1%x3-PEI1%-
600UH2Ox5-FAD, n = 4 
Kinetics M-M-H, p < 0.0001 M-M, n/c 
R
2
 0.9997 0.9861 
Jmax, µA.cm
-2
 26.25 ± 5.266 0.2520 ± 0.0192 
KM, µM 46340 ± 18831 4100 ± 720 
α 0.7335 ± 0.0248  
LRS,µA.cm
-2
.mM
-
1
 
5.664 ± 1.169 0.0615 ± 0.0065 
Table 4-14 
Kinetic parameters, fit, Jmax and KM values calculated from the calibration data in Table 9-14. Jmax, KM, 
α and LRS are presented as Mean ± SEM. 
The calibration data and kinetic parameters obtained for the two recipes are listed in 
Table 9-14 and Table 4-14 respectively, and is graphically represented below in Figure 
4-23; 
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Figure 4-23 
J-concentration plot of PtD-PPD-Naf1%x3-GA-PEI1%-600UH2Ox5-FAD (red trace) and PtD-PPD-
Naf1%x3-PEI1%-600UH2Ox5-FAD (blue trace). The data plotted is taken from Table 9-14 and Table 
4-14. Traces are plotted as Mean J ± SEM with fitted kinetic curve. 
Following on from the trend seen in Sections 4.5 and 4.8.1.3, it is again apparent that 
without sufficiently concentrated GA or in the complete absence of GA there is little or 
no binding of ᴅAAO to the surface of the sensor, and that PEI could be denaturing the 
enzyme. This is shown by the drastically reduced current density of PtD-PPD-Naf1%x3-
PEI1%-600UPBSx5-FAD in the above figure (blue trace). Its Jmax is significantly lower 
than the alternative with 25% GA, p = 0.0159*. The KM concentration again is difficult 
to analyse. As seen previously, when PEI was included in a recipe with GA, the KM 
becomes very large and the SEM also becomes very large as a percentage of the mean. 
Thus there is no significant difference between the two values, p = 0.1108. The LRS of 
the recipe with GA does have a larger LRS, p = 0.0230*. 
Comparing PtD-PPD-Naf1%x3-GA25%-PEI1%-600UH2Ox5-FAD to PtD-PPD-
Naf1%x3-GA25%x3-PEI1%-600UH2Ox5 from Section 4.8.1.2 it is possible to examine 
the influence of FAD on the recipe. It is clear that the FAD does have an effect, the Jmax 
is larger, although not significantly, p = 0.0515, and there is no difference in the KM 
values, p = 0.4782. However the combined analysis exhibited by the LRS is 
significantly higher, p = 0.0432*. Thus some marginal benefit on sensitivity was gained 
by the incorporation of FAD. 
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4.9 Conclusions 
The beginning of this project was aimed at replicating a biosensor that had already been 
designed (Zain et al., 2010). However, it was quickly determined that the proposed 
design, while being a solid basis for the development of a chronic in vivo biosensor, had 
its problems. The main issue was reproducibility, which was attainable only be use of 
an entirely fresh set of solutions every time a sensor was being fabricated. This was an 
impractical situation as the ᴅAAO was not easy to procure at the required activity and it 
was also expensive.  
Preliminary examination of the proposed recipe revealed a number of potential causes 
of the reproducibility problem, based on previous experience within the group and from 
the methodologies and published results from other groups. Thus I set out to explore the 
construction of this biosensor with the aim of optimising it. 
The first issue was the use of Naf after the PPD film had been applied, despite it being 
shown that Naf has strong interference rejection capabilities. It had been shown before 
that this approach led to a reduction in the efficiency of the interference rejection 
properties of biosensors. In cases where PPD is used to reject interferents it is more 
desirable to place the Naf layer underneath the PPD. It is hypothesised that the alcohol 
used in Naf solutions interacts with the polymer. This is difficult to prove however as 
the exact structure of PPD is yet to be elucidated (Section 2.8.4). Never the less it was 
an unusual formulation. 
Secondly, the use of GA at a concentration of 25% was highly unusual. While not 
unheard of, at this concentration GA is typically applied by vapour saturation, rather 
than directly dipping the biosensor into the solution. As previously stated when directly 
applied to the surface of an electrode it is more commonly used at a concentration 
between 2.5% and 0.01%. Thus an investigation was conducted in all aspects of the 
proposed design to elucidate the contribution of each component part and discover any 
benefits of changes that could be considered. 
Initial examination began with the Naf layers applied after the PPD and before the GA 
25%. It was shown that the benefits of the Naf are questionable, beyond a possible 
increase in interference rejection over PPD alone. It appears to interact with the PPD to 
yield a self contained layer that GA appears to have little affinity for. Without the PPD 
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layer the Naf interacts with the GA to reduce the sensitivity of the sensors to a value 
less than if the ᴅAAO was purely adsorbed onto the surface. 
With regard to the GA it appears that the 25% GA is so concentrated that it denatures 
the enzyme, creating too many interactions between the molecules. It was shown that 
approximately the same, 2% GA, and much better, 1% GA, sensitivities are obtainable 
without compromising the enzyme solution. 
Changing the supplier of the enzyme, or rather the activity it was supplied at, did not 
have any beneficial effects, as the original supplier supplied the highest activity form of 
the enzyme. However, changing the enzyme solution from 600UH2O to 600UPBS, 
where the PBS is at pH 8.5, significantly increases sensitivity across the board as well 
as possibly decreasing error and increasing reproducibility. 
Using different polymer growth methods also changed the sensitivity. However, only in 
a situation where there was a possibility of compromising the integrity of the PPD layer 
by decreasing the N2 saturation of the polymerisation process. The use of PEI as a 
binding agent only produced an improvement in the kinetic parameters of the biosensors 
when used in conjunction with BSAGA after the enzyme had been applied. This may be 
due solely to the BSAGA as using PEI before the enzyme was detrimental to sensitivity 
in all cases. FAD also served to improve the sensitivity of biosensors that contained 
PEI. Finally the duplication of layers of GA and ᴅAAO did provide a significant 
increase in the LRS and shows promise. 
Overall, it was possible to reproduce the desired sensitivities, but not in a manner which 
was robust enough for the purposes of a chronic in vivo biosensor. It was not possible, 
despite extensive investigation, to optimise the biosensor design for our needs. An 
alternative would have to be produced, which would be aided greatly by the information 
gleamed in this section of work. 
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5.1 Introduction 
Having thoroughly investigated the possibilities of altering the formulation of the Z.M. 
Zain ᴅ-ser biosensor it was accepted that a different approach was necessary to arrive at 
a recipe which would, without exorbitant costs, fulfil sensitivity requirements and be 
stable enough for chronic in vivo use. To do this it was decided to start at the very 
beginning of the design process and use the information previously gleamed as a rough 
guide. 
It was decided at the beginning of this process that based on previous experience it was 
necessary to combine the elements of the biosensor in a more integrated manner. This 
would mean that different substances would be interspersed within the proposed recipes 
and not layered exclusively. For example the previous design applied the Naf layers 
first, then the GA layers and finally the enzyme. Now the approach was to place layers 
of different substances within the layers of enzyme. 
Consideration also was given to the need to have a primary binding matrix other than 
GA. This was due to the fact that it had been shown that the concentrated 25% enzyme 
was detrimental to the enzyme and that lower percentages opened up the possibility of 
not binding the enzyme to the surface of the electrode with sufficient strength. Thus it 
was decided to use Styrene as an immobilisation matrix, within which all of the other 
compounds would hopefully be bound securely without sacrificing sensitivity or 
function of the biosensor. Styrene had previously been shown to be effective in this 
manner within the group during the design of lactate (Bolger, 2007), aspartate and 
glutamate biosensors (Haughton, pending publication). It has also been widely used by 
other groups where it has been used as a functionalised backbone of the sensor (Poyard 
et al., 1999; Xu & Han, 2004), as a bonding layer (Shimizu et al., 1994) or as a 
substance into which the enzyme was immobilised (Volotovsky & Kim, 1998). In the 
case of this project it was to be used as a monomeric solution into which hopefully the 
other substances would be immobilised as the slow thermal/UV-initiated polymerisation 
takes place. Its use in such circumstances has been characterised by other group 
members, and the data was communicated personally. The basic configuration, of most 
biosensors discussed within this chapter, is as depicted in Figure 5-1. All alterations 
discussed in this chapter centre on this design with various layers being omitted or 
modified or added as detailed in each section. 
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Figure 5-1 
The basic configuration of biosensors discussed within Chapter 5. 
5.2 Basic Constructs of a Biosensor 
5.2.1 Adsorption of ᴅAAO 
The initial stage of the design of a new biosensor began with the simple physical 
adsorption of the enzyme onto the bare metal surface. The aim was to provide basic 
information on the amount of layers of enzyme that could be applied, without the 
addition of a binding agent, before they became self-limiting. This could happen 
because successive layers could block the access of the substrate to the initial layers, or 
because the mass of adsorbed material could pull previously applied quantities of 
substrate off the surface. Either method would cause the sensitivity to cease to increase, 
after a point, or start to decrease. 
To examine this possibility four sensor recipes were examined, PtD-600UH2O, PtD-
600UH2Ox5, PtD-600UH2Ox10 and PtD-600UH2Ox15. The calibration data and kinetic 
considerations obtained are listed in Table 10-1 and Table 5-1. 
The collected calibration data and kinetic fit is plotted in Figure 5-2. The most 
important piece of information that can be immediately gleamed from this diagram and 
the above data is that without a binding agent of any sort the amount of ᴅAAO which 
can be adhered to surface is minimal. The current density across the four recipes is very 
low. 
Examining the findings in more detail another point that becomes quite obvious is that 
with only one dip in the enzyme solution, PtD-600UH2O, there is very little enzyme on 
the surface. Comparing the four designs what is also apparent is the large degree of 
Pt/Ir Disk Surface 
Glutaraldehyde (GA) 
Styrene 
FAD 
ᴅAAO 
PEI 
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error associated with creating the sensors without a binding agent. This only decreases 
for 15 layers of enzyme which appears to suggest that it is quantity of layers ensuring 
uniformity. 
Electrode 
Design 
PtD-600UH2O 
n = 4 
PtD-600UH2Ox5 
n = 3 
PtD-
600UH2Ox10 
n = 4 
PtD-
600UH2Ox15 
n = 4 
Kinetics M-M, n/c 
M-M-H, 
p=0.0003 
M-M-H, 
p=0.0358 
M-M-H, 
p<0.0001 
R
2
 0.1443 0.9975 0.9994 0.9996 
Jmax, µA.cm
-2
 -0.1650 ± 0.0721 3.544 ± 1.271 1.818 ± 0.211 1.053 ± 0.153 
KM, µM 157.5 ± 412.6 18555 ± 15883 8790 ± 1947 14943 ± 4253 
α  0.6739 ± 0.0577 0.9148 ± 0.0347 0.8169 ± 0.0276 
LRS, 
µA.cm
-2
.mM
-
1
 
-1.047 ± 2.440 0.1910 ± 0.0952 0.2068 ± 0.0292 0.0705 ± 0.0099 
Table 5-1 
Kinetic parameters, fit, Jmax and KM values calculated from the calibration data in Table 10-1. Jmax, KM, 
α and LRS are presented as Mean ± SEM. 
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Figure 5-2 
J-concentration plot of the four recipes where 600UH2O was purely adsorbed onto the surface. 
Depicted are PtD-600UH2O (red trace), PtD-600UH2Ox5 (purple trace), PtD-600UH2Ox10 (green trace) 
and PtD-600UH2Ox15 (blue trace). The data plotted is taken from Table 10-1 and Table 5-1. Traces 
are plotted as Mean J ± SEM with fitted kinetic curve. 
Kinetically, if PtD-600UH2Ox5 is compared to PtD-600UH2Ox10 it is seen that there is 
no significant difference in Jmax, p = 0.3123, the KM, p = 0.6038, or LRS, p = 0.8864. 
Indeed there is no significant difference when any of the values of Jmax, KM or LRS are 
compared with each other for the three recipes, PtD-600UH2Ox5, PtD-600UH2Ox10 and 
PtD-600UH2Ox15, except in one case of the LRS values of the latter two recipes, p = 
0.0013**, where PtD-600UH2Ox10 has a higher sensitivity. Thus despite the visual 
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depiction of a decreasing sensitivity from 5 to 10 to 15 dips of enzyme this is not borne 
out by the statistics. Only the sensitivity of 10 and 15 dips is significantly different even 
though the sensitivity of 5 and 10 dips or 5 and 15 dips are not. However the lower 
mean of the 10 dips KM and higher mean of Jmax for 5 dips point to these values having 
most value moving forward. 
5.2.2 The Use of GA as a Binding Agent 
Having discovered very little about the quantity of layers of enzyme that would be 
useful in the fabrication of an electrode it was decided to consider the issue again. This 
time 1% GA was used to provide some binding of enzyme to the surface of the 
electrode and to allow cross-linking of ᴅAAO molecules. It was applied in two general 
formats, PtD-[600UH2O-GA1%] and PtD-[GA1%-600UH2O]. The layers of GA and 
600UH2O were applied 1, 5, 10 and 15 times, with no time between dips and 5 minutes 
drying time between layers. 
The first group to be considered is the recipes where the GA was applied before the 
enzyme; PtD-[GA1%-600UH2O], PtD-[GA1%-600UH2O]x5, PtD-[GA1%-600UH2O]x10 
and PtD-[GA1%-600UH2O]x15. 
From examining Figure 5-3 it is again clear that the biosensors with only 1 layer are far 
inferior to those with 5, 10 or 15 layers. The Jmax is significantly lower than the 10 layer 
or 15 layer protocols, p = 0.0003*** and p = 0.0019** respectively, and its KM is 
significantly larger, p = 0.0001*** and p < 0.0001***. This results in the LRS for the 1 
layer recipe being significantly lower than that of either 10 or 15 layers, p < 0.0001*** 
and p = 0.0008***. Although the KM for 1 layer is less than that for 5 layers, p = 
0.0006***, because the Jmax is also significantly lower, p < 0.0001***, it also has an 
inferior LRS, p < 0.0001***.  
Noticing that both PtD-[GA1%-600UH2O]x10 and PtD-[GA1%-600UH2O]x15 have M-
M-H kinetics rather than the M-M kinetics of the 1 and 5 layer recipes it is found that 
there is no significant differences between these recipes. The Jmax, KM and LRS are all 
non-significantly different, p = 0.4035, p = 0.8329 and p = 0.1350 respectively. 
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Electrode 
Design 
PtD-[GA1%-
600UH2O]x1, 
n=4 
PtD-[GA1%-
600UH2O]x5, 
n=4 
PtD-[GA1%-
600UH2O]x10, 
n=4 
PtD-[GA1%-
600UH2O]x15, 
n=4 
Kinetics M-M, p = 0.9390 M-M, p = 0.6346 
M-M-H, 
p<0.0001 
M-M-H, 
p<0.0001 
R
2
 0.9997 0.9999 0.9993 0.9996 
Jmax, µA.cm
-2
 18.87 ± 0.39 94.17 ± 1.14 64.30 ± 2.24 61.52 ± 1.81 
KM, µM 6149 ± 204 7780 ± 143 2703 ± 156 2755 ± 147 
α   1.452 ± 0.051 1.290 ± 0.035 
LRS, 
µA.cm
-2
.mM
-
1
 
3.069 ± 0.042 12.10 ± 0.08 23.79 ± 0.58 22.33 ± 0.55 
Table 5-2 
Kinetic parameters, fit, Jmax and KM values calculated from the calibration data in Table 10-2. Jmax, KM, 
α and LRS are presented as Mean ± SEM. 
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Figure 5-3 
J-concentration plot of the four recipes where 600UH2O was cross-linked with GA onto the surface. 
Depicted are PtD-[GA1%-600UH2O] (red trace), PtD-[GA1%-600UH2O]x5 (purple trace), PtD-[GA1%-
600UH2O]x10 (green trace) and PtD-[GA1%-600UH2O]x15 (blue trace). The data plotted is taken 
from Table 10-2 and Table 5-2. Traces are plotted as Mean J ± SEM with fitted kinetic curve. 
Turning ones attention to PtD-[GA1%-600UH2O]x5 it is noticeable that while visually 
in Figure 5-3 there appears to be little difference between it and the 10 and 15 layer 
alternatives. However, when the kinetic parameters are examined there is quite a 
difference, owing mainly to the difference kinetic model that fits it best, M-M. Here we 
see that due to this model the Jmax is significantly higher than the other two recipes, p < 
0.0001*** for both, and its KM is also significantly higher, p < 0.0001*** in both cases. 
Thus while the higher Jmax is desirable, the higher KM is not and the resultant LRS is 
significantly lower, p < 0.0001*** and p = 0.0029** respectively. 
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Overall these are promising results, as with only a very basic examination LRS values 
achieved for the 10 and 15 layer recipes in particular are far larger than any of those 
achieved by the recipes examined in Chapter 4. To further explore these results a set of 
alternate recipes were formulated where the order of the GA and ᴅAAO dips were 
reversed within a layer. The results are presented below in Table 5-3 and Figure 5-4. 
Electrode 
Design 
PtD-[600UH2O- 
GA1%]x1, n = 3 
PtD-[600UH2O- 
GA1%]x5, n = 4 
PtD-[600UH2O- 
GA1%]x10, n = 
3 
PtD-[600UH2O- 
GA1%]x15, n = 
3 
Kinetics M-M, p = 0.2275 M-M, n/c M-M, p = 0.0552 M-M, p = 0.5411 
R
2
 0.8519 0.9979 0.9848 0.9989 
Jmax, µA.cm
-2
 91.98 ± 7.51 31.21 ± 3.26 35.52 ± 5.23 25.45 ± 1.22 
KM, µM 322.2 ± 120.1 13869 ± 1897 6556 ± 1535 8407 ± 595.2 
LRS, 
µA.cm
-2
.mM
-
1
 
285.5 ± 89.6 2.250 ± 0.076 5.418 ± 0.500 3.027 ± 0.073 
Table 5-3 
Kinetic parameters, fit, Jmax and KM values calculated from the calibration data in Table 10-3. Jmax, KM 
and LRS are presented as Mean ± SEM. 
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Figure 5-4 
J-concentration plot of the four recipes where 600UH2O was cross-linked with GA onto the surface of 
the electrode. Depicted are PtD-[600UH2O-GA1%]x5 (purple trace), PtD-[600UH2O-GA1%]x10 (green 
trace) and PtD-[600UH2O-GA1%]x15 (blue trace). The data plotted is taken from Table 10-3 and 
Table 5-3. Traces are plotted as Mean J ± SEM with fitted kinetic curve. 
Taking a close look at the calibration data for PtD-[600UH2O- GA1%]x1 one can see 
that there were very strange phenomena taking place where some electrodes were non 
responsive and yet others were very sensitive. This is apparent when observing that in 
some instances the error for a particular calibration point is almost 100% of the mean 
value and that this value also varies greatly across the values. This made plotting the 
 Chapter 5: Styrene as an Immobilisation Matrix 
147 
data difficult and as such it is omitted from Figure 5-4 below. It is also difficult to take 
any meaning from the statistics and as such they will not be compared to the other 
recipes. It is suspected that this occurs as the binding layer is added after the enzyme 
and as such the quantity of ᴅAAO remaining on the surface of the electrode, as it is 
dipped into the GA, is quite variable and unreliable. 
When consideration is given to the other three recipes it is noted that all three are M-M 
kinetics type biosensors. PtD-[600UH2O-GA1%]x5 has a Jmax which does not differ 
from that of PtD-[600UH2O-GA1%]x10, p =  0.4936, but a significantly higher KM, p = 
0.0368*, which results in an LRS that is significantly lower, p = 0.0007***. Compared 
with PtD- [600UH2O-GA1%]x15 the 5 layer recipe has a non-significantly different Jmax 
and KM, p = 0.2089 and p = 0.0635, but together there is a difference in LRS, p = 
0.0009***. 
PtD-[600UH2O-GA1%]x10 produces the best results. As already seen it is significantly 
better than the 5 layer alternative and compared to PtD-[600UH2O-GA1%]x15 its Jmax 
and KM are not significantly different, p = 0.1342 and p = 0.3238, but together they 
yield a sensitivity which is significantly higher, p = 0.0091**. It appears, overall, that 
10 layers is about the optimum number. This is due to its higher LRS in the recipe just 
examined, and that it is equally as sensitive as any other recipe in the PtD-[GA1%-
600UH2O] format, as well as it having favourable M-M-H kinetics. When purely 
absorbed onto the surface it also yielded the lowest KM value. 
It is interesting to note a general comparison between the PtD-[600UH2O-GA1%] and 
the PtD-[GA1%-600UH2O] recipes. Individually each recipe where the GA was applied 
first obtains a higher LRS, p < 0.0001*** for 5 and 10 layer recipes and p = 0.0008*** 
for the 15 layer recipe. This appears to indicate the need for there to be a binding layer 
or cross-linking agent applied to the surface of the electrode before any enzyme is 
applied. This would ensure a stable framework for the rest of the layers to build upon. 
5.2.3 Styrene as a Primary Binding Agent 
Having identified the need for a primary binding agent to ensure adequate adhesion of 
the enzyme to the surface of the electrode it was clear at this point that there was a need 
examine styrene as an agent to fulfil this role. As previously stated, Section 5.1, this 
polymer had been used previously with great effect and success in many different 
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biosensors. Thus, to form a more complete picture a layer study was also conducted 
with only styrene as an ‘immobilisation matrix’.  
Styrene, in pure monomeric form, has a boiling point of 145.14 °C and is therefore 
unlikely to evaporate from the surface of the electrode. Significant surface changes have 
been noted by the group before upon examination by SEM of an electrode after a dip 
into styrene monomer. Without the addition of inhibitors the monomer will undergo 
spontaneous polymerisation (Mayo & Gregg, 1948; Priddy, 1994), and the rate of 
polymerisation can be affected by the availability of oxygen (Miller & Mayo, 1956) 
along with a multitude of other factors which affect the chain transfer mechanism 
(Mayo, 1943; Gregg & Mayo, 1947, 1948; Mayo, 1948; Mayo et al., 1951; Gregg & 
Mayo, 1953; Mayo, 1953). Thus while the quantity and average mass of polymer on the 
surface is unknown there is a slow polymerisation process which occurs as the 
biosensor is being fabricated. Indeed temperatures over 65 °C can initiate runaway 
polymerisations in bulk quantities of styrene. 
The styrene was applied in its 99% monomeric form in a single dip prior to application 
of the enzyme dips. The first dip into 600UH2O was applied immediately after the 
styrene to complete the first layer. 
As in the previous sections four recipes with differing numbers of layers were created; 
PtD-Sty-600UH2Ox5, PtD-Sty-600UH2Ox10, PtD-Sty-600UH2Ox15 and PtD-Sty-
600UH2Ox20. A recipe with one layer was not considered due to the previous poor 
results with this setup. The results obtained are presented in Table 10-4 and Table 5-4. 
The set of results by these four different recipes are a bit erratic but it is possible to put 
meaning to them. They are depicted in Figure 5-5. At 5 layers, the kinetic parameters 
appear favourable, but deteriorate for 10 layers, changing to more favourable values 
again at 15 layers, but with an increased SEM, and finally deteriorate to undesirable 
values again at 20 layers. 
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Electrode Design 
PtD-Sty-600U 
H2Ox5, n=4 
PtD-Sty-600U 
H2Ox10, n=4 
PtD-Sty-600U 
H2Ox15, n=4 
PtD-Sty-600U 
H2Ox20, n=4 
Kinetics 
M-M, p = 
0.6734 
M-M, n/c 
M-M, p = 
0.3125 
M-M, n/c 
R
2
 0.9270 0.9908 0.9986 0.9744 
Jmax, µA.cm
-2
 29.08 ± 3.79 13.95 ± 1.46 43.41± 1.31 3.729 ± 0.261 
KM, µM 3183 ± 1180 10411 ± 2110 7813 ± 479.5 2912 ± 599 
LRS, µA.cm
-2
.mM
-
1
 
9.136 ± 2.370 1.340 ± 0.139 5.556 ± 0.186 1.281 ± 0.188 
Table 5-4 
Kinetic parameters, fit, Jmax and KM values calculated from the calibration data in Table 10-4. Jmax, KM 
and LRS are presented as Mean ± SEM. 
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Figure 5-5 
J-concentration plot of the four recipes where 600UH2O was immobilised in Styrene onto the surface 
of the electrode. Depicted are PtD-Sty-600UH2Ox5 (purple trace), PtD-Sty-600UH2Ox10 (green trace), 
PtD-Sty-600UH2Ox15 (blue trace) and PtD-Sty-600UH2Ox20 (yellow trace). The data plotted is taken 
from Table 10-4 and Table 5-4. Traces are plotted as Mean J ± SEM with fitted kinetic curve. 
It is quite clear that 5 is the optimum amount of layers in the process of immobilising 
ᴅAAO in styrene. Compared with 10 and 20 layers its Jmax is significantly higher, p = 
0.0098** and p = 0.0005*** respectively, but not the 15 layer recipe, compared to 
which it is significantly lower, p = 0.0117*. The KM value is significantly lower than 
that of 10 or 15 layers, p = 0.0243* and p = 0.0109*, although not the 20 layer recipe, p 
= 0.8445. As a result its LRS value of 9.136 ± 2.370 µA.cm
-2
.mM
-1
 is significantly 
larger than the 10 and 20 layer alternatives, p = 0.0167*, p = 0.2292 and p = 0.0456*. It 
is however not significantly larger than the 15 layer recipe, p = 0.2292, despite the mean 
values giving that impression. However when one considers the SEM of the data 
achieved for the 15 layer recipe it is clear that it should be discounted as a possible route 
forward. I believe this is due to 15 layers of enzyme to be an intermediary point 
 Chapter 5: Styrene as an Immobilisation Matrix 
150 
whereby the mass of adsorbed material is on the brink of falling due to its own weight. 
This leads to some biosensors retaining the enzyme and others losing vast quantities of 
it back into solution. Thus large SEM’s are resultant. 
What is also clear is that to obtain the best possible immobilisation and binding of 
ᴅAAO to the surface of the electrode, a combination of the immobilisation in Styrene 
with additional cross-linking or stabilisation agents is necessary. This should enable 
efficient layering of component parts up to 10 layers. This will be achievable as it has 
now been shown that the Styrene can efficiently contain five layers of enzyme and the 
cross-linking agent GA can stabilise up to 10 layers effectively. A combination of these 
two approaches, it was hoped, would therefore yield the best results. 
5.2.4 Water and PBS in the Enzyme Solution 
Given the results obtained previously, see Sections 4.7.1 and 4.7.2, the conclusion was 
reached that it was necessary to compare again 600UH2O and 600UPBS. It was hoped 
to make a clear distinction between the two solutions and to carry only one forward into 
any further investigations. Thus sensors were constructed using styrene as an 
immobilisation matrix and then adding 10 layers of enzyme solution, 600UH2O and 
600UPBS, with different stabilising and cross-linking agents. 
It was hoped that this broad approach using the other substances, that were likely to be 
included in the final fabrication process, would yield the most relevant results. 
Incorporation of these elements could change radically the outcome in comparison to a 
situation where only one of the immobilisation agent, cross-linking substance or 
stabiliser was utilised. Thus the general formulation became PtD-Sty-[Enzyme-
Stabiliser]x10. The first two stabilising substances to be examined were GA1% and 
BSA1%. These two substances were then combined to yield two more solutions which 
were also examined. They were BSAGA, the standard solution where the component 
parts were present in a 1% w/v and 1% v/v concentration respectively, and also 
BSA1%GA0.1%, where the GA was only present as 0.1% v/v concentration. The data 
obtained is presented in Table 10-5, with the associated calculated kinetic parameters in 
Table 5-5. 
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Electrode 
Design 
PtD-Sty-
[600UH2O-
GA1%]x10 
n = 3 
PtD-Sty-
[600UH2O-
BSA1%]x10 
n = 4 
PtD-Sty-
[600UH2O-
BSAGA]x10 
n = 4 
PtD-Sty-
[600UH2O-
BSAGA0.1%]x10
, n = 6 
Kinetics M-M, p =  0.2300 M-M-H, p<0.0001 M-M, p = 0.9696 M-M-H,p< 0.0001 
R
2
 0.9953 0.9995 0.9959 0.9998 
Jmax, µA.cm
-2
 47.74 ± 2.03 1.760 ± 0.197 84.79 ± 3.82 2.904 ± 0.408 
KM, µM 5241 ± 525 23313 ± 6291 6459 ± 636 62372 ± 19381 
α  0.7260 ± 0.0271  0.6894 ± 0.0180 
LRS, 
µA.cm
-2
.mM
-1
 
9.109 ± 0.566 0.07551 ± 0.01197 13.13 ± 0.75 0.04656 ± 0.00794 
Electrode 
Design 
PtD-Sty-
[600UPBS-
GA1%]x10 
n = 8 
PtD-Sty-
[600UPBS-
BSA1%]x10 
n = 4 
PtD-Sty-
[600UPBS-
BSAGA]x10 
n = 4 
PtD-Sty-
[600UPBS-
BSAGA0.1%]x10
, n = 4 
Kinetics M-M, p = 0.2646 M-M-H, p=0.0038 M-M-H, p=0.0131 M-M, p = 0.0675 
R
2
 0.9965 0.9968 0.9991 0.9812 
Jmax, µA.cm
-2
 90.56 ± 4.90 2.996 ± 0.775 61.28 ± 1.533 9.530 ± 0.669 
KM, µM 3538 ± 524 19050 ± 12639 2704 ± 163 3155 ± 651 
α  0.7068 ± 0.0690 1.129 ± 0.046  
LRS, 
µA.cm
-2
.mM
-1
 
25.59 ± 2.59 0.1573 ± 0.0638 22.66 ± 0.84 3.021 ± 0.449 
Table 5-5 
Kinetic parameters, fit, Jmax and KM values calculated from the calibration data in Table 10-5. Jmax, KM, 
α and LRS are presented as Mean ± SEM. 
From a first examination of the calibration data and the associated kinetic model results 
it is clear that one of the recipes has not functioned as well as hoped. This is the recipe 
with the BSA1% as a stabilising agent. Despite BSA being a protein which should 
provide a natural environment for the enzyme to reside in, and its widespread use in 
enzymatic biosensors, it appears to have no ability to help retain the ᴅAAO on the 
surface of the electrode.  
The result is, in the case of both 600UH2O and 600UPBS, that the Jmax and LRS are 
small and the KM is high and has a very large SEM. There is no significant difference 
between any of the kinetic parameters of the two formulations, p = 0.2200, p = 0.7729 
and p = 0.2969 for the Jmax, KM and LRS respectively. Taking the poor sensitivity into 
account these results are not graphed. The results for PtD-Sty-[Enzyme-GA1%]x10 and 
PtD-Sty-[Enzyme-BSAGA]x10 are displayed in Figure 5-6 and Figure 5-7 respectively. 
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Figure 5-6 
J-concentration plot of the sensors designed to elucidate the difference between 600UH2O and 
600UPBS. Depicted are PtD-Sty-[600UH2O-GA1%]x10 (orange trace) and PtD-Sty-[600UPBS-
GA1%]x10 (red trace). The data plotted is taken from Table 10-5 and Table 5-5.  
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Figure 5-7 
J-concentration plot of the sensors designed to elucidate the difference between 600UH2O and 
600UPBS. Depicted are PtD-Sty-[600UH2O-BSAGA]x10 (light blue trace) and PtD-Sty-[600UPBS-
BSAGA]x10 (royal blue trace). The data plotted is taken from Table 10-5 and Table 5-5. 
In the case of PtD-Sty-[600UH2O-GA1%]x10 and PtD-Sty-[600UPBS-GA1%]x10 the 
improved results achieved with the use of PBS pH 8.5 instead of water. The Jmax of the 
600UPBS recipe is significantly higher, p = 0.0006***, the KM is not significantly 
different, p = 0.1008, and the LRS of 25.59 ± 2.59 µA.cm
-2
.mM
-1
 is significantly larger 
than the 600UH2O recipe, p = 0.0004***. 
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The graph of the PtD-Sty-[600UH2O-BSAGA]x10 and PtD-Sty-[600UPBS-BSAGA]x10 
data (Figure 5-7) appears a little bit more complicated. However, examination of the 
calculated kinetic data reveals that once again 600UPBS produces significantly better 
results. The Jmax of the biosensors formulated with the PBS solution is significantly 
lower, p = 0.0012** which is not an ideal result, however, the KM is also significantly 
lower, p = 0.0106*. However, these conflicting positive and negative changes do result 
in an LRS which is 22.66 ± 0.84 µA.cm
-2
.mM
-1
 and significantly larger than the 
600UH2O LRS, p = 0.0001***.  
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Figure 5-8 
J-concentration plot of the sensors designed to elucidate the difference between 600UH2O and 
600UPBS. Depicted are PtD-Sty-[600UH2O-BSAGA0.1%]x10 (light green trace) and PtD-Sty-[600UPBS-
BSAGA0.1%]x10 (dark green trace). The data plotted is taken from Table 10-5 and Table 5-5. Traces 
are plotted as Mean J ± SEM with fitted kinetic curve. 
Once again the benefits of using 600UPBS instead of 600UH2O are clear to see with the 
PtD-Sty-[Enzyme-BSAGA0.1%]x10 recipes (Figure 5-8). It is also easy to see that the 
all the essential kinetic values are vastly inferior compared to the BSAGA and GA 
recipes. Despite this fact, it is still possible to extract useful and relevant information 
about the two enzyme solutions these recipes were designed to compare. Looking first 
at the Jmax the calculated value is significantly larger, p < 0.0001*** and the KM value is 
significantly smaller, p = 0.0283. Both of these results are favourable, and as a result the 
LRS is also significantly larger, p < 0.0001***. 
The conclusion must be, and was, reached that given this set of results it is, almost 
without fail, better to use PBS, with a pH of 8.5, than water when formulating the 
 Chapter 5: Styrene as an Immobilisation Matrix 
154 
enzyme solutions. Thus from this point forward in the project only 600UPBS was used 
while fabricating any biosensor recipes. 
5.3 A Comprehensive Study of the Binding Properties of GA 
Having seen in many previous sections of this project that glutaraldehyde was capable 
of effectively binding ᴅAAO to the surface of an electrode it was decided to undertake a 
comprehensive study of its abilities. Indeed GA is the most widely studied cross-linking 
agent across a wide variety of scientific fields (Migneault et al., 2004) as well as being 
one of the most gentle coupling methods used in enzyme technology (Weetall, 1974). 
Yet despite this there is still a great deal of debate as to its structure and mechanism of 
cross-linking in solution, depending on pH in particular, with up to 11 different forms 
proposed (Aso & Aito, 1962; Richards & Knowles, 1968; Hardy et al., 1969; Korn et 
al., 1972; Monsan et al., 1975; Rembaum et al., 1978; Margel & Rembaum, 1980; 
Tashima et al., 1987; Tashima et al., 1991; Kawahara et al., 1992). GA reacts with a 
variety of functional groups, primarily lysine residues on protein molecules(Weetall, 
1974), and shows little reversibility between pH 7.0 and 9.0 (Okuda et al., 1991). There 
was awareness also that too great a quantity of GA could denature the enzyme and 
prevent it functioning fully. It has been shown previously that there is a very delicate 
balance in this regard which is dependent on the nature of the enzyme (Avrameas & 
Ternynck, 1969; Broun, 1976) concentration of the enzyme and reagent, pH, ionic 
strength of the solution, temperature and reaction time (Jansen & Olson, 1969; Jansen et 
al., 1971; Ottesen & Svensson, 1971; Tomimatsu et al., 1971; Zaborsky & Co, 1973; 
Broun, 1976). Thus it was important not only to consider how and where the GA would 
be included but also to explore the effect of changing the concentration of GA utilised. 
The importance of these changes has already been demonstrated in Section 4.5, Section 
4.8.1.1 and to a lesser extent in Section 4.4.  
A general recipe was followed for these explorations; PtD-Sty-[600UPBS-GA]. Within 
this the electrodes were first dipped into the 600UPBS immediately after the dip into 
styrene. The number, and concentration, of GA dips within the layers were then varied. 
There were always 10 dips into 600UPBS, each on a separate layer. The electrodes were 
allowed to dry for five minutes between layers. While drying they were hung vertically, 
with the active surface pointing downward. 
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To help enable comparison the colourings for the different percentages of GA are 
maintained throughout this section in all figures. 0.1% is red, 0.2% is yellow, 0.5% is 
green, 1.0% is blue, 1.5% is purple and 2.0% is purple. 
5.3.1 Ten Dips into GA 
The first set of recipes devised incorporated a full 10 dips into GA, one for each dip in 
600UPBS. The general recipe took the form of PtD-Sty-[600UPBS-GA]x10 with the 
concentration of GA used being varied within this. The GA concentrations used were; 
0.1%, 0.2%, 0.5%, 1.0%, 1.5% and 2.0% (all v/v). The calibration data for the six 
recipes is presented in Table 10-6, along with the relevant kinetic data below in Table 
5-6. The two least effective percentages of GA for use in this general fabrication 
method are quite apparent when one considers the LRS values that were calculated. 
Both 0.1% and 0.2% only achieve an LRS of approximately 2 – 3 µA.cm-2.mM-1. This 
is about one order of magnitude below the value reached by other concentrations used. 
They will thus not be considered for further statistical examination.  
According to the graphical representation in Figure 5-9  it appears that the 0.5% and 
1.0% recipes are quite similar. Examination of the kinetic parameters backs this 
observation up. The Jmax for 1.0% is significantly higher, p = 0.0184*, but the KM and 
LRS are both not significantly difference, p = 0.05672 and p = 0.4370 respectively. The 
only discernible difference is, therefore, the Jmax, of which 1.0% GA has the better 
value. It appears too that there is little difference between 1.5% and 2.0% when the 
graph below is examined. Examining the figures though, there is a realisation that the 
two recipes are quite different. Firstly the 1.5% GA recipe is M-M kinetics fitted and 
the 2.0% GA analogue conforms to M-M-H kinetics. When the Jmax are compared it is 
discovered that the 1.5% recipe has a significantly higher value, p = 0.0003***. But the 
2% GA yields a significantly lower KM, p = 0.0003***. Finally it is found that the 2% 
also has a significantly better LRS, p = 0.0009***. Thus, it is apparent that the 2% 
recipe is the superior of the two. 
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Electrode Design 
PtD-Sty-[600UPBS-
GA0.1%]x10, n = 3 
PtD-Sty-[600UPBS-
GA0.2%]x10, n = 4 
PtD-Sty-[600UPBS-
GA0.5%]x10, n = 4 
Kinetics M-M-H, p =  0.0028 M-M, p = 0.1176 M-M, p = 0.0624 
R
2
 1.000 1.000 0.9988 
Jmax, µA.cm
-2
 31.87 ± 0.27 27.30 ± 0.22 75.11 ± 1.22 
KM, µM 11126 ± 177.3 11118 ± 176 3213 ± 148 
α 0.9836 ± 0.003342   
LRS, µA.cm
-2
.mM
-
1
 
2.864 ± 0.022 2.456 ± 0.020 23.38 ± 0.75 
Electrode Design 
PtD-Sty-[600UPBS-
GA1.0%]x10, n = 8 
PtD-Sty-[600UPBS-
GA1.5%]x10, n = 3 
PtD-Sty-[600UPBS-
GA2.0%]x10, n = 4 
Kinetics M-M, p = 0.4396 M-M, p = 0.5790 M-M-H, p = 0.0024 
R
2
 0.9882 0.9989 0.9988 
Jmax, µA.cm
-2
 90.56 ± 4.90 39.72 ± 0.52 33.05 ± 0.4989 
KM, µM 3538 ± 524 1573 ± 82 816.2 ± 40.6 
α   1.327 ± 0.085 
LRS, µA.cm
-2
.mM
-
1
 
25.59 ± 2.59 25.25 ± 1.09 40.19 ± 1.64 
Table 5-6 
Kinetic parameters, fit, Jmax and KM values calculated from the calibration data in Table 10-6. Jmax, KM, 
α and LRS are presented as Mean ± SEM. 
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Figure 5-9 
J-concentration plot of sensors created to explore the effect of different GA concentrations when 
applied 10 times. Depicted are PtD-Sty-[600UPBS-GA0.1%]x10 (red trace), PtD-Sty-[600UPBS-
GA0.2%]x10 (yellow trace), PtD-Sty-[600UPBS-GA0.5%]x10 (green trace), PtD-Sty-[600UPBS-
GA1.0%]x10 (blue trace), PtD-Sty-[600UPBS-GA1.5%]x10 (purple trace) and PtD-Sty-[600UPBS-
GA2.0%]x10 (pink trace). The data plotted is taken from Table 10-6 and Table 5-6.  
Among the four recipes of 0.5%, 1.0%, 1.5% and 2.0% different recipes present 
different aspects which are desirable and superior to the others. For instance the 1% has 
a higher Jmax than 0.5%, 1.5% (p < 0.0001***) and 2.0% (p < 0.0001***) and the 2% 
recipe has a lower KM than the 0.5% (p = 0.0006***), 1.0% (p = 0.0013**).  
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The 2% GA also produces an LRS which is higher than 0.5% (p < 0.0001***), 1.0% (p 
= 0.0035**) and 1.5%. However, visually, in Figure 5-9, there appears to be no 
difference in the initial slope. If the raw calibration data is examined, for instance at 
1000 µM, it is seen that there is no difference between 1% and 2%, p = 0.7628. Indeed 
the 1% value is not significantly larger than 1.5%, p = 0.2629, or 0.5%, p = 0.1831, and 
neither is the 2% value, p = 0.6300 and p = 0.7621 respectively.  
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Figure 5-10 
J-concentration plot of sensors created to explore the effect of different GA concentrations when 
applied 10 times. Depicted are PtD-Sty-[600UPBS-GA0.1%]x10 (red trace), PtD-Sty-[600UPBS-
GA0.2%]x10 (yellow trace), PtD-Sty-[600UPBS-GA0.5%]x10 (green trace), PtD-Sty-[600UPBS-
GA1.0%]x10 (blue trace), PtD-Sty-[600UPBS-GA1.5%]x10 (purple trace) and PtD-Sty-[600UPBS-
GA2.0%]x10 (pink trace). The data plotted is taken from Table 10-6 and Table 5-6. Traces are plotted 
as Mean J ± SEM with fitted kinetic curve. 
To help illustrate this graphically an expanded J-concentration plot has been created 
over the range 0 – 1000 µM ᴅ-ser, see Figure 5-10. Here it is possible to see how little 
difference there is between the four percentages, with all of their SEM bars overlapping. 
Closer examination does however reveal that a difference does exist between the 1% 
(blue) and 2% (pink) recipes, the recipes with the highest Jmax and LRS respectively. 
This difference is in their shape over this concentration range. It can be seen that the 1% 
recipe has a very linear increase over this range. However the 2% recipe appears to 
change its slope several times. This is due to the M-M-H kinetic fit. As the α value for 
this kinetic model increases above 1 and towards 2 there is increasing degree of a 
sigmoidal shape to the response, rather than an initial linear response. This particular 
2% GA design has an α value of 1.327 ± 0.085, which appears to be enough for the 
sigmoidal shape to begin to become evident in the plot. 
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5.3.2 Five Dips into GA 
Having examined what happens to the sensitivity of the biosensors when 10 dips of GA 
are applied, it seemed logical to next examine the effect of five dips of GA, one every 
second layer. The general recipe thus became PtD-Sty-[600UPBSx2-GA2.0%]x5. The 
same 0.1%, 0.2%, 0.5%, 1.0%, 1.5% and 2.0% GA concentrations were again 
examined. The calibration data is listed in Table 10-7 with the associated kinetic 
parameters calculated in Table 5-7. These two sets of data are then graphically 
displayed in Figure 5-11. 
A casual perusal of the data and plot shows that the changes observed for 5 dips of GA 
are not as straight forwards as was found to be the case for 10 dips. The sensitivity 
fluctuates more radically between different percentages. The Jmax, in particular, appears 
to alternately increase and decrease for every increase in GA concentration. 
Beginning with the Jmax value, statistically it does not change from 0.1% to 0.2%, p = 
0.0507, nor does it change between 0.2% and 0.5%, p = 0.1203. This is due to the large 
error associated with the calculated value for 0.2%. However it does increase 
significantly from 0.1% and 0.5%, p = 0.0003***. From this value it increases further 
when 1.0% is used, p < 0.0001***. It then decreases significantly as the change is made 
to 1.5%, p < 0.0001***, before finally increasing for 2.0%, p < 0.0001***. The largest 
value of Jmax is found using 1% GA, it is significantly larger than all others including 
2.0%, p = 0.0.127*, except 0.2% GA, which is again due to the large associated error 
with this value. 
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Electrode Design 
PtD-Sty-
[600UPBSx2-
GA0.1%]x5, n = 3 
PtD-Sty-
[600UPBSx2-
GA0.2%]x5, n = 3 
PtD-Sty-
[600UPBSx2-
GA0.5%]x5, n = 3 
Kinetics M-M-H, p < 0.0001 M-M-H, p = 0.0182 M-M, p = 0.2392 
R
2
 0.9998 0.9980 0.9993 
Jmax, µA.cm
-2
 16.70 ± 1.82 76.95 ± 13.99 40.30 ± 0.75 
KM, µM 34824 ± 7758 13033 ± 6100 5949 ± 319 
α 0.7988 ± 0.0219 0.7575 ± 0.0639  
LRS, µA.cm
-2
.mM
-
1
 
4.795 ± 0.055 5.905 ± 1.695 6.774 ± 0.249 
Electrode Design 
PtD-Sty-
[600UPBSx2-
GA1.0%]x5, n = 3 
PtD-Sty-
[600UPBSx2-
GA1.5%]x5, n = 4 
PtD-Sty-
[600UPBSx2-
GA2.0%]x5, n = 4 
Kinetics M-M-H, p = 0.0021 M-M, p = 0.2406 M-M, p = 0.1621 
R
2
 0.9990 0.9995 1.000 
Jmax, µA.cm
-2
 83.64 ± 2.128 29.25 ± 0.65 64.73 ± 0.31 
KM, µM 2060 ± 154 6882 ± 361 5616 ± 71 
α 1.332 ± 0.078   
LRS, µA.cm
-2
.mM
-
1
 
40.60 ± 2.158 4.251 ± 0.135 11.53 ± 0.09 
Table 5-7 
Kinetic parameters, fit, Jmax and KM values calculated from the calibration data in Table 10-7. Jmax, KM, 
α and LRS are presented as Mean ± SEM. 
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Figure 5-11 
J-concentration plot of sensors created to explore the effect of different GA concentrations when 
applied 5 times. Depicted are PtD-Sty-[600UPBSx2-GA0.1%]x5 (red trace), PtD-Sty-[600UPBSx2-
GA0.2%]x5 (yellow trace), PtD-Sty-[600UPBSx2-GA0.5%]x5 (green trace), PtD-Sty-[600UPBSx2-
GA1.0%]x5 (blue trace), PtD-Sty-[600UPBSx2-GA1.5%]x5 (purple trace) and PtD-Sty-[600UPBSx2-
GA2.0%]x5 (pink trace). The data plotted is taken from Table 10-7 and Table 5-7.  
Examining the KM values reveals a similar situation. It begins with the worst value, a 
large KM with significant error for 0.1% GA. This results in no significant change 
between 0.1% and 0.2%, p = 0.0918. The same is also true when comparing 0.2% and 
0.5%, p = 0.3659, owing to the large error also present with 0.2% GA; the SEM is 
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almost 50% of the mean. As with the Jmax, from 0.5% and upwards distinctions are 
much simpler to draw. The KM decreases significantly with 1.0% GA applied five times, 
p = 0.0004***, increases significantly from that value with 1.5% GA, p = 0.0001*** 
before finally decreasing again with the use of 2.0% GA, p = 0.0412*.  
Mirroring the results of the Jmax values, the KM of 1% GA is found to be the best 
(lowest), p < 0.0001*** for 2%, although owing to the large errors of 0.1% and 0.2% 
there is no significant difference in these cases, p = 0.0639 and p = 0.3481 respectively. 
The clearest indication of the overall changes is revealed by the LRS. There is no 
significant difference between 0.1% and 0.2%, p = 0.0854, 0.2% and 0.5%, p = 0.6624, 
although there is an increase from 0.1% to 0.5%, p = 0.0016**. Increasing the GA 
concentration from 0.5% to 1.5% applied 5 times to the electrode produces a significant 
decrease in the LRS, p = 0.0002***, and from 1.5% to 2.0% the LRS increase again 
significantly, p < 0.0001***. The value for 2.0% is also significantly higher than the 
value for 0.5%, p < 0.0001***. 
With consideration of the LRS values, a definite conclusion can be reached that the 1% 
recipe is the most sensitive, as depicted in the J-concentration plot. It has a significantly 
higher LRS than that achieved while using 0.1%, 0.2%, 0.5%, 1.5% and 2.0% GA in the 
same general recipe, p = 0.0029**, p = 0.0002***, p = 0.0041**, p = 0.0035** and p = 
0.0055** respectively. 
5.3.3 Two Dips into GA 
In a continuation of the examination the amount of GA within the recipes was then 
reduced to two dips, one on the fifth and tenth layer. The general recipe thus became 
PtD-Sty-[600UPBSx5-GA]x2 and the same percentages of GA were utilised again.  The 
gathered data from the resultant calibrations and subsequently calculated kinetic data is 
presented in Table 10-8 and Table 5-8. The accompanying J-concentration plot also 
follows the colour convention as per the last two sections, see Figure 5-12. 
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Electrode Design 
PtD-Sty-
[600UPBSx5-
GA0.1%]x2, n = 4 
PtD-Sty-
[600UPBSx5-
GA0.2%]x2, n = 4 
PtD-Sty-
[600UPBSx5-
GA0.5%]x2, n = 3 
Kinetics M-M, p = 0.3742 M-M, p = 0.7657 M-M-H, p = 0.0046 
R
2
 0.9954 0.9968 0.9999 
Jmax, µA.cm
-2
 4.046 ± 0.164 76.95 ± 13.99 30.37 ± 0.58 
KM, µM 5166 ± 498.3 14089 ± 1593 7137 ± 291 
α   1.068 ± 0.017 
LRS, µA.cm
-2
.mM
-
1
 
0.7381 ± 0.0470 5.835 ± 0.279 4.256 ± 0.094 
Electrode Design 
PtD-Sty-
[600UPBSx5-
GA1.0%]x2, n = 3 
PtD-Sty-
[600UPBSx5-
GA1.5%]x2, n = 3 
PtD-Sty-
[600UPBSx5-
GA2.0%]x2, n = 4 
Kinetics M-M-H, p = 0.0081 M-M-H, p = 0.0015 M-M-H, p = 0.0188 
R
2
 0.9998 0.9997 0.9999 
Jmax, µA.cm
-2
 178.8 ± 4.5 55.98 ± 1.80 6.451 ± 0.309 
KM, µM 5049 ± 291 3619 ± 254 15078 ± 1471 
α 1.109 ± 0.030 1.212 ± 0.041 0.9355 ± 0.0205 
LRS, µA.cm
-2
.mM
-
1
 
35.41 ± 1.19 15.47 ± 0.61 0.4278 ± 0.0214 
Table 5-8 
Kinetic parameters, fit, Jmax and KM values calculated from the calibration data in Table 10-8. Jmax, KM, 
α and LRS are presented as Mean ± SEM. 
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Figure 5-12 
J-concentration plot of sensors created to explore the effect of different GA concentrations when 
applied 2 times. Depicted are PtD-Sty-[600UPBSx5-GA0.1%]x2 (red trace), PtD-Sty-[600UPBSx5-
GA0.2%]x2 (yellow trace), PtD-Sty-[600UPBSx5-GA0.5%]x2 (green trace), PtD-Sty-[600UPBSx5-
GA1.0%]x2 (blue trace), PtD-Sty-[600UPBSx5-GA1.5%]x2 (purple trace) and PtD-Sty-[600UPBSx5-
GA2.0%]x2 (pink trace). The data plotted is taken from Table 10-8 and Table 5-8. Traces are plotted 
as Mean J ± SEM with fitted kinetic curve. 
Cursory inspection of the kinetic data allows one to see that the 0.1% and 2.0% recipes 
were largely ineffectual. They yielded low Jmax values, had relatively high KM 
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concentrations and as a result the LRS of both are very low, as can be clearly be seen in 
the plot.  
In detail, and beginning with the Jmax, starting from 4.046 ± 0.164 µA.cm
-2
 with 0.1% it 
increases significantly with the change to 0.2%, p = 0.0008***. From that value it 
increases significantly with 0.5% GA, p = 0.0027**, and significantly further again with 
1.0%, p = 0.0009***, to reach a peak of 178.8 ± 4.5 µA.cm
-2
. The Jmax value then 
decreases significantly as the GA changes from 1.0% to 1.5%, p < 0.0001***, and 
significantly further again with the use of 2.0%, p = 0.0014**. 
The KM values are a more complicated picture. Initially it increases between 0.1% and 
0.2%, p = 0.0128*, before decreasing with 0.5%, p = 0.0232*, and decreasing again 
with 1.0%, p = 0.0071**. The KM continues to decrease with 1.5% GA, p = 0.0208*, 
before increasing again with 2.0%, p = 0.0046**. However, more important, in this 
instance, than the changes with respect to the increasing percentage of GA, is the how 
the KM of 1% GA compares to the others. It is non-significantly different from that of 
0.1%, p = 0.8616, significantly larger than that of 1.5% and significantly smaller than 
0.5%, both already stated. The 1.0% KM is also significantly smaller than that of the 
other two recipes, 0.2% and 2.0%, p = 0.0113* and p = 0.0068** respectively. 
These results combined lead to two recipes that have significantly larger LRS values 
than any of the other recipes. The second highest value is that of 1.5% GA. At 15.47 ± 
0.61 µA.cm
-2
.mM
-1
 it is significantly larger than 0.1%, 0.2%, 0.5% and 2.0%, p = 
0.0017**, p < 0.0001***, p = 0.0030** and p = 0.0016** respectively. The largest LRS 
however is attained by the use of 1.0% GA when applying the GA only twice. Its value 
of 35.41 ± 1.19 µA.cm
-2
.mM
-1
 is significantly larger than 0.1%, 0.2%, 0.5%, 1.5% and 
2.0% (p = 0.0012**, p = 0.0017**, p = 0.0014**, p = 0.0001*** and p = 0.0011**). 
5.3.4 One Dip into GA 
The final alteration to the general recipe considered in the study of GA percentages and 
number of dips involved the use of GA on only one layer for one dip. This dip was 
applied in the final, tenth, layer of enzyme. The general recipe thus became PtD-Sty-
[600UPBS]x10-GA. The data obtained from the six variants of this recipe, using 0.1%, 
0.2%, 0.5%, 1.0%, 1.5% and 2.0% GA, are presented below in Table 10-9 and Table 
5-9. 
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Electrode Design 
PtD-Sty-
[600UPBS]x10-
GA0.1%, n = 4 
PtD-Sty-
[600UPBS]x10-
GA0.2%, n = 3 
PtD-Sty-
[600UPBS]x10-
GA0.5%, n = 4 
Kinetics M-M-H, p = 0.0037 M-M-H, p < 0.0001 M-M-H, p = 0.0016 
R
2
 0.9970 0.9991 0.9998 
Jmax, µA.cm
-2
 1.214 ± 0.355 27.61 ± 12.51 17.07 ± 0.39 
KM, µM 20451 ± 16379 121781 ± 128919 4536 ± 240 
α 0.6598 ± 0.0681 0.6106 ± 0.0380 1.155 ± 0.032 
LRS, µA.cm
-2
.mM
-
1
 
0.05938 ± 0.03027 0.2267 ± 0.1376 3.764 ± 0.117 
Electrode Design 
PtD-Sty-
[600UPBS]x10-
GA1.0%, n = 4 
PtD-Sty-
[600UPBS]x10-
GA1.5%, n = 4 
PtD-Sty-
[600UPBS]x10-
GA2.0%, n = 4 
Kinetics M-M-H, p = 0.0018 M-M-H, p = 0.0011 M-M, p = 0.0853 
R
2
 0.9998 0.9987 0.9812 
Jmax, µA.cm
-2
 24.87 ± 0.69 42.13 ± 1.08 75.73 ± 10.24 
KM, µM 5471 ± 326.0 1919 ± 148 6739 ± 2184 
α 1.161 ± 0.035 1.443 ± 0.099  
LRS, µA.cm
-2
.mM
-
1
 
4.545 ± 0.150 21.96 ± 1.24 11.24 ± 2.23 
Table 5-9 
Kinetic parameters, fit, Jmax and KM values calculated from the calibration data in Table 10-9. Jmax, KM, 
α and LRS are presented as Mean ± SEM. 
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Figure 5-13 
J-concentration plot of sensors created to explore the effect of different GA concentrations when 
applied 1 time. Depicted are PtD-Sty-[600UPBSx5-GA0.1%]x2 (red trace), PtD-Sty-[600UPBSx5-
GA0.2%]x2 (yellow trace), PtD-Sty-[600UPBSx5-GA0.5%]x2 (green trace), PtD-Sty-[600UPBSx5-
GA1.0%]x2 (blue trace), PtD-Sty-[600UPBSx5-GA1.5%]x2 (purple trace) and PtD-Sty-[600UPBSx5-
GA2.0%]x2 (pink trace). The data plotted is taken from Table 10-9 and Table 5-9. Traces are plotted 
as Mean J ± SEM with fitted kinetic curve. 
A glance at the calibration data and kinetic parameters of the 0.1% biosensors and in 
particular the kinetic parameters of the 0.2% indicate that they were not very successful 
fabrications. This is a similar situation with one dip of those GA percentages as was 
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found for the recipes with two dips, see Section 5.3.3. As such these two designs will 
not be statistically discussed. Moving on to consider the other four designs it is plain to 
see the effect of the lower number of GA dips. The sensitivities of 0.5% and 1.0% are 
quite reduced in comparison to the results seen when these concentrations were applied 
two, five and ten times. This is reinforced by the fact that only 1.5% and 2.0% show any 
decent sensitivity. 
The Jmax of 1.0% is significantly higher than the Jmax of 0.5%, p < 0.0001***, and the 
1.5% value is significantly larger again, p < 0.0001***. The highest Jmax is that of 2.0% 
GA, it is larger than the other three percentages, p = 0.0470* for 1.5%, p = 0.0158* for 
1.0% and p = 0.0106* for 0.5%.  
The smallest KM is that of the 1.5% recipe at 1919 ± 148 µM. It is significantly smaller 
than either 0.5% or 1.0%, both p < 0.0001***. The value for 2.0% is not significantly 
different, p = 0.1150, although this is due in a large way to the SEM for the KM being 
more than one third of the mean. The mean of the 1.5% value is less than one third of 
the mean for 2.0%. 
This data is summarised best by considering the LRS values of the designs. The 0.5% 
GA LRS is smallest. The 1% value is significantly larger, p = 0.0063**, the 2.0% value 
is not significantly different from the 1.0% value, p = 0.0576. But, the largest value is 
that of the 1.5% GA recipe. It is significantly larger than the LRS of 2.0%, p = 
0.0057**, 1.0%, p = 0.0008***, and of 0.5%, p = 0.0007***. Therefore in the case of 
one dip of GA added at the end of the 10 layers of enzyme, the use of 1.5% GA yields 
the most sensitive biosensors. 
5.3.5 Discussion of the Trends in GA Alterations 
Examination of the above sets of data series to attempt to elucidate overall or underlying 
trends is a difficult process. Figure 5-14 relates the changing GA% in the recipes to the 
number of times this GA is applied within the protocol.  
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Figure 5-14 
Plots of the trends occurring within the three kinetic properties of the GA dip study. A, displays the 
KM changes, B, the Jmax changes, and the main graph, C, their combined effect on the LRS. All graphs 
are plotted as a function of GA% with the 1 dip series depicted in red, the 2 dip series in blue, the 5 
dip series in blue and the 10 dip series in purple.  
The results in A for Jmax show that overall there is no distinctly better GA%, although 
1% does emerge as appearing to be the best. It results in the single highest value for the 
2 dip and 10 dip protocols with an apparent parabolic increase and decrease to be 
observed, with the 10 dip designs displayed a significantly reduced maximum due to the 
vastly increased amount of cross-linking that must be occurring. This behaviour, while 
retaining greater quantities of enzyme, appears to be restricting the activity of the 
enzyme possibly due to a less flexible matrix. The results for 1 dip GA display almost a 
linear increase with increasing concentration. This can be treated as an expected result 
with the single dip of GA requiring higher and higher concentrations to retain further 
quantities of enzyme. The trend for the 5 dip protocol is more complex, appearing to be 
linear about a single value of J, with alternate recipes resulting in a J higher or lower 
than this fixed value. 
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The trends observed in B, the summary of the KM data are more uniform the those of the 
Jmax values. In general the values for the lower GA concentrations, 0.1% and 0.2% are 
higher than those of the intermediary 0.5%, 1.0% and 1.5%. There is a general trend 
towards increasing KM values observed again over the 1.5% and 2.0% GA recipes, 
except in the case of the 10 dip protocol where the KM continues to decrease. This trend 
can be attributed to the lower concentrations of GA having a more linear kinetic 
behaviour and thus high KM, the high GA concentrations serving to begin to restrict the 
movement and shape of the enzyme, and the intermediate concentrations reaching a 
compromise between retention of sufficient quantities of enzyme without an overly 
rigid matrix which inhibits the activity of the enzyme. 
The combination of these two factors results in two differing trends in the LRS graph. 
For the 1, 2 and 5 dip protocols, there is a period of increasing sensitivity, until a 
maximum is reached, at 1.0% for the 2 and 5 dip recipes and 1.5% for the 1 dip designs, 
followed by a subsequent decrease in the sensitivity. Only the 10 dip designs deviated 
from this pattern, whereby they displayed a linear increase in sensitivity as the GA% 
was increased. 
5.4 A Comprehensive Study of the Binding Properties of BSAGA 
In further pursuit of the most complete picture of how to maximise the sensitivity of the 
ᴅAAO based ᴅ-ser biosensors, a second study was undertaken with BSAGA as a 
stabilising/cross-linking agent. The inclusion of BSA is an important element to study in 
a GA cross-linked enzyme application with the degree of cross-linking greatly affected 
by the presence of lysine in the enzyme structure (Avrameas & Ternynck, 1969) and the 
addition of the inert lysine rich BSA protein a long established method since its first 
suggestion in the 70’s (Broun, 1976). The recipes examined followed the same general 
structure as those for the GA study, except with the GA being replaced by BSAGA. 
The analogue of changing the GA percentage in the previous section was to change the 
percentage of GA within the BSAGA formulation. The BSA concentration was 
maintained at 1% w/v. The GA was altered between 0.1% and 2.0% as previously seen 
to create six solutions as follows; BSAGA0.1%, BSAGA0.2%, BSAGA0.5%, 
BSAGA1.0%, BSAGA1.5% and BSAGA2.0%. Again, the use of these solutions was 
examined for 10, 5, 2 and 1 dips within the 10 layers applied to the sensors and also in 
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keeping with the previous examination of GA the colours used in the following figures 
were maintained from the previous section. Thus BSAGA0.1% will be red, 
BSAGA0.2% yellow, BSAGA0.5% green, BSAGA1.0% blue, BSAGA1.5% purple and 
BSAGA2.0% will be pink. 
5.4.1 Ten Dips into BSAGA 
The first set of recipes incorporated a full 10 dips into BSAGA, one for each dip in 
600UPBS, thus each layer contained enzyme and stabilising agent. The general recipe 
took the form of PtD-Sty-[600UPBS-BSAGA]x10 with the concentration of the GA 
used being varied within the BSAGA recipe.  
For the sake of completeness, a greater set of values which are more representative of 
the range of BSAGA solutions used by other groups, see Section 4.5, were used. The 
GA concentrations used were; 0.005%, 0.01%, 0.02%, 0.05%, 0.1%, 0.2%, 0.5%, 1.0%, 
1.5% and 2.0% (all v/v), while the BSA1% was always 1% w/v. 
The results from the recipes with 0.005%, 0.01%, 0.02% and 0.05% will be considered 
first. The calibration data is presented in Table 10-10 and Table 5-10. This data is 
plotted in Figure 5-15. Included in this plot are also the traces for the 0.1% and 0.2% 
recipes to allow an easier visual comparison between the first and second set of data. 
The data for the 0.1%, 0.2%, 0.5%, 1.0%, 1.5% and 2.0% are presented in Table 10-10 
and Table 5-11 and displayed in Figure 5-16. 
Electrode 
Design 
PtD-Sty-
[600UPBS-
BSAGA0.005%] 
x10, n = 3 
PtD-Sty-
[600UPBS-
BSAGA0.01%] 
x10, n = 4 
PtD-Sty-
[600UPBS-
BSAGA0.02%] 
x10, n = 4 
PtD-Sty-
[600UPBS-
BSAGA0.05%] 
x10, n = 4 
Kinetics M-M, p = 0.7681 M-M, n/c M-M, p = 0.1008 M-M, p = 0.0656 
R
2
 0.9915 0.9418 0.9995 0.9976 
Jmax, µA.cm
-2
 0.8483 ± 0.1095 0.5761 ± 0.0709 1.437 ± 0.022 4.707 ± 0.1393 
KM, µM 10865 ± 2746 2877 ± 1200 3853 ± 182 3350 ± 318 
LRS, 
µA.cm
-2
.mM
-1
 
0.0781 ± 0.0101 0.2003 ± 0.0631 0.3729 ± 0.0126 1.405 ± 0.098 
Table 5-10 
Kinetic parameters, fit, Jmax and KM values calculated from the calibration data in Table 10-10. Jmax, KM 
and LRS are presented as Mean ± SEM. 
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Figure 5-15 
J-concentration plot of sensors created to explore the effect of different GA concentrations within a 
BSAGA solution and then utilised    times to bind ᴅAAO to the surface of the electrode. Depicted are 
PtD-Sty-[600UPBS-BSAGA0.005%]x10 (orange trace), PtD-Sty-[600UPBS-BSAGA0.01%]x10 (grey 
trace), PtD-Sty-[600UPBS-BSAGA0.02%]x10 (dark green trace), PtD-Sty-[600UPBS-BSAGA0.05%]x10 
(brown trace). The data plotted is taken from Table 10-10 and Table 5-10. Also included is PtD-Sty-
[600UPBS-BSAGA0.1%]x10 (red trace) and PtD-Sty-[600UPBS-BSAGA0.2%]x10 (yellow trace) from 
Table 5-11 for clearer comparison with the data presented there.  
It is quite apparent from examination of the kinetic data in Table 5-10 that the recipes 
with the lower percentage of GA were not very sensitive. This is reinforced when they 
are observed in the plot with the BSAGA0.1% and BSAGA0.2% recipes. Here it is 
possible to see that at these lower concentrations the sensitivity appears to increase as a 
direct consequence of the amount of GA incorporated in the BSAGA solution. 
The most successful of these recipes was the PtD-Sty-[600UPBS-BSAGA0.05%]x10 
recipe (brown trace). Only it will be analysed statistically, as analysing the other recipes 
serves no purpose. Comparing the BSAGA0.05% to the BSAGA0.1% recipe it can seen 
that the formers Jmax is significantly lower, p = 0.0001***, and that its KM is also 
significantly lower, p < 0.0001***. This results in an LRS which is not significantly 
different, p = 0.4910. 
Analysing the BSAGA0.05% with the BSAGA0.2% it is observed that the later has a 
significantly higher Jmax, p < 0.0001*** and its KM is significantly larger too, p = 
0.0005***. The resultant LRS is significantly larger than the 0.05% recipe, p = 
0.0001***. Thus while there is no significant difference in the sensitivity of 0.05% and 
0.1%, increasing the percentage further to 0.2% yields a biosensor which is more 
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sensitive. It was demonstrated that increasing the concentration of included GA could 
further increase the sensitivity. This data is presented in Table 10-10 and Table 5-11. 
The first important observation to make with the data collected from the BSAGA0.1% 
to BSAGA2.0% biosensors is that within these six recipes, the one with the lowest Jmax, 
BSAGA0.1% has already been shown to have a higher Jmax than the recipes examined at 
the start of this section. BSAGA0.1%  has significantly lower Jmax when compared to 
0.2%, 0.5%, 1.0%, 1.5% and 2.0%, p < 0.0001***, p = 0.0002***, p = 0.0186*, p < 
0.0001*** and p < 0.0001*** respectively. It has an LRS which is also significantly 
lower than the others, p < 0.0001***, p = 0.0048**, p = 0.0004***, p < 0.0001*** and 
p < 0.0001*** respectively. There is no trend to be observed in the KM values. 
The 0.2% and 1.5% have the second lowest Jmax, and are non-significantly different 
from each other, p = 0.0768. The 2.0% value increases significantly over these two, p = 
0.0013** and p < 0.0001*** respectively. The use of BSAGA0.5% provides a further 
increase, p = 0.0015***, finally reaching a maximum with the use of BSAGA1.0%, p = 
0.0003***. The KM values are quite erratic and all quite large. The largest appears to be 
found using BSAGA1.0%, although it is significantly larger than 0.1%, 0.2%, 0.5%, 
1.5%, p = 0.0340*, p = 0.0169*, p = 0.0273* and p = 0.0003*** respectively, it is non-
significantly different than 0.5%, p = 0.4436. 
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Electrode Design 
PtD-Sty-[600UPBS-
BSAGA0.1%]x10, 
n = 4 
PtD-Sty-[600UPBS-
BSAGA0.2%]x10, 
n = 4 
PtD-Sty-[600UPBS-
BSAGA0.5%]x10, 
n = 3 
Kinetics M-M, p = 0.5133 M-M, p = 0.0644 M-M-H, p = 0.0004 
R
2
 0.9995 1.000 0.9999 
Jmax, µA.cm
-2
 16.09 ± 0.43 33.67 ± 0.12 56.05 ± 2.07 
KM, µM 10853 ± 549 8770 ± 66 12990 ± 1057 
α   0.8902 ± 0.0163 
LRS, µA.cm
-2
.mM
-
1
 
1.482 ± 0.038 3.389 ± 0.016 4.315 ± 0.193 
Electrode Design 
PtD-Sty-[600UPBS-
BSAGA1.0%]x10, 
n = 3 
PtD-Sty-[600UPBS-
BSAGA1.5%]x10, 
n = 4 
PtD-Sty-[600UPBS-
BSAGA2.0%]x10, 
n = 4 
Kinetics M-M-H, p = 0.0014 M-M, p = 0.1572 M-M, p = 0.7249 
R
2
 0.9997 0.9997 0.9992 
Jmax, µA.cm
-2
 99.68 ± 3.743 31.56 ± 0.79 43.55 ± 0.84 
KM, µM 14341 ± 1152 10671 ± 524 6198 ± 264 
α 0.9000 ± 0.0157   
LRS, µA.cm
-2
.mM
-
1
 
6.951 ± 0.299 2.957 ± 0.075 7.026 ± 0.177 
Table 5-11 
Kinetic parameters, fit, Jmax and KM values calculated from the calibration data in Table 10-10. Jmax, KM, 
α and LRS are presented as Mean ± SEM. 
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Figure 5-16 
J-concentration plot of sensors created to explore the effect of different GA concentrations within a 
BSAGA solution and then utilised    times to bind ᴅAAO to the surface of the electrode. Depicted are 
PtD-Sty-[600UPBS-BSAGA0.1%]x10 (red trace), PtD-Sty-[600UPBS-BSAGA0.2%]x10 (yellow trace), 
PtD-Sty-[600UPBS-BSAGA0.5%]x10 (green trace), PtD-Sty-[600UPBS-BSAGA1.0%]x10 (blue trace), 
PtD-Sty-[600UPBS-BSAGA1.5%]x10 (purple trace) and PtD-Sty-[600UPBS-BSAGA2.0%]x10 (pink 
trace). Data is taken from Table 10-10 and Table 5-11. Traces are plotted as Mean J ± SEM with fitted 
kinetic curve. 
Considering the LRS values it is observed that, after the 0.1% recipe already examined, 
the 1.5% value is the smallest. The 0.2% recipe provides a significantly larger LRS 
again, p = 0.0014**.  There is no significant difference between the BSAGA0.2% and 
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0.5%, p = 0.1331. Further improvement is achieved with the use of BSAGA1.0% and 
2.0%. They are also not significantly different from each other, p = 0.8360, but 
significantly more sensitive than 0.2% and 0.5%, p = 0.0019** and p = 0.0011** for 
1.0%, p = 0.0004*** and p = 0.0002*** for 2.0% respectively. Thus the trend for 
recipes incorporating 1.0% GA or 2.0% GA being the most sensitive appears to 
continue when BSAGA solutions are used. 
5.4.2 Five Dips into BSAGA 
As with the GA exploration, the BSAGA study then changed the number of dips to 5 of 
BSAGA to ten dips of 600UPBS. Thus every second layer contained enzyme and 
stabilising agent. The general recipe took the form of PtD-Sty-[600UPBSx2-BSAGA]x5 
with the concentration of the GA used being varied within the BSAGA recipe. The 
examination used the same six BSAGA solutions again. The calibration data collected, 
the resultant kinetic fit information and the resultant plots are displayed in Table 10-11, 
Table 5-12 and Figure 5-17. 
Unlike other general recipes that have been explored there appears to be two distinct 
levels in the plot of response for PtD-Sty-[600UPBSx2-BSAGA]x5. The first level 
encompasses the BSAGA0.1%, BSAGA0.2% and BSAGA0.5% recipes and the 
responses are quite low. There is then a large gap, and a jump in response to ᴅ-ser for 
the 1.0%, 1.5% and 2.0% recipes. The J axis in Figure 5-17 had to be split in order for 
the three lower percentage recipes to be clearly visible. 
Upon examining the figures in detail, this observation is borne out to a certain degree, 
particularly when the Jmax values are considered. The Jmax is a minimum with 0.1% and 
significantly increases with 0.2%, p = 0.0065**, and remains at that level with the 
change to 0.5%, p = 0.1238. These Jmax values are all under 6 µA.cm
-2
. With the change 
of BSAGA0.5% to BSAGA1.0% there is a large increase in Jmax, to the maximum 
reached, to 77.55 ± 2.14 µA.cm
-2
, significantly higher than the 0.5% value, p < 
0.0001***. This value is also significantly larger than the 1.5% and 2.0% value, p = 
0.0009*** and p = 0.0001***.However, more significant is that the 2.0% Jmax is still 
50.68 ± 0.75 µA.cm
-2
, which is an order of magnitude and significantly larger than the 
0.5% value, p < 0.0001***. The 2.0% is significantly smaller than the 1.5% value, p = 
0.0007***. 
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Electrode Design 
PtD-Sty-[600UPBSx2-
BSAGA0.1%]x5, 
n = 3 
PtD-Sty-
[600UPBSx2-
BSAGA0.2%]x5, 
n = 3 
PtD-Sty-
[600UPBSx2-
BSAGA0.5%]x5, 
n = 3 
Kinetics M-M-H, p = 0.0020 M-M, p = 0.6174 M-M-H, p < 0.0001 
R
2
 0.9999 0.9981 1.000 
Jmax, µA.cm
-2
 2.055 ± 0.130 4.811 ± 0.514 5.887 ± 0.206 
KM, µM 17572 ± 2316 21359 ± 3500 21703 ± 1711 
α 0.8883 ± 0.0227  0.7895 ± 0.0095 
LRS, µA.cm
-2
.mM
-
1
 
0.1169 ± 0.0804 0.2252 ± 0.0134 0.2713 ± 0.0119 
Electrode Design 
PtD-Sty-[600UPBSx2-
BSAGA1.0%]x5, 
n = 4 
PtD-Sty-
[600UPBSx2-
BSAGA1.5%]x5, 
n = 4 
PtD-Sty-
[600UPBSx2-
BSAGA2.0%]x5, 
n = 3 
Kinetics M-M-H, p = 0.0097 M-M-H, p = 0.0004 M-M-H, p = 0.0001 
R
2
 0.9998 0.9995 0.9998 
Jmax, µA.cm
-2
 77.55 ± 2.14 62.53 ± 1.25 50.68 ± 0.75 
KM, µM 6477 ± 384 2343 ± 131 2436 ± 101 
α 1.095 ± 0.028 1.303 ± 0.053 1.244 ± 0.035 
LRS, µA.cm
-2
.mM
-
1
 
11.97 ± 0.39 26.69 ± 1.04 20.81 ± 0.59 
Table 5-12 
Kinetic parameters, fit, Jmax and KM values calculated from the calibration data in Table 10-11. Jmax, KM, 
α and LRS are presented as Mean ± SEM. 
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Figure 5-17 
J-concentration plot of sensors created to explore the effect of different GA concentrations within a 
BSAGA solution and then utilised 5 times to bind ᴅAAO to the surface of the electrode. Depicted are 
PtD-Sty-[600UPBSx2-BSAGA0.1%]x5 (red trace), PtD-Sty-[600UPBSx2-BSAGA0.2%]x5 (yellow trace), 
PtD-Sty-[600UPBSx2-BSAGA0.5%]x5 (green trace), PtD-Sty-[600UPBSx2-BSAGA1.0%]x5 (blue trace), 
PtD-Sty-[600UPBSx2-BSAGA1.5%]x5 (purple trace) and PtD-Sty-[600UPBSx2-BSAGA2.0%]x5 (pink 
trace). Data is taken from Table 10-11 and Table 5-12. The J axis is split into two, 0 - 3 µA.cm-2 and 3 – 
75 µA.cm-2 . 
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The KM concentrations also tell a similar story. The 0.1%, 0.2% and 0.5% value are all 
close to 20,000 µM, whereas the 1.0%, 1.5% and 2.0% concentrations are an order of 
magnitude smaller and between 2,000 and 6,000 µM. The KM of 0.2% is not 
significantly different from the 0.1% or the 0.5% value, p = 0.4179 and p = 0.9339 
respectively. Neither is the 0.5% value different from the 0.1% value, p = 0.2247. The 
smallest concentration of the three though, 0.1%, is significantly larger than the value 
for 1.0%, p = 0.0420*. This is in turn significantly larger than the concentration 
calculated for 1.5%, p < 0.0001***, which in turn is not significantly different from the 
KM of BSAGA2.0%, p = 0.6211. 
Looking at the calculated sensitivities the culmination of these results is quite stark. The 
0.1% LRS is very small, as is the 0.2% value, although it is significantly larger, p = 
0.0023**. The LRS of BSAGA0.5% is not increased over 0.2%, p = 0.0617. All of 
these values are less than 0.3 µA.cm
-2
.mM
-1
. The LRS then increases dramatically, by 
two orders of magnitude, to nearly 50 times that value for BSAGA1.0%. This is 
obviously significantly larger than the 0.5% value, p < 0.0001***. The LRS more than 
doubles again for 1.5%, p < 0.0001***, before decreasing slightly with the use of 
BSAGA2.0%, p = 0.0067**. The LRS of 2.0% is still significantly larger than the 1.0% 
recipe, p < 0.0001***. 
5.4.3 Two Dips into BSAGA 
The series of BSAGA recipes continued with the general recipe PtD-Sty-[600UPBSx5-
BSAGA0.2%]x2. In this case the BSAGA solution was only applied on two layers. 
These were the fifth and tenth layers. As before the BSAGA0.1%, BSAGA0.2%, 
BSAGA0.5%, BSAGA1.0%, BSAGA1.5% and BSAGA2.0% solutions were all 
utilised. As was seen in the case of five applications, there seems to be a distinctive split 
in the level of response attained when two dips of BSAGA solution were utilised. This 
split appears in this instance between the BSAG 0.2% and the BSAG0.5% recipes. Both 
the 0.1% and 0.2% formulations appear to have very low sensitivity while the other four 
recipes have a far greater response to changes in the concentration of ᴅ-ser. This is best 
illustrated in the J-concentration plot which again has to have a split J axis. There is 
little point examining in detail the 0.1% and 0.2% recipes other than to say that the 
sensitivity increases with the use of 0.2%, p = 0.0170*.  
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Electrode Design 
PtD-Sty-[600UPBSx5-
BSAGA0.1%]x2, 
n = 3 
PtD-Sty-
[600UPBSx5-
BSAGA0.2%]x2, 
n = 3 
PtD-Sty-
[600UPBSx5-
BSAGA0.5%]x2, 
n = 3 
Kinetics M-M, p = 0.6156 M-M, p < 0.0001 M-M-H, p = 0.0115 
R
2
 0.9787 0.9999 0.9990 
Jmax, µA.cm
-2
 1.601 ± 0.183 8.712 ± 0.306 122.7 ± 12.0 
KM, µM 4919 ± 1542 14163 ± 1109 8615 ± 2159 
α  0.8634 ± 0.0140 0.8265 ± 0.0494 
LRS, µA.cm
-2
.mM
-
1
 
0.3256 ± 0.0685 0.6151 ± 0.0267 14.24 ± 2.19 
Electrode Design 
PtD-Sty-[600UPBSx5-
BSAGA1.0%]x2, 
n = 4 
PtD-Sty-
[600UPBSx5-
BSAGA1.5%]x2, 
n = 4 
PtD-Sty-
[600UPBSx5-
BSAGA2.0%]x2, 
n = 4 
Kinetics M-M-H, p = 0.0095 M-M-H, p = 0.0005 M-M, p = 0.9749 
R
2
 0.9988 0.9999 0.9999 
Jmax, µA.cm
-2
 59.64 ± 0.95 66.57 ± 0.58 87.96 ± 0.57 
KM, µM 818.0 ± 44.4 1494 ± 41 2630 ± 59 
α 1.227 ± 0.073 1.135 ± 0.024  
LRS, µA.cm
-2
.mM
-
1
 
72.91 ± 3.19 44.55 ± 0.91 33.44 ± 0.58 
Table 5-13 
Kinetic parameters, fit, Jmax and KM values calculated from the calibration data in Table 10-12. Jmax, KM, 
α and LRS are presented as Mean ± SEM. 
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Figure 5-18 
J-concentration plot of sensors created to explore the effect of different GA concentrations within a 
BSAGA solution and then utilised twice to bind ᴅAAO to the surface of the electrode. Depicted are PtD-
Sty-[600UPBSx5-BSAGA0.1%]x2 (red trace), PtD-Sty-[600UPBSx5-BSAGA0.2%]x2 (yellow trace), PtD-
Sty-[600UPBSx5-BSAGA0.5%]x2 (green trace), PtD-Sty-[600UPBSx5-BSAGA1.0%]x2 (blue trace), PtD-
Sty-[600UPBSx5-BSAGA1.5%]x2 (purple trace) and PtD-Sty-[600UPBSx5-BSAGA2.0%]x2 (pink 
trace). Data is taken from Table 10-12 and Table 5-13. Traces are plotted as Mean J ± SEM with fitted 
kinetic curve. 
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The Jmax of the BSAGA0.5% recipe is significantly larger than that of the 1.0% or 1.5%, 
p = 0.0344* and p = 0.0427*, but owing to the large error associated with the 0.5% 
value it is not significantly larger than the 2.0% value, p = 0.1012, despite the large 
difference in their mean value. The 2.0% recipe has the second largest Jmax, significantly 
higher than either 1.0% or 1.5%, p < 0.0001*** in both cases. The lowest Jmax is that of 
the 1.0% recipe, which is significantly lower than the Jmax of the BSAGA1.5% recipe, p 
= 0.0008***. 
Unfortunately, the largest KM also occurs with the use of BSAGA0.5%. It does however 
have a large associated SEM and therefore is not significantly larger than the value for 
BSAGA2.0%, the second largest value when the mean value is considered, p = 0.1093. 
For the same reason it is also not larger than the 1.5% concentration or the 2.0% 
concentration, p = 0.0809 and p = 0.0689 respectively. The KM produced by using 
BSAGA2.0% is significantly larger than the value obtained using either 1.5% or 1.0%, 
p < 0.0001*** in both cases. The smallest value of the four is that of BSAGA1.0%. It is 
significantly lower than that achieved using 1.5%, p < 0.0001***. 
Combining the Jmax and KM information and looking at the LRS values provides further 
reinforcement of the trend that those recipes using GA1% yield the best results overall. 
This time 0.5% is the smallest, because of the large KM. It is significantly smaller than 
the LRS of BSAGA2.0%, p = 0.0136*, which is itself smaller than the value for 1.5%, p 
< 0.0001***. The BSAGA1.0% LRS is larger than all of the 0.1%, 0.2%, 0.5%, 1.5% 
and 2.0% values, p = 0.0002***, p = 0.0002***, p < 0.0001***, p = 0.0034** and p = 
0.0012** respectively. 
5.4.4 Conclusions of the GA and BSAGA study 
Unlike in the GA study there were no recipes with only one dip of BSAGA considered. 
This decision was taken for a few reasons. The first being that for GA only there had 
been a marked reduction in sensitivity when only 1 dip of GA was used when compared 
to ten, five and two dips. This was particularly prevalent among the biosensors with the 
lower percentage of GA, with only the higher percentages showing reasonable 
sensitivity. Secondly the additional quantity of BSA that the GA would have to bind in 
the BSAGA recipes would likely further reduce the sensitivity of the biosensors. Lastly, 
with five and two dips of BSAGA there had already been shown how several recipes 
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had suffered greatly with the reduced quantity of GA being utilised. Following, in 
Figure 5-19, is a summary of the kinetic details gathered during the BSAGA study.  
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Figure 5-19 
Plots of the trends occurring within the three kinetic properties of the BSA/GA dip study. A displays 
the KM changes, B the Jmax changes, and the main graph, C, their combined effect on the LRS. All graphs 
are plotted as a function of GA% with the 2 dip series in blue, the 5 dip series in blue and the 10 dip 
series in purple.  
There are marked differences, and some similarities, in the trends displayed when 
compared to the results for the GA study. Firstly the three sets of Jmax results all appear 
to increase towards a maximum before decreasing to mid range values, with an increase 
registering again after the initial post-maximum drop. The maximum occurs again at 1% 
GA, with the exception of the 2 dip designs. The addition of the BSA has removed the 
linear aspect of the 5 dip protocol results, and tempered the maximum J achieved in the 
dip recipes. The highest Jmax attained is now for the 2 dip BSAGA0.5% recipe, followed 
by the ten dip BSAGA1.0% recipe. Previously without the BSA the 2 dip recipe 
GA1.0% recipe had a Jmax double that of any of the other highest values.  
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The addition of the BSA has also had an effect on the KM values. For the lower GA 
concentrations the SEM as a percentage of the mean has been reduced. The trend of 
decreasing KM concentrations as the GA concentration is increased is present again. 
However the is slower to take effect, with the major decreases occurring between 
BSAGA0.5% and BSAGA1.5%, as opposed to between GA0.1% and GA0.5% for the 
GA only protocol. 
The overall result on the LRS is very different when the BSA is included in the recipes. 
The 10 dip protocol changes from a linearly increasing value, peaking at 40 µA.cm
-
2
.mM
-1
, to an unchanging value, between 5 and 8 µA.cm
-2
.mM
-1
, over the range of GA 
concentrations utilised. When 5 dips of BSAGA are utilised, the maximum sensitivity is 
found to shift from GA1.0% to BSAGA1.5%. The peak value is also lower when BSA 
is incorporated. The sensitivities of the 2 dip BSAGA protocols follow the same trend 
as the GA only designs, both peaking at 1.0% GA, but here the inclusion of the BSA 
has doubled the peak LRS value. Thus it was deemed appropriate to take stock of 
results that had been attained and to select a few promising designs which might be 
taken forward for consideration and further modification. In selecting these designs 
overall trends and individual results were taken into account to select biosensors 
showing similarities and consistently good sensitivity. Overall it was judged that recipes 
involving GA1.0% and BSAGA1.0% were the most consistently sensitive designs and 
thus most suited to further examination. It was deemed that recipes where two and five 
dips of the GA or BSAGA was applied were more successful overall than the ten or one 
dip designs. 
The recipes carried forth for further exploration were thus, PtD-Sty-[600UPBSx5-
BSAGA1.0%]x2, PtD-Sty-[600UPBSx2-BSAGA1.0%]x5, PtD-Sty-[600UPBSx5-
GA1.0%]x2 and PtD-Sty-[600UPBSx2-GA1.0%]x5. The kinetic data for these recipes 
and a combined plot of them are shown below for clarity in Table 5-14 and Figure 5-20. 
From looking at the J-concentration plot it is easy to see that even within this small 
segment of similar recipes there are large variances. This would hopefully be useful in 
evaluating future alterations and give a greater scope for improvements to be 
discovered, if not for all then at least for one or two recipes. 
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Electrode 
Design 
PtD-Sty-
[600UPBSx5-
BSAGA1.0%]x2, 
n = 4 
PtD-Sty-
[600UPBSx2-
BSAGA1.0%]x5, 
n = 4 
PtD-Sty-
[600UPBSx5-
GA1.0%]x2, 
n = 3 
PtD-Sty-
[600UPBSx2-
GA1.0%]x5, 
n = 3 
Kinetics 
M-M-H, p = 
0.0095 
M-M-H, p = 
0.0097 
M-M-H, p = 
0.0081 
M-M-H, p = 
0.0021 
R
2
 0.9988 0.9998 0.9998 0.9990 
Jmax, µA.cm
-2
 59.64 ± 0.95 77.55 ± 2.14 178.8 ± 4.5 83.64 ± 2.128 
KM, µM 818.0 ± 44.4 6477 ± 384 5049 ± 291 2060 ± 154 
α 1.227 ± 0.073 1.095 ± 0.028 1.109 ± 0.030 1.332 ± 0.078 
LRS, 
µA.cm
-2
.mM
-
1
 
72.91 ± 3.19 11.97 ± 0.39 35.41 ± 1.19 40.60 ± 2.158 
Table 5-14 
Summary of the kinetic data associated with the four recipes selected for further study. 
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Figure 5-20 
J-concentration plot of the four recipes selected for further investigation. Represented are PtD-Sty-
[600UPBSx5-BSAGA1.0%]x2 (purple trace), PtD-Sty-[600UPBSx2-BSAGA1.0%]x5 (red trace), PtD-Sty-
[600UPBSx5-GA1.0%]x2 (blue trace) and PtD-Sty-[600UPBSx2-GA1.0%]x5 (green trace).  
A quick comparison of these recipes reveals that PtD-Sty-[600UPBSx2-
BSAGA1.0%]x5 has the lowest sensitivity. Significantly larger is the 2 dip GA1% 
recipe, p < 0.0001***. This is not different from the 5 dip GA1% value, p = 0.1024. The 
2 dip BSAGA recipe is significantly larger than either the 2 dip GA1% or 5 dip GA1% 
recipes, p = 0.0002*** and p = 0.0006*** respectively. Worthy of note also is that all 
of these recipes conform to Michaelis-Menten Hill-Type kinetics. 
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5.5 An Extensive Study of PEI Included With Styrene 
The short examination conducted with PEI, in Section 4.8.1., was not very structured or 
comprehensive. Thus given its use and success in other biosensor designs it was decided 
to study the possibility of using it in a more structured way. The method of inclusion 
was selected as immediately after the dip into styrene, and before the first dip of enzyme 
solution. This was in the hope that the combination of PEI and Sty could provide a 
favourable and stable matrix for the retention of the enzyme. Such favourable 
interactions have been observed before with polyelectrolyte substances in general 
(Gibson et al., 1996) but also for carbon paste based biosensors for detecting ᴅ- and ʟ-
amino acids (Johansson et al., 1993; Kacaniklic et al., 1994) and the immobilisation of 
biocatalyst via adsorption to solids supports (Kamath et al., 1988; Senthuran et al., 
1997). It is known that inclusion of PEI can alter the pH in the microenvironment of the 
enzyme as compared to the bulk solution (Goldstein, 1976) thus while it can be of 
benefit, increasing stability during storage, against temperature changes and some 
irreversible inactivating mechanisms (Andersson & Hatti-Kaul, 1999) it also has the 
potential to change the position of the enzyme in relation to its iso-electric point and 
thus the activated charged groups in its structure. This could be a negative or positive 
change, and this study is required to elucidate which effect is most likely. 
5.5.1 PEI 1% Included After Styrene 
The four recipes selected at the end of the last section, as having the best prospect for 
high sensitivity, were altered to allow for the inclusion of the PEI. The first alteration 
performed was the inclusion of PEI1.0%. The four recipes thus became; PtD-Sty-
PEI1.0%-[600UPBSx5-BSAGA1.0%]x2, PtD-Sty-PEI1.0%-[600UPBSx2-
BSAGA1.0%]x5, PtD-Sty-PEI1.0%-[600UPBSx5-GA1.0%]x2 and PtD-Sty-PEI1.0%-
[600UPBSx2-GA1.0%]x5. The calibration data for these recipes is presented in Table 
10-13. 
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Electrode 
Design 
PtD-Sty-
PEI1.0%-
[600UPBSx5-
BSAGA1.0%]x2, 
n=4 
PtD-Sty-
PEI1.0%-
[600UPBSx2-
BSAGA1.0%]x5, 
n=4 
PtD-Sty-
PEI1.0%-
[600UPBSx5-
GA1.0%]x2, 
n=4 
PtD-Sty-
PEI1.0%-
[600UPBSx2-
GA1.0%]x5, 
n=4 
Kinetics 
M-M-H, 
p = 0.0299 
M-M-H, 
p < 0.0001 
M-M, 
p = 0.1212 
M-M, 
p = 0.6255 
R
2
 0.9998 1.000 0.9969 0.9995 
Jmax, µA.cm
-2
 56.02 ± 1.55 25.63 ± 0.21 83.52 ± 4.19 52.80 ± 1.41 
KM, µM 6574 ± 397 9065 ± 166 5976 ± 757 8706 ± 500 
α 1.070 ± 0.026 0.9575 ± 0.0052   
LRS, 
µA.cm
-2
.mM
-
1
 
8.522 ± 0.283 2.827 ± 0.029 13.98 ± 1.12 6.064 ± 0.194 
Table 5-15 
Kinetic parameters, fit, Jmax and KM values calculated from the calibration data in Table 10-13. Jmax, KM, 
α and LRS are presented as Mean ± SEM. 
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Figure 5-21 
J-concentration plot of the four recipes selected for further investigation when modified with 
PEI1.0%. Represented are PtD-Sty-PEI1.0%-[600UPBSx5-BSAGA1.0%]x2 (purple trace), PtD-Sty-
PEI1.0%-[600UPBSx2-BSAGA1.0%]x5 (red trace), PtD-Sty-PEI1.0%-[600UPBSx5-GA1.0%]x2 (blue 
trace) and PtD-Sty-PEI1.0%-[600UPBSx2-GA1.0%]x5 (green trace). 
The kinetic fit data calculated in Table 5-15 clearly shows an overall decrease in the 
sensitivity of all recipes when compared to the original recipes without PEI1.0%. 
Comparing only with their non-PEI analogues the Jmax value of the 2 dip BSAGA1.0% 
is unchanged, p = 0.0934, the 5 dip BSAGA1.0% value is reduced, p = 0.0002***, the 2 
dip GA1.0% recipe is decreased, p < 0.0001***, and the 5 dip GA1.0% is also reduced, 
p < 0.0001***.Examining the KM values in the same manner a similar deterioration of 
the concentrations calculated is also observed. The 2 dip BSAGA1.0% recipe with 
PEI1.0% is significantly increased, p = 0.0007***, over the value for the recipe without 
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the PEI. The 5 dip BSAGA1.0% design is also significantly increased, p = 0.0035**, as 
is the 5 dip GA1.0%, p = 0.0001***. The 2 dip GA1.0% KM value is unchanged, p = 
0.3639.  
The overall sensitivities returned by the recipes altered with PEI1.0% are all negatively 
affected. The LRS of the 2 dip BSAGA1.0% design is significantly lower, p = 
0.0003***, so is the 5 dip BSAGA1.0%, p = 0.0002***. The 2 dip GA1% and 5 dip 
GA1% recipes are also significantly reduced, p < 0.0001***, p = 0.0039**. 
In Figure 5-21 the colours and symbols used are maintained from Figure 5-20 in Section 
5.4.4 for the same general recipes. Thus 2 dip BSAGA is the purple trace, 5 dip 
BSAGA is the red trace, 2 dip GA is the blue trace and 5 dip GA is the green trace. 
An observation may also be made that the two GA1.0% recipes are no longer 
conforming to M-M-H kinetics. In Figure 5-21 it can be seen too that the shape of the 
kinetic curves are now very similar, with no dramatic change noticeable from the initial 
linear region into the region where the rate is limited by diffusion and the substrate has 
saturated the enzyme. 
Overall the addition of a PEI1.0% dip after the Sty, and before the enzyme and BSAGA 
or GA layers were applied, was not of benefit, when compared to the recipe without 
PEI, to the current density, KM concentration or the sensitivity values. 
5.5.2 PEI 0.1% Included After Styrene 
The same four recipes were next altered with PEI0.1% after the Sty dip. The four 
recipes thus became; PtD-Sty-PEI0.1%-[600UPBSx5-BSAGA1.0%]x2, PtD-Sty-
PEI0.1%-[600UPBSx2-BSAGA1.0%]x5, PtD-Sty-PEI0.1%-[600UPBSx5-GA1.0%]x2 
and PtD-Sty-PEI0.1%-[600UPBSx2-GA1.0%]x5. The calibration data for these recipes 
is presented below in Table 10-14. It was hoped that a lower percentage might produce 
better results than the PEI1.0% designs. However, examination of the calibration data 
and the resultant kinetic fits, calculated and displayed in Table 5-16, shows that the 
results for PEI0.1% are similar to those for PEI1.0%.  
 Chapter 5: Styrene as an Immobilisation Matrix 
182 
Electrode 
Design 
PtD-Sty-
PEI0.1%-
[600UPBSx5-
BSAGA1.0%]x2, 
n=4 
PtD-Sty-
PEI0.1%-
[600UPBSx2-
BSAGA1.0%]x5, 
n=3 
PtD-Sty-
PEI0.1%-
[600UPBSx5-
GA1.0%]x2, 
n=4 
PtD-Sty-
PEI0.1%-
[600UPBSx2-
GA1.0%]x5, 
n=4 
Kinetics 
M-M, 
p = 0.0609 
M-M, 
p = 0.2162 
M-M, 
p = 0.4588 
M-M-H, 
p = 0.0228 
R
2
 0.9992 0.9957 0.9998 0.9999 
Jmax, µA.cm
-2
 73.90 ± 2.41 60.57 ± 1.96 45.51 ± 0.59 37.12 ± 0.87 
KM, µM 8104 ± 585 2287 ± 270 6260 ± 201 5795 ± 309 
α    1.068 ± 0.024 
LRS, 
µA.cm
-2
.mM
-
1
 
9.119 ± 0.377 26.49 ± 2.45 7.270 ± 0.146 6.406 ± 0.194 
Table 5-16 
Kinetic parameters, fit, Jmax and KM values calculated from the calibration data in Table 10-14. Jmax, KM, 
α and LRS are presented as Mean ± SEM. 
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Figure 5-22 
J-concentration plot of the four recipes selected for further investigation when modified with 
PEI0.1%. Represented are PtD-Sty-PEI0.1%-[600UPBSx5-BSAGA1.0%]x2 (purple trace), PtD-Sty-
PEI0.1%-[600UPBSx2-BSAGA1.0%]x5 (red trace), PtD-Sty-PEI0.1%-[600UPBSx5-GA1.0%]x2 (blue 
trace) and PtD-Sty-PEI0.1%-[600UPBSx2-GA1.0%]x5 (green trace). 
Comparing each result to its original form, as per Section 5.4.4, it can be seen that the 
Jmax values are often significantly poorer. The 2 dip BSAGA value is significantly 
higher, p = 0.0113*. But, the 5 dip BSAGA Jmax is significantly lower, p = 0.0025**, 
the 2 dip GA value is significantly lower, p = 0.0012**, and the 5 dip GA value is also 
lower, p < 0.0001***. 
Concentrations indicative of the KM have also changed dramatically, and not in a 
preferable direction. The concentration at which the KM is found for the 2 dip BSAGA 
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design is significantly higher, p = 0.0011**, as it the 5 dip BSAGA value, p = 
0.0004***, the 2 dip value, p = 0.0161*, and the 5 dip GA value, p = 0.0002***. 
Combining Jmax values which are generally smaller and KM values which are larger than 
the original values is sure to lead to reduced sensitivities across all recipes, and this is 
the case. The 2 dip BSAGA and 5 dip BSAGA LRS values are significantly reduced, p 
= 0.0003*** and p = 0.0279* respectively. This is also the case for 2 and 5 dips of 
GA1.0%, which have significantly lower sensitivities, p = 0.0018** and p = 0.0040** 
respectively. Thus the use of a lower percentage concentration of PEI did not yield 
better results than the original designs either. 
5.5.3 PEI 5% Included After Styrene 
In a final effort to determine whether PEI could be of benefit the sensitivity of a ᴅAAO 
based ᴅ-ser biosensor one last approach was considered. This was an approach which 
had been utilised before within the research group. It proved effective when other 
methods of including PEI did not. The premise of this method was to use a stronger 
solution of PEI for an initial interaction with the enzyme. Along with this a lower 
concentration of PEI was applied in the middle of the dipping process to help secure and 
interact with the outer layers of enzyme. Two variations of this approach were 
examined. 
5.5.3.1 PEI 5% Used In Conjunction with PEI 1.0% 
The first approach was to use an initial PEI5.0% dip between the Sty and the 600UPBS 
on the first layer. The second dip of PEI was a dip into PEI1.0% on the fifth layer after 
the other dips of that layer had been applied. Thus the second dip of PEI had five layers 
of 600UPBS underneath and above it. The same four recipes from Section 5.4.4 were 
used as the basis for the new designs. They when modified became; PtD-Sty-PEI5.0%-
[600UPBSx5-BSAGA1.0%]x2-PEI1.0%(5), PtD-Sty-PEI5.0%-[600UPBSx2-
BSAGA1.0%]x5-PEI1.0%(5), PtD-Sty-PEI5.0%-[600UPBSx5-GA1.0%]x2-PEI1.0%(5) 
and PtD-Sty-PEI5.0%-[600UPBSx2-GA1.0%]x5-PEI1.0%(5). 
The calibration data for these recipes is listed in Table 10-15, the kinetic fit data in 
Table 5-17 and the results are depicted in Figure 5-23. Here again the colours and 
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symbols used in the figure are consistent with those previously used for the same 
general formulation.  
Electrode 
Design 
PtD-Sty-
PEI5.0%-
[600UPBSx5-
BSAGA1.0%]x2-
PEI1.0%(5), n=4 
PtD-Sty-
PEI5.0%-
[600UPBSx2-
BSAGA1.0%]x5-
PEI1.0%(5), n=4 
PtD-Sty-
PEI5.0%-
[600UPBSx5-
GA1.0%]x2-
PEI1.0%(5), 
n=3 
PtD-Sty-
PEI5.0%-
[600UPBSx2-
GA1.0%]x5-
PEI1.0%(5), 
n=4 
Kinetics 
M-M, 
p = 0.6133 
M-M, 
p = 0.2150 
M-M-H, 
p = 0.0031 
M-M-H, 
p = 0.3457 
R
2
 0.9675 1.000 0.9998 0.9984 
Jmax, µA.cm
-2
 22.51 ± 3.95 46.21 ± 0.21 73.99 ± 5.99 78.02 ± 2.33 
KM, µM 6359 ± 2742 5513 ± 67 21348 ± 3478 7180 ± 451 
α   0.8840 ± 0.0252  
LRS, 
µA.cm
-2
.mM
-
1
 
3.540 ± 0.951 8.382 ± 0.066 3.466 ± 0.285 10.87 ± 0.38 
Table 5-17 
Kinetic parameters, fit, Jmax and KM values calculated from the calibration data in Table 10-15. Jmax, KM, 
α and LRS are presented as Mean ± SEM. 
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Figure 5-23 
J-concentration plot of the four recipes selected for further investigation when modified with 
PEI5.0% and PEI1.0%. Represented are PtD-Sty-PEI5.0%-[600UPBSx5-BSAGA1.0%]x2-PEI1.0%(5) 
(purple trace), PtD-Sty-PEI5.0%-[600UPBSx2-BSAGA1.0%]x5-PEI1.0%(5) (red trace), PtD-Sty-
PEI5.0%-[600UPBSx5-GA1.0%]x2-PEI1.0%(5) (blue trace) and PtD-Sty-PEI5.0%-[600UPBSx2-
GA1.0%]x5-PEI1.0%(5) (green trace). 
Unfortunately, as with the other recipes where PEI was utilised, it is quite clear that 
there has once again been a deterioration of the kinetic parameters of the various 
electrode types produced. The modification with PEI5.0% and PEI1.0% appear to have 
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been detrimental to all kinetic parameters, including the loss of M-M-H kinetic fit in all 
but one case. 
Statistically, the Jmax value of the 2 dip BSAGA design has decreased, p = 0.0028**. 
The 5 dip BSA and 2 dip GA recipes have also seen a decrease in their Jmax values, p = 
0.0007*** and p = 0.0002*** respectively. There is no significant change in the Jmax of 
the 5 dip GA design, p = 0.1475. The KM values describe a similar picture of decline. 
The 2 dip and 5 dip BSAGA biosensors show no significant change in the KM 
concentration, p = 0.1366 and p = 0.0902 respectively. The 2 dip and 5 dip GA recipes 
on the other hand show significantly higher KM values, p = 0.0429* and p = 0.0002*** 
respectively. 
Sensitivity, calculated from the combined Jmax and KM figures, provides a clear 
summary of these statistics. All of the recipes show a significantly reduced LRS, p = 
0.0002***, p = 0.0028**, p < 0.0001*** and p = 0.0054** for 2 dip BSAGA, 5 dip 
BSAGA, 2 dip GA and 5 dip GA respectively. Thus again it is clear to see that the use 
of PEI has not improved the sensitivity of the biosensors. This is most likely due to a 
inhibitory interaction between the positive charges on the PEI and the groups that exist 
on the outside of the enzyme molecule. It could also be due, in part, to an increased 
diffusional barrier for the ᴅ-serine and H2O2 to pass through. 
5.5.3.2 PEI 5% Used In Conjunction with PEI 0.1% 
In a final attempt to incorporate PEI within the biosensor designs the strong initial 
binding dip and weaker consolidation dip was attempted again. This time it was 
attempted with PEI5.0% and PEI0.1%. Thus the four recipes became; PtD-Sty-PEI5.0%-
[600UPBSx5-BSAGA1.0%]x2-PEI0.1%(5), PtD-Sty-PEI5.0%-[600UPBSx2-
BSAGA1.0%]x5-PEI0.1%(5), PtD-Sty-PEI5.0%-[600UPBSx5-GA1.0%]x2-PEI0.1%(5) 
and PtD-Sty-PEI5.0%-[600UPBSx2-GA1.0%]x5-PEI0.1%(5). 
The calibration data for these recipes is presented in Table 10-16 and the kinetic fit 
information in Table 5-18. Plotted in Figure 5-24 is the information from both tables. 
As in the last three sections the colours and symbols used within the graph are 
consistent with those used for the unmodified recipes chosen in Section 5.4.4.It is clear 
that again the use of PEI has resulted in a deterioration of all of the relevant kinetic 
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parameters. This is borne out by the statistics. Comparison of the results is in relation to 
the recipes in Section 5.4.4, before alteration with PEI.  
Electrode 
Design 
PtD-Sty-
PEI5.0%-
[600UPBSx5-
BSAGA1.0%]x2-
PEI0.1%(5), n=4 
PtD-Sty-
PEI5.0%-
[600UPBSx2-
BSAGA1.0%]x5-
PEI0.1%(5), n=4 
PtD-Sty-
PEI5.0%-
[600UPBSx5-
GA1.0%]x2-
PEI0.1%(5), 
n=3 
PtD-Sty-
PEI5.0%-
[600UPBSx2-
GA1.0%]x5-
PEI0.1%(5), 
n=4 
Kinetics 
M-M-H, 
p = 0.0012 
M-M, 
p = 0.8846 
M-M, 
p = 0.3743 
M-M, 
p = 0.6904 
R
2
 1.000 0.9999 0.9986 0.9990 
Jmax, µA.cm
-2
 72.83 ± 1.89 50.66 ± 0.35 10.32 ± 0.63 77.11 ± 1.96 
KM, µM 13257 ± 721 5842 ± 102 13089 ± 1461 7871 ± 407 
α 0.9350 ± 0.0121    
LRS, 
µA.cm
-2
.mM
-
1
 
5.494 ± 0.157 8.672 ± 0.096 0.7887 ± 0.0413 9.798 ± 0.275 
Table 5-18 
Kinetic parameters, fit, Jmax and KM values calculated from the calibration data in Table 10-16. Jmax, KM, 
α and LRS are presented as Mean ± SEM. 
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Figure 5-24 
J-concentration plot of the four recipes selected for further investigation when modified with 
PEI5.0% and PEI0.1%. Represented are PtD-Sty-PEI5.0%-[600UPBSx5-BSAGA1.0%]x2-PEI0.1%(5) 
(purple trace), PtD-Sty-PEI5.0%-[600UPBSx2-BSAGA1.0%]x5-PEI0.1%(5) (red trace), PtD-Sty-
PEI5.0%-[600UPBSx5-GA1.0%]x2-PEI0.1 %(5) (blue trace) and PtD-Sty-PEI5.0%-[600UPBSx2-
GA1.0%]x5-PEI0.1%(5) (green trace). 
Statistically the Jmax of the 2 dip BSAGA is reduced, p = 0.0008***, as it for the 5 dip 
BSAGA and 2 dip GA recipes, p = 0.0011** and p = 0.0007*** respectively. The 5 dip 
GA design has a Jmax which is unchanged with the inclusion of PEI5.0% and PEI1.0%, p 
= 0.0761.  
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The KM values have also deteriorated, with large increases to be seen in some cases. 
The 2 dip BSAGA has a significantly larger KM, p = 0.0004***, but the 5 dip BSAGA 
recipe has a non-significantly different value, p = 2089. The 2 dip GA and 5 dip GA 
recipes also have increased KM concentrations, p = 0.0327* and p < 0.0001*** 
respectively. 
Summarising these changes it can be seen that all the LRS values are lower than in the 
unmodified recipes. The sensitivity is lower for 2 dip BSAGA, 5 dip BSAGA, 2 dip GA 
and 5 dip GA, p = 0.0002***, p = 0.0037**, p = 0.0012** and p = 0.0050**.Having 
examined a range of options that endeavoured to include PEI in a productive manner it 
was decided to discontinue these efforts. After several attempts of changing the method 
of combination, the recipe within which it was combined and the concentration of the 
PEI utilised, it became clear that it was not likely to be a useful addition to a ᴅ-ser 
biosensor. 
5.6 The Incorporation of FAD into Selected Designs 
With the elimination of PEI as a potential method for increasing the sensitivity of the 
biosensors it was decided to pursue other interesting substances. One of particular 
interest was FAD. This vital cofactor was already present within the enzyme and was 
essential for substrate turnover. Thus inclusion of extra quantities of it held a substantial 
possibility for improving sensitivity. The inclusion of FAD in Section 4.8.2 had already 
shown promising signs that it would indeed produce a beneficial effect. Examined is the 
effect of placing the FAD before and after the application of the enzyme dip within that 
particular layer. This could alter the layer of enzyme that the particular dip of FAD 
interacts with. Placed before the enzyme dip the FAD might interact more with the 
bound enzyme of previous layers and minimally with the dip of enzyme that followed. 
Placed after the enzyme dip it is likely that the FAD interacts predominantly with the 
enzyme applied just previous and which had not yet been bound/ or dried onto previous 
layers. 
5.6.1 FAD Included Before ᴅAAO 
The first approach considered was to include FAD at a concentration of 0.02 mM 
(FAD0.02). A dip of this was included on the same layers as either BSAGA1.0% or 
GA1.0% in their respective recipes. The dip into FAD occurred before the dip into 
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600UPBS, which itself was before the BSAGA1.0% or GA1.0%. The same four recipes 
used throughout the PEI study were used for the FAD study. When the FAD0.02 was 
included the recipes took the form of; PtD-Sty-[600UPBSx5-FAD0.02(befE)-
BSAGA1.0%]x2, PtD-Sty-[600UPBSx2-FAD0.02(befE)-BSAGA1.0%]x5, PtD-Sty-
[600UPBSx5-FAD0.02(befE)-GA1.0%]x2 and PtD-Sty-[600UPBSx2-FAD0.02(befE)-
GA1.0%]x5, where (befE) indicates the FAD dip occurred before the enzyme dip in that 
particular layer. The calibration data collected from these recipes is presented in Table 
10-17. Some improvements in the kinetic parameters are found, when FAD0.02 is 
included in this manner, and other values are unchanged. But, in general, there is an 
undesirable change in the kinetic fits presented in Table 5-19.  
The Jmax of 2 dip BSAGA is significantly improved, p < 0.0001***, but the Jmax of 2 dip 
GA and 5 dip GA show a significant decrease, both p < 0.0001***. The 5 dip BSAGA 
shows no change, p = 0.6898. The KM concentration of the 2 dip BSAGA recipe is 
significantly increased, p = 0.0002***, as is the 5 dip BSAGA value, p = 0.0305*. The 
2 dip GA KM is unchanged, p = 0.0985, and the 5 dip GA concentration is significantly 
higher, p = 0.0007***. 
The sensitivities displayed by these new designs are not encouraging. The 2 dip 
BSAGA1.0% design and the 5 dip BSAGA1.0% design both show significant decreases 
in their LRS, p = 0.0003*** and p = 0.0112* respectively. The 2 dip and 5 dip GA1.0% 
also, unfortunately, show significant decreases in their sensitivities relative to the 
recipes before FAD0.02 modification, p < 0.0001*** and p = 0.0042** respectively. 
Thus overall it cannot be said that the inclusion of FAD 0.02mM benefitted the 
biosensor design. 
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Electrode 
Design 
PtD-Sty-
[600UPBSx5-
FAD0.02(befE)-
BSAGA1.0%]x2, 
n=4 
PtD-Sty-
[600UPBSx2-
FAD0.02(befE)-
BSAGA1.0%]x5, 
n=4 
PtD-Sty-
[600UPBSx5-
FAD0.02(befE)-
GA1.0%]x2, n=3 
PtD-Sty-
[600UPBSx2-
FAD0.02(befE)-
GA1.0%]x5, n=4 
Kinetics 
M-M-H, 
p = 0.0176 
M-M-H, 
p = 0.0034 
M-M, 
p = 0.3009 
M-M, 
p = 0.4113 
R
2
 1.000 0.9998 0.9990 0.9999 
Jmax, µA.cm
-2
 113.5 ± 1.9 79.08 ± 2.96 51.29 ± 1.46 56.39 ± 0.65 
KM, µM 8761 ± 331 8193 ± 737 5739 ± 418 7826 ± 201 
α 0.9652 ± 0.0110 0.8998 ± 0.0224   
LRS, 
µA.cm
-2
.mM
-
1
 
12.96 ± 0.27 9.652 ± 0.511 8.937 ± 0.419 7.205 ± 0.108 
Table 5-19 
Kinetic parameters, fit, Jmax and KM values calculated from the calibration data in Table 10-17. Jmax, KM, 
α and LRS are presented as Mean ± SEM. 
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Figure 5-25 
J-concentration plot of the four recipes selected for further investigation when modified with 
FAD0.02. Represented are PtD-Sty-[600UPBSx5-FAD0.02(befE)-BSAGA1.0%]x2 (purple trace), PtD-
Sty-[600UPBSx2-FAD0.02(befE)-BSAGA1.0%]x5 (red trace), PtD-Sty-[600UPBSx5-FAD0.02(befE)-
GA1.0%]x2 (blue trace) and PtD-Sty-[600UPBSx2-FAD0.02(befE)-GA1.0%]x5 (green trace). 
5.6.2 FAD Included After ᴅAAO 
Taking into account the sometimes unchanged and improved values shown sporadically 
with FAD at 0.02 mM concentration, it was decided to examine its use again, this time 
at a concentration of 0.08 mM (FAD0.08). The same four recipes were used, except that 
this time around the FAD0.08 dip was applied after the 600UPBS dip and before the 
binding layer of BSAGA1.0% or GA1.0% was applied. Dips of FAD0.08 were only 
applied on layers that also have a binding layer applied. 
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Electrode 
Design 
PtD-Sty-
[600UPBSx5-
FAD0.08-
BSAGA1.0%]x2 
n = 4 
PtD-Sty-
[600UPBSx2-
FAD0.08-
BSAGA1.0%]x5 
n = 4 
PtD-Sty-
[600UPBSx5-
FAD0.08-
GA1.0%]x2 
n = 3 
PtD-Sty-
[600UPBSx2-
FAD0.08-
GA1.0%]x5 
n = 4 
Kinetics 
M-M-H, 
n/c 
M-M-H, 
p = 0.0051 
M-M-H, 
p = 0.0007 
M-M-H, 
p = 0.0096 
R
2
 0.9882 0.9999 0.9997 0.9998 
Jmax, µA.cm
-2
 25.42 ± 4.52 49.15 ± 0.47 56.72 ± 0.5284 77.12 ± 0.98 
KM, µM 9214 ± 1549 2654 ± 73 878.0 ± 27.8 1805 ± 71.54 
α 2.717 ± 0.638 1.061 ± 0.015 1.207 ± 0.040 1.094 ± 0.028 
LRS, 
µA.cm
-2
.mM
-
1
 
2.759 ± 0.116 18.52 ± 0.34 64.61 ± 1.63 42.73 ± 1.21 
Table 5-20 
Kinetic parameters, fit, Jmax and KM values calculated from the calibration data in Table 10-18. Jmax, KM, 
α and LRS are presented as Mean ± SEM. 
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Figure 5-26 
J-concentration plot of the four recipes selected for further investigation when modified with 
FAD0.02. Represented are PtD-Sty-[600UPBSx5-FAD0.08-BSAGA1.0%]x2 (purple trace), PtD-Sty-
[600UPBSx2-FAD0.08-BSAGA1.0%]x5 (red trace), PtD-Sty-[600UPBSx5-FAD0.08-GA1.0%]x2 (blue 
trace) and PtD-Sty-[600UPBSx2-FAD0.08-GA1.0%]x5 (green trace). 
The recipes to be examined were thus; PtD-Sty-[600UPBSx5-FAD0.08-
BSAGA1.0%]x2, PtD-Sty-[600UPBSx2-FAD0.08-BSAGA1.0%]x5, PtD-Sty-
[600UPBSx5-FAD0.08-GA1.0%]x2 and PtD-Sty-[600UPBSx2-FAD0.08-GA1.0%]x5. 
They were calibrated as before for their response to ᴅ-ser and the data collected is 
presented in Table 10-18. The kinetic fit information for the calibration data and a 
depiction of the resultant J-concentration curves are shown in Table 5-20 and Figure 
5-26. 
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The kinetic parameters show that the results obtained with the use of FAD0.08 were 
quite mixed. On one hand the 2 dip BSAGA1.0% recipe appears to suffer, with 
unfavourable increases and decreases in the parameters and a very severe sigmoidal fit, 
but the other designs seem to have improved on the results obtained without the 
FAD0.08.  
Beginning with the 2 dip BSAGA and 5 dip BSAGA recipes, the Jmax values have both 
significantly decreased, p = 0.0051** and p = 0.0010** respectively. The KM values 
have reacted differently with the 2 dip BSAGA concentration increasing significantly, p 
= 0.0123*, and the 5 dip BSAGA KM decreasing, p = 0.0023**. This results in the 2 dip 
BSAGA LRS being significantly decreased, p = 0.0002***, and the 5 dip BSAGA 
design showing a significant increase in sensitivity, p < 0.0001***. 
The 2 dip GA1.0% recipes has a significant decrease in Jmax, p = 0.0014**, as does the 5 
dip GA1.0% recipe, p = 0.0277. The KM of 2 dip GA1.0% is significantly reduced, p = 
0.0049**, and the 5 dip GA1.0% concentration shows a non-significant change, p = 
0.1587. The sensitivity of the 5 dip GA1.0% design is unchanged, p = 0.3976. However, 
the 5 dip design has an LRS that is significantly increased over the non FAD0.08 
recipes, p = 0.0001*** 
5.7 Conclusion 
With the conclusion in Chapter 4 that the initially proposed design was not fit for the 
purposes intended, a process of designing a new biosensor began. This process started 
from the very basic concept of adsorbing ᴅAAO onto the bare metal surface. From there 
it progressed to a simple study of how many layers of the enzyme could optimally be 
built up on the electrode surface using GA as a cross-linking agent, and then the 
introduction of an ‘immobilisation matrix’; styrene. Styrene was combined with some 
commonly used elements in the design of biosensors, GA, BSA and BSA/GA, and a 
further examination of the optimal build up of layers occurred. These studies yielded the 
observation that, overall, 10 layers of ᴅAAO, combined within the immobilisation 
matrix and some other agents, would likely yield the best results in the long run. 
The second issue resolved was that of the formulation of the enzyme solution. This 
issue was initialled raised in Section 4.7.1, and in Section 5.2.4 the matter was settled 
with a PBS solution with a pH of 8.5 and 600 U/mL of ᴅAAO definitively coming out 
 Chapter 5: Styrene as an Immobilisation Matrix 
192 
as the best all round choice. At this time it was also observed that BSA on its own did 
not produce any favourable sensitivity and was excluded from further study. Thus the 
basic structure of the evolving biosensor came to be; a bare Pt/Ir disk surface, an initial 
layer of the immobilisation matrix styrene, 10 layers of ᴅAAO PBS 600U and 
interspersed within these ten layers would be some combination of GA, BSA/GA or 
other substances.  
The investigation into the use of GA within this general formula was the first thorough 
and very comprehensive study which moved the project forward to a definite design 
protocol. More than six concentrations of GA (although only six are reported for clarity 
and due to the poor results of other recipes) were tested, with 1, 2, 5 and 10 dips being 
interspersed among the enzyme dips for all concentrations. This process was repeated 
for a study using BSA/GA, where once again the concentration of GA used within this 
formula was up 10 different concentrations. Overall these studies yielded a strong set of 
results which generally indicated that the use of 1% GA, dipped 2 or 5 times with the 10 
layers of ᴅAAO produced the best results. 
At this time the decision was taken to select the four most promising recipes and carry 
them forward to further studies. Utilising more recipes than this would have enormously 
increased the number of permutations and combinations to be examined. The four 
recipes selected were PtD-Sty-[600UPBSx5-BSAGA1.0%]x2, PtD-Sty-[600UPBSx2-
BSAGA1.0%]x5, PtD-Sty-[600UPBSx5-GA1.0%]x2 and PtD-Sty-[600UPBSx2-
GA1.0%]x5.  
These selected protocols were then studied and examined in the context of the inclusion 
of PEI. Despite the beneficial effects shown in other biosensor designs, it was found 
that there was no combination involving PEI which improved on any of the vital kinetic 
parameters of the proposed biosensor. A further exploration involving FAD did 
however yield promising results under certain circumstances. When used in conjunction 
with, and only on those layers where GA 1.0% was present, and in between the enzyme 
and GA dip, the addition of 0.08 mM FAD was shown to maintain or increase the 
sensitivity of the biosensor when compared to the analogue biosensor without FAD. 
However, if the FAD was included before the enzyme and GA dip, or in conjunction 
with BSA/GA in any way, the result was a significantly decreased sensitivity in all 
cases. 
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Thus, in combination with the first four most promising protocols there were now two 
more recipes to consider in relation to any further improvements. These were; PtD-Sty-
[600UPBSx5-FAD0.08-GA1.0%]x2 and PtD-Sty-[600UPBSx2-FAD0.08-GA1.0%]x5. 
In summary, while it was considered that significant progress had been made towards a 
sensitive and reproducible biosensor it was hoped that further changes could be made 
which would provide superior sensitivity. It was encouraging that the enzyme solution 
was now being used continuously for multiple fabrication processes without changing 
the results. 
  
 Chapter 5: Styrene as an Immobilisation Matrix 
194 
References 
 
Andersson MM & Hatti-Kaul R. (1999). Protein stabilising effect of polyethyleneimine. 
Journal of Biotechnology 72, 21-31. 
 
Aso C & Aito Y. (1962). Intramolecular-Intermolecular Polymerization of 
Glutaraldehyde. Bulletin of the Chemical Society of Japan 35, 1426-1426. 
 
Avrameas S & Ternynck T. (1969). The cross-linking of proteins with glutaraldehyde 
and its use for the preaparation of immunoadsorbernts. Immunochemistry 6, 53-
66. 
 
Bolger FB. (2007). The in vitro and in vivo characterisation and application of real time 
sensors and biosensors for neurochemical studies of brain energy metabolism. In 
Department of Chemistry. National University of Ireland, Maynooth. 
 
Broun GB. (1976). [20] Chemically aggregated enzymes. In Methods in Enzymology, 
ed. Klaus M, pp. 263-280. Academic Press. 
 
Gibson TD, Pierce BLJ, Hulbert JN & Gillespie S. (1996). Improvements in the stability 
characteristics of biosensors using protein-polyelectrolyte complexes. Sensors 
and Actuators B: Chemical 33, 13-18. 
 
Goldstein L. (1976). Kinetic behavior of immobilized enzyme systems. In Methods in 
Enzymology, ed. Klaus M, pp. 397-443. Academic Press. 
 
Gregg RA & Mayo FR. (1947). Chain transfer in the polymerisation of styrene. III. The 
reactivities of hydrocarbons toward the styrene radical. Discussions of the 
Faraday Society 2, 328-337. 
 
Gregg RA & Mayo FR. (1948). Chain transfer in the polymerisation of styrene. II. The 
reaction of styrene with carbon tetrachloride. Journal of the American Chemical 
Society 70, 2373-2378. 
 
Gregg RA & Mayo FR. (1953). Chain transfer in the polymerisation of styrene. VII. 
Compounds containing halogens, oxygen and nitrogen. Journal of the American 
Chemical Society 75, 3530-3533. 
 
Hardy PM, Nicholls AC & Rydon HN. (1969). The nature of glutaraldehyde in aqueous 
solution. Journal of the Chemical Society D: Chemical Communications 0, 565-
566. 
 
 Chapter 5: Styrene as an Immobilisation Matrix 
195 
Haughton E. (pending publication). Real-time Neurochemical Analysis of Excitatory 
Amino Acids: Enzyme-modified Microelectrochemical Biosensors for Aspartate 
and Glutamate. In Department of Chemistry. National University of Ireland, 
Maynooth, (pending publication). 
 
Jansen EF & Olson AC. (1969). Properties and enzymatic activities of papain 
insolubilized with glutaraldehyde. Arch Biochem Biophys 129, 221-227. 
 
Jansen EF, Tomimatsu Y & Olson AC. (1971). Cross-linking of α-chymotrypsin and 
other proteins by reaction with glutaraldehyde. Arch Biochem Biophys 144, 394-
400. 
 
Johansson E, Marko-Varga G & Gorton L. (1993). Study of a reagent- and mediator-
less biosensor for D-amino acids based on co-immobilized D-amino acid 
oxidase and peroxidase in carbon paste electrodes. J Biomater Appl 8, 146-173. 
 
Kacaniklic V, Johansson K, Marko–Varga G, Gorton L, Jönsson–Pettersson G & 
Csöregi E. (1994). Amperometric biosensors for detection of L- and D-amino 
acids based on coimmobilized peroxidase and L- and D-amino acid oxidases in 
carbon paste electrodes. Electroanalysis 6, 381-390. 
 
Kamath N, Melo JS & D’Souza SF. (1988). Urease immobilized on polyethyleneimine 
cotton cloth. Applied Biochemistry & Biotechnology 19, 251-258. 
 
Kawahara J-i, Ohmori T, Ohkubo T, Hattori S & Kawamura M. (1992). The structure of 
glutaraldehyde in aqueous solution determined by ultraviolet absorption and 
light scattering. Anal Biochem 201, 94-98. 
 
Korn AH, Feairheller SH & Filachoine EM. (1972). Glutaraldehyde: Nature of the 
reagent. Journal of Molecular Biology 65, 525-529. 
 
Margel S & Rembaum A. (1980). Synthesis and Characterization of 
Poly(glutaraldehyde). A Potential Reagent for Protein Immobilization and Cell 
Separation. Macromolecules 13, 19-24. 
 
Mayo FR. (1943). Chain transfer in the polymerization of styrene. I. The reaction of 
solvents with free radicals. Journal of the American Chemical Society 65, 2324-
2329. 
 
Mayo FR. (1948). Chain transfer in the polymerisation of styrene. IV. The effect of 
chain length on the reaction of styrene and carbon tetrachloride. Journal of the 
American Chemical Society 70, 3689-3694. 
 
 Chapter 5: Styrene as an Immobilisation Matrix 
196 
Mayo FR. (1953). Chain transfer in the polymerisation of styrene. VIII. Chain transfer 
with bromobenzene and mechanism of thermal initiation. Journal of the 
American Chemical Society 75, 6133-6141. 
 
Mayo FR & Gregg RA. (1948). Effects of inhibitors on the polymerization of styrene. 
Journal of the American Chemical Society 70, 1284-1286. 
 
Mayo FR, Gregg RA & Matheson MS. (1951). Chain transfer in the polymerisation of 
styrene. VI. Chain transfer with styrene and benzoyl peroxide; the efficiency of 
initiation and the mechanism of chain termination. Journal of the American 
Chemical Society 73, 1691-1700. 
 
Migneault I, Dartiguenave C, Bertrand MJ & Waldron KC. (2004). Glutaraldehyde: 
behaviour in aqueous solution, reaction with proteins, and application to enzyme 
crosslinking. BioTechniques 37, 790-802. 
 
Miller AA & Mayo FR. (1956). Oxidation of unsaturated compounds. I. The oxidation 
of styrene. Journal of the American Chemical Society 78, 1017-1023. 
 
Monsan P, Puzo G & Mazarguil H. (1975). Study of the mechanism of glutaraldehyde-
protein bond formation. Biochimie 57, 1281. 
 
Okuda K, Urabe I, Yamada Y & Okada H. (1991). Reaction of glutaraldehyde with 
amino and thiol compounds. Journal of Fermentation and Bioengineering 71, 
100-105. 
 
Ottesen M & Svensson B. (1971). Modification of papain by treatment with 
glutaraldehyde under reducing and non-reducing conditions. Comptes-rendus 
des travaux du Laboratoire Carlsberg 38, 171. 
 
Poyard S, Martelet C, Jaffrezic-Renault N, Cosnier S & Labbe P. (1999). Association of 
a poly(4-vinylpyridine-co-styrene) membrane with an inorganic/organic mixed 
matrix for the optimization of glucose biosensors. Sensors & Actuators B: 
Chemical 58, 380-383. 
 
Priddy DB. (1994). Recent advances in styrene polymerization. In Polymer Synthesis, 
pp. 67-114. Springer Berlin Heidelberg. 
 
Rembaum A, Margel S & Levy J. (1978). Polyglutaraldehyde: A new reagent for 
coupling proteins to microspheres and for labeling cell-surface receptors. 
Journal of Immunological Methods 24, 239-250. 
 
 Chapter 5: Styrene as an Immobilisation Matrix 
197 
Richards FM & Knowles JR. (1968). Glutaraldehyde as a protein cross-linking reagent. 
Journal of Molecular Biology 37, 231-233. 
 
Senthuran A, Senthuran V, Mattiasson B & Kaul R. (1997). Lactic acid fermentation in 
a recycle batch reactor using immobilized Lactobacillus casei. Biotechnology & 
Bioengineering 55, 841-853. 
 
Shimizu M, Kanai Y, Uchida H & Katsube T. (1994). Integrated biosensor employing a 
surface photovoltage technique. Sensors & Actuators B: Chemical 20, 187-192. 
 
Tashima T, Imai M, Kuroda Y, Yagi S & Nakagawa T. (1991). Structure of a new 
oligomer of glutaraldehyde produced by aldol condensation reaction. The 
Journal of Organic Chemistry 56, 694-697. 
 
Tashima T, Kawakami U, Harada M, Sakata T, Satoh N, Nakagawa T & Tanaka H. 
(1987). Isolation and Identification of New Oligomers in Aqueous Solution of 
Glutaraldehyde(Analytical,Chemical). Chemical & pharmaceutical bulletin 35, 
4169-4180. 
 
Tomimatsu Y, Jansen EF, Gaffield W & Olson AC. (1971). Physical chemical 
observations on the α-chymotrypsin glutaraldehyde system during formation of 
an insoluble derivative. Journal of Colloid and Interface Science 36, 51-64. 
 
Volotovsky V & Kim N. (1998). Cyanide determination by an ISFET-based peroxidase 
biosensor. Biosensors & Bioelectronics 13, 1029-1033. 
 
Weetall HH. (1974). Immobilized enzymes. Analytical applications. Analytical 
Chemistry 46, 602A-615a. 
 
Xu S & Han X. (2004). A novel method to construct a third-generation biosensor: Self-
assembling gold nanoparticles on thiol-functionalized poly(styrene-co-acrylic 
acid) nanospheres. Biosensors & Bioelectronics 19, 1117-1120. 
 
Zaborsky OR & Co CR. (1973). Immobilized enzymes, vol. 18901. CRC press 
Cleveland. 
  
6. CYLINDER ELECTRODES, METHYL 
METHACRYLATE AS AN IMMOBILISATION 
MATRIX AND IN VITRO 
CHARACTERISATION 
  
 Chapter 6: Cylinder Electrodes, MMA & In Vitro Characterisation 
199 
6.1 Introduction 
Despite the discovery of two FAD recipes which displayed similar or better sensitivity 
than the originally proposed design it was still considered possible to improve on these 
recipes. An area of concern was to do with the actual live currents being measured, as 
opposed to the calculated current density (J) values. When the sensitivity was converted 
to the current change expected to be seen for a concentration change of 100 µM in ᴅ-ser 
the results were not favourable. For PtD-Sty-[600UPBSx5-FAD0.08-GA1.0%]x2, with a 
sensitivity of 64.61 ± 1.63 µA.cm
-2
.mM
-1
, the current flowing through an electrode at 
100 µM ᴅ-ser is 0.7298 ± 0.0200 nA. For the LRS of PtD-Sty-[600UPBSx5-
BSAGA1.0%]x2, 72.91 ± 3.19 µA.cm
-2
.mM
-1
, the measured current would be 0.8947 ± 
0.0391 nA. These are two very low currents. While it is possible to monitor changes at 
this level it was decided it would be much more beneficial to explore possibilities for 
increasing this current.  
Of primary concern was the knowledge that the interference from ascorbic acid (AA), 
which would react at the surface of the electrode in vivo, would generate a current of 
approximately 0.8 to 1.2 nA on 2 mm cylinder hydrogen peroxide biosensors (O'Brien 
et al., 2007), 0.6 to 1.0 nA on 1 mm cylinder bare Pt/Ir electrodes (Rothwell et al., 
2008) and 0.25 nA for a bare Pt/Ir disk electrode (Rothwell et al., 2009) (all at 400 µM 
AA). This information lead to the first attempted alteration, a change in the geometry of 
the electrode from a disk to a 0.5 mm cylinder surface. Although a change in the 
electrode geometry to a larger surface area was likely to increase the interference as 
demonstrated above, it was likely to increase the currents achieved to an even greater 
extent. This is due to the ‘edge-effect’ whereby the interference due to AA is reduced, 
when current densities are considered, by using a cylinder rather than a disk electrode 
(Rothwell et al., 2009). This reduction in response is due to an edge density for a 1 mm 
cylinder which is 32 times smaller than the corresponding 125 µm disk, which yields an 
AA current ~ 20 times lower. Although it has previously been shown that it is difficult 
to achieve the same sensitivity when using a cylinder electrode (Zain et al., 2010) the 
decrease should be not of the same magnitude as the change in AA sensitivity. It was 
hoped that overall an increase in the ᴅ-ser/AA current ratio likely to be encountered in 
the in vivo environment. 
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The basic configuration, of most biosensors discussed within this chapter, is as depicted 
in Figure 6-1. All alterations discussed in this chapter centre on this design with various 
layers being omitted or modified or added as detailed in each section. 
 
Figure 6-1 
The basic configuration of biosensors discussed within Chapter 6. 
6.2 Cylinder Electrodes and MMA – Protocol Improvements 
6.2.1 The Use of Electrodes with a Cylindrical Surface 
Having decided to embark on an inspection of the possibilities offered by a cylinder 
electrode it became necessary to choose the dimensions of this new electrode. A very 
important parameter that was necessary to consider was the intended end use of the 
biosensor. In this regard it was highly likely that the final electrode design could see use 
in mice, as a knockout strain lacking in ᴅAAO has been indentified which would be 
very interesting in terms of future study (Miyoshi et al., 2012). While 1 mm and 2 mm 
electrodes were suitable for use in rat brains, it was felt that these sizes of electrode 
were too large for use in a mouse. Thus considering the dimensions of a mouse brain it 
was decided to use only a 0.5 mm cylinder length. This meant that the cylinder surface 
was still the dominant surface, being 4 times longer than the electrode diameter, and the 
edge density (ratio of edge length to surface area, important parameter in AA rejection 
when PPD is being utilised) was reduced from 319 cm
-1
 to 1.88 cm
-1
. 
Even distribution of the various components of the biosensor on this new surface was 
considered to be a problem. This would be a cause for the reduction in sensitivity seen 
previously, along with the fact that the layers of substance applied would also be 
thinner. In an attempt to overcome this problem different mechanism for drying the 
electrodes were considered. The methods were; the normal method of hanging the 
Pt/Ir Cylinder Surface 
Glutaraldehyde (GA) 
MMA 
ᴅAAO 
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electrode so that the active disk surface pointed vertically down to the ground, an 
inverted method where the electrodes were placed standing with the disk surface 
pointing vertically upwards towards the sky, and a final method whereby the electrodes 
were spun horizontally about their axis using the equipment described in Section 3.4.1. 
Lastly it was necessary to consider which biosensor recipe or recipes would be used to 
examine the properties of the cylinder electrode and drying methods. The decision was 
made to use PtC-Sty-[600UPBSx5-GA1.0%]x2 (first seen in Section 5.3.3 as a disk 
electrode). The main considerations behind this were that it was similar to the two disk 
based recipes which provided the highest sensitivity, it had the largest Jmax of the recipes 
previously considered (178.8 ± 4.5 µA.cm
-2
), and that it had a relatively large KM at ~ 
5000 µM. It was hoped this combination of properties would allow an easier distinction 
to be drawn between the different cylinder drying methods. 
The calibration data obtained when biosensors were constructed according to the recipe 
PtC-Sty-[600UPBSx5-GA1.0%]x2 on 0.5 mm long cylinder electrodes is presented in 
Table 11-1. These electrodes were dried by three methods; normal, inverted and spun. 
The relevant kinetic data for the three variants is presented below in Table 6-1. 
From the kinetic data and the J-concentration plot, Figure 6-2, it is quite clear that there 
are distinctly different results produced by the three drying methods. The method of 
spinning the electrodes as they dry immediately appears to produce the best results. This 
is borne out when considered statistically too. The spun electrodes have the largest Jmax, 
14.78 ± 0.55 µA.cm
-2
, which is significantly larger than both the normal and inverted 
electrodes, p = 0.0320* and p = 0.0009*** respectively. The normal method produces a 
Jmax also significantly larger than the inverted electrodes, p = 0.0048**. The KM 
concentration for the spun electrodes is the smallest value. It is significantly smaller 
than the value for the normal electrodes, p = 0.0047**, although it is not significantly 
different from the value of the inverted electrodes, p = 0.1482, owing to the large SEM 
associated with this drying method. The normal and inverted also have non-significantly 
different KM concentrations, p = 0.4950. 
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Electrode Design 
PtC-Sty-
[600UPBSx5- 
GA1.0%]x2, n = 4 
Normal 
PtC-Sty-
[600UPBSx5- 
GA1.0%]x2, n = 4 
Inverted 
PtC-Sty-[600UPBSx5- 
GA1.0%]x2, n = 4 
Spun 
Kinetics M-M, p = 0.9906 M-M, p = 0.0914 M-M-H, p = 0.0165 
R
2
 0.9930 0.9473 0.9935 
Jmax, µA.cm
-2
 12.72 ± 0.49 7.784 ± 1.020 14.78 ± 0.55 
KM, µM 3082 ± 343.4 4210 ± 1415 1456 ± 141 
α   1.359 ± 0.142 
LRS, µA.cm
-2
.mM
-
1
 
4.128 ± 0.324 1.849 ± 0.408 10.15 ± 0.71 
Table 6-1 
Kinetic parameters, fit, Jmax and KM values calculated from the calibration data in Table 11-1. Jmax, KM, 
α and LRS are presented as Mean ± SEM. 
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Figure 6-2 
J-concentration plot of the PtC-Sty-[600UPBSx5-GA1.0%]x2 recipe when made using three different 
drying methods. The normal method is depicted by the red trace, spun electrodes by the blue trace 
and inverted electrodes by the green trace. 
When the sensitivity of the three drying methods is considered the stark difference seen 
in the plot comes to the fore. The spun electrodes have the largest LRS, 10.15 ± 0.71 
µA.cm
-2
.mM
-1
. It is significantly larger than that of the normal or inverted biosensor 
designs, p = 0.0003*** and p < 0.0001*** respectively. The normal electrodes, in turn, 
have a significantly larger LRS than the inverted electrodes, p = 0.0047**. Thus it is 
clear to see that there is a distinct advantage to be gained by spinning electrodes with a 
cylindrical geometry as the substituent solutions are drying on to the surface. Therefore, 
from this point forward, all biosensors fabricated using cylinder electrodes were spun 
horizontally, along the electrode axis, as they were drying.  
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Having determined the efficacy of the drying methods it was now important to examine 
whether a gain had been made in terms of the current achieved by the electrodes. 
Previously for the same recipe on a disk surface a sensitivity of 35.41 ± 1.19 µA.cm
-
2
.mM
-1
 had been obtained, 3.5 times larger than the cylinder electrode LRS. The ratio of 
surface area when comparing the cylinder surface to the disk surface is ~ 17:1. 
Therefore, in terms of current, the cylinder electrode has produced a current almost 5 
times larger than the disk alternative. This is shown when the LRS is converted to a 
current response for 100 µM ᴅ-ser; the result is now 2.119 ± 0.148 nA. This is a much 
improved result, already significantly improved on any of the best recipes for a disk 
surface and as such the decision was made to continue using cylinder electrodes. 
6.2.2 MMA as an Immobilisation Matrix 
In the quest for continuing improvement in the sensitivity and stability of our 
biosensors, the group runs trials with different immobilisation methods. One of these 
methods involved the substitution of Sty with methyl methacrylate (MMA). This is a 
very interesting substance which unlike Sty has been approved for use, in its 
polymerised form, in a wide variety of life science technologies, such as hard contact 
lenses, as cement for and hip replacements, as replacement intraocular lens, dentures, 
cosmetic surgery and dental fillings. This would obviously be an advantageous material 
to use in the construction of biosensors, as long as it didn’t reduce the sensitivity of the 
sensors. MMA has seen use in biosensing applications previously (Hall et al., 1996; 
Bean et al., 2005; Dai et al., 2008; Hervás Pérez et al., 2008), and has been successfully 
utilised within the group for sensor applications (Bolger et al., 2011a), with its presence 
on the sensor surface confirmed by scanning electron microscopy, although the degree 
of polymerisation is unknown. Indeed, there was a US patent filed in regard to its use in 
biosensing application (Patent no: 5,284,140 Date: Feb 8
th
 1994). The monomer has a 
boiling point of 100.5 °C and it, by a very similar mechanism to styrene, spontaneously 
polymerises when inhibitors are not present, with a multitude of factors affecting the 
rate of polymerisation (Lingnau et al., 1980; Stickler & Meyerhoff, 1981; Lingnau & 
Meyerhoff, 1983, 1984b; Lingnau & Meyerhoff, 1984a; Srinivasan et al., 2011; Liu et 
al., 2012) 
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Electrode 
Design 
PtC-MMA-
[600UPBSx5-
GA1.0%]x2 
n = 8 
PtC-Sty-
[600UPBSx5- 
GA1.0%]x2 
n = 4 
PtC-{MMA-
[600UPBSx5-
GA1.0%]x2}x2 
n = 8 
PtC-{Sty-
[600UPBSx5-
GA1.0%]x2}x2 
n = 8 
Kinetics M-M, p = 0.3800 
M-M-H, 
p = 0.0165 
M-M-H, 
p < 0.0001 
M-M-H, 
p = 0.0002 
R
2
 0.9986 0.9935 0.9995 0.9996 
Jmax, µA.cm
-2
 14.94 ± 0.18 14.78 ± 0.55 28.30 ± 0.19 22.00 ± 0.23 
KM, µM 1355 ± 62 1456 ± 141 627.0 ± 14.9 1275 ± 38 
α  1.359 ± 0.142 1.368 ± 0.035 1.144 ± 0.028 
LRS,  
µA.cm
-2
.mM
-
1
 
11.02 ± 0.40 10.15 ± 0.71 45.14 ± 0.90 17.25 ± 0.37 
Table 6-2 
Kinetic parameters, fit, Jmax and KM values calculated from the calibration data in Table 11-2. Jmax, KM, 
α and LRS are presented as Mean ± SEM. 
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Figure 6-3 
J-concentration plot of the PtC-Sty-[600UPBSx5-GA1.0%]x2 (red trace), PtC-{Sty-[600UPBSx5-
GA1.0%]x2}x2 (green trace), PtC-MMA-[600UPBSx5-GA1.0%]x2 (purple trace) and PtC-{MMA-
[600UPBSx5-GA1.0%]x2}x2 (blue trace). 
Combined with an examination of MMA as an immobilisation matrix there was also an 
interest in examining how a second application would affect sensitivity. Another 
approach which had been previously explored it had shown a benefit in a limited 
number of circumstances (Haughton, pending publication). As explained in Section 
3.5.5, a second application would be applied one hour after the initial application, 
resulting in a doubling of the layers within the complete protocol. The recipes to be 
utilised to explore both of these possible advancements were; PtC-Sty-[600UPBSx5-
GA1.0%]x2, PtC-{Sty-[600UPBSx5-GA1.0%]x2}x2, PtC-MMA-[600UPBSx5-
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GA1.0%]x2 and PtC-{MMA-[600UPBSx5-GA1.0%]x2}x2. The calibration results for 
these designs are listed in Table 11-2. 
A striking aspect of the calibration results and the kinetic data, shown in Table 6-2, is 
the similarity between the Sty and MMA recipes with one application. The Jmax values 
are not significantly different, p = 0.8010, and neither are the KM concentrations, p = 
0.4557. As a consequence there is also no statistical difference in their sensitivities, p = 
0.2758. The only difference between them is the shape of their kinetic curve, with the 
Sty design conforming to M-M-H and the MMA design best described by a M-M curve. 
There is however a marked difference in both the case of Sty and MMA when 
comparing the one application protocol with the two application protocol. For Sty, the 
two application method has a significantly higher Jmax than the single application, p < 
0.0001***, but the KM value is not different, p = 0.3031. The overall result is a 
significantly better LRS, p < 0.0001***. Upon increasing the MMA design to two 
applications within the protocol there is also an increase in the Jmax, p < 0.0001***, and, 
unlike Sty, a significantly lower KM, p < 0.0001***. Together the result is a 
significantly increased sensitivity, p < 0.0001***. 
Finally, there are significant differences between the Sty and MMA double applications 
protocols. They both conform to M-M-H kinetics but that is where the similarities end. 
The MMA recipe with two applications shows a significantly higher Jmax and a 
significantly lower KM, p < 0.0001*** for both. Combined together the two values 
result in a significantly higher LRS, p < 0.0001***, for the MMA 2 application recipe. 
It is quite clear that this is a far superior recipe, in terms of sensitivity and current, to 
any formulations examined previously. Not only is it a cylinder electrode, but it has a 
sensitivity which is at least twice as large as any other cylinder recipe considered. The 
LRS is also less than half that of the most sensitive disk electrode design, despite it 
having a surface area 17 times larger. Thus for a concentration of 100 µM ᴅ-ser it is 
returning a current of 9.425 ± 0.188 nA. 
The difference between the Sty and MMA is likely due to their structure. The Sty, with 
its benzene ring, will form a denser and less porous polymer which might be 
advantageous in retaining enzyme but a hindrance to the permeability of species into 
and out of the active site of the ᴅAAO. The polymeric form of MMA will contain, 
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instead of benzene rings, flexible side chains, which could be less successful at retain 
enzyme but allow greater quantities of substrate and product to circulate at the biosensor 
surface. I suggest this is the reason that the two application MMA protocol is 
significantly more sensitive than the Sty two application protocol or either single 
application design. 
6.3 Further Examination of MMA Based Recipes 
6.3.1 Previous Best Recipes Re-Examined 
Having seen the benefits of MMA, with regard to sensitivity improvements, it was 
deemed necessary to explore again the recipes which had yielded the best results for 
disk electrodes and Sty (Section 5.4.4). These recipes were not modified to include 
MMA, instead of Sty, and a second application was added to results in four new 
protocols; PtC-{MMA-[600UPBSx5-GA1.0%]x2}x2, PtC-{MMA-[600UPBSx2-
GA1.0%]x5}x2, PtC-{MMA-[600UPBSx5-BSAGA1.0%]x2}x2 and PtC-{MMA-
[600UPBSx2-BSAGA1.0%]x5}x2. The calibration data collected for these protocols is 
displayed in Table 11-3 with the accompanying kinetic data in Table 6-3. All four 
designs are graphically represented in Figure 6-4.  
Upon first glance it is clear to see that the 2 dip BSAGA1% is no longer the recipe 
which performs best, in fact it is now the worst of the four recipes. The two 5 dip 
recipes appear to be identical and the 2 dip GA1% recipe from the previous section 
appears to offer the best performance. Statistically the 2 dip BSAGA design has the 
lowest Jmax, it is significantly smaller than the 2 dip GA, 5 dip GA and 5 dip BSAGA 
recipes, p = 0.0006***, p = 0.0008*** and p < 0.0001*** respectively. It also has the 
largest mean KM value but due to the large SEM also associated with it is only 
significantly larger than the 2 dip GA recipe, p = 0.0435*. It is not significantly 
different from the 5 dip GA and 5 dip BSAGA recipes, p = 0.0628 and p = 0.0655 
respectively. The LRS value is however significantly smaller than the 2 dip and 5 dip 
GA, p < 0.0001*** for both, and the 5 dip BSAGA protocols, p = 0.0005***. 
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Electrode 
Design 
PtC-{MMA-
[600UPBSx5-
GA1%]x2}x2 
n = 8 
PtC-{MMA-
[600UPBSx2-
GA1%]x5}x2 
n = 4 
PtC-{MMA-
[600UPBSx5-
BSAGA1%]x2}x2 
n = 4 
PtC-{MMA-
[600UPBSx2-
BSAGA1%]x5}x2 
n = 4 
Kinetics 
M-M-H, 
p < 0.0001 
M-M, 
p = 0.4378 
M-M, 
p = 0.2785 
M-M, 
p = 0.6220 
R
2
 0.9995 0.9997 0.9934 0.9985 
Jmax, µA.cm
-2
 28.30 ± 0.19 26.07 ± 0.29 7.365 ± 1.338 26.45 ± 0.65 
KM, µM 627.0 ± 14.9 3264 ± 118 19407 ± 5578 3532 ± 272 
α 1.368 ± 0.035    
LRS,  
µA.cm
-
2
.mM
-1
 
45.14 ± 0.90 7.989 ± 0.213 0.3795 ± 0.041 7.488 ± 0.418 
Table 6-3 
Kinetic parameters, fit, Jmax and KM values calculated from the calibration data in Table 11-3. Jmax, KM, 
α and LRS are presented as Mean ± SEM. 
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Figure 6-4 
J-concentration plot of the four recipes selected in Section 5.4.4 when modified to utilise MMA and 
with a second application in the protocol. Displayed are PtC-{MMA-[600UPBSx5-GA1.0%]x2}x2 (red 
trace), PtC-{MMA-[600UPBSx2-GA1.0%]x5}x2 (green trace), PtC-{MMA-[600UPBSx5-
BSAGA1.0%]x2}x2 (yellow trace) and PtC-{MMA-[600UPBSx2-BSAGA1.0%]x5}x2 (blue trace). 
Considering now the two 5 dip recipes it is possible to see how similar they are. The 
Jmax, KM, and LRS for the two recipes are all non-significantly different, p = 0.6114, p = 
0.4007 and p = 0.3270 respectively. They are both best described by M-M kinetic 
curves. The 2 dip GA recipe undoubtedly provides the best results of the four protocols. 
This becomes evident when it is statistically analysed against the 5 dip GA, 2 dip 
BSAGA and 5 dip BSAGA recipes. It has the largest Jmax, p < 0.0001*** for 5 dip GA, 
and p = 0.0005*** for 2 dip BSAGA, excepting the 5 dip BSAGA recipe, p = 0.0713. It 
also has the smallest KM concentration, p = 0.0002***, p = 0.0435* and p = 0.0018** 
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respectively. As a result it has a far superior sensitivity when compared to the same 
recipes, p < 0.0001*** for all. 
It was becoming clear that the PtC-{MMA-[600UPBSx5-GA1.0%]x2}x2 recipe was 
likely to be the most sensitive design that would be found. This is due to the two dips of 
GA providing a small amount of cross-linking that helps secure the ᴅAAO in the MMA 
matrix without denaturing the enzyme as the five dip GA design appears to. In the case 
of the BSAGA recipe the opposite seems to be the case, with the smaller quantity of 
BSAGA dips have a very low sensitivity, likely due to insufficient quantities of GA 
being available due to it mainly linking the BSA. With increased levels of BSAGA it is 
seen that the sensitivity improves significantly. 
6.3.2 Addition of FAD to the GA 1% Recipes 
In order to ensure complete exploration of protocols that had previously yielded good 
results it was necessary however to re-examine how the incorporation of FAD would 
affect this new stand-out design. Previously, for the similar recipe based around Sty and 
with only one application, FAD had enhanced sensitivity significantly. To elucidate 
how it would react in a MMA matrix two new protocols were conceived; PtC-{MMA-
[600UPBSx5-FAD0.08-GA1.0%]x2}-x2 and PtC-{MMA-[600UPBSx5-GA1.0%]x2-
FAD0.08(5)}x2. Thus, as in the previous advantageous arrangement it was first 
incorporated on the fifth and tenth layer, after the 600UPBS but before the GA1.0%, i.e. 
twice per application and four dips overall. Secondly it was incorporated into only the 
fifth layer, again after the 600UPBS and before the GA1.0%, two dips overall.  
The calibration data for the two new recipes is displayed above in Table 11-4, with the 
original for comparison. Following, in Table 6-4, is the kinetic data obtained when the 
three recipes were analysed. From the calibration data and some of the kinetic 
calculations the three recipes look very similar. However, statistically the differences 
can be shown. As hinted at by Figure 6-5, the recipe with FAD emerges as the strongest 
protocol. This is quite different to the results seen in Section 5.6.2, where the influence 
of FAD is a positive one. 
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Electrode 
Design 
PtC-{MMA-
[600UPBSx5-
GA1%]x2}x2, n = 8 
PtC-{MMA-
[600UPBSx5-
GA1.0%]x2-
FAD0.08(5)}x2, n = 4 
PtC-{MMA-
[600UPBSx5-
FAD0.08-
GA1.0%]x2}-x2, n = 4 
Kinetics M-M-H, p < 0.0001 M-M, p = 0.1388 M-M-H, p = 0.0140 
R
2
 0.9995 0.9996 0.9985 
Jmax, µA.cm
-2
 28.30 ± 0.19 34.53 ± 0.64 29.87 ± 0.76 
KM, µM 627.0 ± 14.9 1966 ± 122 1339 ± 110 
α 1.368 ± 0.035  1.293 ± 0.103 
LRS,  
µA.cm
-2
.mM
-1
 
45.14 ± 0.90 17.56 ± 0.83 22.32 ± 1.38 
Table 6-4 
Kinetic parameters, fit, Jmax and KM values calculated from the calibration data in Table 11-4. Jmax, KM, 
α and LRS are presented as Mean ± SEM. 
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Figure 6-5 
J-concentration plot of the data in Table 11-4 and Table 6-4. PtC-{MMA-[600UPBSx5-GA1%]x2}x2 is 
red, PtC-{MMA-[600UPBSx5-GA1.0%]x2-FAD0.08(5)}x2 is green and PtC-{MMA-[600UPBSx5-
FAD0.08-GA1.0%]x2}-x2 is the blue trace. 
Between the two FAD recipes all parameters are quite different. The recipe with two 
dips of FAD overall (green trace) has a significantly higher Jmax than four dip FAD 
recipe (blue trace), p = 0.0003***. The two dip FAD recipe also has a significantly 
higher KM concentration, p = 0.0017**. Combined, this leads to a two dip FAD recipe 
with significantly lower LRS, p = 0.0103*, than a four dip FAD recipe.  
The design with no FAD has a lower Jmax than the two dip FAD protocol, p < 
0.0001***, but not the four dip FAD protocol, with which there is no significant 
difference, p = 0.0856. Not using FAD does however produce a significantly lower KM 
value than both the two dip and four dip FAD recipes, p < 0.0001*** and p = 
0.0004*** respectively. It is this significantly lower KM which means that the design 
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without FAD has a significantly higher sensitivity than the protocols containing FAD, p 
< 0.0001*** in both cases. Thus in the case of cylinder recipes, formulated with MMA 
and not Sty and when two applications are applied within the protocol it is found that 
not using FAD produces a more sensitive biosensor than when using FAD. This is in 
direct contrast to some results for disk electrodes using single applications and Sty as an 
immobilisation matrix. A possible reason for this is that due to the increased surface 
area the quantity/concentration of FAD added is insufficient to be found in close enough 
proximity to the enzyme to be effective and could likely be occupying valuable cross-
linking sites without providing any additional benefit. 
6.3.3 An Additional Layer of MMA 
At this time, before accepting the PtC-{MMA-[600UPBSx5-GA1%]x2}x2 design as the 
preferred recipe, it was deemed necessary to briefly check the stability of the 
biosensors. A set of biosensors was fabricated, calibrated, and then calibrated again 1 
and 4 days later, having been stored at 4ºC  between each calibration. The results are 
listed in the top half of Table 11-5 and Table 6-5. The results are also depicted in Figure 
6-6, where the initial Day 0 calibration is plotted in red, the Day 1 calibration in orange 
and the Day 4 calibration in yellow. 
Distinct differences were noticed between the results over the 5 days. One-way 
ANOVA of the Jmax values for the PtC-{MMA-[600UPBSx5-GA1%]x2}x2 results show 
that there is no difference between Day 0 and Day 1, p > 0.0500, there was a significant 
decrease between Day 0 and Day 4, p < 0.0010***, and a significant decrease between 
Day 1 and Day 4, p < 0.0100**. There are no significant differences when the KM 
values are examined. All comparisons return a non-significant result of p < 0.0500. 
Finally the sensitivities also show a change. There is a significant decrease in the LRS 
from Day 0 to Day 1, p < 0.0100**, and a significant decrease between Day 0 and Day 
4, p < 0.0100**. However there is no significant change in sensitivity between Day 1 
and Day 4, p < 0.0500. Thus, after an initial decrease the LRS appears to reach a stable 
level.  
 Chapter 6: Cylinder Electrodes, MMA & In Vitro Characterisation 
211 
Electrode Design 
PtC-{MMA-
[600UPBSx5-
GA1%]x2}x2 
DAY 0, n = 4 
PtC-{MMA-
[600UPBSx5-
GA1%]x2}x2 
DAY 1, n = 4 
PtC-{MMA-
[600UPBSx5-
GA1%]x2}x2 
DAY 4, n = 4 
Kinetics M-M, p =  0.2807 M-M, p = 0.6172 M-M, p = 0.9574 
R
2
 0.9472 0.9386 0.9375 
Jmax, µA.cm
-2
 34.40 ± 1.217 31.59 ± 1.510 22.41 ± 1.007 
KM, µM 727.6 ± 113.4 1581 ± 299 1261 ± 233.0 
α    
LRS, µA.cm
-2
.mM
-
1
 
47.27 ± 6.38 19.98 ± 3.10 17.76 ± 2.75 
Electrode Design 
PtC-{MMA-
[600UPBSx5-
GA1%]x2}x2-MMA 
DAY 0, n = 4 
PtC-{MMA-
[600UPBSx5-
GA1%]x2}x2-MMA 
DAY 1, n = 4 
PtC-{MMA-
[600UPBSx5-
GA1%]x2}x2-MMA 
DAY 4, n = 4 
Kinetics M-M-H, p = 0.0008 M-M-H, p = 0.0175 M-M, p = 0.6348 
R
2
 0.9882 0.9989 0.9738 
Jmax, µA.cm
-2
 32.40 ± 0.48 42.09 ± 1.41 45.15 ± 1.25 
KM, µM 635.4 ± 31.1 785.5 ± 74.7 1116 ± 131 
α 1.315 ± 0.092 1.925 ± 0.437  
LRS, µA.cm
-2
.mM
-
1
 
50.99 ± 2.12 53.58 ± 4.48 40.46 ± 4.01 
Table 6-5 
Kinetic parameters, fit, Jmax and KM values calculated from the calibration data in Table 11-5. Jmax, KM, 
α and LRS are presented as Mean ± SEM. 
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Figure 6-6 
J-concentration plot of the PtC-{MMA-[600UPBSx5-GA1%]x2}x2 and PtC-{MMA-[600UPBSx5-
GA1%]x2}x2-MMA biosensors calibrated over a period of 5 days. For PtC-{MMA-[600UPBSx5-
GA1%]x2}x2 Day 0 is depicted in red, Day 1 in orange and Day 4 in yellow. The Day 0 calibration of 
PtC-{MMA-[600UPBSx5-GA1%]x2}x2-MMA is the purple trace, Day 1 is dark blue and Day 4 is light 
blue.  
In an attempt to control the level of the decrease, which was significant and almost half 
of the starting value, it was decided to incorporate an extra layer of MMA. This layer 
would be applied as a single dip, after the second application had been allowed to dry 
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for an hour at 4 ºC. The electrodes would then be stored in a fridge for at least 3 hours 
before being calibrated. The first important aspect to be considered with this change was 
to see if it would alter the initial kinetic parameters of the electrodes in any significant 
way. By comparing the two Day 0 sets of results it can be seen that there is no 
significant difference between the Jmax, KM, or LRS of the results, p = 0.1769, p = 
0.4902 and p = 0.6186 respectively. Thus having established that there is no significant 
difference between the Day 0 kinetic parameters it was then possible to consider how 
the electrodes with the extra MMA layer changed over the 5 day period. Firstly, the Jmax 
is significantly increased on Day 1 compared to Day 0, p < 0.0010***, and significantly 
increased on Day 4 when compared to Day 0, p < 0.0010***. There is no significant 
difference between Day 1 and Day 4, p > 0.0500. Contrastingly, there is no difference in 
the KM concentration between Day 0 and Day 1, p > 0.0500.  
Now considering the sensitivity of the protocol with the extra layer of MMA the full 
benefit of this layer can be determined. Using one-way ANOVA it is seen that there is 
no statistical difference between the sensitivity across the three calibrations and the 5 
days, p < 0.0500 for all comparisons. The extra MMA dip has stabilised the sensitivity 
of the electrodes. This stabilisation is further elucidated when the sensitivity of the two 
recipes is compared on the three calibration days. We have already seen that the Day 0 
results are not significantly different. When we consider Day 1 and Day 4 we can see 
that the PtC-{MMA-[600UPBSx5-GA1%]x2}x2 recipe has a significantly lower 
sensitivity that the PtC-{MMA-[600UPBSx5-GA1%]x2}x2-MMA protocol, p = 
0.0008*** and p = 0.0034** respectively. It was decided based on all previous data that 
PtC-{MMA-[600UPBSx5-GA1%]x2}x2-MMA was going to be the optimal electrode 
design. Its sensitivity appeared to be stable and of a favourable magnitude, 50.99 ± 2.12 
µA.cm
-2
.mM
-1
 for a 0.5 mm cylinder electrode, is a very satisfactory result when 
compared to a starting point of 63 ± 2 µA.cm
-2
.mM
–1
 for a disk electrode. 
6.4 Interference Rejection Strategies 
Having discovered what was considered the optimal protocol for sensitivity there was 
now the issue of interference to be considered. Ascorbic acid is the most prevalent 
electroactive interferent in brain ECF, present at a concentration of 400 µM (Miele & 
Fillenz, 1996). It is used a benchmark with which to quantify the ability of biosensors to 
reject all interference from electroactive substances and only detect the target analyte. In 
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order to reject interferents two substances were employed which had been shown to be 
highly successful previously (see Section 1.3), o-PD and Naf. In order to quantify the 
success of these substances it was necessary to also examine how H2O2 and AA are 
detected in the absence of these substances. It was also necessary to study how these 
substances would affect the sensitivity of the biosensors to ᴅ-ser. 
6.4.1 Hydrogen Peroxide and AA without Interference Rejection Layers 
Firstly, it is necessary to state how H2O2 and AA behave at the bare metal surface and 
without any interference rejection or other substances incorporated from the recipe. This 
will provide a basis for quantifying the effectiveness of the rejection layers once 
applied. Thus, PtC and was calibrated for response to H2O2 and AA up to 1000 µM. The 
results are presented below in Table 11-6, with the associated linear regression and fit 
data in Table 6-6. These results are then plotted in Figure 6-7. 
It is very clear from the calibration that the AA has a far higher rate of reaction than 
H2O2 at the Pt/Ir surface. The current from a 1000 µM solution of AA is more than 
twice as high as that of H2O2, it is a significantly larger difference, p < 0.0001***. 
There is also a significant difference between the LRS values with the AA value again 
significantly higher, p = 0.0002***. 
 
PtC, H2O2 
n = 24 
PtC, AA 
n = 8 
Slope, µA.cm
-2
.mM
-1
 170.0 ± 2.5 437.5 ± 3.8 
R
2
 0.9980 0.9997 
Y – intercept -0.9536 ± 0.8829 2.992 ± 2.312 
X - intercept 5.610 -6.838 
J @ 1000 µM, µA.cm
-
2
 
170.8 ± 15.3 437.9 ± 30.2 
 
Table 6-6 
Linear regression fit data for PtC when calibrated for response to AA and H2O2. Data is presented as 
Mean ± SEM where appropriate. 
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Figure 6-7 
J-concentration plot for the calibration of PtC. Depicted is the response to H2O2 (blue trace) and AA 
(red trace. Data is drawn from Table 11-6 and Table 6-6. 
6.4.2 P-o-PD Grown by CV and CPA 
To attempt to remove interference from electroactive species the first approach 
considered was the use of a polymer film created from o-PD. This polymerised oPD 
film (P-o-PD) has previously been grown by two methods, indeed both had been used in 
the early development of ᴅ-ser sensors by Z.M. Zain (see Section 4.2). These methods 
were: by CPA (PPD) and by CV (PPDCV). To investigate the interferent rejection 
properties of P-o-PD grown by both of these methods the following two recipes were 
fabricated and calibrated for response to AA: PtC-PPD-{MMA-[600UPBSx5-
GA1%]x2}x2-MMA and PtC-PPDCV-{MMA-[600UPBSx5-GA1%]x2}x2-MMA. The 
results of these calibrations are presented in Table 11-7. 
Inspecting the linear regression data for the PPD we can see a very large value for the x-
intercept value, as well as a very poor R
2
 value of 0.6957. Bearing these in mind and 
examining the calibration points plotted in Figure 6-8 it is clear that it is not possible to 
fit a linear regression to the PPD data. This is a positive outcome as it has been 
documented that when grown and functioning optimally P-o-PD should display a ‘self-
blocking’ mechanism (Lowry & O'Neill, 1994; Craig & O'Neill, 2003). This mechanism 
demonstrates that not only is the polymer preventing AA from reaching the surface of 
the electrode but that when small quantities do react at the surface the products 
produced are blocking the pathways to the surface for other molecules of AA. The 
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observation of this effect is a satisfactory result. Subsequently the linear fit for the PPD 
curve was omitted from Figure 6-8 as it made no sense to include it and its does not 
appear to fit the points well (as indicated by the poor R
2
 value). 
Polymerisation Method 
PPD 
n = 16 
PPDCV 
n = 4 
Slope, µA.cm
-2
.mM
-1
 0.2099 ± 0.0694 0.1466 ± 0.0062 
R
2
 0.6957 0.9929 
Y – intercept 0.0756 ± 0.0420 0.0070 ± 0.0038 
X - intercept -360.2 -47.65 
J @ 1000 µM, µA.cm
-2
 0.236 ± 0.017 0.152 ± 0.087 
 
Table 6-7 
Linear regression fit data when PPD and PPDCV are compared for response to AA while incorporated 
into PtC-PoPD-{MMA-[600UPBSx5-GA1%]x2}x2-MMA. Data is presented as Mean ± SEM where 
appropriate. 
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Figure 6-8 
J-concentration plot for the calibration of PtC-P-o-PD-{MMA-[600UPBSx5-GA1%]x2}x2-MMA, where 
the method of polymerisation of the P-o-PD was changed. Depicted are the CPA method (PPD) in blue 
and the CV method (PPDCV) in green. Data is drawn from Table 11-7 and Table 6-7. 
On the other hand the PPDCV calibration displays a distinctly linear response. This is not 
a desirable result as it means that there will be no self-blocking of AA and as the 
concentration of it fluctuates in an in vivo environment the background current will also 
fluctuate. This will obscure current changes due to changing levels of ᴅ-ser. It thus 
appears that CV is not a favourable method to grow the P-o-PD layer. 
Statistically it is not reasonable to compare the slopes of the linear fits. A better 
comparison is to compare the current density at particular concentrations. At 1000 µM 
AA, which should be the plateau region of an ideally behaving self-blocking response, 
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there is no significant difference between the two responses, p = 0.4146. At 400 µM, the 
physiological concentration, there is a significant difference, with the PPD value being 
the larger value, p = 0.0012**. This difference, although it may appear better to have a 
lower response at physiological level, is not a good thing as it is more important to have 
a consistent response over different concentration levels. An attribute that can be seen 
when the 400 µM and 1000 µM responses are compared for PPD, p = 0.3127. Now, the 
same comparison for PPDCV also yields no significant difference, p = 0.4202, but 
looking at the J values and the plot it is easy to see that for PPDCV this non-significant 
result is due to the much larger error in its values, and that there is quite a large scope 
for the current to change. 
6.4.3 Naf before CV and CPA Grown P-oPD 
In an effort to further improve interference rejection a second strategy was examined. 
This was the incorporation of Naf with a P-o-PD film. As previously stated in Section 
4.4, Naf used after the application of a P-o-PD film can have a detrimental effect 
(Friedemann et al., 1996). But, it has also been shown that Naf used in the correct 
manner can have significant interferent rejection properties (Pan & Arnold, 1996; Xu et 
al., 2002; Brown & Lowry, 2003; López et al., 2006; Hervás Pérez et al., 2008; Brown 
et al., 2009). Thus, it was decided to incorporate the Naf underneath the P-o-PD layer. 
This lead to two new designs to be tested for AA response: PtC-Naf-PPD-{MMA-
[600UPBSx5-GA1%]x2}x2-MMA and PtC-Naf-PPDCV-{MMA-[600UPBSx5-
GA1%]x2}x2-MMA. The Naf was applied by dipping into 1% Naf, five times with five 
minutes drying time between each layer. The results of these calibrations are presented 
in Table 11-8. As in the previous section, when the linear fit data in Table 6-8 is 
examined it is clear that neither set of data is suitable for a linear fit. This is a favourable 
result for reasons explained also in the last section. As such no fit is ascribed to either 
the Naf-PPD (blue) or Naf-PPDCV (green) in Figure 6-9.  
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Interference Layers 
Naf-PPD 
n = 24 
Naf-PPDCV 
n = 4 
Slope, µA.cm
-2
.mM
-1
 -0.0219 ± 0.0170 0.1032 ± 0.0255 
R
2
 0.2927 0.8044 
Y – intercept 0.0196 ± 0.0103 0.0258 ± 0.0154 
X - intercept 894.3 -249.7 
J @ 1000 µM, µA.cm
-2
 -0.011 ± 0.030 0.106 ± 0.018 
 
Table 6-8 
Linear regression fit data when Naf-PPD and Naf-PPDCV are compared for response to AA while 
incorporated into PtC-Naf-PoPD-{MMA-[600UPBSx5-GA1%]x2}x2-MMA. Data is presented as Mean ± 
SEM where appropriate. 
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Figure 6-9 
J-concentration plot for the AA calibration of sensors with combined Naf-P-o-PD interference layers. 
Depicted are the CPA method (Naf-PPD) in blue and the CV method (Naf-PPDCV) in green. Data is 
drawn from Table 11-8 and Table 6-8. 
Comparison by concentration best illustrates the difference between the two protocols. 
At 400 µM the Naf-PPD layers produce a response which is not significantly different 
from the Naf-PPDCV response, p = 0.0800. For 1000 µM, there is a significant 
difference, with the Naf-PPDCV J value significantly higher than the Naf-PPD figure, p 
= 0.0033**. Encouragingly there is no significant difference between the 400 and 1000 
µM J values for Naf-PPD, p = 0.3800, or for Naf-PPDCV, p = 0.3598. 
The differences between the Naf-P-o-PD and P-o-PD protocols are also significant. The 
PPD response at 400 µM is significantly higher than the Naf-PPD response, p < 
0.0001***, but the PPDCV value is not significantly different compared to the Naf-
PPDCV value at 400 µM, p = 0.7575. At 1000 µM there are also significant differences, 
Naf-PPD produces a significantly lower current than the PPD only protocol, p < 
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0.0001***. However, again there is no significant difference between Naf-PPDCV and 
PPDCV, p = 0.6285. 
Overall the Naf-PPD protocol produces the best results. At 1000 µM, the plateau value, 
its response is significantly lower than that for PPD and Naf-PPDCV, although it is not 
significantly lower than that of PPDCV due to the large error associated with this recipe, 
p = 0.569. In fact the response to AA at 1000 µM can be said to be zero, which is a 
remarkable result. It was considered the preferred choice for use as an interference 
rejection solution. 
6.4.4 Effects on Electrode Sensitivity of Interferent Layers 
An important consideration when choosing an interferent rejection strategy is also to 
consider the difference, if any, they will cause in sensitivity. It had been seen before 
within the group that the inclusion of PPD could in some cases enhance sensitivity. 
Thus it was necessary to calibrate various recipes, with the interferent layers 
incorporated, for response to ᴅ-ser. The recipes were: PtC-{MMA-[600UPBSx5-
GA1%]x2}x2-MMA, PtC-Naf-PPD-{MMA-[600UPBSx5-GA1%]x2}x2-MMA, PtC-
PPD-{MMA-[600UPBSx5-GA1%]x2}x2-MMA and PtC-PPDCV-{MMA-[600UPBSx5-
GA1%]x2}x2-MMA The results are displayed in Table 11-9. The associated calculated 
kinetic parameters are listed in Table 6-9 and all this information is summarised in 
Figure 6-10. 
Unfortunately the most immediate and obvious effect of the interference rejection layers 
is the loss of a substantial amount of sensitivity to ᴅ-ser when the Naf-PPD combination 
is utilised. However, while this is not a desirable effect, it is not detrimental either. The 
most important properties of a biosensor are selectivity and sensitivity, both must be 
given equal consideration and it is essential to find an appropriate combination where a 
compromise is reached and one parameter is not sacrificed at the expense of the other.  
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Electrode 
Design 
No interferent 
rejection layer 
n = 16 
with Naf-PPD 
n = 52 
 with PPD 
n = 4 
with PPDCV 
n = 4 
Kinetics 
M-M-H, 
p = 0.0003 
M-M-H, 
p < 0.0001 
M-M, 
p = 0.1036 
M-M-H, 
p = 0.0016 
R
2
 0.9969 0.9999 0.9982 0.9994 
Jmax, µA.cm
-2
 34.63 ± 0.66 24.08 ± 0.14 42.88 ± 0.63 40.55 ± 0.43 
KM, µM 649.4 ± 37.2 1462 ± 23 1122 ± 69 688.3 ± 24.7 
α 1.417 ± 0.101 1.178 ± 0.016  1.199 ± 0.051 
LRS,  
µA.cm
-2
.mM
-
1
 
53.33 ± 2.47 16.47 ± 0.18 38.22 ± 1.99 58.91 ± 1.74 
Table 6-9 
Kinetic parameters, fit, Jmax and KM values calculated from the calibration data in Table 11-9. Jmax, KM, 
α and LRS are presented as Mean ± SEM. 
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Figure 6-10 
J-concentration plot of the data in Table 11-9 and Table 6-9 which elucidate the effect of interferent 
rejection layers on sensitivity. The purple trace is the full MMA recipe without any interferent 
rejection layers. The blue trace is PPD recipe, the green trace is PPDCV and the red trace is the Naf-
PPD recipe.  
From the Jmax attained by the basic recipe with no P-o-PD or Naf layers, there is a 
significant increase upon incorporation of PPD or PPDCV, p < 0.0001*** for both, as 
seen by the group with previous work. Conversely though, there is a significant 
decrease in the Jmax value when Naf-PPD is used, p < 0.0001***, compared to the no 
interference layer, PPD and PPDCV recipes. Between the Jmax of the PPD protocol and 
the PPDCV recipe there is also a significant difference, p = 0.0012**, with the PPD 
value the larger of the two. 
There are also significant differences to be found in the KM values. There is no 
significant difference between the basic recipe and the PPDCV design, p = 0.3970. The 
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PPD protocols KM is significantly higher than the basic and the PPDCV recipes, p < 
0.0001*** and p = 0.0010** respectively. Finally the Naf-PPD recipe has the highest 
KM value of the four. It is significantly larger than the basic, PPD and PPDCV protocols, 
p < 0.0001***, p = 0.0002*** and p < 0.0001*** respectively. The LRS of the basic 
recipe is not significantly changed when PPDCV is incorporated, p = 0.2894. Both the 
basic and PPDCV designs has significantly higher sensitivities when compared to the 
recipe that has PPD included, p = 0.0087** and p = 0.0002*** respectively. The lowest 
LRS if found with the Naf-PPD recipe. It is significantly lower than the basic, PPD and 
PPDCV designs, p < 0.0001***, p = 0.0016** and p = 0.0002*** respectively. 
This lower LRS of the Naf-PPD, as previously stated, is not a desirable result. It is 
possibly due to a number of reasons. The first is that the extra layers of Naf could be 
behaving as a diffusional barrier which is reducing the quantity of H2O2, produced in the 
enzymatic reaction, reaching the Pt/Ir surface of the electrode. The second possibility is 
that because of the charge on ᴅ-ser, its approach to the electrode and ᴅAAO could be 
retarded by the anionic nature of the Naf. Thus the use of Naf proved to be a double 
edged sword. It was however, one that it was decided to accept. Due to the low 
concentrations reported for ᴅ-ser in the in vivo environment, the advantage of having 
almost no interference from AA and other electroactive species was outweighed by the 
loss in sensitivity associated with this advantage. Thus the decision was made that the 
final protocol for the design of the ᴅ-ser biosensor would be PtC-Naf-PPD-{MMA-
[600UPBSx5-GA1%]x2}x2-MMA. 
6.5 In Vitro Characterisation – Stability  
Having settled on a definite protocol it was now necessary to begin an extensive 
characterisation of the sensor and its behaviour under a variety of situations and after 
‘treatments’. These treatments would hopefully reinforce the biosensor as a valid design 
capable of handling the in vivo environment and performing the task it was designed to 
do. Thus a range of in vitro treatments were devised and carried out on the biosensor 
design, the treatments were designed to exceed the severity of any environmental 
condition likely to be found in vivo. The first series of these tests to be devised were 
stability tests. These tests were designed to test how the biosensor sensitivity would be 
maintained over extended periods and uses.  
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6.5.1 Repeated Calibration Stability – Short Term 
The first stability test was a very simple one, a repeated calibration test over a short time 
period, see Section 3.6.2. The calibration data for the six calibrations is listed in Table 
11-10. The number of calibration points was increased to provide more concise 
information. Forthwith the full protocol will not be listed and only the treatment will be 
discussed. Below, in Table 6-10, the relevant kinetic data for the six consecutive 
calibrations is listed. Statistical analysis carried out on the six calibrations was one-way 
ANOVA in type, as the electrodes differed only be treatment. 
Examining the Jmax values gives a first indication of the changes that occurred. Between 
Cal 1 and Cal 2, and Cal 1 and Cal 3 there was no significant change, both p > 0.0500. 
But between Cal 1 and Cal 4, 5 and 6 there was a significant decrease in Jmax, p < 
0.0010*** for all three comparisons. There was no significant change between Cal 2 
and Cal 3 either, p < 0.0500. However, Cal 4, 5, and 6 all showed a significant decrease 
from Cal 2, p > 0.0010*** for all three. There was a significant drop in the Jmax for Cal 
4, 5 and 6 compared to Cal 3, p < 0.0010*** in all cases. However, between Cal 4 and 
Cal 5 there was no significant change in the Jmax, p > 0.0500. There were significant 
decreases to be seen between both Cal 4 and Cal 6, and Cal 5 and Cal 6, p < 0.0010*** 
for both comparisons. All of these changes are alluded to upon close examination of the 
J values at 15,000 µM ᴅ-ser in Table 11-10. 
The changes in the KM concentrations are only infrequently significant. Comparing Cal 
1 to the other five calibrations there is no significant change in any of them, p > 0.0500, 
except between Cal 1 and Cal 4, where Cal 4 is significantly higher, p < 0.0010***. The 
KM of Cal 2 is not significantly different from either Cal 3 or Cal 6, p > 0.0500 in both 
cases, but Cal 4 and Cal 5 are both significantly higher, p < 0.0010*** and p < 
0.0100** respectively. The KM concentration of Cal 3 is not significantly different from 
Cal 4, Cal 5 or Cal 6, all p > 0.0500. Cal 4 and Cal 5 are also non-significantly different, 
p > 0.0500, but the Cal 4 KM is significantly higher than the Cal 6 value, p < 0.0100**. 
There is no significant change in the concentration between Cal 5 and Cal 6, p > 0.0500. 
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Calibration Cal 1, n = 8 Cal 2, n = 8 Cal 3, n = 8 
Kinetics M-M, p =  0.1450 M-M-H, p = 0.0014 M-M, p = 0.4900 
R
2
 0.9965 0.9989 0.9979 
Jmax, µA.cm
-2
 21.54 ± 0.47 21.05 ± 0.42 20.41 ± 0.45 
KM, µM 2114 ± 152 1927 ± 97 2502 ± 151 
α  1.168 ± 0.047  
LRS, µA.cm
-2
.mM
-
1
 
10.19 ± 0.55 10.93 ± 0.37 8.516 ± 0.339 
Calibration Cal 4, n = 8 Cal 5, n = 8 Cal 6, n = 8 
Kinetics M-M, p = 0.5511 M-M, p = 0.6772 M-M-H, p = 0.0047 
R
2
 0.9979 0.9980 0.9991 
Jmax, µA.cm
-2
 16.80 ± 0.33 17.00 ± 0.31 13.50 ± 0.27 
KM, µM 3045 ± 174 2684 ± 148 2185 ± 111 
α   1.131 ± 0.042 
LRS, µA.cm
-2
.mM
-
1
 
5.517 ± 0.223 6.336 ± 0.254 6.177 ± 0.205 
Table 6-10 
Kinetic parameters, fit, Jmax and KM values calculated from the calibration data in Table 11-10. Jmax, KM, 
α and LRS are presented as Mean ± SEM. 
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Figure 6-11 
Bar chart of the sensitivities of the biosensor following repeated calibration. Stars at the top of the 
graph depict the significance of change compared Cal 1 and stars sitting at the top of the bar illustrate 
degree of change relative to the previous calibration. 
The LRS values are depicted in Figure 6-11. The stars of significance at the top of the 
graph indicate change compared to Cal 1. The stars just at the top of the bars indicate 
change from the previous Cal, for example those on top of the bar for Cal 4 indicate the 
change relative to Cal 3. An absence of stars indicates there was no significant change. 
This convention will be maintained forthwith. There are significant changes to be seen 
in sensitivity, particularly in the range of Cal 2 to Cal 4. The LRS doesn’t change 
between Cal 1 and Cal 2, p > 0.0500, there is a significant decrease from Cal 1 to Cal 3, 
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p < 0.0100**, and Cal 4, 5 and 6 are all also significantly lower in sensitivity compared 
to Cal 1, p < 0.0010*** for all three comparisons. Looking at Cal 2 it is found that all of 
Cal 3, 4, 5 and 6 result in a significantly lower LRS, p < 0.0010*** for all four 
calibrations. Cal 3 also produces a similar set of comparisons, with all of Cal 4, Cal 5 
and Cal 6 significantly lower in sensitivity, p < 0.0010***, p < 0.0100** and p < 
0.0100** respectively. Once Cal 4 has occurred there are no longer any significant 
changes, with Cal 4 and Cal 5, Cal 4 and Cal 6, and Cal 5 and Cal 6 not displaying any 
significant changes in LRS, p < 0.0500 for all comparisons. 
Considering the LRS results as percentages of the initial calibration the different 
calibrations read as follow: Cal 1 – 100.0 ± 5.4%, Cal 2 – 107.3 ± 3.6%, Cal 3 – 80.0 ± 
3.3%, Cal 4 – 54.1 ± 2.2%, Cal 5 – 62.2 ± 2.5% and Cal 6 – 60.6 ± 2.0%. Thus after a 
period of initial decrease in sensitivity, the LRS appears to settle at approximately 60% 
of the initial value. 
6.5.2 Repeated Calibration Stability – Long Term 
The second part of the stability series was to repeat the six calibration process but over 
an extended period of time. The calibration data for this trial is displayed in Table 11-11 
and the calculated kinetic parameters are listed in Table 6-11.  
The changes that occur in the Jmax appear minimal when compared to Day 0 but some 
are significant and comparisons between other days are more often than not significant. 
From Day 0 there is no significant change in the Jmax when compared to Day 1, Day 7 or 
Day 21, p > 0.0500 for all three. There is a significant increase, Day 0 to Day 3, p < 
0.0500*, and a significant decrease from Day 0 to Day 28, p < 0.0010***. There are no 
significant changes in the Jmax from Day 1 to Day 3 or Day 1 to Day 7, p > 0.0500 for 
both cases.  There are, however, significant decreases from Day 1 to Day 21 and Day 1 
to Day 28, p < 0.0100** and p < 0.0010*** respectively. The Jmax does not change 
significantly between, Day 3 and Day 7, p > 0.0500, but decreases significantly from 
Day 3 to Day 21 and from Day 3 to Day 28, p < 0.0010***. Examination of Day 21 and 
Day 28 also presents significantly lower Jmax values when compared to Day 7, p < 
0.0010*** in both cases. Finally, there is significant change in the Jmax between Day 21 
and Day 28, p > 0.0500. 
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The KM concentrations change significantly after Day 0 and Day 1, but there after the 
changes are not significant. The KM Day 0 and Day 1 do not differ significantly, p > 
0.0500. But other days do differ, Days 3, 7, 21 and 28 all present concentrations that are 
significantly higher than Day 0, p < 0.0010*** for all four. Examining Day 1 it is found 
that there are again significant increases in the KM values for Day 3, 7, 21 and 28, p 
<0.0100** for Days 3 and 7, and p < 0.0010*** for Days 21 and 28. However, when 
Day 3, Day 7, Day 21 and Day 28 KM concentrations are compared in any manner the 
result is a non-significant change, p > 0.0500, for all possible comparisons of KM. 
The main changes in the LRS values have been summarised in Figure 6-12. The 
changes are more pronounced than those for the first stability test. From the initial 
calibration on Day 0 all subsequent calibrations on later days display a significant 
reduction in sensitivity, p < 0.0010*** for all five days. The same is true for the Day 1 
calibration, whereby the calibrations on Day 3, Day 7, Day 21 and Day 28 are all also 
affected by a significantly lower sensitivity, p < 0.0010*** for all four days. The first 
non-significant change comes between Day 3 and Day 7, where there is no significant 
difference in the LRS to be found, p > 0.0500.  Day 21 has a significantly lower 
sensitivity than Day 3 though, p < 0.0100**, as does Day 28, p < 0.0010***. Days 21 
and 28 also display a lower sensitivity than Day 7, p < 0.0010*** in both cases. Finally, 
there is no significant change in the LRS between Day 21 and Day 28. 
In percentage terms, with Day 0 being 100.0 ± 1.7%, the LRS of the other calibrations 
read as: Day 1 – 76.9 ± 1.6%, Day 3 – 33.1 ± 0.8%, Day 7 – 36.6 ± 0.8%, Day 21 – 22.3 
± 0.6% and Day 28 – 19.8 ± 1.3%. Thus there appears to be a major decrease in 
sensitivity over the initial 3 days with it remaining stable for the rest of the first week 
and a further loss in sensitivity between week 1 and week 3. 
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Calibration Day 0, n = 4 Day 1, n = 4 Day 3, n = 4 
Kinetics M-M-H, p < 0.0001 M-M-H, p < 0.0001 M-M, p = 0.3418 
R
2
 0.9996 0.9995 0.9992 
Jmax, µA.cm
-2
 19.60 ± 0.15 20.79 ± 0.24 22.99 ± 0.32 
KM, µM 1128 ± 25 1558 ± 46 4000 ± 148 
α 1.330 ± 0.032 1.225 ± 0.033  
LRS, µA.cm
-2
.mM
-
1
 
17.37 ± 0.30 10.93 ± 0.37 5.747 ± 0.141 
Calibration Day 7, n = 4 Day 21, n = 4 Day 28, n = 4 
Kinetics M-M-H, p = 0.0011 M-M, p = 0.1570 M-M-H, p = 0.0415 
R
2
 0.9997 0.9988 0.9969 
Jmax, µA.cm
-2
 21.63 ± 0.35 18.31 ± 0.35 15.28 ± 0.91 
KM, µM 3400 ± 128 4723 ± 220 4437 ± 553 
α 1.091 ± 0.024  1.188 ± 0.087 
LRS, µA.cm
-2
.mM
-
1
 
6.363 ± 0.143 3.876 ± 0.115 3.443 ± 0.233 
Table 6-11 
Kinetic parameters, fit, Jmax and KM values calculated from the calibration data in Table 11-11. Jmax, KM, 
α and LRS are presented as Mean ± SEM. 
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Figure 6-12 
Bar chart of the sensitivities of the biosensor following repeated calibration of biosensors over a four 
week period. Stars at the top of the graph depict the significance of change compared Day 0 and stars 
sitting at the top of the bar illustrate degree of change relative to the previous calibration. 
These results suggest that time between calibrations does affect the sensitivity 
displayed, as the closely spaced calibrations of the first stability test showed less of a 
decrease. However, another factor is also alluded to, that being the repeated cooling and 
reheating of the electrodes and ᴅAAO when they are stored at 4 ºC between 
calibrations. This factor is also hinted at in the short term stability testing whereby the 
largest decrease in sensitivity occurred between Cal 3 and Cal 4 when the electrodes 
were stored at 4 ºC  overnight before Cal 4, 5 and 6 were carried out the following day. 
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Indeed, the electrodes were stable over the course of the three calibrations on the second 
day. Thus not only does it appear that time affects the sensitivity but also a repeated 
cooling of the electrodes, below the temperature where the enzyme is designed to be 
active, and reheating to a temperature close to a physiological level for calibration, 25 
ºC. 
6.5.3 Long Term Stability – Shelf Life Study 
The final component of the stability testing was to test biosensors with only two 
calibrations – a shelf-life test. The results of the calibrations are displayed below in 
Table 11-12, with the corresponding kinetic fits detailed in Table 6-12. 
Statistically there is no difference between the Jmax values of Day 0 and Day 21, p = 
0.1384. A significant difference does appear between Day 0 and Day 28, with Day 28 
displaying the larger value, p = 0.0098**. There is also a significant increase in Jmax 
from Day 21 to Day 28, p = 0.0224*. The KM concentration of Day 0 is significantly 
lower than the Day 21 and Day 28 concentration, p = 0.0009* and p = 0.0015** 
respectively. Between Day 21 and 28 however there is no significant change in the KM 
value, p = 0.0987. 
The sensitivities decline significantly after the initial Day 0 calibrations. Both Day 21 
and 28 are significantly lower, p < 0.0001***. The Day 21 LRS is also significantly 
lower than the Day 28 value, p = 0.0050**. In terms of percentage of the Day 0 
calibration, the results are as follows: Day 0 – 100.0 ± 0.7 %, Day 21 – 43.0 ± 1.3 % 
and Day 28 – 52.3 ± 1.7 %. The Day 21 and Day 28 LRS results are higher than those 
for the long term repeated calibration results for the same time between calibrations. 
This reinforces the theory that repeated calibration affects the sensitivity. They are also 
decreased compared to Cal 1 - 6 in the short term study, and Day 1 in the long term 
study, again reinforcing the theory that time and temperature fluctuations also affect the 
sensitivity. The significant increase in sensitivity between Day 21 and Day 28 could 
possibly indicate that given long enough, after the first calibration, the components of 
the biosensor are slowly interacting and arriving at a stable configuration. 
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Calibration Day 0, n = 8 Day 21, n = 4 Day 28, n = 4 
Kinetics M-M-H, p < 0.0001 M-M, p < 0.0001 M-M, p = 0.3418 
R
2
 0.9996 0.9962 0.5406 
Jmax, µA.cm
-2
 27.28 ± 0.10 28.21 ± 0.45 30.27 ± 0.50 
KM, µM 1489 ± 14 3582 ± 157 3160 ± 149 
α 1.188 ± 0.010   
LRS, µA.cm
-2
.mM
-
1
 
18.32 ± 0.12 7.876 ± 0.235 9.579 ± 0.316 
Table 6-12 
Kinetic parameters, fit, Jmax and KM values calculated from the calibration data in Table 11-12. Jmax, KM, 
α and LRS are presented as Mean ± SEM. 
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Figure 6-13 
J-concentration plot of the effect an extended period of storage would have on the biosensor. In red is 
the response at Day 0. The green trace depicts Day 21 and the blue trace Day 28. 
6.6 In Vitro Characterisation – Bio-Compatibility 
A second important set of characterisation tests carried out on the biosensors were 
designed to test the biocompatibility of the biosensors. This means attempting to 
determine how they would react in an in vivo environment and how that environment 
would react to them. Would the native constituents attack the biosensor components or 
encase it to protect the brain? To try to elucidate the influence of these factors a series 
of tests were carried out which would test the biosensor compatibility with protein, lipid 
and the brain tissue from a rat (Kane & O'Neill, 1998). 
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6.6.1 BSA 1% Treatment 
The first bio-compatibility treatment used involved the protein BSA (as used previously 
in various biosensor protocols). This protein was made up as a 1 % solution and after an 
initial Day 0 calibration the sensors were stored in this solution at 4 ºC, and calibrated 
again on Day 1, Day 3, Day 7, Day 10 and Day 14. The calibration data is listed in 
Table 11-13 and the associated kinetic fit and parameters are shown in Table 6-13.  
It is immediately clear, both from the two tables of data and Figure 6-14, that the 
treatment with BSA 1% causes radical changes in all parameters of the biosensor. 
Beginning with the Jmax values, it can be seen that compared to Day 0 all other days 
have significantly reduced values, p < 0.0010*** for all. There is no significant change 
between Day 1 and Day 3, p > 0.0500. However, all of Day 7, 10 and 14 are 
significantly lower than both Day 1 and Day 3, p < 0.0010*** in all cases. The Jmax for 
Day 10 and 14 are also significantly lower than that shown by Day 7, p < 0.0010*** for 
both. There is no significant difference between the Jmax of Day 10 and Day 14, p > 
0.0050. 
The KM values are also significantly affected by the treatment. From the initial low of 
Day 0, there is a significant increase observed when compared to Day 1, p < 0.0100**, 
Day 3, p < 0.0010***, Day 7, p < 0.0010***, and Day 14, p < 0.0010***. There is no 
significant difference between Day 0 and Day 10, p > 0.0500. Between Day 1 and Day 
3 and Day 1 and Day 7 there are also significant increases in the KM concentration to be 
observed, p < 0.0010*** in both cases. Again there is no significant difference between 
Day 1 and Day 10, p > 0.0500. However there is a significant increase between Day 1 
and Day 14, p < 0.0010***. There are no significant differences between Day 3 and 7, 
Day 3 and 14, or Day 7 and 14, p > 0.0500 in all three cases. Day 10 is has a 
significantly lower concentration calculated for its KM than either Day 3, Day 7 or Day 
14, p < 0.0010*** in all instances. 
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Calibration Day 0, n = 4 Day 1, n = 4 Day 3, n = 4 
Kinetics M-M-H, p < 0.0001 M-M-H, p = 0.0013 M-M, p = 0.1926 
R
2
 0.9996 0.9995 0.9992 
Jmax, µA.cm
-2
 23.26 ± 0.40 17.94 ± 0.38 19.25 ± 0.95 
KM, µM 1536 ± 69 4287 ± 205 8069 ± 800 
α 1.237 ± 0.052 1.108 ± 0.028  
LRS, µA.cm
-2
.mM
-
1
 
15.15 ± 0.48 4.184 ± 0.113 2.386 ± 0.127 
Calibration Day 7, n =4 Day 10, n = 4 Day 14, n = 4 
Kinetics M-M, p = 0.1648 M-M-H, p = 0.0104 M-M, p = 0.1655 
R
2
 0.9997 0.9988 0.9969 
Jmax, µA.cm
-2
 11.63 ± 0.31 5.580 ± 0.417 7.231 ± 0.211 
KM, µM 9524 ± 476 3329 ± 433 8992 ± 510 
α  1.805 ± 0.318  
LRS, µA.cm
-2
.mM
-
1
 
1.221 ± 0.031 1.676 ± 0.123 0.8041 ± 0.0235 
Table 6-13 
Kinetic parameters, fit, Jmax and KM values calculated from the calibration data in Table 11-13. Jmax, KM, 
α and LRS are presented as Mean ± SEM. 
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Figure 6-14 
Bar chart of the sensitivities of the biosensor following storage in a BSA 1% solution over two weeks. 
The changes that occur in the sensitivities of the electrodes are illustrated in Figure 
6-14. It is easy to see that the changes are quite dramatic. From the initial high of Day 0, 
all other days in comparison are significantly less sensitive, p < 0.0010*** for all days. 
Day 3, 7, 10 and 14 also have significantly lower LRS values than Day 1, p < 
0.0010*** in all instances. All sensitivities are again reduced when then compared to 
Day 3, p < 0.0010*** for Day 7 and Day 14 and p < 0.0100** for Day 10. Between Day 
7 and Day 10, there is a significant increase in the LRS, p < 0.0500*, and there is a non-
significant change between Day 7 and Day 14, p > 0.0500. There is, finally, a 
significant decrease from Day 10 to Day 14, p < 0.0010***. 
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Converting the LRS values to a percentage of the initial Day 0 starting value the extent 
of the changes becomes clear. The percentages are: Day 0 – 100.0 ± 3.2%, Day 1 – 27.6 
± 0.7%, Day 3 – 15.7 ± 0.8%, Day 7 – 8.1 ± 0.2%, Day 10 – 11.1 ± 0.8% and Day 14 – 
5.3 ± 0.2%. Thus in the first day of the treat over 70% of sensitivity is lost. From that 
point until Day 3 a further 30% of the remaining sensitivity is lost. By Day 14 there has 
been a loss of approximately 95% of the initial sensitivity.  
As a rough guide to the amount of this decrease that has been caused by the BSA 1% 
and not the other factors previously discussed it is useful to use the percentage changes 
encountered in Section 6.5.2. The effects of the 4 ºC storage conditions and subsequent 
heating and cooling of the electrodes, six calibrations on the same biosensors, and an 
extended time period (although not as long in the case of the BSA 1% treatment) are all 
built into the percentage changes obtained in that study. Thus, subtracting the 
percentage changes in that section from the changes in this section will give a guide to 
the effect of just the BSA 1%. When this is done the extra degradation caused by the 
BSA 1% treatment are as follows: Day 1 – 49 ± 2.4%, Day 3 – 17.3 ± 1.7%, Day 7 – 
28.6 ± 1.0%, Day 10 – 11.3 ± 1.5%, Day 14 – 14.5 ± 1.5%. 
6.6.2 BSA 10% Treatment 
In continuation of the bio-compatibility test a further protein treatment study was 
conducted. This time a BSA 10% solution was used. The same experimental protocol as 
for BSA 1% was followed with electrodes being calibrated six times from Day 0 – Day 
14, with the same intervals. The data obtained from the calibration is listed in Table 
11-14 and Table 6-14. 
Each day after the Day 0 calibration has a significantly lower Jmax than the Day 0 value, 
p < 0.0010*** for Day 1, 3, 7, 10 and 14.  Between Day 1 and Day 3 there is a 
significant decrease in Jmax, p < 0.0100**. Day 7, Day 10 and Day 14 all have a 
significantly lower Jmax than the Day 1 value, p < 0.0010*** for all comparisons. The 
same is true for Day 3, where again, the Day 7, 10 and 14 values of Jmax are 
significantly decreased, p < 0.0010***. After the Day 7 calibration there is a significant 
decrease to Day 10, p < 0.0500*, and Day 14, p < 0.0010***. But there is no significant 
difference between Day 10 and Day 14 when the Jmax values are compared, p > 0.0500. 
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Calibration Day 0, n = 4 Day 1, n = 4 Day 3, n = 4 
Kinetics M-M-H, p < 0.0001 M-M, p = 0.1118 M-M, p = 0.5193 
R
2
 0.9997 0.9995 0.9994 
Jmax, µA.cm
-2
 31.57 ± 0.31 23.08 ± 0.23 20.52 ± 0.29 
KM, µM 1714 ± 45 3209 ± 92 5116 ± 173 
α 1.147 ± 0.024   
LRS, µA.cm
-2
.mM
-
1
 
18.42 ± 0.33 7.193 ± 0.144 4.010 ± 0.085 
Calibration Day 7, n =4 Day 10, n = 4 Day 14, n = 4 
Kinetics M-M-H, p = 0.0254 M-M, p = 0.1488 M-M-H, p = 0.0459 
R
2
 0.9972 0.9929 0.9982 
Jmax, µA.cm
-2
 13.35 ± 0.64 10.80 ± 0.50 10.09 ± 0.59 
KM, µM 3534 ± 372 4800 ± 545 5807 ± 702 
α 1.184 ± 0.082  1.133 ± 0.065 
LRS, µA.cm
-2
.mM
-
1
 
3.778 ± 0.228 2.251 ± 0.162 1.737 ± 0.110 
Table 6-14 
Kinetic parameters, fit, Jmax and KM values calculated from the calibration data in Table 11-14. Jmax, KM, 
α and LRS are presented as Mean ± SEM. 
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Figure 6-15 
Bar chart of the sensitivities of the biosensor following storage in a BSA 10% solution over two 
weeks. 
There are fewer significant changes in the KM concentrations that were calculated for 
the 6 calibrations. The KM of Day 0 and Day 1 do not vary significantly, p > 0.0500. But 
the concentrations for Day 3, 7, 10 and 14 are all significantly higher than that of Day 0, 
p < 0.0010*** for Day 3, 10 and 14 and p < 0.0500* for Day 10. From the Day 1 value 
of KM there is a significant increase at Day 3 and Day 14, p < 0.0500* and p < 0.0100** 
respectively. But there is no significant difference between Day 1 and 7 or Day 1 and 
10, p > 0.0500 for both. Following the Day 3 calibration there is no significant change 
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in the KM concentration for any of Day 7, 10 or 14, p > 0.0500 for all three. There is 
also no difference between the KM of Day 7 and Day 10, p > 0.0500, but Day 14 shows 
a significant increase when compared to Day 7, p < 0.0100**. 
As per the previous section the changes in the LRS of the biosensors, when treated with 
BSA 10%, are displayed graphically in Figure 6-15. It can be seen that all subsequent 
days display a lower sensitivity than that for Day 0, p < 0.0010*** for all days (see the 
stars at the top of the bar chart). There is a similar picture when the LRS for Day 1 is 
considered and compared to the subsequent calibrations, again all are significantly 
lower, p < 0.0010*** for all comparisons. Between Day 3 and Day 7 however, there is 
no significant change in the sensitivity value, p > 0.0500. However, both Day 10 and 14 
are significantly lower than not only the Day 3 LRS, p < 0.0010*** for both, but also 
when compared to the Day 7 sensitivity, p < 0.0010*** for both. Lastly, there is no 
significant change in the LRS when Day 10 is compared with Day 14, p > 0.0500. 
As before, consideration of the LRS values in terms of percentage of the Day 0 value 
helps elucidate the changes that occurred. The percentages read as follows: Day 0 – 100 
± 1.8%, Day 1 – 39.1 ± 0.8%, Day 3 – 21.8 ± 0.5%, Day 7 – 20.5 ± 1.2%, Day 10 – 
12.2 ± 0.9%, Day 14 – 9.4 ± 0.6%. Now, using the same analysis as was used for BSA 
1% to eliminate the deterioration in sensitivity caused by other factors, the results for 
the long-term stability trials are subtracted. Application of this process results in values, 
which approximate the extra reduction in sensitivity solely to BSA 10%, they are: Day 1 
– 37.8 ± 2.4%, Day 3 – 11.3 ± 1.3%, Day 7 – 16.1 ± 2.1%, Day 10 – 10.1 ± 1.5%, and 
Day 14 – 10.4 ± 1.9%. 
The BSA 10% treatment has less of an effect on sensitivity than the 1% treatment. This 
is not without precedent as an earlier biosensor design for ᴅ-serine also demonstrated 
this unusual characteristic. It is most likely due to the 1% solution being of the right 
concentration to bind to available sites in the biosensor matrix and block up the pores 
within the matrix as well as the enzyme channels and to remain firmly set there. 
However, with the 10% solution the greater quantity and mass of BSA being deposited 
onto the biosensor is more easily de-adsorbed from the surface once transferred to the 
calibration cell, due to the increased weight and thickness of the layer and the greater 
concentration difference with the bulk solution. 
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6.6.3 PEA 1% Treatment 
The third component of the bio-compatibility study was to examine what would happen 
to the biosensor when it was exposed to a lipid. The lipid chosen was PEA, and it was 
made up as a 1% solution. The electrodes were stored in this solution over a two week 
period, during which six calibrations were carried out, again on Day 0, Day 1, Day 3, 
Day 7, Day 10 and Day 14. The calibration data for these tests is displayed in Table 
11-15, along with the accompanying kinetic parameters in Table 6-15. 
Similar to the results of the protein treatment trial, the electrodes show a deterioration in 
the vital kinetic parameters following treatment with the lipid PEA 1% solution. This is 
very evident when the Jmax values are considered. When comparing the value obtained 
for any day to the Jmax value of any day later in the trial, the later day always has a 
significantly reduced value, p < 0.0010*** for all cases where Days 0, 1, 3 and 7 are the 
first day chosen in the comparison. The only time this is not the case is when Day 10 is 
compared to Day 14, in this case there has been no significant change in the calculated 
Jmax, p > 0.0500. Thus the Jmax undergoes a regular and consistently significant decrease 
until the very last day of the trial. 
There are fewer significant changes in the concentrations calculated for the Michaelis-
Menten constant, KM. Initially there is a non-significant change between Day 0 and Day 
1, p > 0.0500, followed by a significant increase on Day 3 compared to Day 0, p < 
0.0500*. Days 7, 10 and 14 all then have a significantly higher KM compared to Day 1. 
When Day 1 is considered in comparison to Day 3 no significant change is found to 
have occurred, p > 0.0500. However, Day 7, Day 10 and Day 14 all display 
significantly higher KM concentrations, p < 0.0100**, p < 0.0500* and p < 0.0010*** 
respectively. Day 7 and Day 10 present no significant change compared to Day 3, p > 
0.0500 for both, but there is a significant increase when Day 14 is compared to Day 3, p 
< 0.0100**. The concentrations calculated for Day 10 and Day 14 are not significantly 
different from that calculated for Day 7, p > 0.0500 in both instances, and there is also a 
non significant change between Day 10 and Day 14, p > 0.0500. 
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Calibration Day 0, n = 4 Day 1, n = 4 Day 3, n = 4 
Kinetics M-M-H, p < 0.0001 M-M-H, p < 0.0001 M-M, p = 0.9007 
R
2
 0.9994 0.9998 0.9992 
Jmax, µA.cm
-2
 26.32 ± 0.25 23.99 ± 0.24 17.44 ± 0.27 
KM, µM 1141 ± 31 2465 ± 56 4709 ± 179 
α 1.365 ± 0.040 1.233 ± 0.023  
LRS, µA.cm
-2
.mM
-
1
 
23.07 ± 0.47 9.733 ± 0.138 3.704 ± 0.090 
Calibration Day 7, n =4 Day 10, n = 4 Day 14, n = 4 
Kinetics M-M, p = 0.9071 M-M, p = 0.5080 M-M, p = 0.0588 
R
2
 0.9972 0.9991 0.9870 
Jmax, µA.cm
-2
 10.56 ± 0.38 4.808 ± 0.090 4.610 ± 0.432 
KM, µM 7049 ± 539 6282 ± 260 9139 ± 1647 
α    
LRS, µA.cm
-2
.mM
-
1
 
1.498 ± 0.064 0.7653 ± 0.0186 0.5044 ± 0.0466 
Table 6-15 
Kinetic parameters, fit, Jmax and KM values calculated from the calibration data in Table 11-15. Jmax, KM, 
α and LRS are presented as Mean ± SEM. 
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Figure 6-16 
Bar chart of the sensitivities of the biosensor following storage in a PEA 1% solution over two weeks. 
The bar chart in Figure 6-16 gives an indication of the changes that occur in the LRS 
values over the course of the treatment. In nearly all cases the changes are significant. 
The only two non-significant results are illustrated in the chart. Those comparisons are 
between Day 7 and Day 10, and Day 10 and Day 14, p > 0.0500. All other possible 
comparisons between the six days are significantly different, p < 0.0010*** in all cases, 
with the later Day or calibration resulting in a significantly lower sensitivity. 
The LRS values as a percentage of the initial Day 0 value are as follows: Day 0 – 100 ± 
2.1%, Day 1 – 42 ± 0.6%, Day 3 – 16.1 ± 0.4%, Day 7 – 6.5 ± 0.3%, Day 10 – 3.3 ± 
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0.1% and Day 14 – 2.2 ± 0.2%. Removing the other factors which are involved in the 
degradation of the biosensor sensitivity gives an approximate quantification of the effect 
of the PEA 1% solution. The percentage extra degradation attributable to the PEA 1% 
solution is: Day 1 – 34.7 ± 2.2%, Day 3 – 17.0 ± 1.2%, Day 7 – 30.1 ± 1.1%, Day 10 – 
19.0 ± 1.7% and Day 14 – 17.6 ± 1.5%. Thus the PEA 1% solution contributed about a 
25% extra loss in sensitivity at any particular time. 
6.6.4 PEA 10% Treatment 
As with the BSA protein treatment, the PEA lipid treatment was repeated with the PEA 
concentration being increased to 10%.  The calibration data is listed in Table 11-16, and 
the associated kinetic fits and parameters are shown in Table 6-16. 
There are significant changes across all of the Jmax values for this PEA 10% study. 
Every single value is significantly lower than those before it. Examining Day 0, all 
subsequent days show a significant fall in Jmax, p < 0.0010*** for all days when 
compared to Day 0. The same is true for Day 1, with Day 3, 7, 10 and 14 all 
significantly lower, p < 0.0010*** for all comparisons. From the Jmax value of Day 3, 
there are significant decreases observed to Day 7, 10 and 11, p < 0.0100**, p < 
0.0010*** and p < 0.0010*** respectively. At Day 7 the Jmax is significantly larger than 
its value at Day 10 or Day 14, p < 0.0010*** in both instances. Lastly, the Jmax at Day 
14 is significantly lower than the Jmax observed at Day 10. 
Calibration Day 0, n = 4 Day 1, n = 4 Day 3, n = 4 
Kinetics M-M-H, p < 0.0001 M-M-H, p = 0.0072 M-M-H, p = 0.0235 
R
2
 0.9996 0.9960 0.9915 
Jmax, µA.cm
-2
 34.35 ± 0.40 16.48 ± 0.57 12.49 ± 0.70 
KM, µM 1871 ± 55 1929 ± 163 2382 ± 298 
α 1.193 ± 0.030 1.282 ± 0.102 1.332 ± 0.158 
LRS, µA.cm
-2
.mM
-
1
 
18.36 ± 0.36 8.534 ± 0.480 5.245 ± 0.411 
Calibration Day 7, n =4 Day 10, n = 4 Day 14, n = 4 
Kinetics M-M, p = 0.3242 M-M, p = 0.9936 M-M, p = 0.2480 
R
2
 0.9992 0.9921 0.9943 
Jmax, µA.cm
-2
 9.294 ± 0.303 5.137 ± 0.542 2.677 ± 0.334 
KM, µM 15481 ± 813 15357 ± 2619 23416 ± 4188 
α    
LRS, µA.cm
-2
.mM
-
1
 
0.6004 ± 0.0127 0.3345 ± 0.0231 0.1143 ± 0.0653 
Table 6-16 
Kinetic parameters, fit, Jmax and KM values calculated from the calibration data in Table 11-16. Jmax, KM, 
α and LRS are presented as Mean ± SEM. 
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Figure 6-17 
Bar chart of the sensitivities of the biosensor following storage in a PEA 10% solution over two 
weeks. 
From Table 6-16 it should also be clear that there are some significant changes in the 
KM concentrations observed over the two week trial period. Comparing Day 0 with Day 
1 and Day 0 with Day 3, there is statically a non-significant difference between the 
concentrations, p > 0.0500 for both. However, when compared to Day 0 there is a 
significant increase in the KM for Day 7, p < 0.0100**, Day 10, p < 0.0100**, and Day 
14, p < 0.0010***. There is a non-significant change between Day 1 and Day 3, p > 
0.0500. Taking the KM of Day 1 and Day 3 it is found that there are significant increases 
to be observed when they are compared to Day 7, p < 0.0100** for both, Day 10, p < 
0.0100** for both, and Day 14, p < 0.0010*** for both also. The KM concentrations of 
Day 7 compared to Day 10 and 14, and Day 10 compared to Day 14 are all not 
significantly different, p > 0.0050 in all three cases.  
The illustration of the LRS values in Figure 6-17, demonstrates the size and significance 
of the changes that occurred over the two weeks the biosensors were treated with PEA 
10%. When the Day 0 LRS is compared to any value that was observed afterwards there 
is a significant decrease associated with it, p < 0.0010***. The same is true when the 
same comparisons are performed with either the Day 1 LRS or Day 3 LRS, where all 
subsequent values are significantly lower, p < 0.0010*** in all cases. Comparing the 
sensitivity of Day 7 to Day 10 or Day 14 and the sensitivity of Day 10 to Day 14, there 
are no significant differences to found, p > 0.0500 for the three pairs of values. 
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The conversion of the LRS values to a percentage of the initial value yields: Day 0 – 
100.0 ± 2.0%, Day 1 – 46.5 ± 2.6%, Day 3 – 28.5 ± 2.2%, Day 7 – 3.3 ± 0.1%, Day 10 
– 1.8 ± 0.1% and Day 14 – 0.62 ± 0.04%. As in previous cases, removing the effects 
accumulated when the long-term stability test was run gives an approximate indication 
of the further degradation caused solely by the PEA 10%: Day 1 – 30.3 ± 4.2%, Day 3 – 
4.5 ± 3.0%, Day 7 – 33.4 ± 0.9%, Day 10 – 20.5 ± 0.8% and Day 14 – 19.2 ± 1.4%. 
6.6.5 Brain Tissue Treatment 
The final component of the bio-compatibility trials was an ex vivo trial. This involved 
the treatment of the electrodes with a segment of brain tissue from a Wistar rat, as it has 
been extensively shown that exposure to the brain can reduce the sensitivity of 
enzymatic biosensors by 70% (Garguilo & Michael, 1995; Wilson & Gifford, 2005), 
which was attributable solely to fouling caused by biological molecules. It is well 
known that implantation of a device into brain tissue and the associated brain injury 
triggers a foreign body response (FBR) (Morais et al., 2010). This FBR results a 
cascade of acute responses for inflammatory and wound healing purposes. The 
substances released in this environment are responsible for the loss of sensitivity seen 
with implantation and the brain tissue test is an attempt to quantify its effects on the 
biosensor. These effects have also been shown for non-enzymatic sensors to varying 
degrees (Brown et al., 2009; Bolger et al., 2011a) and in particular for carbon paste 
electrodes (Ormonde & O'Neill, 1989, 1990; Bolger et al., 2011b). 
The brain was removed from a subject less than one hour post-mortem and immediately 
frozen without cleaning or preservation techniques. This ensured that as much of the 
natural substances found in the brain were retained in the sample. When the trial was to 
be conducted, a 5 mm
3
 segment was cut off the frozen brain and allowed to thaw. Once 
thawed the sample was placed into a container with 0.5 mL of water. This prevented the 
tissue from drying out and adhering to the electrode surface. If the sample dried out, 
removing or inserting the electrodes would lead to substantial amounts of damage to the 
electrodes. The electrodes were inserted into the tissue sample, so that the active surface 
was completely immersed into the tissue, after initial calibration. They were stored this 
way, at 4 ºC, between subsequent calibrations. The calibration data for the trial, which 
took place over two weeks, is displayed in Table 11-17 with the associated kinetic fit 
and constants listed in Table 6-17. 
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It is quite apparent from the kinetic data that there are differences in the Jmax values over 
the course of the treatment. In fact, these differences are large enough to be significant 
in all cases. For each comparison possible, the later calibration has a significantly 
reduced Jmax compared to the earlier calibration, p < 0.0010*** for all instances except 
that of Day 3 compared to Day 7 where p < 0.0100**. The KM values also undergo 
change; however they are only significant when considering comparisons involving Day 
0. From Day 0 the concentration increases significantly when compared to Day 1 and 
Day 3, p < 0.0500* for both, Day 7, p < 0.0100**, and Day 14, p < 0.0010***.  
However, after Day 0, from Day 1 forward there are no more significant changes to be 
found. All comparisons involving solely Day 1, 3, 7 & 14 are non-significantly 
different, p > 0.0500. This is a positive result, demonstrating that, despite a decreasing 
Jmax, after an initial increase in the KM the kinetic curve retains at least one constant 
parameter. This is despite the harsh treatment of repeated calibrations and long-term 
storage in brain tissue. Previous studies have only looked at the effect after a few hours 
of implantation (Ormonde & O'Neill, 1990; Garguilo & Michael, 1995) or for two 
calibrations over 3 days (Bolger et al., 2011a). 
Calibration Day 0, n = 4 Day 1, n = 4 Day 3, n = 4 Day 7, n =4 
Day 14, n = 
4 
Kinetics 
M-M-H,  
p < 0.0001 
M-M,  
p = 0.9706 
M-M-H,  
p < 0.0001 
M-M,  
p = 0.5680 
M-M-H,  
p = 0.0427 
R
2
 0.9996 0.9959 0.9963 0.9843 0.9962 
Jmax, 
µA.cm
-2
 
14.80 ± 0.10 
9.372 ± 
0.228 
7.126 ± 
0.207 
5.849 ± 
0.297 
3.299 ± 
0.156 
KM, µM 920.0 ± 19.7 2183 ± 172 2222 ± 136 2527 ± 396 2915 ± 312 
α 
1.331 ± 
0.030 
 
1.573 ± 
0.123 
 
1.202 ± 
0.095 
LRS, 
 µA.cm
-2
.mM
-1
 
16.09 ± 0.27 
4.293 ± 
0.254 
3.207 ± 
0.130 
2.315 ± 
0.265 
1.132 ± 
0.072 
Table 6-17 
Kinetic parameters, fit, Jmax and KM values calculated from the calibration data in Table 11-17. Jmax, KM, 
α and LRS are presented as Mean ± SEM. 
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Figure 6-18 
Bar chart of the sensitivities of the biosensor following storage in a brain tissue sample over two 
weeks. 
Due to the decreasing Jmax there are significant changes to be found in the sensitivity 
values. The LRS values of Day 1, Day 3, Day 7 and Day 14 are all significantly reduced 
compared to Day 0, p < 0.0010***. Between Day 1 and Day 3 there is also a significant 
reduction, p < 0.0500*. Day 7 and 14 are further reduced compared to Day 0, p < 
0.0010***. There are no significant changes in sensitivity between Day 3 and Day 7, > 
0.0500. Day 14, however, is significantly reduced in LRS compared to Day 3 and Day 
7, p < 0.0010*** and p < 0.0500* respectively. 
To help quantify the changes in sensitivity it is useful to convert the LRS values to a 
percentage of the initial value: Day 0 – 100.0 ± 1.7%, Day 1 – 26.7 ± 1.6%,Day 3 – 
19.9% ± 0.8%, Day 7 – 14.3 ± 1.6% and Day 14 – 7.0 ± 0.5%. It is also useful again to 
compare these percentages to the decreases experienced over the course of the first 5 
calibrations of the long-term stability study in order to elucidate the percentage 
decreases attributable solely to the brain tissue treatment: Day 1 – 50.2 ± 3.2%, Day 3 – 
13.2 ± 1.6%, Day 7 – 22.2 ± 2.5%, Day 14 – 15.3 ± 1.1%. The decrease of 73.3% 
experienced between Day 0 and Day 1 (~ 15 hours in the brain tissue sample) is similar 
to the 70% decrease seen by Garguilo and Michael after 7 hours of exposure.  
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6.7 In Vitro Characterisation – pH and Temperature Effects 
Following the stability and bio-compatibility testing it was also necessary to test how 
the biosensor would behave at extremes of pH and at physiological temperatures. The 
pH changes are akin to a stress test to see how changes in pH could affect the activity of 
the enzyme in particular. The temperature trial is necessary as the biosensor will be 
operating at 37 ºC in vivo whereas all the testing has been carried out at 25 ºC. 
6.7.1 pH Changes 
While it is not likely that the pH of the brain environment will vary significantly from 
7.4 it is known to occur (Zimmerman & Wightman, 1991), it was decided to test what 
effect pH changes would produce on the biosensor sensitivity. It is likely the enzyme 
could lose activity if it is subject to extremes of pH (Burton, 1951; Dixon & Kleppe, 
1965b; Brunori et al., 1971; Horiike et al., 1976) as ᴅAAO is biologically designed to 
operate at 7.4. The pH values of 6.5 and 8.0 were chosen (Bolger et al., 2011a) as the 
test values of pH and the standard PBS of pH 7.4 was altered to achieve these values. 
The calibration data obtained is presented in Table 11-18 with the relevant calculated 
kinetic data displayed in Table 6-18. 
Calibration 
pre pH 8.0 
n = 4 
pH 8.0 
n = 4 
 pre pH 6.5 
n = 4 
pH 6.5 
n = 4 
Kinetics 
M-M-H,  
p < 0.0001 
M-M-H, 
p < 0.0001 
M-M-H, 
p = 0.0132 
M-M-H, 
p = 0.0025 
R
2
 0.9996 0.9966 0.9930 0.9947 
Jmax, µA.cm
-2
 28.94 ± 0.21 33.07 ± 0.67 19.23 ± 2.20 12.43 ± 1.03 
KM, µM 903.9 ± 20.6 974.6 ± 74 4367 ± 1486 5823 ± 824 
α 1.251 ± 0.028 1.435 ± 0.102 0.7667 ± 0.0754 1.445 ± 0.140 
LRS,  
µA.cm
-2
.mM
-1
 
32.02 ± 0.57 33.93 ± 1.64 4.404 ± 1.002 2.135 ± 0.133 
Table 6-18 
Kinetic parameters, fit, Jmax and KM values calculated from the calibration data in Table 11-18. Jmax, KM, 
α and LRS are presented as Mean ± SEM. 
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Figure 6-19 
Comparison of the changes caused to the sensitivity of the biosensor by changing the pH of the 
calibration buffer. Shown in red is the pH 7.4 pre pH 8.0, pH is in yellow, the green trace is pH 7.4 pre 
pH 6.5 and the blue trace is pH 6.5. 
There are contrasting results for the two pH trials. It appears that the pH 8.0 calibration 
has no effect on the sensitivity of the biosensor whereas the pH 6.5 calibration seems to 
have had a negative impact on sensitivity. When the Jmax values are considered there is 
no significant difference between the pre 8.0 and 8.0 value, p > 0.0500. But, 
contrastingly, there is a significant decrease found from the pre 6.5 Jmax to the 6.5 value, 
p < 0.0500*. Looking at the KM concentrations, it is found that in the case of both the 
pH 8.0 and the pH 6.5 trials there are no significant differences between the pH 7.4 pre 
calibration and the altered pH calibrations, p > 0.0500 in both cases. 
Consideration of the LRS changes gives an overall indication of the changes within the 
two tests. Statistically it is discovered that between the pre pH 8.0 calibration and the 
pH 8.0 calibration there is a non-significant change in the sensitivity, p > 0.0500. The 
same is true for the pre pH 6.5 and pH 6.5 calibrations where no significant difference is 
found, p > 0.0500. Examining the percentages involved, illustrated in Figure 6-19 gives 
an alternative indication of how the two treatments affect the sensitivity of the 
biosensor. The pre pH 8.0 calibration returns 100 ± 1.8% and the pH 8.0 calibration has 
a sensitivity of 106.0 ± 5.1%. The pre pH 6.5 calibration yielded a sensitivity of 100.0 ± 
22.8% and the pH 6.5 calibration itself was 48.5 ± 3.0% as sensitive. Comparing this 
result to the first two calibrations of the short-term repeated calibration trial, which were 
100.0 ± 5.4% and 107.3 ± 3.6% sensitive respectively, further illustrates the point that 
there has been no significant change in the sensitivity for the pH 8.0 trial. However, it 
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does indicate that mean sensitivity value of the pH 6.5 trial had decreased by 
approximately half. This change may be due to the isoelectric point (IEP) of the 
enzyme, which has been determined to be pH 6.24 (Yagi & Ohishi, 1972). As a 
molecule approaches its IEP from a pH above the IEP it loses its net negative charge 
and becomes neutral. The changes which occur within the molecule at this point can be 
irreversible and may potentially affect the activity of an enzyme. Effects similar to this 
have been seen before, where as the pH approaches 6.0 the activity decreases, with peak 
activity in the region of pH 8.0 – 9.0 (Pernot et al., 2008; Zain et al., 2010). 
6.7.2 Temperature Changes 
It was not possible during the development of the biosensor to run all calibrations at the 
physiological temperature of 37 ºC. This is the temperature at which the biosensor 
would be operating at in vivo and indeed the temperature that it is operates at in a 
natural environment. Thus, a trial was conducted whereby the experimental apparatus 
was heated up to 37.0 ± 0.2 ºC and maintained at this temperature throughout a 
calibration. The results of an initial calibration and a post 37 °C calibration, both at 
room temperature and the 37 ºC calibration are displayed in Table 11-19 with the 
kinetic fit data listed in Table 6-19. 
There are significant changes to be found across all of the Jmax values. The 37 ºC value 
is significantly lower than the pre 37 ºC Jmax, p < 0.0500*. The post 37 ºC calibration 
also has a significantly decreased Jmax when compared to the pre 37 ºC  value, p < 
0.0010***. Lastly the post 37 ºC is also significantly lower than the 37 ºC result, p < 
0.0010***.  
Calibration pre 37 ºC, n = 4 37 ºC, n = 4 post 37 ºC, n = 4 
Kinetics M-M, p = 0.2484 M-M, p = 0.7614 M-M, p = 0.1150 
R
2
 0.9978 0.9989 0.9966 
Jmax, µA.cm
-2
 21.96 ± 0.45 20.55 ± 0.23 11.73 ± 0.28 
KM, µM 3012 ± 179 1829 ± 72 2607 ± 189 
LRS, µA.cm
-2
.mM
-1
 7.292 ± 0.307 11.23 ± 0.34 4.500 ± 0.237 
Table 6-19 
Kinetic parameters, fit, Jmax and KM values calculated from the calibration data in Table 11-19. Jmax, KM, 
α and LRS are presented as Mean ± SEM. 
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Figure 6-20 
J-concentration plot of the pre 37 ºC calibration (green trace), the calibration at 37 ºC (red trace) and 
the post 37 ºC calibration (blue trace). 
Examining the KM concentrations it is seen that a different pattern of significant 
changes were brought about the 37 ºC treatment. From the initial concentration of the 
pre 37 ºC calibration there is a significant decrease in the value for the 37 ºC result, p < 
0.0100**. The post 37 ºC result is then significantly increased when compared to the 37 
ºC calibration, p < 0.0500*. Interestingly, the change between the pre 37 ºC and post 37 
ºC KM results is not significant, p > 0.0500.  
The combination of the fluctuating Jmax and KM values results in significant changes in 
the sensitivities of the biosensors. The initial response of the pre 37 ºC is increased 
significantly by the calibration at 37 ºC, p < 0.0010***. From this peak, the LRS 
decreases significantly with the post 37 ºC calibration, p < 0.0010***. There is also a 
significant decrease observed when the pre 37 ºC and post 37 ºC sensitivities are 
compared, p < 0.0010***. In terms of percentage of the initial LRS result, the three 
values are: pre 37 ºC – 100.0 ± 4.2%, 37 ºC – 154.0 ± 4.7%, post 37 ºC – 61.7 ± 3.3%. 
These are favourable values when compared to the short-term repeated calibration 
values of: Cal 1 – 100.0 ± 5.4%, Cal 2 – 107.3 ± 3.6%, Cal 3 – 80.0 ± 3.3%. It shows 
that the when utilised in an environment at physiological temperature the ᴅAAO does 
turnover substrate at a higher rate, this is to be expected as it is closer to the 
environment within which the enzyme evolved to function in. But it also shows again 
that fluctuation in temperature can cause a reduction in sensitivity, similar to the effects 
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shown by the changes in pH and the effects of refrigeration during the short-term and 
long-term stability testing. 
6.8 In Vitro Characterisation – Interference Studies 
Having decided on an interference rejection mechanism, the combination of Naf and 
PPD, and tested it for its rejection of AA from the electrode surface it was now 
necessary to complete a more thorough examination of the interference characteristics 
of the biosensor. To do this a combination of three different studies were utilised. The 
first was a combined calibration where a range of amino acids were injected into the 
PBS in series to test the reaction of the immobilised ᴅAAO to the presence of amino 
acids other than ᴅ-ser. Secondly, ᴅ-alanine, the most commonly occurring amino acid, 
by concentration other than ᴅ-ser, was calibrated in full for the biosensors response to it. 
Lastly the biosensor was calibrated for response to a range of other electroactive species 
found in the ECF and brain environment.  
6.8.1 Amino-Acids and Glycine 
There is a substantial range and variety of amino acids present in the brain, with both 
the ᴅ- and ʟ- analogues commonly occurring. Due to the non-selective nature of ᴅAAO 
(Ferraris et al., 2008) it is necessary to quantify the level of reactivity of the biosensor 
to these other amino acids. It should be noted that the stereospecifity specific of ᴅAAO 
is absolute, ʟ-amino acids do not inhibit or act as substrates for it (Molla et al., 2003). 
Despite this, for completeness and to be comparable to previously published data the 
calibration was carried out across a range of ᴅ- and ʟ-amino acids as well as glycine. 
Glycine is also a co-agonist at the NR1 subunit of the NMDA glutamate receptor 
(Danysz & Parsons, 1998). 
The amino acid substrates used were: the ᴅ- and ʟ- isomers of serine (ser), alanine (ala), 
aspartic acid (asp), phenylalanine (phe), glutamic acid (glut), arginine (arg), proline 
(pro) and histidine (his) along with ᴅ-lysine (ᴅ-lys), ᴅ-tyrosine (ᴅ-tyr) and glycine (gly). 
Further amino acids appear in Section 6.8.3 as electroactive interferents. 
The responses obtained during this trial are displayed in Table 6-20 and plotted in 
Figure 6-21. The responses were calculated using the settled level of the previous 
substrate as a new baseline. This is in some cases lead to a negative response as the 
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levels settled further over an extended period of time, or the addition of another 
substrate diluted the quantity of active substrate reaching the enzyme. There is also the 
added factor of possible baseline drift occurring over such a long calibration, over 3 
hours long. 
As expected it is clear to see that the ʟ-amino acids and glycine, when error is taken into 
account, produce no response from the biosensor. There is little or no response from ᴅ-
glut, ᴅ-lys and ᴅ-tyr. The currents recorded for ᴅ-asp, ᴅ-arg and ᴅ-his are approximately 
half that of ᴅ-ser. ᴅ-phe and ᴅ-ala produce a response level similar to that of ᴅ-ser, while 
ᴅ-pro is approximately twice as reactive as these three ᴅ-amino acids.  These are not 
unexpected results as an increased kcat, catalytic rate, for ᴅ-pro has been widely reported 
along with similar levels of activity for ᴅ-ser, ᴅ-ala and ᴅ-phe (Dixon & Kleppe, 1965a; 
Molla et al., 2006). The varying responses are also due to the different types of ᴅ-amino 
acids used: arg, his and lys have positively charged side chains, asp and glu have 
negatively charged side chains (at physiological pH), ser has polar uncharged side 
chains, ala, phe and tyr all contain hydrophobic side chains. Along with the charge 
differences gly, pro and ala are aliphatic compounds, phen and tyr are aromatic 
compounds, asp and glu are acidic, arg, his and lys are basic in nature and finally ser is 
hydroxylic. The combination of these characteristics as well as the differences in size 
and shape will all contribute to the varying response of the biosensor to the different 
amino acids. Perhaps most important of all is the varying substrate affinity and catalytic 
efficiency the different ᴅ-amino acids have for ᴅAAO (Dixon & Kleppe, 1965a). 
 
J, 10 µM, µA.cm
-2
, n = 6 
 
J, 10 µM, µA.cm
-2
, n = 6 
Substrate Mean ± SEM Substrate Mean ± SEM 
ᴅ-ser 0.065 0.005 ʟ-ser -0.003 0.003 
ᴅ-ala 0.073 0.006 ʟ-ala -0.021 0.008 
ᴅ-asp 0.034 0.008 ʟ-asp 0.006 0.005 
ᴅ-phe 0.083 0.009 ʟ-phe 0.007 0.002 
ᴅ-glut 0.008 0.004 ʟ-glut -0.011 0.005 
ᴅ-pro 0.143 0.021 ʟ-pro -0.018 0.016 
ᴅ-arg 0.030 0.012 ʟ-arg -0.002 0.007 
ᴅ-his 0.035 0.005 ʟ-his 0.009 0.008 
ᴅ-lys -0.009 0.003 Gly -0.006 0.006 
ᴅ-tyr 0.013 0.012 
   
Table 6-20 
Calibration data for a range of amino acids. The indicated values are the response following to 10 µM 
of the amino acid, having taken the resting value of the previous substrate as a new baseline. 
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Figure 6-21 
The 10 µM response of the biosensor to various amino acids. 
The large responses obtained for ᴅ-ala, ᴅ-phe and ᴅ-pro are not of any major 
significance as previously explained (Section 0). ᴅ-ser is, in general, the ᴅ-amino acid 
that is highest in concentration and two orders of magnitude greater than ᴅ-ala and ᴅ-
asp, the next two most prolific amino acids (Hashimoto et al., 1993; Morikawa et al., 
2001; Wolosker et al., 2002; Hamase et al., 2005). Thus even with equal sensitivity to 
these substrates the likely effect on the output signal would only be ~ 1% of the changes 
in signal due to ᴅ-ser. 
6.8.2 ᴅ-Alanine 
Having identified that there was a significant response to ᴅ-ala and being aware that it 
was the most prolific ᴅ-amino acid apart from ᴅ-ser it was decided to conduct a full 
calibration to elicit better the response of the biosensor to this substrate. It was hoped 
that this would also allow a better quantification of the likely interference in signal from 
the other ᴅ-amino acids. Being able to put a definite figure on the sensitivity to ᴅ-ala 
along with the relative concentrations know by brain region would allow a finer 
resolution of the quantity of interference likely. Thus a full ᴅ-ala calibration was 
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conducted on biosensors previously calibrated for ᴅ-ser response. The results are 
displayed in Table 11-20. 
The kinetic parameters are listed in Table 6-21, and contribute to the plot in Figure 
6-22. Statistically, there is no significant difference between the Jmax values of the pre 
and post ᴅ-ser calibrations, p > 0.0500, but the ᴅ-ala calibration has a significantly 
higher Jmax value than either the pre or post calibration, p < 0.0010*** in both cases.  
These statistical differences also hold true when the KM concentration is examined. The 
pre and post calibrations are non-significantly different, p > 0.0500, and the ᴅ-ala 
calibration is significantly different to both the pre and post concentrations, p < 
0.0010***. In the case of the KM however the ᴅ-ala value is significantly higher.   
Not surprisingly, the LRS values also show the same statistical differences as the Jmax 
and KM. The pre and post calibrations are equally as sensitive, p > 0.0500, and the ᴅ-ala 
shows a significantly higher sensitivity than both the ᴅ-ser calibrations, p < 0.0010***. 
It is clear that without other amino acids present that ᴅAAO has quite an affinity for ᴅ-
ala, and is almost twice as sensitive to it as ᴅ-ser. 
Calibration pre ᴅ-alanine, n = 4 ᴅ-alanine, n = 4 post ᴅ-alanine, n = 4 
Kinetics M-M-H, p < 0.0001 M-M-H, p = 0.0005 M-M-H, p = 0.0003 
R
2
 0.9995 0.9984 0.9984 
Jmax, µA.cm
-2
 13.49 ± 0.11 17.68 ± 0.26 13.14 ± 0.23 
KM, µM 1198 ± 29 818.1 ± 39.5 1238 ± 62 
A 1.385 ± 0.036 1.209 ± 0.053 1.247 ± 0.059 
LRS, µA.cm
-2
.mM
-1
 11.26 ± 0.20 21.61 ± 0.83 10.62 ± 0.39 
Table 6-21 
Kinetic parameters, fit, Jmax and KM values calculated from the calibration data in Table 11-20. Jmax, KM, 
α and LRS are presented as Mean ± SEM. 
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Figure 6-22 
J-concentration plot of the ᴅ-ala calibration (red trace) with the pre (dark blue trace) and post (light 
blue trace  ᴅ-ser calibration. 
However what is also shown in this set of tests is that exposure to ᴅ-ala appears to have 
maintained the sensitivity of the biosensors towards ᴅ-ser. If the short term repeated 
calibrations are re-examined it is seen that the LRS of Cal 1 and Cal 3 are 100.0 ± 5.4% 
and 80.0 ± 3.3% respectively. Here the first and second ᴅ-ser calibrations (Cal 1 and Cal 
3 respectively) post sensitivities of 100.0 ± 1.8% and 94.3 ± 3.5% respectively. The ᴅ-
ala calibration has a sensitivity of 191.9 ± 7.3% compared to a Cal 2 value of 107.3 ± 
3.6%. If exposure to other ᴅ-amino acids improves or maintains the sensitivity of the 
enzyme and the biosensors towards ᴅ-ser then this can only be beneficial for in vivo 
applications. Finally the approximate ratio of ᴅ-ser to ᴅ-ala in the cerebellum as 
reported by Hamase is 35:1 (Hamase et al., 2005; Miyoshi et al., 2009; Miyoshi et al., 
2011) and with the biosensor almost twice as sensitive to ᴅ-ala the maximum signal due 
to ᴅ-ala is likely to be in the range of 5% of the ᴅ-ser signal. Although as seen in the 
long amino acid calibration, due to varying affinities of the different ᴅ-amino acids for 
ᴅAAO it is possible that it could be much less, when other substrates are competing 
with each other for access to the ᴅAAO. 
6.8.3 Native Electroactive Species 
Having already explored the interference from the primary electroactive interferent in 
the brain, AA, see Section 6.4, it was necessary to establish what the effect, if any, the 
other electroactive species in the ECF would have. Having shown that the combination 
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of the Naf and PPD layers could eliminate interference from the high concentrations of 
AA it was unlikely that any other electroactive species would produce a response, but it 
verification was still essential. Chosen for testing were AA and its oxidised form 
dehydroascorbic acid (DHAA), the amino acids, ʟ-cysteine (ʟ-cys), ʟ-tryptophan (ʟ-trp) 
and ʟ-tyrosine, (ʟ-tyr), the metabolite of purine nucleotides – uric acid (UA), the 
monoamine neurotransmitters dopamine (DA) and 5-hydroxytryptamine (serotonin) (5-
HT), three of their metabolites – homovanillic acid (HVA), 5-hydroxyindoleacetic acid 
(5-HIAA) and 3,4-dihydroxyphenylacetic acid (DOPAC), and another anti-oxidant ʟ-
glutathione. 
The experiment was conducted similar to the amino acid calibration except that it was 
conducted under an atmosphere of nitrogen and all solutions were nitrogen saturated. 
The substances were added as a standard aliquot, of 100 µL, which contained an ECF 
concentration for the particular substrate. After an initial small increase in current due to 
convective effect the signal quickly settled back to, or below, baseline levels during the 
quiescent period and as the ‘self-blocking mechanism’ took effect. This can clearly be 
seen in Figure 6-23. 
The concentration of ʟ-gluta, ʟ-cys, ʟ-trp and ʟ-tyr in the ECF are unknown, therefore 
relatively high µM values were chosen (O'Brien et al., 2007), all other values were 
chosen to be at least the in vivo concentration of consensus. The only substance where 
the concentration to be used was difficult to determine was DA, as there is ongoing 
controversy over the proposed levels in vivo with values ranging from 0.05 µM 
(Zetterström et al., 1983) to 0.0005 µM (Cartmell et al., 2000). Thus, to cover all 
possibilities a high level of 0.5 µM was chosen. 
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Figure 6-23 
The raw data trace obtained for one electrode during the interferent calibration. Each dotted line 
indicated the addition of the next species.  
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Figure 6-24 
Bar chart of the sensitivity of the biosensor to various electroactive interferents. 
Examining the data a number of interesting and satisfying points are illustrated. Firstly 
the large response to AA, the first substance injected is to be expected, as the ‘self-
blocking mechanism’ in the polymer has not had time to establish. A similar, large, 
initial response was shown when the polymer layers were being characterised in Section 
6.4.3 for only a 200 µM AA concentration, yet after this the current decreases with time 
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as self-blocking occurs. Indeed this can be seen to occur in this instance in both Figure 
6-23 and in the overall figures as a lot of the later injections display a negative response. 
Indeed the total overall response is similar to that shown in Section 6.4.3 for 400 µM 
AA despite a substantially greater quantity and variety of electroactive species being 
present. These are encouraging results overall, and they show that once the biosensors 
have been allowed to settle in an in vivo environment, the milieu of different species 
present should not affect detection of ᴅ-ser beyond affecting the baseline current.  
6.9 In Vitro Characterisation – Oxygen Dependency Studies 
As ‘first generation’ biosensors, the ᴅ-ser sensors designed operate by oxidising the 
H2O2 produced by an enzyme. ᴅAAO is an oxidase enzyme, and as already detailed in 
Section 2.7 and 2.8.2, oxygen is required for it, in particular the FAD unit, to function 
correctly. Therefore, as with all oxidase based biosensors, it is necessary to determine if 
changes in the oxygen level of brain will affect the sensitivity of the sensor. Oxygen in 
the ECF is usually maintained at ~ 50 µM (Zimmerman & Wightman, 1991), with a 
drop below ~ 30 µM likely to lead to cell death. At atmospheric conditions, that all 
experiments have been carried out at so far, the PBS that the electrodes reside in will 
maintain an oxygen level of ~ 240 µM (Foster et al., 1993).  
The results of the oxygen dependence experiments are detailed in the following 
sections. The quantity of data involved in the graphs to follow is huge (~7000 points) 
and therefore will only be graphically represented.  
6.9.1 Oxygen Dependence at 10 µM ᴅ-serine 
The first concentration of ᴅ-ser to be examined was 10 µM, slightly above the accepted 
level in vivo. It would be unlikely under normal circumstances for levels in the ECF to 
exceed this level, unless a specific drug treatment or a direct local injection of ᴅ-ser 
were utilised to bring it about. Thus oxygen dependency at this concentration is very 
important. The results of the experiments carried out in the presence of 10 µM ᴅ-ser are 
displayed in Figure 6-25: 
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Figure 6-25 
The oxygen dependence of the biosensor in the presence of 10 µM ᴅ-ser. A & B: the raw data recorded 
for two sets of biosensors as the oxygen level was first decreased (blue trace) and then increased 
(red trace) with the accompanying M-M curve for the two sets of data in each case (black curve). C: 
the data from all four traces was combined. The mean ± SEM are plotted in purple and orange 
respectively. The black line is the smoothed trace for all points. The blue curve is the M-M fit for this 
smoothed trace. 
In Figure 6-25, graphs A and B are the raw data traces for two different sets of 
biosensors. Each trace is the mean of the data from the three biosensors used in that 
experiment. The blue trace is the data collected as the oxygen concentration was 
decreased by removing the air source and bubbling N2 through the PBS. Once the 
reading on the oxygen and ᴅ-ser sensors had reached a plateau, and remained there 
stable for 1 minute, the N2 was removed and air was bubbled into the cell again. This 
process lead to the production of the red trace as the dissolved O2 levels increased 
towards 240 µM again. It is very clear that during the time at near zero dissolved O2 that 
ᴅ-ser was still finding its way into the active site of the enzyme and that decreased 
activity, caused by the lack of oxygen, was leading to a build up of substrate within the 
enzyme molecules. This is evidenced in the very large increase in current as air is again 
pumped into the cell. The red trace shows a large spike and overshoots the maximum 
current by some considerable amount. In A the current reaches 126% of Jmax, and in B 
the values reaches 149% of the maximum current. These bursts of activity are short 
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lived however, as the time taken to reach 50 µM from the zero point is approximately 
18 and 20 seconds for A and B respectively. At this point the currents have returned to 
the Jmax value again.  
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Figure 6-26 
A detailed view of the oxygen dependence of the biosensor in the presence of    µM ᴅ-ser. The mean 
± SEM are plotted in purple and orange respectively. The black line is the smoothed trace for all 
points. The blue curve is the M-M fit for this smoothed trace. The blue arrow indicates the calculated 
KM(O2). 
A closer examination of the behaviour of the biosensors in the lower oxygen level 
environment is afforded in Figure 6-26. The black trace is obtained with an in built 
smoothing function in Prism, the analysis and graphing software, where each point is 
smoothed with 30 neighbours on either side using a sixth degree polynomial. This is the 
most complex smoothing feature offered by the programme. This smoothed data, and 
even the raw means (in purple) show that the response of the biosensor is well above 
90% of Jmax levels. Indeed, the response has not reached 100% of Jmax when the O2 level 
reaches 60 µM, therefore the variance in the signal between 30 and 50 µM O2 is 
minimal. The accepted level of response for oxygen independence to be declared is 80% 
of Jmax. Achieving this by 5 µM O2 demonstrates that the biosensor is oxygen 
independent for 10 µM of ᴅ-ser. 
The blue trace is a Michaelis-Menten Kinetic fit for the smoothed function of the data. 
Only an M-M fit was considered as the oxygen interaction occurs at a single site and 
does not produce cooperativity (it was not possible for Prism to fit a M-M-H curve to 
the data in some cases). The Jmax of the fit was found to be 96.79 ± 0.19 % of the value 
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calculated for the individual raw traces in Figure 6-25, due most likely to the smoothing 
process, where the effect of outliers is reduced, and the limited fall off in current 
observed as the dissolved O2 approached 0 µM lead to an R
2
 value of 0.2425. The 
KM(O2) was found to be 0.502 ± 0.025 µM O2 (indicated by the blue arrow).  
6.9.2 Oxygen Dependence at 20 µM ᴅ-serine 
At approximately three times the proposed in vivo concentration of ᴅ-ser, 20 µM would 
be a stringent test of whether the biosensor design would be useful and successful in an 
in vivo environment. The raw traces in A and B of Figure 6-27 are quite similar to those 
observed for 10 µM of ᴅ-ser. As the dissolved O2 levels increase from their zero level 
(red trace) there again is a large spike observed as the enzyme units all become active as 
the oxygen rapidly diffuses through the solution and into the active sites. In this instance 
for A the spike reaches a maximum value of 153% of the Jmax value approximately 5 
seconds after the air supply is re-established. The spike lasts for approximately 17 
seconds and returns to the level of the Jmax as the dissolved O2 content reaches 55 µM. 
For B, the maximum J reached is 187% of the maximum value of the kinetic fit. This 
occurred 6 seconds after the reintroduction of air to the solution, and the spike lasted a 
total of 18 seconds before returning to the Jmax value as the dissolved O2 concentration 
was approximately 60 µM. 
In Figure 6-28 it can be seen that for 20 µM ᴅ-ser, similar to 10 µM, the recorded 
currents are over 90% of Jmax when the O2 concentration is 30 µM, and has not yet 
reached the Jmax value by 60 µM O2. Thus once again there is little change in the signal 
when the O2 concentration is varied between 30 and 50 µM. Oxygen independence, at 
least 80% of the Jmax, is achieved at just above 20 µM oxygen. The M-M fit of the 
smoothed data has a Jmax corresponding to 100.2 ± 0.20% of the individual calibrations. 
There is an associated KM(O2) of 1.460 ± 0.047 µM and an R
2
 value of 0.5646. 
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Figure 6-27 
The oxygen dependence of the biosensor in the presence of 20 µM ᴅ-ser. A & B: the raw data recorded 
for two sets of biosensors. C: the data from all four traces combined.  
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Figure 6-28 
A detailed view of the oxygen dependence of the biosensor in the presence of 2  µM ᴅ-ser.  
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6.9.3 Oxygen Dependence at 50 µM ᴅ-serine 
The testing of oxygen dependence at 50 µM ᴅ-ser, 10 times the proposed physiological 
concentration was the third concentration of ᴅ-ser used to elucidate the characteristics of 
the biosensors. The results are displayed below in Figure 6-29: 
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Figure 6-29 
The oxygen dependence of the biosensor in the presence of 50 µM ᴅ-ser. A & B: the raw data recorded 
for two sets of biosensors. C: the data from all four traces combined.  
Once again, this time with 50 µM ᴅ-serine, it is possible to see the large overshoot of 
the currents recorded during the increasing oxygen levels phase of the experiment (red 
traces in Figure 6-29, parts A and B). For calibration A the current reaches in excess of 
195% of the maximum current calculated by the kinetic fit (black curve). This occurs 
after 8 seconds after the air supply has been reinstated. The period of increased activity 
lasts for 23 seconds overall and the signal returns to the Jmax as the dissolved oxygen 
content passes 75 µM. In the case of calibration B the overshoot peaks at 205% after 10 
seconds. The increased activity period lasts 22 seconds in total and the J returns to the 
maximum level as the concentration of O2 in solution passes 75 µM. 
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Figure 6-30 
A detailed view of the oxygen dependence of the biosensor in the presence of 5  µM ᴅ-ser. 
The M-M kinetic fit curve (blue trace in Figure 6-30), modelled on the black trace of 
smoothed data, has a Jmax equivalent to 104.2 ± 0.3% of that calculated for the raw data 
in A and B. The KM(O2) of 3.804 ± 0.103 µM (blue arrow) is larger than that of the 20 
µM ᴅ-ser calibration, and the R2 value of 0.7797 shows a much closer fit to M-M 
kinetics. This is due to the steeper decrease in the recorded signal at lower O2 levels. 
Once again it is satisfactory to see that the response has reached at least 90% of Jmax at 
30 µM O2, and that the variance between 30 and 50 µM is minimal with the response 
still not reaching Jmax by 60 µM O2. The minimum acceptable level of signal response, 
80%, is reached when the dissolved oxygen concentration is approximately 20 µM. 
6.9.4 Oxygen Dependence at 100 µM ᴅ-serine 
To complete the set of oxygen dependence calibrations a concentration of 100 µM ᴅ-ser 
was studied. This concentration is far in excess of any likely to be seen in vivo even 
with significant external manipulation. The results are presented below in Figure 6-31: 
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Figure 6-31 
The oxygen dependence of the biosensor in the presence of 100 µM ᴅ-ser. A & B: the raw data 
recorded for two sets of biosensors. C: the data from all four traces combined.  
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Figure 6-32 
A detailed view of the oxygen dependence of the biosensor in the presence of     µM ᴅ-ser. 
As with the three other concentrations of ᴅ-ser utilised in this study, there is a large 
overshoot in the J values as oxygen is resupplied to the system (red traces in A and B, 
Figure 6-31) for 100 µM ᴅ-ser. In experiment A the period of higher activity peaks at 
176% of the Jmax after 11 seconds. The period of activity lasts in total 27 seconds before 
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returning the Jmax value at approximately 90 µM O2. A peak J that is 180% of the Jmax is 
attained for calibration B after 10 seconds. The overshoot in current lasts for a total of 
22 seconds and returns to the Jmax when the dissolved oxygen content reaches 80 µM. 
In Figure 6-32 it can be seen that the kinetic curve (blue trace) and the mean values 
(purple) and the smoothed values (black trace) all reach the 80% of Jmax mark between 
30 and 32 µM dissolved oxygen content. At 50 µM O2 the J value is still less than 90% 
of the maximum and is only just reaching 90% as the oxygen content increases to 60 
µM. While this is on the limit of being called oxygen independent it is still satisfactory 
to observe that the variance in the signal size is less than 10% over the physiological 
range. This again is a more than satisfactory result - it would only be in very rare 
circumstances that the physiological concentration of ᴅ-ser could reach 100 µM, such as 
severe manipulation by external forces or drugs. The M-M curve fitted to the data has 
an R
2
 value of 0.9015, a Jmax of 102.3 ± 0.3% of the individually fitted Jmax values, and a 
KM(O2) of 8.141 ± 0.166 µM O2 (indicated by the blue arrow). 
6.10 In Vitro Characterisation – Other Parameters 
6.10.1 Limit of Detection 
A very important characteristic for any sensor is its limit of detection (LOD). This value 
is the minimum concentration of a particular substrate that the sensor can be said to 
reliably detect. The main factor influencing the baseline or background signal and the 
quantity of noise associated with it. Thus the LOD is calculated as three times the 
standard deviation (SD) of the baseline values. Below this value the signal is 
determined to be compromised or unreliable due to the noise inherent in any detection 
system, and any changes smaller than this cannot be attributed to a change in the analyte 
levels. Thus the baseline data for the 52 biosensors used in 6.4.4, to calculate the final 
sensitivity, were analysed to determine the LOD. These sensors had a mean baseline of 
0.102 µA.cm
-2
, with a SD of ± 0.007 µA.cm
-2
. The sensitivity of these sensors was 
calculated as 16.47 ± 0.18 µA.cm
-2
.mM
-1
. Thus the SD converts to a concentration of 
4.250 ± 0.047 x 10
-4
 mM. The limit of detection of these biosensors is thus 0.425 ± 
0.005 µM. 
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6.10.2 Response Time 
During the in vitro experiments, measurements were taken under quiescent conditions 
to eliminate the effect of convection from the calculation of the system kinetics, see 
Section 2.3. However, to determine response time in a 20 mL cell it is not possible to 
rely solely on diffusion of substrate through the media, a small amount of convection 
must be introduced to ensure an even and quick distribution. Thus, to determine the 
response time of the biosensor it was necessary to conduct an experiment where there 
was constant stirring of the solution in the cell during the calibration procedure, at ~ 1 
Hz. The response time of the biosensors is determined from this calibration. While this 
convection is not representative of the in vivo environment, where there will be no flow 
effect, it is the best compromise for this situation. The response time is calculated as the 
time taken for the signal to reach 90% of the new level subsequent to an alteration of the 
concentration. The start point is the time point where the first changes in current are 
noticed. An example of the analysis parameters are illustrated in Figure 6-33.  
 
Figure 6-33 
The raw data trace for the response of E2 as   µL of     mM ᴅ-ser solution was injected into the cell 
to bring the overall concentration from 50 up to 60 µM. Each point corresponds to 0.25 seconds. 
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 [ᴅ-serine] 5 - 10 µM 10 - 20 µM 
Electrode E1 E2 E3 E4 E1 E2 E3 E4 
Original Baseline, nA 0.784 0.956 0.502 0.421 0.896 1.008 0.610 0.476 
New Baseline, nA 0.877 1.016 0.601 0.476 1.076 1.116 0.801 0.578 
Difference, nA 0.093 0.060 0.099 0.055 0.181 0.108 0.191 0.102 
90% of Difference, nA 0.084 0.054 0.089 0.049 0.163 0.097 0.172 0.092 
90% Threshold, nA 0.868 1.010 0.591 0.470 1.058 1.105 0.782 0.568 
Time Taken, s 9.125 8.500 9.125 10.500 1.375 3.875 5.750 7.750 
[ᴅ-serine] 20 - 40 µM 40 - 50 µM 
Electrode E1 E2 E3 E4 E1 E2 E3 E4 
Original Baseline, nA 1.091 1.131 0.807 0.582 1.446 1.377 1.275 0.804 
New Baseline, nA 1.447 1.362 1.245 0.802 1.645 1.503 1.480 0.921 
Difference, nA 0.355 0.230 0.438 0.221 0.199 0.125 0.205 0.117 
90% of Difference, nA 0.320 0.207 0.394 0.198 0.179 0.113 0.184 0.105 
90% Threshold, nA 1.411 1.339 1.201 0.780 1.625 1.490 1.459 0.909 
Time Taken, s 5.125 9.500 1.375 5.125 9.000 7.750 0.750 5.500 
[ᴅ-serine] 50 - 60 µM 60 - 100 µM 
Electrode E1 E2 E3 E4 E1 E2 E3 E4 
Original Baseline, nA 1.773 1.562 1.462 0.932 1.849 1.775 1.690 1.035 
New Baseline, nA 1.995 1.675 1.728 1.035 2.525 2.198 2.487 1.446 
Difference, nA 0.222 0.113 0.266 0.103 0.676 0.423 0.796 0.411 
90% of Difference, nA 0.200 0.102 0.239 0.092 0.608 0.380 0.717 0.370 
90% Threshold, nA 1.973 1.664 1.701 1.025 2.457 2.155 2.407 1.405 
Time Taken, s 10.250 5.875 11.250 1.000 1.500 1.250 10.500 1.125 
Table 6-22 
Data collected for the determination of the response time of the biosensor. 
The red line indicates the mean level of the signal for 50 µM ᴅ-ser. This was calculated 
as the mean of 20 seconds of recorded data previous to the point of injection. The 
yellow line indicates the new level which was recorded after the injection had occurred; 
again this was taken as the mean of 20 second period 30 seconds after the injection had 
taken place. The green line is the 90% threshold the current had to cross to be 
considered the end point of the response time. The vertical black line is the time-point 
where the injection occurred and the current began to climb above the previous baseline. 
The time between the black line and where the trace crosses the green line was 
calculated as the response time. 
This analysis was performed on all four electrodes used in the calibration for 6 different 
concentration changes. The changes used were the in the range 5 to 100 µM, chosen to 
reflect the range where changes might be expected to occur during in vivo 
experimentation. The data collected during this analysis is recorded in Table 6-22. From 
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this data the mean, standard deviation and standard error of mean were calculated. The 
mean ± SEM was found to be 5.95 ± 0.75 s with an SD of ± 3.66 s (n = 24).  
6.11 Conclusions 
With the perceived need to improve the currents being detected, as opposed to the 
sensitivity as described by the J value, a new approach was considered.  This involved 
firstly the alteration of the electrode surface to a 0.5 mm cylinder from the original disk, 
and secondly the exchange of the styrene for MMA as an immobilisation matrix. The 
new cylinder surface produced a marked increase in the currents being achieved at the 
proposed physiological levels. With MMA used in a two application process the 
sensitivity, as a function of surface area, was also improved four-fold.  
Together these results were chosen as the best path forward for the biosensor protocol. 
The sensitivity of PtC-{MMA-[600UPBSx5-GA1.0%]x2}x2 is 45.14 ± 0.90 µA.cm
-
2
.mM
-1
, as compared to PtD-Sty-[600UPBSx5-GA1.0%]x2 and PtD-Sty-[600UPBSx5-
FAD0.08-GA1.0%]x2 which have sensitivities of 35.41 ± 1.19 µA.cm
-2
.mM
-1
 and 64.61 
± 1.63 µA.cm
-2
.mM
-1 
respectively. This is especially impressive considering that the 
cylinder protocol had roughly 16 times the surface area of the disk electrodes. With this 
in mind, the reintroduction of FAD to the cylinder protocol was examined. However, it 
was found in this instance that the new formulation did not accept FAD very well and 
the sensitivities were significantly reduced. Thus it appeared that the best recipe had 
been discovered in PtC-{MMA-[600UPBSx5-GA1.0%]x2}x2. 
With this in mind a quick stability trial was performed. It was found that there was a 
significant loss of sensitivity over 5 days which was considered unacceptable. A 
solution was found in the application of a further layer of MMA which served to 
encapsulate and stabilise the substances already on the surface. This alternative, PtC-
{MMA-[600UPBSx5-GA1.0%]x2}x2-MMA provided a significantly better retention of 
sensitivity, and was selected as the best design to be used as long as interference 
rejection layers could successfully be incorporated within it. It has a sensitivity of 53.33 
± 2.47 µA.cm
-2
.mM
-1
. 
The selection of the interference layer offered two possibilities. A P-o-PD layer, grown 
by CPA (PPD) which would block out the majority of interference and slightly decrease 
the sensitivity to 38.22 ± 1.99 µA.cm
-2
.mM
-1
, or a combination of PPD with 5 layers of 
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Naf applied before it which completely blocked out AA interference but significantly 
reduced the sensitivity further to only 16.47 ± 0.18 µA.cm
-2
.mM
-1
. In the context of the 
small currents that would be attainable in vivo the consensus was that a greater degree 
of interference rejection would provide the best overall solution. Thus, the Naf-PPD 
combination was chosen, yielding a final biosensor protocol of PtC-Naf-PPD-{MMA-
[600UPBSx5-GA1.0%]x2}x2. 
Thus, the in vitro characterisation of the final biosensor design began. Firstly the 
stability was tested over a short period of time and with repeated calibrations. This 
provided a reference for the effects of repeated calibration, as opposed to time or 
treatment effects, for the remainder of the characterisation. The protocol was also tested 
for stability over multiple calibrations over a long period of time. It was found that 
repeated calibration could reduce sensitivity by between 40 and 45% over 4 to 6 
calibrations in a short space of time and by up to 80% with repeated calibration over a 
long period of time. It appears that a major factor affecting this loss is the heating, 
cooling, wetting and drying processes that take place when the sensors are put into and 
out of storage. Single calibrations over an extended period of time also alluded to the 
effect time had on the sensors. This is possibly due to the continuing slow interaction of 
the molecule layers in the biosensor, which alters the composition or bonding between 
the substances present. 
Bio-compatibility studies illustrated that the biosensors are affected to a greater degree 
by protein (BSA) than lipid (PEA) treatments. Unusually a low level of BSA, 1%, 
degraded the sensitivity further than a 10% BSA treatment, but this had been seen 
previously for the characterisation of an earlier ᴅ-ser biosensor design and is thus an 
expected result. Exposure to a brain tissue sample elicited drastic changes in the 
sensitivity, reducing it by 50% after one day when the repeated calibration effect was 
taken out. The effects noticed in these studies are possibly far greater than those that 
would be experienced in an in vivo environment and the constant flux of the sensors in 
and out of the respective solutions and tissue samples could expose the biosensing 
membrane to far greater damage than if it was only inserted once and then remained 
stationary.  
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Temperature and pH changes also produced some effect on the biosensor sensitivity. 
But it was no more than is to be expected following the repeated calibration procedures 
and the effect that both of these elements have on the functioning of an enzyme. 
When tested for sensitivity towards other amino acids it is found that there is no 
significant sensitivity towards any of the ʟ-amino acids or glycine. Some ᴅ-amino acids 
were detected while others were not. ᴅ-ser, ᴅ-ala and ᴅ-phe were all detected to the 
same degree, while the biosensor was twice as sensitive to ᴅ-pro as it was to the later 
three. When calibrated individually the biosensor was twice as sensitive to ᴅ-ala as it 
was to ᴅ-ser, but this is in-line with reported kinetic rates and affinities. As with the 
initial interference testing for AA, the design was found to be equally unresponsive to 
the 11 other common electroactive species. 
The final, and vitally important, characteristic explored is the oxygen independence of 
the protocol. It is found that the design is oxygen independent up to a concentration of 
100 µM ᴅ-ser. Subsequent to this satisfactory result, the limit of detection was 
determined to be 0.425 ± 0.005 µM and the biosensor has a response time of 5.95 ± 0.75 
s. This biosensor was ultimately decided to be fit for chronic in vivo utilisation. 
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7.1 Introduction 
The overall aim of this thesis was to produce a ᴅ-amino acid oxidase based biosensor 
capable of detecting ᴅ-serine, and the changes in its concentration, in the mammalian 
brain. Having completed the in vitro development and characterisation of such a 
biosensor, and being satisfied with the results, it was deemed necessary to perform a 
preliminary investigation of the performance of the biosensor in vivo. Without this it is 
not possible to quantify the success of the biosensor design as physiological 
circumstances are uniquely challenging.  
Previously Pernot et al. had demonstrated the performance of their ᴅ-ser biosensor in 
the frontal cortex of a rat (strain unknown) (Pernot et al., 2008). However, the rat was 
anaesthetised with a ketamine/xylazine mixture during the procedure. It is known that 
ketamine acts on the NMDA receptor (Hirota & Lambert, 1996), and hence influences 
the glutamatergic system, as well as influencing NO synthesis (Aroni et al., 2009). Both 
of these systems are highly implicated in the regulation of ᴅ-ser levels physiologically, 
see Section 1.4. Their work demonstrated an increasing level of ᴅ-ser in the brain over 3 
hours, following an intraperitoneal (i.p.) injection of 1 g ᴅ-ser/kg body weight. 
Zain has also demonstrated the functioning of a ᴅAAO biosensor in the striatum of 
Sprague-Dawley rats (Zain et al., 2010). The rats were also anaesthetised, this time with 
a chloralose/ethyl carbamate mixture. It was found possible to demonstrate a brief 
response, about three seconds, to a high concentration, 5 µL of a 100 mM solution, of ᴅ-
ser. The ᴅ-ser was delivered by microinjection beside the implanted biosensor. It was 
discovered that there appeared to be a highly effective uptake system removing the 
injected ᴅ-ser, as the signal dropped back below baseline in less than 1 second, and a 
high concentration of ᴅ-ser was required to elicit a response. 
With both of these studies demonstrating results obtained under anaesthetic, it was 
decided to try to obtain results from an awake and freely moving animal. To do this two 
different devices would need to be implanted into a subject; a microdialysis probe, for 
the delivery of substances into the brain, and the ᴅAAO biosensor, to monitor any 
changes that were elicited. The results are all taken from one animal, where a biosensor 
was co-implanted into the right striatum with a microdialysis probe and a second 
biosensor implanted into the left striatum. This was due to time constraints on further 
experimentation, and that this study was meant to be only a preliminary investigation 
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into the correct functioning of the final biosensor design. The striatum was chosen as it 
is a large, and surgically easy to find, area of the cerebrum which forms part of the basal 
ganglia in the subcortical region of the telencephalon (see Section 1.1). 
7.2 aCSF Perfusion 
The first effect to be studied was the effect that an aCSF perfusion would have on the 
response of the biosensors as this would be the vehicle for all other perfused substances. 
Thus it was administered into the right striatum of the subject and the response 
monitored on the biosensor in the right and left striatum.  
n = 6 Mean ± S.D. ± S.E.M. 
Initial Baseline Current (I, nA) 0.851 0.473 0.193 
Maximum/Minimum Current (I, nA) 0.609 0.340 0.139 
Time to max/min Current (hrs) 00:54:43 00:19:21 00:07:54 
 Overall Current Change (I, nA) -0.242 0.145 0.059 
% Current change from Baseline -28.1 5.9 2.4 
Post Baseline (I, nA) 0.752 0.440 0.180 
Time to Post Baseline (end perfusion) (hrs) 01:16:10 00:23:17 00:09:30 
Post Baseline % Change -12.1 9.2 3.8 
Table 7-1 
Data collected from perfusions of aCSF into the right striatum of a rat 
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Figure 7-1 
An aCSF perfusion from day 14 of the experiment period. The red arrows indicate the start and end of 
the perfusion. The blue line is the trace from the electrode in the right striatum next to the 
microdialysis probe, the green trace is the biosensor is the left striatum. 
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7.3 Serine Perfusions 
Having established how the vehicle affected the signal, it was possible to examine using 
both stereoisomers of serine in the perfusate. It was hoped that different concentrations 
of ᴅ-ser would elicit different quantities of change in the signal with some producing 
decreases in the signal and others increases. It was also necessary to look at the effect ʟ-
ser would have on the current. It would be hoped that there would be a similar response 
as that elicited for aCSF, as ʟ-ser is not a substrate for ᴅAAO and does not inhibit its 
function (Figure 6-21)(Pollegioni et al., 2007). Taken together these results would be 
verifiable evidence that the sensor was functioning as intended. 
7.3.1 ᴅ-serine perfusions 
Thus a range of ᴅ-serine concentrations were chosen in the hope of returning a range of 
responses. This began at 10 µM and increased up to 1000 µM. The same protocol was 
followed as with aCSF perfusions. 
7.3.1.1 10 µM ᴅ-serine 
ᴅ-ser perfusions began with a 10 µM concentration of ᴅ-ser made up in an aCSF 
solution. The perfusion was performed in the same manner as before. However a 
problem did occur during the experiment. In order to keep the subject calm and relaxed 
human presences were avoided, as much as possible, within the experimental room 
while perfusions were in progress. To this end, and bearing in mind that the aCSF 
perfusions took, on average, nearly 55 minutes to reach a baseline, after an initial 5 
minute observation period the subject was left alone until the 40
th
 minute. At this time it 
was found that the perfusion tube had come away from the probe inlet.  
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Figure 7-2 
Perfusion of ᴅ-ser. 
Examination of the data, presented in Figure 7-2, clearly displays the occurrence of this 
after approximately 15 minutes after the commencement of the experiment (first red 
arrow). Following this, the recorded signal (blue trace) for the biosensor next to the 
probe, begins to increase again. This continues until the tubing is re-attached in the 50
th
 
minute, second red arrow) whereby the current then returns to a decreasing trend. After 
a baseline is reached the perfusion is stopped, the third red arrow, and the signal is 
allowed to find its new baseline. 
Taking account of the break in the perfusion the results overall are as follows: it took 
46:40 minutes to reach the perfusion response level, the current decreasing from 0.414 
nA to 0.295 nA, a decrease of 0.119 nA or 28.8% less than the pre-perfusion level. It 
took 1:12:20 hours for the current to return to a stable level after the perfusion was 
ended. The current at this point was 0.388 nA, 6.4% below the pre-perfusion level. 
7.3.1.2 20 µM ᴅ-serine 
A perfusion of 20 µM ᴅ-ser yielded similar results to the 10 µM perfusion.  
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Figure 7-3 
Perfusion of ᴅ-ser. 
The pre-perfusion current was 0.415 nA. After 40:15 minutes the current reached its 
stable in-perfusion level of 0.310 nA. This was 0.105 nA or 25.4 % below the pre-
perfusion level. Following the ending of the perfusion it took 1:22:10 hours for the 
signal to reach a stable post-perfusion level of 0.465. This was 12.0% higher than the 
pre-perfusion level. 
It is interesting to note that against the background of the response to the perfusion 
some global signal changes on both sensors are visible. At approximately the 80, 90 and 
120 minute marks in Figure 7-3 it is possible to see three different and similar, in time, 
size and shape, current changes. Unfortunately there are no records of any physical 
activity or any other occurrences at those times. It does, however, illustrate that the 
biosensors are detecting the chemical changes occurring within the in vivo environment, 
with the local effect of the perfusions and global changes both detectable. 
7.3.1.3 100 µM ᴅ-serine 
Having failed to illicit an increase in current for either 10 or 20 µM ᴅ-ser, both of which 
are more concentrated than the proposed in vivo levels, it was decided to increase the 
perfusate concentration to 100 µM ᴅ-ser in the hope of producing a higher response. 
Unfortunately, as can be seen in Figure 7-4, this response failed to materialise. Instead, 
from a pre-perfusion value of 0.447 nA, the current decreased to 0.340 nA after 42:25 
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minutes. This represented a decrease in current of 23.9%, or 0.107 nA, from the pre-
perfusion level.  
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Figure 7-4 
Perfusion of ᴅ-ser. 
From when the perfusion was ceased it took 2:00:00 hours for the current to reach a 
new stable post-perfusion level of 0.448 nA, an increase of 0.2% over the original pre-
perfusion response. It is interesting to note the depression of the signal in the left 
hemisphere (green trace). This could be a global response to the sudden influx of large 
quantities of ᴅ-ser, where the systems in the brain are trying to remove excess quantities 
of ᴅ-ser. This in turn has depressed the levels in areas away from the microdialysis 
probe. Several hours after the perfusion has ended it is seen that the responses stabilise, 
to approximately their original values.  
7.3.1.4 1000 µM ᴅ-serine 
In a final attempt to produce an increase in the signal a very concentrated perfusate 
solution of 1000 µM ᴅ-ser was used. Based on previous results there was little 
confidence that this would result in any significant difference from the responses to ᴅ-
ser perfusions carried out previously. Indeed, observation of the results obtained, see 
Figure 7-5, shows that result was very similar to those already achieved. Per-perfusion 
the current was 0.435 nA. After 49:40 minutes of perfusion it reached a stable in-
perfusion level of 0.341 nA, 0.094 nA or 21.6% below the pre-perfusion value.  
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Figure 7-5 
Perfusion of ᴅ-ser. 
Once the perfusion was stopped the current rose for 43:20 minutes to a new post-
perfusion baseline of 0.513 nA, this was 18.1% above the pre-perfusion level. As seen 
with the 100 µM perfusion, the 1000 µM perfusion appears to produce some sort of a 
global response, where the biosensor in the left hemisphere also experiences a decrease 
in current. Post-perfusion, both biosensors register increases in current above the pre-
perfusion baseline level for several hours. 
7.3.1.5 ᴅ-serine Perfusions Conclusions 
Overall the ᴅ-ser perfusions have not produced the desired results to confirm that the 
biosensor is functioning correctly. It is possible however to observe some interesting 
global and local changes that indicate that the biosensors are indeed detecting ᴅ-ser. 
However, the complex system, outlined in Section 1.6, which is responsible for the ᴅ-
ser concentration in the ECF, appears to be very efficient at removing excess quantities 
of the amino acid and at keeping the concentration constant to prevent any 
excitotoxicity  occurring (Shleper et al., 2005). In order to produce categorically 
different responses, by perfusion, it was decided to look at interrupting these 
endogenous processes.  
This is not an unprecedented situation as similar observations were made during the 
characterisation of a glutamate biosensor by other members of our group (data currently 
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unpublished), where perfusion of various concentrations of glutamate continually 
resulted in a decreased response. Indeed, increases in current were only achieved by the 
introduction of uptake blockers in combination with stimulated release. Considering that 
glutamate and ᴅ-ser are inextricably linked parts of the same neurotransmission system 
(Schell et al., 1995) it could be expected that they would both be regulated in a similarly 
strict manner.   
Further evidence for this tightly regulated system is evident from the in vivo work 
carried out with a ᴅ-ser biosensor previously (Zain et al., 2010). Here it was 
demonstrated that an increase of only about 0.020 nA, and lasting only 2 or 3 s, was 
achievable using a 5 µL microinjection of 100 mM ᴅ-ser. This concentration is two 
orders of magnitude higher than any used during this perfusion study. Following this 
increase a decrease of similar magnitude for less than 1 s was also noted as the removal 
systems over-compensated for a brief period. 
7.3.2 ʟ-serine perfusion 
As a further clarification of the functioning of the biosensor it was necessary to show 
that it did not respond increased levels of an ʟ-amino acid. ʟ-ser was chosen, which is a 
known precursor to ᴅ-ser in combination with serine racemase (Wolosker et al., 1999). 
However, an increase in production of ᴅ-ser would only be found if the serine racemase 
mechanism was activated. Since no stimuli for this system are being provided there 
should be no issue with a perfusion of ʟ-ser resulting in an increase in ᴅ-ser 
concentration. 
When the 1000 µM perfusion of ʟ-ser was conducted, see Figure 7-6, it was, as 
expected, found that there was no increase in the ᴅ-ser concentration, this is in 
agreement with Figure 6-21. Indeed the biosensor response to the perfusion was similar 
to that expected from an aCSF perfusion, the vehicle in all the perfusions. The pre-
perfusion current was 0.459 nA. After 27:50 minutes of perfusion the current reached a 
new in-perfusion level of 0.352 nA. This was 0.107 nA or 23.3% below the pre-
perfusion response. Once the perfusion was stopped it took 28:00 minutes for the signal 
to reach its post-perfusion level of 0.457 nA, just 0.4% below the pre-perfusion level. 
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Figure 7-6 
A perfusion of ʟ-ser. 
It is clear that the response for the ʟ-ser perfusion is very similar to that for either the 
aCSF or ᴅ-ser perfusions. The only major difference is the short time taken for the in-
perfusion and post perfusion levels to be reached. Less than half an hour was required in 
both cases, as opposed to between 45 minutes and 1 hour 20 minutes for the previously 
mentioned experiments. 
7.4 Veratridine Perfusion 
When it was realised that it was necessary to stimulate the endogenous release and 
production or block the clearance systems in order to witness a positive change in the 
current an exploration of work conducted by others began. A chemical which 
immediately provoked interest was Veratridine. A voltage-dependant sodium channel 
activator (Catterall, 1975; Catterall & Coppersmith, 1981; Romei et al., 2011), it keeps 
these channels open for a long time (Bönisch et al., 1983), actively preventing 
inactivation. This has the potential to cause neurotoxicity, and has been shown to cause 
cell death (Jordan et al., 2000; Koike & Ninomiya, 2000; Koike et al., 2000) through 
overstimulation of the second intra-membrane receptor site, and is thus classed as very 
toxic. It has, however, been shown to have a beneficial property in staving off cell death 
by apoptosis (Tanaka & Koike, 1997). More importantly to our purposes it has been 
shown to evoke the release of ᴅ-serine and glucose (Lowry et al., 1998; Rosenberg et 
al., 2010). Interestingly, it has also been reported that a 200 µM perfusion of 
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Veratridine has also been shown to lower the concentration of ᴅ-ser (Hashimoto et al., 
2000). For the experiments carried out 100 µM Veratridine in aCSF was utilised, the 
same concentration as used in the Rosenberg et al. ᴅ-serine study, and twice that used in 
the Lowry et al. glucose study. The first result obtained is shown below in Figure 7-7. 
Here two perfusions carried out in close proximity are shown. The rapid return to 
baseline after the first perfusion allowed the second to be undertaken, and the results 
mirror each other quite closely. 
Over the two perfusions the average decrease from the baseline was 25.4%, which 
occurred 27:55 ± 00:20 minutes after the start of the perfusion. Following cessation of 
the perfusion, the post-perfusion level was reached in 22:10 ± 05:00 minutes and was on 
average 2.2 ± 1.0% higher than the pre-perfusion level. Apart from the rapid return to a 
stable post-perfusion current the response is quite similar to that already demonstrated 
for the ᴅ-ser, ʟ-ser and aCSF perfusions. The rapid return to baseline levels could be 
indicative of an effect of the Veratridine; however the lack of evidence for an effect 
during the perfusion means it is not possible to draw any conclusions from this data. 
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Figure 7-7 
A perfusion of Veratridine. 
In an attempt to see if this possibility could be further clarified a more complex 
experiment was carried out. Using a liquid swivel, to switch between perfusion 
solutions, aCSF was perfused followed by Veratridine, before returning to an aCSF 
perfusion. The results are displayed in Figure 7-8. 
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While it is not conclusive this experiment does appear to offer some indication that the 
Veratridine is producing an increase in the signal. Initially with the perfusion of aCSF 
the current decreases by 24.6% over 01:19:15 hours. From the point where the 
Veratridine reaches the probe (first thick red arrow) until the point where the second 
perfusion of aCSF reaches the probe (second thick red arrow) the current increases by 
3.9% over 01:21:35 hours. This occurs after an initial decrease in the response as the 
Veratridine takes effect. With the commencement of the second perfusion of aCSF, the 
current proceeds to decrease by 2.7% from its Veratridine level to almost exactly the 
same level as for the first aCSF perfusion. However, these changes are minimal and 
larger more definite changes are required to say that an increase in the signal was 
produced. 
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Figure 7-8 
The compound perfusion sequence of aCSF, Veratridine and aCSF again. The first thin arrow indicates 
the start of the first aCSF perfusion. The second thin arrow indicates the switch-over to Veratridine, 
with the thicker arrow marking the point where the Veratridine would have reached the probe. The 
third thin arrow marks the switch-back to aCSF. The second thicker arrow marks the point where the 
solution would have filled the tubing and reaches the probe. The final thin arrow marks the end of the 
perfusion sequence. Thick arrows allow for the dead volume. 
7.5 Mg.ATP Perfusion 
Having failed to illicit any definitive, positive response from simple ᴅ-ser perfusions or 
the blanket stimulation approach of the glutamate pathway by Veratridine, the decision 
was taken to look at a more focus, ᴅ-ser specific approach. This meant looking at the 
mechanisms by which ᴅ-ser levels are regulated within the brain environment. While it 
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is capable of degrading ᴅ-ser, the distribution of ᴅAAO does not locally correspond to 
that of ᴅ-ser (Schell et al., 1995), and if any blockers of its action were utilised then the 
biosensor would also cease to function. There are also no transporters which are 
selective to ᴅ-ser only, instead there are a few low-affinity non-specific transporters 
thought to be involved in its re-uptake (Pollegioni & Sacchi, 2010). Thus action in this 
direction appeared to be a futile exercise. This left one major point in the proposed 
metabolic pathway of ᴅ-ser where action could be taken: the serine racemase (SR) 
pathway. It has been shown that SR distribution is similar to that of ᴅ-ser (Wolosker et 
al., 1999) and that it is inextricably linked to the levels of ᴅ-ser in the brain 
environment. There is substantive evidence (de Miranda et al., 2002; Strisovsky et al., 
2003; Foltyn et al., 2005) that both Mg
2+
 and ATP are physiological co-factors which 
activate SR and promote higher activity. A full discussion of all the above issues can be 
found in Sections 1.4 and 1.5. 
Thus in an attempt to promote the conversion of ʟ-ser to ᴅ-ser by SR an Mg.ATP 
complex was obtained. A 1000 µM solution of the Mg.ATP complex was formulated in 
aCSF for perfusion. Initially, two perfusions were conducted to ascertain the 
effectiveness of this type of treatment in an awake animal. The first was a short 
perfusion, lasting only 15 minutes. The second was a longer perfusion, continued until a 
stable response was achieved; this took 50 minutes to be confirmed. The results of both 
perfusions are displayed in Figure 7-9 A and B respectively. Both perfusions took place 
on the same day, and as can be seen from the time axes, the second perfusion began two 
and half hours after the ending of the first perfusion. 
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Figure 7-9 
A: A short perfusion lasting only 15 minutes of 1mM Mg.ATP. B: A 1 hour perfusion of Mg.ATP until a 
stable response was achieved. 
It is a satisfying result to see that initially the 15 minute perfusion of Mg.ATP produces 
an increase in the signal. By the end of the perfusion the signal has only increased 0.7% 
above the pre-perfusion level. Post-perfusion the signal continues to increase reaching a 
peak of 5.2% higher than the pre-perfusion current 21:20 minutes after the perfusion 
began and 6 minutes after it ended. The signal then decreases rapidly, finally settling at 
a post-perfusion response 47:20 minutes later that is 4.2% below the initial value. 
The second, longer perfusion depicts a different, but similar response. This time there is 
no increase above baseline, and the current reaches a stable in-perfusion level, that is 
7.1% below the initial value, after 40:00 minutes. However, similar to the short 
perfusion there is a period where, over the first 20 minutes, there is little change in the 
signal, with the current only 1.5% below the initial value. After this point the current 
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decreases more rapidly. The post-perfusion response is quite similar to the in-perfusion 
response, 6.8% below the pre-perfusion current 01:03:45 hours after the perfusion has 
ended. 
A possible explanation for the differences in the signals obtained is that for the first 
perfusion the SR mechanism initially responds positively, producing ᴅ-ser from ʟ-ser. 
Then after the initial 20 minute period where the levels increase, the brain finds a 
mechanism to either remove the excess ᴅ-ser or prevent it being produced, thereby 
protecting it from neurotoxic damage. This mechanism is evidenced also by the second 
perfusion where, for about a 20 minute period again, the signal does not change to any 
large degree, and then begins to decrease much more rapidly. The reason that an 
increase was not evident in the second perfusion is possibly that this protective system 
had already been primed and activated only two hours previously and thereby held the 
level of ᴅ-ser constant before beginning to decrease it again. It was also possible that a 
certain amount of the store of ʟ-ser had already been utilised and was not available to 
the same extent to be converted to ᴅ-ser. 
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Figure 7-10 
A 1 hour perfusion of  mM ʟ-ser and 1mM Mg.ATP. 
Taking stock of these results a further experiment was planned and conducted. This 
involved the perfusion of 1000 µM of ʟ-ser along with the 1000 µM of Mg.ATP for a 
period of 1 hour. It was hoped that this combination could further elucidate what was 
happening in the previous two experiments and confirm a signal increase. The perfusion 
is depicted in Figure 7-10. The results are similar to those experienced for the 1 hour 
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perfusion of 1 mM Mg.ATP. The signal reaches a minimum, during the perfusion, after 
58:45 minute which is 12.2% below the pre-perfusion level. Once the perfusion has 
ceased, it takes 35:15 minutes to reach a stable post-perfusion level which is 10.7% 
below the pre-perfusion current. However, within this there are two interesting features. 
Similar to the two Mg.ATP only perfusions there is an initial period where little change 
occurs. In this case, after 19:05 minutes the current has only decreased by 0.1%, after 
which point it decreases rapidly. There is also an initial increase in the current after the 
perfusion has ceased. This peaks after 05:40 minutes at a current that is only 4.9% 
below the pre-perfusion baseline.  
Given the similarities between the Mg.ATP and Mg.ATP & ʟ-ser perfusions over 1 
hour, it was decided to also conduct an Mg.ATP & ʟ-ser perfusion over 15 minutes to 
investigate if this would also produce similarities with the 15 minute Mg.ATP 
experiment.  
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Figure 7-11 
A  5 minute perfusion of  mM ʟ-ser and 1mM Mg.ATP. 
This experiment, depicted in Figure 7-11, did bear striking similarities with the previous 
experiment, Figure 7-9 A. Initially, during the perfusion the current increases by 1.7% 
after the 15 minutes have elapsed, then for 13:15 minutes after the end of the perfusion 
the current continues to increase up to a level 9.9% above the pre-perfusion baseline. 
The current eventually settles at a post-perfusion baseline 56:35 minutes after the end of 
the perfusion with a current that is 2.2% below the starting value. The addition of the ʟ-
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ser to the perfusate seems to have augmented the increases in current achieved both 
during and after the perfusion, as well as the length of time that the current increases 
for. It also appears to have retarded the decrease in current post-perfusion. This backs 
up the possibility that a lowering in the concentration of available ʟ-ser, during the first 
two Mg.ATP only perfusions, had an effect on the results. 
7.6 EDTA Perfusions 
A vital component in the SR pathway for the formation of ʟ- and ᴅ-ser, EDTA is 
responsible for the regulation of its α,β elimination process. This process is responsible 
for the conversion of ᴅ-ser to pyruvate and ammonia, which is a constant process that is 
fast enough to regulate ᴅ-ser levels in intact cells (Wolosker, 2011).  
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Figure 7-12 
A 1 mM EDTA perfusion. 
EDTA can act by complexing available Mg
2+
 and Ca
2+
, thereby reducing the activity of 
SR and stabilising the levels of ᴅ-ser by preventing its elimination. Thus it could be 
used to artificially increase the amounts of ᴅ-ser by decreasing the turnover rate and 
extending its lifetime. This method, while completely different to the action of 
Mg.ATP, which not only dramatically increases the production but also elimination of 
ᴅ-ser, is the other side of the mechanism of SR. 
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The perfusion of 1 mM EDTA, Figure 7-12, confirmed this mechanism and was 
reinforced by the similarities with the in vitro results obtained with transfected HEK 
293 cells (Foltyn et al., 2005). Initially during the perfusion there was an increase to 
approximately 6% above the pre-perfusion level, and then a decrease in the signal to 6% 
below the initial value. This was then followed by a period of sustained increase, 
whereby at the end of the hour-long perfusion the current had increased to an in-
perfusion level of 8.5% above the starting baseline. This increase continued for the 
almost 12 hours, whereby after 11:42:20 the post-perfusion current was 93.8% higher 
than the pre-perfusion level. The transfected cell study displayed an increase in ᴅ-ser 
concentration over 6 hours, the total length of time readings were taken for (Foltyn et 
al., 2005). 
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Figure 7-13 
A perfusion of  mM ᴅ-ser and 1mM EDTA. 
As an analogue to the ʟ-ser and Mg.ATP perfusion, and to investigate further the 
mechanism of ᴅ-ser regulation a 1 mM EDTA with 1 mM ᴅ-ser perfusion was also 
conducted, see Figure 7-13. Overall after the hour long perfusion there was a 30.9% 
decrease in the current from the pre-perfusion level. The post-perfusion baseline was 
attained 01:06:35 minutes after the end of the perfusion and the signal was 14.0% less 
than the initial value. What is significant about this is that the current decrease is larger 
than that for an aCSF or ᴅ-ser perfusion. This could indicate that, due to the large 
quantity of ᴅ-ser being perfused that the removal mechanisms have activated. But, now 
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with the EDTA complexing available Mg
2+
 and Ca
2+
 there is also no ᴅ-ser being 
produced in the astrocytes, further reducing the in vivo concentration. 
7.7 NO Perfusion 
A further mechanism which is proposed to regulate the action of SR is a feedback 
control instigated by NMDAr’s. The activation NMDAr’s in turn activates neuronal 
nitric oxide synthase (Kuriyama & Ohkuma, 1995; Dawson & Dawson, 1996). This 
post-synaptic NO feeds back into pre-synaptic cells where it S-nitrosylates SR, 
inactivating it, and thereby decreases the concentration of ᴅ-ser (Mustafa et al., 2007). 
This correlates with data suggesting that presence NO and ᴅ-ser regulate the activity of 
SR (Shoji et al., 2006b, a)  NMDAr activation also promotes translocation of SR to 
dendritic membranes which leads to prolonged inhibition of SR, however, this 
mechanism is not mediated by the associated production of NO (Balan et al., 2009). 
To determine if NO could have any effect on the ᴅ-ser signal produced by the biosensor 
it was decided to perfuse a high concentration of NO. Despite the possible danger posed 
by this, as NO is a highly reactive free radical liable to cause neurotoxicity, it is also 
necessary as its half-life in vivo is only 2 – 6 seconds (Wilson, 2002). The NO was 
produced by a previously described method (Brown et al., 2005), at the time of 
production and immediate concentration determination by UV-Vis the NO was present 
in solution at ~ 700 µM. However, this solution of NO is unstable and degrades by up to 
20% in an hour. Thus it was possible that the concentration decreased to 500 µM both 
during the time that it took to purge the lines with the solution and set up the experiment 
as well as the time taken to perform the experiment. Two perfusions were carried out, 
the first of which was 15 minutes long and is depicted in Figure 7-14.  
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Figure 7-14 
A 15 minute perfusion of NO. 
The perfusion of NO produced some unusual but, upon reflection, entirely expected 
features. The primary one is the drastic spike in the signal immediately after the 
perfusion begins. This is due to the detection of NO at the surface of the electrode. NO 
is similar in size to O2 and H2O2 and thus it can penetrate the interference rejection 
layer, and can be oxidised between + 600 mV and + 900 mV vs. SCE. This is normally 
not an issue as the in vivo concentration of NO is less than 1 µM. With a perfusion of 
500 – 700 µM however there is a noticeable current produced. Initially at the start of the 
perfusion this produces an increase of 29.7% in the current compared to the pre-
perfusion reading. Post-perfusion with the removal of the supply of NO there is 
decrease of 26.5% in the current, when compared to the pre-perfusion level. These 
changes are similar and do indicate that it is solely the oxidation of the NO at the Pt 
surface which is responsible for these features. Aside from this, it is noticeable that 
within the perfusion the signal decreases by 18.1% of the pre-perfusion current over 15 
minutes, and post-perfusion it increases by 14.8% to settle 0.1% below the initial 
current 50:20 minutes after the perfusion has ended. 
To investigate if these effects were reproducible the perfusion was repeated, this time 
extending over 30 minutes. The results are graphed in Figure 7-15: 
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Figure 7-15 
A 30 minute perfusion of NO. 
It is clear to see that the same NO detection effects are present again, producing a large 
increase in the signal at the start of the perfusion and a large decrease in current at the 
end of the perfusion. However, with the increased perfusion time the changes during 
and after the perfusion are more pronounced. As a percentage of the initial pre-perfusion 
current, the signal decreases by 26.1% during the perfusion and proceeds to increase by 
22.2% post-perfusion to what appears to be a stable level after 27:10 minutes. This post-
perfusion signal is 2.9% below the pre-perfusion current. Interestingly though, it can be 
seen that after approximately one hour of a stable signal the current then begins to 
increase, this increase continues until 3:16:45 hours after the perfusion has ended with 
the signal rising to a level 8.7% above the pre-perfusion current. It remains at the level 
for four hours before decreasing slowly back to a current similar to the initial post-
perfusion current. It is difficult to say if this is effect is due to the NO perfusion, or to 
what it may be attributable and further experimentation is required to investigate if it is 
reproducible.  
7.8 ʟ-NAME Perfusion 
Nω-Nitro-ʟ-arginine methyl ester hydrochloride (ʟ-NAME) has been shown to prevent 
the production of NO by inhibiting the function of all forms of nitric oxide synthase 
(NOS) (Alderton et al., 2001). Having shown that NO perfusions could reduce the 
concentration of ᴅ-ser it was decided that ʟ-NAME could be used to examine whether 
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the reverse process also occurred. Thus a perfusion of 100 µM ʟ-NAME was carried 
out, the results of which are illustrated in Figure 7-16: 
180 210 240 270 300 330 360 390 420 450
60
80
100
120
Time, min
%
 o
f 
B
a
se
li
n
e
 
Figure 7-16 
A perfusion of ʟ-NAME. 
It is quite clear that ʟ-NAME produced only a decrease in current. This decrease 
bottomed out at a level 36.8% below the pre-perfusion current 55:10 minutes after the 
perfusion began. This was the largest decrease observed during any perfusion. After the 
perfusion ended, 01:39:45 hours elapsed before a stable post-perfusion signal was 
attained. This signal was 9.8% less than the pre-perfusion current. The larger than 
previously seen decrease could be due to any number of factors; an unusually elevated 
ᴅ-ser level to begin with, ʟ-NAME producing no effect on the ᴅ-ser metabolic pathway 
and thus behaving no different to an aCSF perfusion, a reduction in the background 
signal due to the loss of NO interference, an undetermined effect of ʟ-NAME which 
adversely effects the release or production of ᴅ-ser. It is not possible to say was causes 
this decrease and further experimentation would be required to elucidate and provide 
insight into this issue. 
7.9 AA Perfusion 
All of the previous perfusions and results were examined in the light of complete 
interference rejection. It was felt that after 16 days of implantation that it was necessary 
 Chapter 7: Preliminary In Vivo Study 
293 
to test this assumption. As a result, an aCSF solution containing 1000 µM AA was 
perfused, and the results can be seen in Figure 7-17. 
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Figure 7-17 
A perfusion of 1 mM AA. 
While there is no doubt that the large concentration of AA did initially increase the 
signal current, an 18.5% increase after 3:45 minutes, it was not a long lived effect. After 
38:00 minutes the current had reduced back to a level only 2.1% above the pre-
perfusion response. Given that the ‘self-blocking’ mechanism would have 30 minutes to 
react and form against this concentration of AA, from the 400 µM typical in vivo level 
(Miele & Fillenz, 1996), during an in vitro calibration this is a very satisfactory result. It 
would be expected that the complete constantly changing environment in vivo would 
lengthen this settling time. Just before the cessation of the perfusion, 1:35:55 hours, the 
current was only 0.5% higher than the initial value. Following the ending of the 
perfusion the current proceeds to decrease rapidly, eventually finding a post-perfusion 
level, 17.5% below the initial pre-perfusion response, after 49:50 minutes. The 
similarity of the initial increase and final decrease, coupled with the in-perfusion 
activation of the ‘self-blocking’ mechanism coincide to provide evidence that the 
interference rejection layers are functioning as desired even after 16 days exposure to 
the in vivo environment.  
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7.10 Saline Injection 
Before any experiments could be carried out by s.c. injection it was necessary to 
determine what effect or artefact would be visible, see Figure 7-18.  
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Figure 7-18 
An s.c. injection of 1 mL saline. 
These effects could be due to either the stress of receiving the injection or the vehicle 
itself. In this case an injection of 1 mL of normal saline solution was the vehicle. It is 
immediately clear that vehicle produces no effect at all, and that the injection is almost 
negligible for either biosensor when compared to the general signal changes and noise. 
This is a satisfactory and expected result. 
7.11 MK-801 Injection 
With the considerable interest in ᴅ-ser due to its hypothesised role in the pathology of 
schizophrenia, it made sense to briefly explore this possibility. Probably the most 
common ways to induce schizophrenic stereotypy, in accordance with the glutamate 
hypothesis, is by the administration of MK-801 (Tsai & Coyle, 2002), a non-
competitive antagonist of the NMDA receptor. It acts by binding to the interior ion 
channel of an activated NMDAr and prevent the passage of Ca
2+ 
(Huettner & Bean, 
1988). Thus although the binding sites for glutamate and ᴅ-serine are available, the 
receptor cannot carry out its function once activated.  
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The use of MK-801 has illustrated the involvement of ᴅ-ser in NMDAr induced 
neurotoxicity (Shleper et al., 2005), the regulation of CREB phosphorylation in Müller 
glia of the retina (Lamas et al., 2007; Chavira-Suárez et al., 2008) and the up-regulation 
of SR and ᴅAAO mRNA expression (Yoshikawa et al., 2004a; Yoshikawa et al., 
2004b). Furthermore, ᴅAAO-/- mice, which have elevated levels of ᴅ-ser, display an 
attenuation of MK-801 induced schizophrenic-like symptoms (Hashimoto et al., 2005). 
With this in mind it was considered highly likely that a systemic administration of 0.3 
mg/kg MK-801 would produce some effect on the ᴅ-ser levels recorded in the striatum. 
The results obtained are displayed in Figure 7-19. 
There is an effect on ᴅ-ser levels in both the left (green trace) and right (blue trace) 
striatum. However, they do differ. In the left striatum the signal increases from the pre-
injection level by a maximum of 12.9% after 25 minutes. The current then begins to 
decrease, reaching a minimum level of 19.6% below the baseline after 5 hours. At this 
point the levels increase for a period of an hour, but stabilise back to the lower level and 
this low level is maintained until at least 10 hours after the injection took place. At this 
point the current is still 20.1% below the pre-injection value.  
The right striatum appears to be affected differently by the injection. After 25 minutes 
the current has increased by 8.9% from its pre-injection level. It continues to increase 
until 160 minutes after the injection at which point it is 21.6% above the baseline value. 
This elevated level is then maintained until approximately 7 hours have elapsed, at 
which point the response is 16.4% above the initial value, before it begins to decrease. 
By the time 10 hours have passed since the injection, the current has fallen back to 4.3% 
below the initial value and appears stable at this level. 
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Figure 7-19 
An MK-801 s.c. injection, 0.3 mg/kg in 1 ml saline. The top graph depicts the first 5 hours after the 
injection and the bottom graph a total of 10 hours. 
In summary the systemic administration of MK-801 produces an increase in ᴅ-ser 
levels. This is possibly due to the fact that the NMDAr’s have become inactive, and in 
an effort to restore normal signalling processes the brain has elevated the concentration 
of ᴅ-ser, one of the coagonists of the NMDA receptor. That the two different 
hemispheres respond differently could be due to a number of reasons, but it is felt that it 
could mainly be due to the fact that a large number of experiments over 16 days have 
been carried out on the right striatum, and that the combined microdialysis probe and 
biosensor have, due to their size, induced a greater degree of damage and subsequent 
gliosis in the right hemisphere (Jaquins-Gerstl & Michael, 2009), leading it to appear to 
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behave differently in this instance. The extent of gliosis has been shown to alter the 
apparent concentration of substances within the ECF (Jaquins-Gerstl et al., 2011). 
7.12 Conclusions 
With the stated aim of this thesis being the development of a ᴅ-ser biosensor capable of 
detecting endogenous changes in vivo it was important to demonstrate that the final 
protocol was capable of doing exactly that. As such, biosensors were implanted into the 
right and left striatum of a rat, with a microdialysis probe co-implanted in the right 
striatum to allow the delivery of desired substances into the vicinity of the electrode in 
the right striatum. It is necessary to demonstrate both an increase and decrease in the 
response of the electrodes due to imposed changes, via microdialysis, that are most 
likely only attributable to ᴅ-ser. 
Initially this was attempted by perfusing different concentrations of ᴅ-ser in aCSF, the 
vehicle was also perfused to provide a reference. When this was done it was found that 
there was no conclusive difference found between any concentration used, with aCSF, 
10 µM, 20 µM, 100 µM and 1000 µM ᴅ-ser producing decreases in current of 28.1%, 
28.8%, 25.4%, 23.9% and 21.6% from the initial baseline. Given the concentration of ᴅ-
ser perfused, these changes were not of a magnitude which indicated that ᴅ-ser was 
being detected. It is evident that there is a very effective internal mechanism present 
which maintains and tightly regulates the concentration of ᴅ-ser in vivo. Similar results 
to this have been observed for the in vivo detection of glutamate, the signalling partner 
of ᴅ-ser. A perfusion of ʟ-ser producing a decrease in current that was similar to that of 
an aCSF perfusion. This was an expected result. 
Bearing these results in mind targeting the release, uptake, production and destruction 
mechanisms are other methods available to elicit a change in the ᴅ-ser concentration. 
The first target was the release mechanism, and the drug Veratridine was utilised. A 
substance which opens and locks open sodium channels, it has been shown previously 
to elicit positive and negative changes in the concentration of ᴅ-ser and other 
substances. In this study it produced a decrease of 25.4% when perfused on its own and 
when perfused between two aCSF perfusions it failed to produce any conclusive change 
at all.  
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The production and degradation mechanism was the next to be targeted. The transport 
and uptake mechanisms are complex and not fully determined for ᴅ-ser. This means that 
the action of SR was probed. Initially with Mg.ATP to induce an increased rate of 
forward reaction for the conversion of ʟ-ser to ᴅ-ser and secondly by EDTA to stabilise 
the ᴅ-ser level against α,β-elimination by SR. Perfusing both of these substances 
produced very similar responses. For short 15 minute perfusions a short increase in 
current was observed, and for longer hour long perfusions the level was maintained for 
the first 20 minutes before beginning a slow decrease. These were positive results which 
indicate that is it possible to both induce and detect increases in the ᴅ-ser concentration 
in vivo.  
A further point that was targeted for analysis was the S-nitrosylation and thereby 
inactivation of SR by NO. A perfusion of NO, while detecting the high level of NO 
itself, observed a decrease in ᴅ-ser current. A perfusion of ʟ-NAME, which is a non-
selective NOS inhibitor that reduces NO levels also produced a decrease in the ᴅ-ser 
current. This decrease was at least 36% below the baseline which, when taken with the 
data for multiple aCSF perfusions and the NO perfusion data makes this data difficult to 
interpret, and further investigation is required. 
Interference rejection was confirmed on the 16
th
 day after implantation by perfusion of 
1000 µM of AA. The result confirmed that the Naf-PPD layer was standing up to the 
complex in vivo environment and ensuring an interference free signal. Finally an MK-
801 s.c. injection demonstrated altered ᴅ-ser concentration in both hemispheres of the 
brain, producing first an increase and then a decrease in the observed currents.  
Overall, the biosensor developed is suitable for in vivo chronic monitoring of ᴅ-ser 
concentrations. However, extensive further study is required to fully characterise the 
biosensor, particularly in the in vivo environment. 
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8.1 General Conclusions 
The stated aim of this thesis was to design and characterise a ᴅAAO based biosensor 
capable of detecting endogenous changes in ᴅ-ser in vivo. This desire stemmed from the 
recent determination of ᴅ-ser as an important neurotransmitter, with responsibility for 
involving many process and implication is the pathology of multiple major diseases. 
Thus a device which could reliably monitor its concentration in vivo and therefore be 
usable as a tool to elucidate the complicated pathways and mechanism by which it acted 
and was controlled is viewed as an important technological advance. It would also have 
further implications in the development of new treatments and drugs, as well as 
diagnosis for disease states. At the offset, it appeared that there was a functional 
biosensor available that could be characterised and utilised in the in vivo environment in 
a short space of time. However, this did not turn out to be the case. 
Multiple and extensive efforts were made to reproduce the biosensor with the properties 
described by Z. M. Zain. It was discovered that this was only possible when each set of 
sensors was fabricated using completely fresh solutions. Even under these conditions it 
was not guaranteed that the desired sensitivity would be attained, with the possibility of 
achieving a success rate of 1 in 4 or less even with new solutions. An extensive and 
thorough investigation into the proposed biosensor design was conducted. This 
examined each individual component in order to determine its effects and decipher any 
problems that were inherent in the manufacturing protocol. It was discovered that the 
high concentration of glutaraldehyde that was utilised was responsible for the 
degradation of the enzyme solution, resulting in it losing its activity after only a few 
uses. There also appears to be an issue with the interaction of the Nafion
®
 layers and the 
P-o-PD layer. It has been shown that application of Naf after P-o-PD degrades the P-o-
PD layer, resulting in lower interference rejection. The Naf layer also provided a further 
complication whereby it appears to form such a solid matrix with the P-o-PD that the 
adherence of the subsequent GA and ᴅAAO layers are little better than that observed at 
a bare metal surface. This is not the case with Naf free designs. Many alterations and 
process changes were investigated and undertaken to remedy these issues, but no 
satisfactory resolution was found. The information gleamed however was quite useful 
and with this in mind the decision was made to explore brand new protocols and design 
a new biosensor. 
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This process began in Chapter 5 with the basic adsorption, cross-linking and 
immobilisation techniques being examined. These processes evolved and got 
increasingly more complex as more information was gleamed. Some results of this are; 
the utilisation of 600UPBS enzyme solution instead of 600UH2O, BSA and PEI not 
being utilised in the basic design, GA only being utilised on specific layers of the 
protocol, and additional amounts of FAD being of benefit under a particular set of 
circumstances. This exploration into a new model of biosensor for ᴅ-ser ended with a 
styrene-based immobilisation matrix which contained the sensing element ᴅAAO and 
the cross-linking component GA. Several promising recipes were discovered. However, 
it was felt that a problem remained with the physical currents being achieved, despite 
what was considered good levels of sensitivity in comparison to other biosensor 
designs. This meant that some basic changes would have to be made to these designs to 
seek improvements and finally settle on a single recipe for manufacturing the biosensor. 
Chapter 6 saw the culmination of these efforts. The major changes undertaken were; the 
alteration of the Pt/Ir electrode geometry from a 125 µm disk surface to a 500 µm long 
cylinder with a 125 µm diameter, and the changing of the immobilisation matrix 
substance to methyl methacrylate and the discontinuation of styrene. Both solutions 
brought substantial increases in the basic currents being recorded. With a final design of 
the sensing elements settled upon it then became necessary to examine interference 
rejection solutions and how they would fit in with or alter the sensing properties of the 
biosensor. A combination, involving an initial five layers of Naf followed by a PPD 
layer that was electro-polymerised onto the surface via CPA, was chosen. These two 
processes were completed before the application of the sensing layer elements. 
Subsequent to the issues of sensitivity and selectivity being resolved a thorough and 
often harsh examination of the characteristics of the biosensor was conducted. Stability 
is affected by time - repeated short-term and long-term use affects the sensitivity of the 
biosensor but not in a manner which is a cause for major concern. Exposure to protein, 
lipid and brain tissue also reduced the sensitivity, but only in a manner consistent with 
expectations from other biosensor designs. Also in line with expectations are the effects 
that changes in temperature and pH produce on the biosensor. 
A comprehensive study on the interference rejection properties of the design illustrate 
that there is no interference to be found from either ʟ-amino acids or electroactive 
species. Any interference from ᴅ-amino acids is minimal and not likely to be 
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problematic in vivo due to their relative concentrations; ᴅ-ser is by far the most prolific. 
Oxygen independence was established up to 100 µM ᴅ-ser and with a limit of detection 
which is one tenth of the proposed in vivo concentration and with a 6 second response 
time the biosensor was determined to be suitable for in vivo use following its extensive 
in vitro characterisation. 
In vivo implantation highlighted possible issues that may occur with any experiment or 
treatment that relates to ᴅ-ser concentration alteration, as it appears to be very tightly 
regulated. It was not possible to increase the response of the sensor by perfusion ᴅ-ser 
alone, or by blanket stimulation of the ion dependant signalling system. Nevertheless, 
through focused and specific pharmacological alteration of the systems that control the 
production and destruction of ᴅ-ser it was possible to show increases and decreases in ᴅ-
ser concentration, long and short-term effects and some of the complex interplay that 
exists between these systems. However, a lot more extensive work is required to 
determine any specific attributes and draw any definite conclusions. 
With the usefulness of the biosensor demonstrated with the experiments conducted 
already a clear direction for the use of the biosensor has been shown. Further 
experimentation on the action of SR, to include the substances indentified in this thesis 
which appear to affect and more novel inhibitors or activators would be a very useful 
and highly informative exercise. There is a large scope for examining what changes 
substances like MK-801, and other NMDAr and glutamatergic system activators, 
inhibitors, competitive and non-competitive agonists and antagonists, produce on ᴅ-ser 
levels in the long and short term and with different levels of exposure. 
The most exciting possibilities are in the pairing of this technology with other sensing 
technologies. Already identified as targets of interest are glutamate, NO and pyruvate. 
Studying the interplay between all of these systems, not only under the manipulations 
alluded to in the previous paragraph but especially in animal models of disease would 
be a thoroughly exciting prospect that could yield many important discoveries in 
relation to the pathology of degenerative brain disorders. Finally, if the proposed work 
is conducted in the near future, this technology could see its finest moment as it is used 
to monitor the effectiveness and clinical development of new and novel treatments for 
these disease states. 
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Electrode 
Design 
PtD-PPD-Naf1%x5-
GA25%x1-
600UH2Ox10, n=13 
PtD-PPD-Naf1%x3-
GA25%x3-
600UH2Ox10, n=7 
PtD-PPD-Naf1%x3-
GA25%x3-600UH2Ox5, 
n=4 
[ᴅ-Serine] 
µM 
Mean, J, 
µA.cm
-2 
± SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
0 0 0 0 0 0 0 
10 0.088 0.014 0.081 0.012 0.070 0.009 
20 0.161 0.024 0.157 0.021 0.145 0.022 
50 0.334 0.045 0.368 0.036 0.276 0.057 
100 0.647 0.101 0.670 0.072 0.435 0.118 
200 1.080 0.142 1.288 0.128 0.753 0.212 
500 2.222 0.308 2.869 0.303 1.711 0.448 
1000 4.151 0.507 5.224 0.570 4.206 1.070 
2000 7.360 0.835 9.301 0.981 5.200 1.367 
3000 9.493 1.083 12.378 1.128 7.033 1.734 
5000 13.626 1.399 16.499 1.715 9.541 2.422 
7000 15.552 1.471 19.469 1.883 11.227 2.755 
Table 9-1 
ᴅ-ser calibration data for the 3 variations of sensor design. Data presented as J values with Mean ± 
SEM. 
[ᴅ-Serine], 
µM 
E1, J, 
µA.cm
-2
 
E2, J, 
µA.cm
-2
 
E3, J, 
µA.cm
-2
 
E4, J, 
µA.cm
-2
 
E5, J, 
µA.cm
-2
 
E6, J, 
µA.cm
-2
 
E7, J, 
µA.cm
-2
 
E8, J, 
µA.cm
-2
 
0 0 0 0 0 0 0 0 0 
10 0.500 0.020 0.070 0.085 0.101 0.059 0.099 0.114 
20 0.918 0.165 0.187 0.193 0.180 0.121 0.170 0.231 
50 2.140 0.301 0.398 0.420 0.359 0.255 0.262 0.469 
100 4.310 0.501 0.724 0.834 0.681 0.489 0.425 0.851 
200 9.655 2.014 1.710 2.882 1.257 0.960 0.713 1.649 
500 16.777 3.088 2.875 3.415 3.023 2.115 1.298 3.866 
1000 38.753 6.077 7.331 16.071 8.040 3.717 2.111 8.752 
2000 39.528 8.415 10.184 13.023 8.237 7.076 3.370 12.431 
3000 40.917 9.467 12.948 20.647 11.544 9.262 4.451 15.752 
5000 41.456 17.052 19.716 27.017 16.119 12.278 6.000 18.043 
8000 38.144 13.148 22.100 30.076 18.504 15.685 8.317 22.219 
10000 38.101 15.589 25.523 33.902 18.797 14.933 8.224 33.581 
Table 9-2 
ᴅ-ser calibration data for the 8 electrodes prepared by PtD-PPD-Naf1%x3-GA25%x3-600UH2Ox10 
with freshly prepared solutions. Data presented as J values with Mean ± SEM 
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[ᴅ-Serine], 
µM 
E1, J, 
µA.cm
-2
 
E2, J, 
µA.cm
-2
 
E3, J, 
µA.cm
-2
 
E4, J, 
µA.cm
-2
 
E5, J, 
µA.cm
-2
 
E6, J, 
µA.cm
-2
 
E7, J, 
µA.cm
-2
 
E8, J, 
µA.cm
-2
 
0 0 0 0 0 0 0 0 0 
10 0.366 0.050 0.038 0.072 0.024 0.034 0.019 0.035 
20 0.539 0.128 0.072 0.091 0.044 0.063 0.061 0.069 
50 1.608 0.176 0.232 0.367 0.101 0.143 0.158 0.141 
100 2.599 0.385 0.334 0.361 0.190 0.277 0.293 0.253 
200 4.435 0.552 0.588 0.579 0.348 0.519 0.574 0.479 
500 11.305 1.767 1.499 1.653 0.744 1.119 1.276 1.053 
1000 18.926 2.809 2.560 2.551 1.313 2.037 2.397 1.927 
2000 24.137 4.256 4.107 4.587 2.165 3.616 4.171 3.241 
3000 29.782 5.571 5.996 8.203 2.947 4.833 5.725 4.665 
5000 32.919 7.351 8.186 12.072 3.942 6.528 8.035 6.424 
8000 42.911 10.944 14.290 
 
4.856 12.196 14.195 9.563 
10000 42.128 11.699 15.444 
 
5.386 13.631 16.009 8.730 
Table 9-3 
ᴅ-ser calibration data for the 8 electrodes prepared by PtD-PPD-Naf1%x3-GA25%x3-600UH2Ox10 
with freshly prepared solutions after 7 days of storage at 4°C. Data presented as J values with Mean ± 
SEM 
Electrode 
Design 
PtD-Naf1%x3-
GA25%x3-
600UH2Ox5, n=4 
PtD-GA25%x3-
600UH2Ox5, n=4 
PtD-Naf1%x3-
600UH2Ox5, n=4 
[ᴅ-Serine] 
µM 
Mean, J 
µA.cm
-2 
SEM, J 
µA.cm
-2
 
Mean, J 
µA.cm
-2 
SEM, J 
µA.cm
-2
 
Mean, J 
µA.cm
-2 
SEM, J 
µA.cm
-2
 
0 0 0 0 0 0 0 
10 0.112 0.014 0.049 0.013 0.160 0.038 
20 0.249 0.020 0.126 0.039 0.356 0.080 
50 0.700 0.078 0.320 0.105 0.797 0.183 
100 1.241 0.255 0.538 0.159 1.369 0.311 
200 2.407 0.472 0.947 0.274 2.493 0.586 
500 4.946 0.472 1.726 0.459 5.830 1.309 
1000 9.784 1.004 2.867 0.731 10.792 1.923 
2000 22.108 3.517 4.773 1.125 17.047 4.321 
3000 23.645 3.606 6.492 1.511 25.396 5.727 
5000 33.934 5.107 8.818 1.988 31.964 8.443 
7000 39.518 6.343 11.117 2.480 39.975 9.970 
Table 9-4 
ᴅ-ser calibration data for the 4 alterations of prepared PtD-PPD-Naf1%x3-GA25%x3-600UH2Ox5 to 
explore the influence of the Naf1%x3 dips on the sensitivity of the electrode. The values for PtD-PPD-
Naf1%x3-GA25%x3-600UH2Ox5 have been omitted for clarity but can be found in Table 9-1. Data 
presented as J values with Mean ± SEM. 
 Appendix 1 
314 
%GA 
used 
0.5%, n = 4 1%, n = 3 2%, n = 8 
[ᴅ-Serine], 
µM 
Mean, J, 
µA.cm
-2 
± SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2
 
± SEM, 
J, µA.cm
-
2
 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
0 0 0 0 0 0 0 
10 0.002 0.001 0.102 0.021 0.047 0.011 
20 0.003 0.001 0.215 0.027 0.082 0.017 
50 0.007 0.002 0.533 0.033 0.164 0.035 
100 0.009 0.002 1.116 0.053 0.435 0.117 
200 0.019 0.003 2.247 0.063 0.751 0.157 
500 0.039 0.006 5.316 0.158 1.298 0.297 
1000 0.059 0.008 9.517 0.203 2.255 0.490 
2000 0.088 0.012 18.077 0.518 4.147 0.871 
3000 0.108 0.013 23.715 0.204 5.938 1.185 
5000 0.142 0.018 32.615 0.756 9.412 2.059 
8000 0.181 0.023 43.282 1.433 10.776 2.354 
10000 0.202 0.025 46.796 2.247 12.426 2.343 
%GA 
used 
5%, n = 3 10%, n = 3 25%, n = 4 
[ᴅ-Serine], 
µM 
Mean, J, 
µA.cm
-2 
± SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2
 
± SEM, 
J, µA.cm
-
2
 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
0 0 0 0 0 0 0 
10 0.008 0.004 0.006 0.005 0.014 0.008 
20 0.018 0.010 0.011 0.008 0.048 0.017 
50 0.042 0.023 0.028 0.012 0.146 0.035 
100 0.084 0.043 0.059 0.020 0.303 0.071 
200 0.154 0.080 0.119 0.029 0.601 0.128 
500 0.346 0.181 0.268 0.061 1.215 0.241 
1000 0.624 0.320 0.449 0.105 1.990 0.365 
2000 1.100 0.566 0.775 0.182 2.998 0.520 
3000 1.482 0.758 1.030 0.240 3.910 0.651 
5000 2.099 1.077 1.445 0.330 5.405 0.854 
8000 2.820 1.426 1.911 0.437 7.253 1.227 
10000 3.144 1.635 2.100 0.478 8.339 1.404 
Table 9-5 
ᴅ-ser calibration data for the 6 variations of prepared PtD-PPDcv-3xNaf1%-3xGA25%-5x600UH2O to 
investigate the influence of GA% on the sensitivity of the biosensor. Listed is the data obtained when 
0.5%, 1%, 2%, 5%, 10% and 25% GA were utilised.  
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Enzyme 
soln. used 
200 U.mL
-1
 soln, 
1.9 U.g
-1
 solid, 
Fluka, n = 8 
100 U.mL
-1
 soln, 
2.3 U.g
-1
 solid, 
Sigma, n = 8 
250 U.mL
-1
 soln, 
2.3 U.g
-1
 solid, 
Sigma, n = 8 
600 U.mL
-1
 soln, 
2.3 U.g
-1
 solid, 
Sigma, n = 3 
[ᴅ-Serine] 
µM 
Mean, 
 J, 
µA.cm
-
2
 
± SEM, 
 J, 
µA.cm
-
2
 
Mean, 
 J, 
µA.cm
-
2
 
± SEM, 
 J, 
µA.cm
-
2
 
Mean, 
 J, 
µA.cm
-
2
 
± SEM, 
 J, 
µA.cm
-
2
 
Mean, 
 J, 
µA.cm
-
2
 
± SEM, 
 J, 
µA.cm
-
2
 
0 0 0 0 0 0 0 0 0 
10 0.072 0.020 0.085 0.031 0.285 0.082 0.454 0.107 
20 0.157 0.027 0.129 0.057 0.620 0.144 
  
50 0.298 0.052 0.304 0.091 0.777 0.180 0.651 0.179 
100 0.408 0.089 0.568 0.124 1.264 0.278 
  
200 1.514 0.170 1.001 0.183 0.968 0.408 1.012 0.333 
500 3.769 0.329 1.958 0.254 3.625 1.043 3.100 0.732 
1000 6.526 0.966 3.322 0.363 5.712 1.106 5.100 1.017 
1500 8.371 1.170 4.464 0.441 7.898 1.182 7.544 1.917 
2000 10.155 1.423 5.409 0.523 9.993 1.438 10.360 2.665 
3000 12.561 2.044 6.995 0.688 14.666 2.075 
18.026 
1 1.373 
1 
5000 17.237 2.927 10.317 0.938 21.180 3.064 
21.898 
2 2.382 
2 
7000 
  
12.423 1.123 25.869 3.574 
  
8000 
  
14.307 0.734 
  
24.171 2.680 
Table 9-6 
ᴅ-ser calibration data for the 4 variations of PtD-PPD-Naf1%x5-GA25%-Enzymex10. Listed is the data 
obtained when using enzyme solids supplied by Fluka Chemic and Sigma. Different calibration steps 
were used as they were sourced over a period of time (1 4000 µM, 2 6000µM), this does not affect the 
fitting of kinetic curves or comparative analysis. 
Electrode 
Design 
Naf1%x5-GA25%-
600U+Ax10, n=4 
Naf1%x3-GA25%x3-
600U+Ax10, n=3 
Naf1%x3-GA25%x3-
600U+Ax5, n=7 
[ᴅ-ser] 
µM 
Mean, J, 
µA.cm
-2 
± SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
0 0 0 0 0 0 0 
10 0.049 0.064 0.309 0.068 0.069 0.010 
20 0.136 0.055 0.588 0.157 0.199 0.014 
50 0.299 0.096 1.169 0.352 0.311 0.038 
100 0.507 0.239 2.075 0.576 0.662 0.058 
200 0.938 0.242 4.051 0.716 1.101 0.127 
500 2.476 0.473 7.036 0.235 2.432 0.287 
1000 4.256 0.754 11.724 0.685 4.421 0.549 
1500 5.579 0.931 
  
6.179 0.745 
2000 6.865 1.119 19.963 2.378 7.592 0.969 
3000 9.904 1.851 26.725 2.332 9.893 1.129 
5000 13.117 2.162 33.451 3.080 13.913 1.549 
Table 9-7 
ᴅ-ser calibration data for the 3 variations of the biosensors in Table 9-1 where the enzyme solutions 
have been changed to include stabilising additives. 
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Electrode 
Design 
PtD-PPD-Naf1%x3-GA25%x3-
600H2Ox3 n = 4 
PtD-PPD-Naf1%x3-GA25%x3-
600U+Ax3 n = 4 
[ᴅ-Serine], 
µM 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
0 0 0 0 0 
10 0.053 0.023 0.018 0.008 
20 0.053 0.021 0.031 0.014 
50 0.196 0.066 0.072 0.031 
100 0.381 0.122 0.127 0.057 
200 0.741 0.234 0.220 0.105 
500 1.939 0.596 0.477 0.235 
1000 3.635 1.100 0.844 0.425 
1500 
  
1.144 0.586 
2000 6.400 1.954 1.410 0.723 
3000 9.021 2.628 1.884 0.984 
5000 11.974 3.496 2.680 1.402 
Table 9-8 
ᴅ-ser calibration data for the recipe PtD-PPD-Naf1%x3-GA25%x3-Enzymex3 using two different 
enzyme solutions. The first is the 600UH2O solution standardly used and the second is the 600U+A 
solution where the enzyme solution has been changed to include stabilising additives. 
Electrode 
Design 
GA 2%, 
600UH2O, n = 4 
GA 2%, 
 600UPBS, n = 3 
GA 25%, 
600UH2O, n = 4 
GA 25%, 
600UPBS, n = 7 
[ᴅ-Serine] 
µM 
Mean, J, 
µA.cm
-2
 
SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2
 
SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2
 
SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2
 
SEM, J, 
µA.cm
-2
 
0 0 0 0 0 0 0 0 0 
10 0.026 0.015 0.062 0.005 0.070 0.009 0.078 0.012 
20 0.045 0.025 0.109 0.011 0.145 0.022 0.178 0.013 
50 0.116 0.055 0.238 0.023 0.276 0.057 0.352 0.031 
100 0.239 0.104 0.437 0.037 0.435 0.118 0.644 0.065 
200 0.461 0.192 0.835 0.066 0.753 0.212 1.598 0.274 
500 1.120 0.449 1.936 0.169 1.711 0.448 2.811 0.323 
1000 2.094 0.819 3.554 0.273 4.206 1.070 7.443 1.695 
2000 3.767 1.536 6.292 0.461 5.200 1.367 8.962 1.251 
3000 5.130 2.082 8.584 0.696 7.033 1.734 12.010 1.957 
5000 6.617 2.626 12.301 0.989 9.541 2.422 16.604 2.448 
7000 
    
11.227 2.755 
  
8000 9.525 3.762 15.992 1.156 
  
18.578 2.677 
10000 10.729 4.215 18.013 1.467 
  
21.507 3.708 
Table 9-9 
ᴅ-ser calibration data for the recipe PtD-PPD-Naf1%x3-GAx3-Enzymex5. Two different enzyme 
solutions were utilised, the first is the 600UH2O solution standardly used and the second is the 
600UPBS solution where the enzyme solution has been made in PBS with a pH 8.5. Also utilised were 
two concentrations of GA, 2% and 25%. 
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Electrode 
Design 
PPDa, 2% GA, 
600UH2O, n = 4 
PPDa, 2% GA, 
600UPBS, n = 4 
PPDcv, 2% GA, 
600UH2O, n = 8 
PPDcv, 2% GA, 
600UPBS, n = 4 
ᴅ-Serine, 
µM 
Mean, 
J, 
µA.cm
-
2
 
± SEM, 
J, 
µA.cm
-
2
 
Mean, 
J, 
µA.cm
-
2
 
± SEM, 
J, 
µA.cm
-
2
 
Mean, 
J, 
µA.cm
-
2
 
± SEM, 
J, 
µA.cm
-
2
 
Mean, 
J, 
µA.cm
-
2
 
± SEM, 
J, 
µA.cm
-
2
 
0 0 0 0 0 0 0 0 0 
10 0.070 0.019 0.099 0.021 0.047 0.011 0.089 0.006 
20 0.119 0.030 0.140 0.039 0.082 0.017 0.176 0.015 
50 0.278 0.073 0.316 0.089 0.164 0.035 0.339 0.020 
100 0.502 0.129 0.637 0.181 0.435 0.117 0.712 0.053 
200 0.937 0.244 1.248 0.354 0.751 0.157 1.299 0.083 
500 2.114 0.536 3.152 0.903 1.298 0.297 2.986 0.197 
1000 3.716 0.950 5.870 1.634 2.255 0.490 5.435 0.381 
2000 6.633 1.700 10.286 2.721 4.147 0.871 9.637 0.850 
3000 9.152 2.390 13.357 3.667 5.938 1.185 12.541 1.192 
5000 12.879 3.375 17.160 4.204 9.412 2.059 17.657 1.734 
8000 17.187 4.556 22.118 4.803 10.776 2.354 23.437 2.251 
10000 19.246 5.151 23.778 4.955 12.426 2.343 26.315 2.481 
Table 9-10 
ᴅ-ser calibration data for the recipe PtD-PPD-Naf1%x3-GA2%x3-Enzymex5. Two different enzyme 
solutions were utilised, the first is the 600UH2O solution standardly used and the second is the 
600UPBS solution where the enzyme solution has been made in PBS with a pH 8.5. The PPD 
formulation was also changed between PPD (normal N2 saturated solution, CPA), PPDa (CPA, exposed 
to atmosphere during polymerisation) and PPDcv (normal N2 saturated solution, CV). 
Electrode 
Design 
PtD-PPD-Naf1%x3-[GA2%x3-
600UH2Ox5]x2, n = 4 
PtD-PPD-Naf1%x3-GA2%-
600UH2Ox5, n = 4 
[ᴅ-serine], 
µM 
Mean, 
J, µA.cm
-2
 
± SEM, 
J, µA.cm
-2
 
Mean, 
J, µA.cm
-2
 
± SEM, 
J, µA.cm
-2
 
0 0 0 0 0 
10 0.030 0.012 0.026 0.015 
20 0.073 0.022 0.045 0.025 
50 0.183 0.051 0.116 0.055 
100 0.322 0.091 0.239 0.104 
200 0.648 0.174 0.461 0.192 
500 1.602 0.417 1.120 0.449 
1000 3.058 0.810 2.094 0.819 
2000 5.329 1.427 3.767 1.536 
3000 7.832 2.030 5.130 2.082 
5000 11.561 2.948 6.617 2.626 
Table 9-11 
The ᴅ-ser calibration data for the recipes PtD-PPD-Naf1%x3-GA2%x3-600UH2Ox5 and PtD-PPD-
Naf1%x3-[GA2%x3-600UH2Ox5]x2. 
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Electrode 
Design 
PtD-PPD-Naf1%x3-GA25%x3-
PEI1%-600UH2Ox5, n = 4 
[ᴅ-serine], µM 
Mean 
 J, µA.cm
-2
 
± SEM 
 J, µA.cm
-2
 
0 0 0 
10 0.006 0.001 
20 0.012 0.002 
50 0.026 0.007 
100 0.058 0.012 
200 0.111 0.023 
500 0.242 0.052 
1000 0.413 0.098 
2000 0.662 0.187 
3000 0.876 0.244 
5000 1.282 0.376 
8000 1.776 0.572 
10000 2.037 0.679 
Table 9-12 
The ᴅ-ser calibration data for the recipes PtD-PPD-Naf1%x3-GA25%x3-PEI1%-600UH2Ox5. 
Electrode 
Design 
PtD-PPD-Naf1%x3-600UH2Ox5-
PEI1%-BSAGA, n = 4 
PtD-PPD-Naf1%x3-GA25%-
600UH2Ox5-PEI1%-BSAGA, n = 4 
[ᴅ-serine], 
µM 
Mean, 
J, µA.cm
-2
 
± SEM, 
J, µA.cm
-2
 
Mean, 
J, µA.cm
-2
 
± SEM, 
J, µA.cm
-2
 
0 0 0 0 0 
10 0.008 0.002 1.007 0.915 
20 0.011 0.005 1.193 1.067 
50 0.023 0.008 0.999 0.775 
100 0.063 0.016 1.323 0.845 
200 0.098 0.025 1.479 0.756 
500 0.143 0.031 2.817 1.155 
1000 0.260 0.049 5.274 1.379 
2000 0.401 0.081 8.029 1.569 
3000 0.533 0.103 12.126 2.929 
5000 0.698 0.143 18.525 2.892 
8000 0.915 0.182 20.343 2.888 
Table 9-13 
The ᴅ-ser calibration data for the recipes PtD-PPD-Naf1%x3-600UH2Ox5-PEI1%-BSAGA and PtD-PPD-
Naf1%x3-GA25%-600UH2Ox5-PEI1%-BSAGA. 
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Electrode 
Design 
PtD-PPD-Naf1%x3-GA-PEI1%-
600UH2Ox5-FAD, n = 4 
PtD-PPD-Naf1%x3-PEI1%-
600UH2Ox5-FAD, n = 4 
[ᴅ-serine], 
µM 
Mean, 
J, µA.cm
-2
 
± SEM, 
J, µA.cm
-2
 
Mean, 
J, µA.cm
-2
 
± SEM, 
J, µA.cm
-2
 
0 0 0 0 0 
10 0.059 0.012 0.007 0.001 
20 0.085 0.021 0.009 0.001 
50 0.168 0.030 0.013 0.002 
100 0.320 0.044 0.016 0.003 
200 0.508 0.081 0.023 0.005 
500 0.958 0.179 0.036 0.010 
1000 1.461 0.254 0.055 0.017 
2000 2.305 0.405 0.081 0.027 
3000 3.091 0.623 0.098 0.035 
5000 4.334 0.592 0.132 0.048 
8000 5.738 0.784 0.168 0.062 
10000 6.376 0.810 0.184 0.068 
Table 9-14 
The ᴅ-ser calibration data for the recipes PtD-PPD-Naf1%x3-600UH2Ox5-PEI1%-BSAGA and PtD-PPD-
Naf1%x3-GA25%-600UH2Ox5-PEI1%-BSAGA. 
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Electrode 
Design 
PtD-600UH2O 
n = 4 
PtD-600UH2Ox5 
n = 3 
PtD-600UH2Ox10 
n = 4 
PtD-600UH2Ox15 
n = 4 
ᴅ-Serine, 
µM 
Mean, 
J, 
µA.cm
-
2
 
± SEM, 
J, 
µA.cm
-
2
 
Mean, 
J, 
µA.cm
-
2
 
± SEM, 
J, 
µA.cm
-
2
 
Mean, 
J, 
µA.cm
-
2
 
± SEM, 
J, 
µA.cm
-
2
 
Mean, 
J, 
µA.cm
-
2
 
± SEM, 
J, 
µA.cm
-
2
 
0 0 0 0 0 0 0 0 0 
100 0.066 0.576 0.088 0.040 0.026 0.005 0.020 0.005 
200 -0.010 0.529 0.166 0.065 0.053 0.021 0.030 0.013 
400 -0.118 0.471 0.269 0.096 0.112 0.059 0.056 0.026 
600 -0.108 0.345 0.332 0.121 0.145 0.080 0.069 0.031 
800 -0.277 0.346 0.353 0.155 0.186 0.096 0.089 0.039 
1000 -0.343 0.306 0.447 0.184 0.206 0.108 0.100 0.045 
1500 -0.330 0.246 0.547 0.212 0.307 0.172 0.139 0.058 
2000 -0.346 0.180 0.610 0.238 0.364 0.214 0.169 0.073 
3000 -0.129 0.131 0.819 0.279 0.500 0.309 0.227 0.094 
4000 -0.024 0.047 0.946 0.307 0.597 0.373 0.270 0.110 
5000 0.019 0.008 1.050 0.332 0.681 0.422 0.305 0.124 
6000 0.031 0.081 1.109 0.358 0.749 0.461 0.338 0.137 
Table 10-1 
The ᴅ-ser calibration data for the recipes PtD-600UH2O, PtD-600UH2Ox5, PtD-600UH2Ox10 and PtD-
600UH2Ox15. 
Electrode 
Design 
PtD-[GA1%-
600UH2O]x1, n=4 
PtD-[GA1%-
600UH2O]x5, n=4 
PtD-[GA1%-
600UH2O]x10, 
n=4 
PtD-[GA1%-
600UH2O]x15, 
n=4 
ᴅ-Serine, 
µM 
Mean, 
J, 
µA.cm
-2
 
± SEM, 
J, 
µA.cm
-2
 
Mean, 
J, 
µA.cm
-2
 
± SEM, 
J, 
µA.cm
-2
 
Mean, 
J, 
µA.cm
-2
 
± SEM, 
J, 
µA.cm
-2
 
Mean, 
J, 
µA.cm
-2
 
± SEM, 
J, 
µA.cm
-2
 
0 0 0 0 0 0 0 0 0 
100 0.312 0.153 1.276 0.324 1.108 0.248 1.162 0.400 
200 0.616 0.283 2.474 0.626 2.233 0.452 2.400 0.755 
400 1.160 0.572 4.692 1.183 4.335 0.855 4.703 1.454 
600 1.693 0.858 6.827 1.727 6.629 1.147 7.298 2.099 
800 2.148 1.080 8.754 2.249 9.307 1.388 10.505 2.409 
1000 2.603 1.315 10.812 2.785 11.990 1.592 12.531 3.563 
1500 3.679 1.812 15.067 3.865 18.617 2.418 19.754 4.862 
2000 4.706 2.352 19.003 4.872 24.958 2.666 24.651 6.550 
3000 6.146 3.045 26.294 6.697 35.100 3.751 32.105 8.883 
4000 7.528 3.780 32.183 8.146 41.566 4.128 38.370 9.905 
5000 8.322 4.135 36.844 9.351 45.744 4.549 41.728 10.139 
6000 9.385 4.713 40.900 10.550 48.394 4.778 45.152 8.891 
Table 10-2 
The ᴅ-ser calibration data for the recipes PtD-[GA1%-600UH2O]x1, PtD-[GA1%-600UH2O]x5, PtD-
[GA1%-600UH2O]x10 and PtD-[GA1%-600UH2O]x15. 
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Electrode 
Design 
PtD-[600UH2O- 
GA1%]x1, n=3 
PtD-[600UH2O- 
GA1%]x5, n=4 
PtD-[600UH2O- 
GA1%]x10, n=3 
PtD-[600UH2O- 
GA1%]x15, n=3 
ᴅ-Serine, 
µM 
Mean, 
J, 
µA.cm
-2
 
± SEM, 
J, 
µA.cm
-2
 
Mean, 
J, 
µA.cm
-2
 
± SEM, 
J, 
µA.cm
-2
 
Mean, 
J, 
µA.cm
-2
 
± SEM, 
J, 
µA.cm
-2
 
Mean, 
J, 
µA.cm
-2
 
± SEM, 
J, 
µA.cm
-2
 
0 0 0 0 0 0 0 0 0 
100 11.282 9.555 0.321 0.093 0.412 0.085 0.329 0.067 
200 32.727 29.511 0.528 0.059 0.829 0.152 0.639 0.129 
400 35.710 29.273 1.154 0.255 1.741 0.307 1.192 0.297 
600 81.993 37.267 1.468 0.169 2.630 0.406 1.709 0.340 
800 77.739 33.124 1.776 0.185 3.445 0.513 2.169 0.496 
1000 75.096 30.248 2.135 0.179 4.381 0.523 2.649 0.639 
1500 75.707 27.856 2.995 0.212 6.319 0.764 3.830 0.936 
2000 69.449 26.844 3.780 0.225 8.149 0.961 4.784 1.039 
3000 71.964 22.584 5.321 0.307 11.494 1.278 6.677 1.620 
4000 68.731 23.861 7.199 0.538 14.360 1.468 8.313 1.871 
5000 92.747 61.589 8.232 0.463 16.786 1.492 9.769 2.312 
6000 100.256 67.989 9.439 0.475 15.246 1.748 10.349 2.258 
Table 10-3 
The ᴅ-ser calibration data for the recipes PtD-[600UH2O-GA1%]x1, PtD-[600UH2O-GA1%]x5, PtD-
[600UH2O-GA1%]x10 and PtD-[600UH2O-GA1%]x15. 
Electrode 
Design 
PtD-Sty-
600UH2Ox5, n=4 
PtD-Sty-
600UH2Ox10, n=4 
PtD-Sty-
600UH2Ox15, n=4 
PtD-Sty-
600UH2Ox20, n=4 
ᴅ-Serine, 
µM 
Mean, 
J, 
µA.cm
-2
 
± SEM, 
J, 
µA.cm
-2
 
Mean, 
J, 
µA.cm
-2
 
± SEM, 
J, 
µA.cm
-2
 
Mean, 
J, 
µA.cm
-2
 
± SEM, 
J, 
µA.cm
-2
 
Mean, 
J, 
µA.cm
-2
 
± SEM, 
J, 
µA.cm
-2
 
0 0 0 0 0 0 0 0 0 
40 0.194 0.059 0.135 0.018 0.223 0.106 0.062 0.032 
50 0.569 0.231 0.141 0.037 0.247 0.117 0.083 0.056 
60 0.560 0.253 0.219 0.033 0.358 0.173 0.140 0.087 
100 1.272 0.479 0.256 0.075 0.493 0.232 0.238 0.135 
200 2.572 0.946   0.995 0.479 0.399 0.141 
500 6.256 1.225 1.181 0.195 2.849 1.279 0.749 0.166 
1000 5.021 1.301 1.733 0.224 4.793 2.405 1.245 0.210 
2000 7.809 1.661 2.121 0.294 8.566 4.682 1.430 0.418 
3000 13.524 3.072   11.803 6.868 1.545 0.638 
5000 22.394 4.697 4.351 0.599 17.024 9.028 2.411 0.685 
8000 24.925 3.459   21.744 12.251 2.779 0.523 
10000 17.158 3.390 6.558 1.228 25.495 13.841 2.615 0.510 
15000 23.536 3.837 8.474 2.014 27.894 15.626 3.404 0.553 
Table 10-4 
The ᴅ-ser calibration data for the recipes PtD-Sty-600UH2Ox5, PtD-Sty-600UH2Ox10, PtD-Sty-
600UH2Ox15 and PtD-Sty-600UH2Ox20. 
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Electrode 
Design 
PtD-Sty-
[600UH2O-
GA1%]x10 
n = 3 
PtD-Sty-
[600UH2O-
BSA1%]x10 
n = 4 
PtD-Sty-
[600UH2O-
BSAGA]x10 
n = 4 
PtD-Sty-
[600UH2O-
BSAGA0.1%]x10
, n = 6 
[ᴅ-
Serine], 
µM 
Mean, 
J, 
µA.cm
-
2 
± SEM, 
J, 
µA.cm
-
2
 
Mean, 
J, 
µA.cm
-
2
 
± SEM, 
J, 
µA.cm
-
2
 
Mean, 
J, 
µA.cm
-
2
 
± SEM, 
J, 
µA.cm
-
2
 
Mean, 
J, 
µA.cm
-
2
 
± SEM, 
J, 
µA.cm
-
2
 
0 0 0 0 0 0 0 0 0 
40 0.413 0.123 0.016 0.005 0.116 0.007 0.014 0.005 
50 0.540 0.167 0.020 0.007 0.443 0.039 0.018 0.006 
60 0.674 0.217 0.023 0.007 0.578 0.021 0.023 0.008 
100 1.058 0.357 0.034 0.013 1.478 0.135 0.031 0.012 
200 1.745 0.531 
  
3.244 0.430   
500 3.866 0.754 0.100 0.045 7.450 1.410 0.102 0.042 
1000 7.756 0.687 0.158 0.073 11.775 3.559 0.158 0.064 
2000 12.241 1.789 0.256 0.121 19.892 5.609 0.256 0.097 
3000 17.179 2.015 
  
25.311 7.212   
5000 22.636 2.925 0.446 0.215 35.472 9.599 0.428 0.137 
8000 30.797 3.636 0.542 0.261 48.159 11.565   
10000 32.632 4.372 0.616 0.293 54.745 11.598 0.641 0.196 
15000 33.524 5.230 0.745 0.357 56.961 12.547 0.792 0.235 
Electrode 
Design 
PtD-Sty-
[600UPBS-
GA1%]x10 
n = 8 
PtD-Sty-
[600UPBS-
BSA1%]x10 
n = 4 
PtD-Sty-
[600UPBS-
BSAGA]x10 
n = 4 
PtD-Sty-
[600UPBS-
BSAGA0.1%]x10
, n = 4 
[ᴅ-
Serine], 
µM 
Mean, 
J, 
µA.cm
-
2 
± SEM, 
J, 
µA.cm
-
2
 
Mean, 
J, 
µA.cm
-
2
 
± SEM, 
J, 
µA.cm
-
2
 
Mean, 
J, 
µA.cm
-
2
 
± SEM, 
J, 
µA.cm
-
2
 
Mean, 
J, 
µA.cm
-
2
 
± SEM, 
J, 
µA.cm
-
2
 
0 0 0 0 0 0 0 0 0 
40 1.059 0.117 0.012 0.003 0.461 0.079 0.141 0.058 
50 1.363 0.179 0.024 0.012 0.802 0.086 0.240 0.117 
60 1.615 0.232 0.026 0.013 1.198 0.129 0.278 0.139 
100 2.554 0.339 0.040 0.019 2.061 0.214 0.414 0.205 
200 3.706 0.323 
  
3.633 0.413   
500 11.501 1.310 0.279 0.209 7.862 0.871 1.428 0.683 
1000 20.259 2.128 0.327 0.215 15.254 1.941 2.504 1.208 
2000 31.242 1.722 0.494 0.317 25.044 2.460 4.241 2.003 
3000 35.752 2.342 
  
31.282 3.507   
5000 61.669 6.792 0.840 0.535 42.030 5.363 4.800 0.699 
8000 64.132 8.105 1.068 0.687 48.061 5.096   
10000 65.104 2.974 1.128 0.717 50.088 5.616 7.178 1.585 
15000 71.378 3.628 1.388 0.884 52.639 6.014 8.363 1.711 
Table 10-5 
The ᴅ-ser calibration data for the recipes devised to examine the difference in sensitivity when 
600UPBS is used in place of 600UH2O. 
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Electrode 
Design 
PtD-Sty-[600UPBS-
GA0.1%]x10, n = 3 
PtD-Sty-[600UPBS-
GA0.2%]x10, n = 4 
PtD-Sty-[600UPBS-
GA0.5%]x10, n = 4 
[ᴅ-Serine], 
µM 
Mean, J, 
µA.cm
-2 
± SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
0 0 0 0 0 0 0 
40 0.128 0.052 0.105 0.023 1.077 0.228 
50 0.156 0.063 0.131 0.028 1.318 0.254 
60 0.199 0.079 0.157 0.034 1.376 0.289 
100 0.319 0.128 0.263 0.056 2.386 0.386 
500 1.445 0.582 1.214 0.259 9.706 0.649 
1000 2.711 1.095 2.303 0.493 17.039 0.594 
5000 9.975 3.956 8.408 1.779 47.084 5.087 
10000 15.096 5.894 12.973 2.733 57.512 7.593 
15000 
  
15.669 3.260 60.056 7.964 
Electrode 
Design 
PtD-Sty-[600UPBS-
GA1.0%]x10, n = 8 
PtD-Sty-[600UPBS-
GA1.5%]x10, n = 3 
PtD-Sty-[600UPBS-
GA2.0%]x10, n = 4 
[ᴅ-Serine], 
µM 
Mean, J, 
µA.cm
-2 
± SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
0 0 0 0 0 0 0 
40 1.059 0.117 1.343 0.365 0.892 0.280 
50 1.363 0.179 1.651 0.454 1.205 0.370 
60 1.615 0.232 1.572 0.504 1.486 0.464 
100 2.554 0.339 2.804 0.851 2.332 0.697 
500 11.501 1.310 9.088 2.681 10.827 3.137 
1000 20.259 2.128 15.089 4.366 18.802 5.284 
5000 61.669 6.792 31.184 4.142 31.215 7.849 
10000 65.104 2.974 34.235 3.586 31.428 7.409 
15000 71.378 3.628 35.431 3.530 32.067 7.117 
Table 10-6 
The ᴅ-ser calibration data for the general recipe PtD-Sty-[600UPBS-GA]x10. There were 6 difference 
percentages of GA used, 0.1%, 0.2%, 0.5%, 1%, 1.5% and 2%. 
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Electrode 
Design 
PtD-Sty-[600UPBSx2-
GA0.1%]x5, n = 3 
PtD-Sty-[600UPBSx2-
GA0.2%]x5, n = 3 
PtD-Sty-[600UPBSx2-
GA0.5%]x5, n = 3 
[ᴅ-Serine], 
µM 
Mean, J, 
µA.cm
-2 
± SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
0 0 0 0 0 0 0 
40 0.048 0.010 1.799 1.394 0.291 0.059 
50 0.053 0.008 1.942 1.419 0.365 0.077 
60 0.083 0.010 2.061 1.421 0.442 0.090 
100 0.141 0.019 2.470 1.452 0.720 0.162 
500 0.570 0.043 5.562 1.322 3.073 0.550 
1000 0.921 0.055 8.641 1.261 5.569 0.955 
5000 2.951 0.138 25.399 2.792 18.033 2.044 
10000 4.458 0.306 35.208 3.956 26.056 2.764 
15000 5.661 0.803 40.048 4.380 28.974 1.637 
Electrode 
Design 
PtD-Sty-[600UPBSx2-
GA1.0%]x5, n = 3 
PtD-Sty-[600UPBSx2-
GA1.5%]x5, n = 4 
PtD-Sty-[600UPBSx2-
GA2.0%]x5, n = 4 
[ᴅ-Serine], 
µM 
Mean, J, 
µA.cm
-2 
± SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
0 0 0 0 0 0 0 
40 1.043 0.109 0.177 0.081 0.439 0.079 
50 1.545 0.175 0.219 0.112 0.556 0.099 
60 1.789 0.205 0.254 0.136 0.657 0.118 
100 2.935 0.339 0.435 0.220 1.099 0.198 
500 12.058 2.079 1.902 1.041 5.166 1.101 
1000 21.545 3.556 3.609 2.072 9.792 2.047 
5000 65.100 17.933 12.200 6.584 30.439 5.323 
10000 74.314 20.277 17.740 8.186 41.681 7.246 
15000 77.684 21.290 19.792 8.904 46.945 8.301 
Table 10-7 
The ᴅ-ser calibration data for the general recipe PtD-Sty-[600UPBSx2-GA]x5. There were 6 difference 
percentages of GA used, 0.1%, 0.2%, 0.5%, 1%, 1.5% and 2%. 
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Electrode 
Design 
PtD-Sty-[600UPBSx5-
GA0.1%]x2, n = 4 
PtD-Sty-[600UPBSx5-
GA0.2%]x2, n = 4 
PtD-Sty-[600UPBSx5-
GA0.5%]x2, n = 3 
[ᴅ-Serine], 
µM 
Mean, J, 
µA.cm
-2 
± SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
0 0 0 0 0 0 0 
40 0.055 0.024 0.329 0.181 0.155 0.035 
50 0.089 0.027 0.320 0.035 0.185 0.040 
60 0.108 0.038 0.375 0.066 0.221 0.046 
100 0.161 0.050 1.086 0.378 0.384 0.083 
500 0.424 0.096 3.212 1.185 1.736 0.364 
1000 0.682 0.139 5.518 1.996 3.265 0.672 
5000 1.918 0.289 20.835 8.449 12.272 1.387 
10000 2.741 0.564 36.437 13.804 18.018 1.505 
15000 2.916 0.614 41.699 16.408 20.846 1.432 
Electrode 
Design 
PtD-Sty-[600UPBSx5-
GA1.0%]x2, n = 3 
PtD-Sty-[600UPBSx5-
GA1.5%]x2, n = 3 
PtD-Sty-[600UPBSx5-
GA2.0%]x2, n = 4 
[ᴅ-Serine], 
µM 
Mean, J, 
µA.cm
-2 
± SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
0 0 0 0 0 0 0 
40 1.445 0.227 0.265 0.075 0.025 0.005 
50 1.839 0.290 0.402 0.078 0.032 0.007 
60 2.223 0.351 0.491 0.081 0.042 0.008 
100 3.843 0.677 0.663 0.183 0.066 0.014 
500 12.970 0.974 5.238 1.450 0.267 0.056 
1000 24.393 1.684 9.232 2.645 0.469 0.100 
5000 89.386 3.351 33.581 3.296 1.676 0.348 
10000 121.585 7.145 43.259 6.206 2.639 0.549 
15000 137.583 9.136 
  
3.206 0.675 
Table 10-8 
The ᴅ-ser calibration data for the general recipe PtD-Sty-[600UPBSx5-GA]x2. There were 6 difference 
percentages of GA used, 0.1%, 0.2%, 0.5%, 1%, 1.5% and 2%. 
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Electrode 
Design 
PtD-Sty-
[600UPBS]x10-
GA0.1%, n = 4 
PtD-Sty-
[600UPBS]x10-
GA0.2%, n = 3 
PtD-Sty-
[600UPBS]x10-
GA0.5%, n = 4 
[ᴅ-Serine], 
µM 
Mean, J, 
µA.cm
-2 
± SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
0 0 0 0 0 0 0 
40 0.014 0.003 0.132 0.066 0.126 0.062 
50 0.018 0.003 0.166 0.060 0.171 0.081 
60 0.028 0.003 0.202 0.050 0.206 0.095 
100 0.048 0.007 0.496 0.208 0.316 0.159 
500 0.094 0.006 0.963 0.146 1.338 0.728 
1000 0.148 0.013 1.362 0.164 2.395 1.323 
5000 0.329 0.039 3.483 0.436 9.056 5.073 
10000 0.490 0.063 4.871 0.676 12.195 6.816 
15000 0.534 0.068 6.040 0.850 13.625 7.598 
Electrode 
Design 
PtD-Sty-
[600UPBS]x10-
GA1.0%, n = 4 
PtD-Sty-
[600UPBS]x10-
GA1.5%, n = 4 
PtD-Sty-
[600UPBS]x10-
GA2.0%, n = 4 
[ᴅ-Serine], 
µM 
Mean, J, 
µA.cm
-2 
± SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
0 0 0 0 0 0 0 
40 0.130 0.068 0.572 0.058 0.529 0.092 
50 0.168 0.091 0.703 0.075 0.697 0.114 
60 0.197 0.104 0.853 0.088 0.855 0.140 
100 0.333 0.168 1.376 0.143 1.425 0.237 
500 1.556 0.711 6.011 0.708 6.813 1.319 
1000 2.973 1.350 11.001 1.252 12.786 2.606 
5000 11.668 4.709 34.085 5.885 32.744 4.633 
10000 16.859 5.797 39.001 6.104 38.999 4.522 
15000 18.846 6.357 39.441 5.816 56.629 6.452 
Table 10-9 
The ᴅ-ser calibration data for the general recipe PtD-Sty-[600UPBS]x10-GA. There were 6 difference 
percentages of GA used, 0.1%, 0.2%, 0.5%, 1%, 1.5% and 2%. 
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Electrode 
Design 
PtD-Sty-[600UPBS-
BSAGA0.005%] 
x10, n = 3 
PtD-Sty-[600UPBS-
BSAGA0.01%] 
x10, n = 4 
PtD-Sty-[600UPBS-
BSAGA0.02%] 
x10, n = 4 
PtD-Sty-[600UPBS-
BSAGA0.05%] 
x10, n = 4 
[ᴅ-
Serine], 
µM 
Mean, 
J, 
µA.cm
-2 
± SEM, 
J, 
µA.cm-2 
Mean, 
J, 
µA.cm
-2
 
± SEM, 
J, 
µA.cm-2 
Mean, 
J, 
µA.cm
-2
 
± SEM, 
J, 
µA.cm-2 
Mean, 
J, 
µA.cm
-2
 
± SEM, 
J, 
µA.cm-2 
0 0 0 0 0 0 0 0 0 
40 0.006 0.003 0.099 0.042 0.025 0.007 0.114 0.042 
50 0.011 0.003 0.069 0.022 0.032 0.009 0.139 0.055 
60 0.007 0.005 0.057 0.017 0.034 0.010 0.163 0.064 
100 0.015 0.005 0.055 0.013 0.054 0.016 0.240 0.096 
500 0.039 0.030 0.096 0.018 0.175 0.048 0.682 0.268 
1000 0.073 0.052 0.146 0.027 0.289 0.075 1.057 0.407 
5000 0.242 0.210 0.333 0.065 0.804 0.200 2.723 0.963 
10000 0.446 0.315 0.444 0.090 1.044 0.254 3.622 1.227 
15000 0.472 0.368 0.504 0.106 1.141 0.278 3.819 1.189 
Electrode 
Design 
PtD-Sty-[600UPBS-
BSAGA0.1%]x10, n = 4 
PtD-Sty-[600UPBS-
BSAGA0.2%]x10, n = 4 
PtD-Sty-[600UPBS-
BSAGA0.5%]x10, n = 3 
[ᴅ-
Serine], 
µM 
Mean, J, 
µA.cm
-2 
± SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
0 0 0 0 0 0 0 
40 0.084 0.006 0.151 0.027 0.351 0.126 
50 0.122 0.011 0.200 0.042 0.373 0.163 
60 0.147 0.011 0.238 0.048 0.470 0.189 
100 0.220 0.014 0.437 0.078 0.724 0.308 
500 0.769 0.053 1.850 0.293 3.025 1.347 
1000 1.351 0.075 3.445 0.581 5.036 2.183 
5000 5.157 0.616 12.221 1.963 16.935 7.410 
10000 7.771 1.225 17.916 2.989 24.603 10.044 
15000 9.281 1.650 21.262 3.659 29.890 10.525 
Electrode 
Design 
PtD-Sty-[600UPBS-
BSAGA1.0%]x10, n = 3 
PtD-Sty-[600UPBS-
BSAGA1.5%]x10, n = 4 
PtD-Sty-[600UPBS-
BSAGA2.0%]x10, n = 4 
[ᴅ-
Serine], 
µM 
Mean, J, 
µA.cm
-2 
± SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
0 0 0 0 0 0 0 
40 0.409 0.135 0.139 0.022 0.322 0.019 
50 0.582 0.158 0.184 0.030 0.415 0.036 
60 0.721 0.198 0.212 0.033 0.500 0.043 
100 1.117 0.322 0.353 0.054 0.802 0.062 
500 4.313 1.245 1.503 0.199 3.294 0.273 
1000 8.653 2.401 2.392 0.298 5.917 0.565 
5000 27.743 9.555 10.111 1.344 20.232 2.588 
10000 41.858 14.278 15.408 1.736 27.158 3.593 
15000 50.849 17.153 18.335 1.988 30.760 4.522 
Table 10-10 
The ᴅ-ser calibration data for the general recipe PtD-Sty-[600UPBS-BSAGA]x10. Presented are the ten 
different solutions of BSAGA used. 
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Electrode 
Design 
PtD-Sty-[600UPBSx2-
BSAGA0.1%]x5, n = 3 
PtD-Sty-[600UPBSx2-
BSAGA0.2%]x5, n = 3 
PtD-Sty-[600UPBSx2-
BSAGA0.5%]x5, n = 3 
[ᴅ-
Serine], 
µM 
Mean, J, 
µA.cm
-2 
± SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
0 0 0 0 0 0 0 
40 0.001 0.006 -0.023 0.023 0.035 0.006 
50 0.006 0.009 -0.024 0.026 0.045 0.009 
60 0.008 0.012 -0.022 0.028 0.053 0.011 
100 0.018 0.010 -0.012 0.031 0.081 0.014 
500 0.085 0.010 0.100 0.053 0.293 0.058 
1000 0.153 0.030 0.196 0.067 0.471 0.087 
5000 0.508 0.193 0.958 0.218 1.413 0.214 
10000 0.771 0.309 1.489 0.282 2.061 0.311 
15000 0.957 0.408 2.002 0.389 2.521 0.384 
Electrode 
Design 
PtD-Sty-[600UPBSx2-
BSAGA1.0%]x5, n = 4 
PtD-Sty-[600UPBSx2-
BSAGA1.5%]x5, n = 4 
PtD-Sty-[600UPBSx2-
BSAGA2.0%]x5, n = 3 
[ᴅ-
Serine], 
µM 
Mean, J, 
µA.cm
-2 
± SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
0 0 0 0 0 0 0 
40 0.280 0.074 0.703 0.160 0.544 0.122 
50 0.391 0.108 0.905 0.205 0.663 0.160 
60 0.510 0.142 1.093 0.247 0.794 0.198 
100 0.915 0.269 1.829 0.413 1.403 0.357 
500 4.573 1.398 7.787 1.780 6.438 1.662 
1000 8.544 2.628 14.765 3.384 12.138 3.072 
5000 33.724 8.880 46.143 8.438 36.261 7.157 
10000 47.266 11.450 53.937 8.252 43.151 6.209 
15000 55.720 13.598 57.448 8.421 45.804 6.208 
Table 10-11 
The ᴅ-ser calibration data for the general recipe PtD-Sty-[600UPBSx2-BSAGA]x5. There were 6 
difference percentages of GA used within the BSAGA solution, 0.1%, 0.2%, 0.5%, 1.0%, 1.5% and 
2.0%. 
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Electrode 
Design 
PtD-Sty-[600UPBSx5-
BSAGA0.1%]x2, n = 3 
PtD-Sty-[600UPBSx5-
BSAGA0.2%]x2, n = 3 
PtD-Sty-[600UPBSx5-
BSAGA0.5%]x2, n = 3 
[ᴅ-
Serine], 
µM 
Mean, J, 
µA.cm
-2 
± SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
0 0 0 0 0 0 0 
40 0.112 0.106 0.039 0.009 0.885 0.161 
50 0.007 0.007 0.055 0.013 1.311 0.157 
60 0.087 0.078 0.076 0.012 1.550 0.270 
100 0.106 0.089 0.111 0.024 2.309 0.305 
500 0.083 0.016 0.445 0.067 10.748 1.675 
1000 0.246 0.085 0.822 0.116 18.928 2.571 
5000 0.793 0.188 2.528 0.354 46.271 5.435 
10000 1.181 0.182 3.686 0.466 66.646 23.226 
15000 1.130 0.176 4.475 0.521 74.560 28.064 
Electrode 
Design 
PtD-Sty-[600UPBSx5-
BSAGA1.0%]x2, n = 4 
PtD-Sty-[600UPBSx5-
BSAGA1.5%]x2, n = 4 
PtD-Sty-[600UPBSx5-
BSAGA2.0%]x2, n = 4 
[ᴅ-
Serine], 
µM 
Mean, J, 
µA.cm
-2 
± SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
0 0 0 0 0 0 0 
40 2.032 0.102 1.307 0.248 1.203 0.276 
50 2.588 0.125 1.694 0.322 1.630 0.348 
60 3.130 0.141 2.042 0.391 1.912 0.448 
100 4.852 0.209 3.266 0.623 3.470 0.757 
500 19.949 0.703 14.602 2.813 13.299 2.347 
1000 33.700 1.619 25.747 4.410 24.934 4.793 
5000 55.316 6.393 53.520 2.778 57.345 9.037 
10000 56.598 7.632 59.377 3.005 69.739 10.001 
15000 57.162 7.520 62.018 3.390 74.886 10.971 
Table 10-12 
The ᴅ-ser calibration data for the general recipe PtD-Sty-[600UPBSx5-BSAGA]x2. There were 6 
difference percentages of GA used within the BSAGA solution, 0.1%, 0.2%, 0.5%, 1.0%, 1.5% and 
2.0%. 
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Electrode 
Design 
PtD-Sty-
PEI1.0%-
[600UPBSx5-
BSAGA1.0%]x2, 
n=4 
PtD-Sty-
PEI1.0%-
[600UPBSx2-
BSAGA1.0%]x5, 
n=4 
PtD-Sty-
PEI1.0%-
[600UPBSx5-
GA1.0%]x2, 
n=4 
PtD-Sty-
PEI1.0%-
[600UPBSx2-
GA1.0%]x5, 
n=4 
ᴅ-Serine, 
µM 
Mean, 
J, 
µA.cm
-
2
 
± SEM, 
J, 
µA.cm
-2
 
Mean, 
J, 
µA.cm
-
2
 
± SEM, 
J, 
µA.cm
-
2
 
Mean, 
J, 
µA.cm
-
2
 
± SEM, 
J, 
µA.cm
-
2
 
Mean, 
J, 
µA.cm
-
2
 
± SEM, 
J, 
µA.cm
-
2
 
0 0 0 0 0 0 0 0 0 
40 0.237 0.064 0.136 0.019 1.449 0.956 0.281 0.069 
50 0.291 0.067 0.183 0.026 1.853 1.216 0.340 0.083 
60 0.431 0.093 0.229 0.033 2.238 1.477 0.439 0.102 
100 0.736 0.145 0.353 0.048 3.617 2.409 0.694 0.172 
500 3.598 0.617 1.530 0.226 5.253 0.326 3.080 0.755 
1000 6.254 1.031 2.739 0.399 13.744 4.497 5.597 1.328 
5000 24.177 3.960 9.259 1.378 36.973 4.930 18.771 4.096 
10000 33.920 5.611 13.429 1.687 52.171 8.021 28.821 5.453 
15000 39.755 6.570 15.837 1.846 60.183 9.254 33.138 6.408 
Table 10-13 
The ᴅ-ser calibration data for the recipes which included PEI1.0% after the dip into Sty and before a 
dip into 600UPBS. 
Electrode 
Design 
PtD-Sty-
PEI0.1%-
[600UPBSx5-
BSAGA1.0%]x2, 
n=4 
PtD-Sty-
PEI0.1%-
[600UPBSx2-
BSAGA1.0%]x5, 
n=3 
PtD-Sty-
PEI0.1%-
[600UPBSx5-
GA1.0%]x2, 
n=4 
PtD-Sty-
PEI0.1%-
[600UPBSx2-
GA1.0%]x5, 
n=4 
ᴅ-Serine, 
µM 
Mean, 
J, 
µA.cm
-
2
 
± SEM, 
J, 
µA.cm
-2
 
Mean, 
J, 
µA.cm
-
2
 
± SEM, 
J, 
µA.cm
-
2
 
Mean, 
J, 
µA.cm
-
2
 
± SEM, 
J, 
µA.cm
-
2
 
Mean, 
J, 
µA.cm
-
2
 
± SEM, 
J, 
µA.cm
-
2
 
0 0 0 0 0 0 0 0 0 
40 0.431 0.056 0.905 0.088 0.344 0.078 0.216 0.015 
50 0.561 0.077 0.965 0.064 0.442 0.100 0.277 0.017 
60 0.669 0.090 1.123 0.071 0.539 0.123 0.363 0.024 
100 1.100 0.151 1.507 0.106 0.863 0.199 0.574 0.038 
500 4.936 0.711 13.802 7.253 3.539 0.831 2.567 0.629 
1000 8.934 1.248 17.870 7.338 6.258 1.434 4.903 0.999 
5000 27.165 3.349 40.386 5.066 19.959 4.488 16.958 2.169 
10000 41.419 4.924 47.745 3.267 28.320 6.128 24.101 2.484 
15000 47.871 5.381 54.600 1.682 31.950 6.770 27.098 2.925 
Table 10-14 
The ᴅ-ser calibration data for the recipes which included PEI0.1% after the dip into Sty and before a 
dip into 600UPBS. 
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Electrode 
Design 
PtD-Sty-
PEI5.0%-
[600UPBSx5-
BSAGA1.0%]x2-
PEI1.0%(5), n=4 
PtD-Sty-
PEI5.0%-
[600UPBSx2-
BSAGA1.0%]x5-
PEI1.0%(5), n=4 
PtD-Sty-
PEI5.0%-
[600UPBSx5-
GA1.0%]x2-
PEI1.0%(5), n=3 
PtD-Sty-
PEI5.0%-
[600UPBSx2-
GA1.0%]x5-
PEI1.0%(5), n=4 
ᴅ-Serine, 
µM 
Mean, 
J, 
µA.cm
-
2
 
± SEM, 
J, 
µA.cm
-2
 
Mean, 
J, 
µA.cm
-
2
 
± SEM, 
J, 
µA.cm
-
2
 
Mean, 
J, 
µA.cm
-
2
 
± SEM, 
J, 
µA.cm
-
2
 
Mean, 
J, 
µA.cm
-
2
 
± SEM, 
J, 
µA.cm
-
2
 
0 0 0 0 0 0 0 0 0 
40 0.146 0.036 0.344 0.083 0.186 0.016 0.020 0.012 
50 0.187 0.045 0.405 0.086 0.224 0.025 0.189 0.055 
60 0.242 0.051 0.519 0.099 0.279 0.029 0.260 0.064 
100 0.402 0.087 0.791 0.152 0.632 0.134 0.718 0.175 
500 1.771 0.406 3.683 0.773 2.568 0.155 4.230 0.772 
1000 1.710 0.364 7.154 1.436 4.618 0.201 9.453 1.772 
5000 11.846 2.563 21.960 3.642 16.283 0.453 32.061 5.149 
10000 11.488 2.443 29.890 4.959 24.728 0.463 47.140 8.466 
15000 16.819 3.521 33.718 5.014 31.408 1.314 52.292 8.261 
Table 10-15 
The ᴅ-ser calibration data for the recipes which included PEI5.0% after the dip into Sty and before a 
dip into 600UPBS and a dip into PEI1.0% on the fifth layer after the other dips had been applied. 
Electrode 
Design 
PtD-Sty-
PEI5.0%-
[600UPBSx5-
BSAGA1.0%]x2-
PEI0.1%(5), n=4 
PtD-Sty-
PEI5.0%-
[600UPBSx2-
BSAGA1.0%]x5-
PEI0.1%(5), n=4 
PtD-Sty-
PEI5.0%-
[600UPBSx5-
GA1.0%]x2-
PEI0.1%(5), n=3 
PtD-Sty-
PEI5.0%-
[600UPBSx2-
GA1.0%]x5-
PEI0.1%(5), n=4 
ᴅ-Serine, 
µM 
Mean, 
J, 
µA.cm
-
2
 
± SEM, 
J, 
µA.cm
-2
 
Mean, 
J, 
µA.cm
-
2
 
± SEM, 
J, 
µA.cm
-
2
 
Mean, 
J, 
µA.cm
-
2
 
± SEM, 
J, 
µA.cm
-
2
 
Mean, 
J, 
µA.cm
-
2
 
± SEM, 
J, 
µA.cm
-
2
 
0 0 0 0 0 0 0 0 0 
40 0.309 0.063 0.363 0.077 0.032 0.009 0.344 0.050 
50 0.419 0.091 0.456 0.088 0.040 0.010 0.475 0.064 
60 0.500 0.101 0.571 0.110 0.051 0.013 0.511 0.068 
100 0.759 0.154 0.929 0.177 0.076 0.019 0.908 0.109 
500 3.268 0.660 3.780 0.694 0.382 0.080 4.428 0.538 
1000 6.004 1.233 7.586 1.564 0.710 0.144 8.909 1.111 
5000 20.729 4.214 23.270 3.717 2.748 0.685 29.147 4.158 
10000 31.840 6.194 32.071 5.697 4.660 1.160 44.843 6.177 
15000 38.424 7.179 36.423 7.185 5.418 1.426 49.801 7.614 
Table 10-16 
The ᴅ-ser calibration data for the recipes which included PEI5.0% after the dip into Sty and before a 
dip into 600UPBS and a dip into PEI0.1% on the fifth layer after the other dips had been applied. 
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Electrode 
Design 
PtD-Sty-
[600UPBSx5-
FAD0.02(befE)-
BSAGA1.0%]x2, 
n=4 
PtD-Sty-
[600UPBSx2-
FAD0.02(befE)-
BSAGA1.0%]x5, 
n=4 
PtD-Sty-
[600UPBSx5-
FAD0.02(befE)-
GA1.0%]x2, n=3 
PtD-Sty-
[600UPBSx2-
FAD0.02(befE)-
GA1.0%]x5, n=4 
ᴅ-Serine, 
µM 
Mean, 
J, 
µA.cm
-
2
 
± SEM, 
J, 
µA.cm
-2
 
Mean, 
J, 
µA.cm
-
2
 
± SEM, 
J, 
µA.cm
-
2
 
Mean, 
J, 
µA.cm
-
2
 
± SEM, 
J, 
µA.cm
-
2
 
Mean, 
J, 
µA.cm
-
2
 
± SEM, 
J, 
µA.cm
-
2
 
0 0 0 0 0 0 0 0 0 
40 0.513 0.162 0.501 0.050 0.648 0.155 0.371 0.071 
50 1.065 0.170 0.694 0.075 0.630 0.142 0.463 0.093 
60 1.177 0.124 0.853 0.094 0.739 0.151 0.447 0.100 
100 1.673 0.116 1.331 0.140 1.139 0.189 0.914 0.179 
500 6.586 0.490 6.393 0.743 4.401 0.504 3.583 0.712 
1000 12.397 0.861 10.162 0.806 7.926 0.869 6.347 1.063 
5000 41.804 3.401 30.663 3.618 23.062 3.333 21.794 2.910 
10000 60.417 5.403 43.458 4.898 33.462 4.708 31.867 4.215 
15000 71.160 5.558 49.850 5.540 36.742 5.494 36.950 4.709 
Table 10-17 
The ᴅ-ser calibration data for the recipes which included FAD0.02 before the dip into 600UPBS on the 
same layers that BSAGA or GA were to be applied. 
Electrode 
Design 
PtD-Sty-
[600UPBSx5-
FAD0.08-
BSAGA1.0%]x2 
n = 4 
PtD-Sty-
[600UPBSx2-
FAD0.08-
BSAGA1.0%]x5 
n = 4 
PtD-Sty-
[600UPBSx5-
FAD0.08-
GA1.0%]x2 
n = 3 
PtD-Sty-
[600UPBSx2-
FAD0.08-
GA1.0%]x5 
n = 4 
ᴅ-Serine, 
µM 
Mean, 
J, 
µA.cm
-
2
 
± SEM, 
J, 
µA.cm
-2
 
Mean, 
J, 
µA.cm
-
2
 
± SEM, 
J, 
µA.cm
-
2
 
Mean, 
J, 
µA.cm
-
2
 
± SEM, 
J, 
µA.cm
-
2
 
Mean, 
J, 
µA.cm
-
2
 
± SEM, 
J, 
µA.cm
-
2
 
0 0 0 0 0 0 0 0 0 
40 0.162 0.028 0.720 0.148 1.716 0.360 1.392 0.276 
50 0.159 0.027 0.853 0.172 2.168 0.461 1.774 0.346 
60 0.244 0.026 1.018 0.188 2.497 0.525 2.102 0.412 
100 0.323 0.042 1.644 0.314 3.961 0.873 3.293 0.657 
500 0.485 0.058 7.183 1.379 18.193 3.424 14.896 3.010 
1000 2.259 0.319 12.660 2.222 31.241 5.833 26.588 5.394 
5000 3.894 0.459 32.676 2.999 50.500 5.368 57.888 12.118 
10000 14.213 1.394 39.511 3.875 53.707 5.487 67.694 13.442 
15000 20.040 1.464 42.301 4.299 55.013 5.691 69.579 12.254 
Table 10-18 
The ᴅ-ser calibration data for the recipes which included FAD0.08 after the dip into 600UPBS and 
before the BSAGA or GA dip was applied. It was only used on the same layers that BSAGA or GA was 
to be applied. 
  
11. APPENDIX 3: MEAN AND SEM DATA 
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Electrode 
Design 
PtC-Sty-[600UPBSx5- 
GA1.0%]x2, n = 4 
Normal 
PtC-Sty-[600UPBSx5- 
GA1.0%]x2, n = 4 
Inverted 
PtC-Sty-[600UPBSx5- 
GA1.0%]x2, n = 4 
Spun 
ᴅ-Serine, 
µM 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
0 0 0 0 0 0 0 
40 0.189 0.037 0.030 0.007 0.224 0.080 
50 0.208 0.036 0.049 0.012 0.333 0.112 
60 0.265 0.040 0.070 0.024 0.382 0.131 
100 0.359 0.073 0.124 0.040 0.693 0.237 
200 0.616 0.136 0.219 0.048 1.282 0.451 
500 1.885 0.387 0.590 0.163 3.466 1.077 
1000 3.485 0.555 1.026 0.258 4.568 1.458 
2000 4.591 0.920 2.434 0.528 8.524 2.291 
3000 6.056 1.075 3.099 0.635 11.582 2.348 
5000 8.058 1.076 4.076 0.752 12.943 2.684 
8000 9.971 1.689 6.771 1.220 13.400 2.300 
10000 9.056 1.426 5.297 0.898 13.492 1.757 
15000 10.557 0.657 5.207 0.584 13.944 2.402 
Table 11-1 
The ᴅ-ser calibration data returned when the recipe PtC-Sty-[600UPBSx5- GA1.0%]x2 was examined 
under different drying conditions. 
Electrode 
Design 
PtC-MMA-
[600UPBSx5-
GA1.0%]x2, n = 8 
PtC-Sty-
[600UPBSx5- 
GA1.0%]x2, n = 4 
PtC-{MMA-
[600UPBSx5-
GA1.0%]x2}x2 n=8 
PtC-{Sty-
[600UPBSx5-
GA1.0%]x2}x2 n=8 
ᴅ-Serine, 
µM 
Mean, 
J, 
µA.cm
-
2
 
± SEM, 
J, 
µA.cm
-2
 
Mean, 
J, 
µA.cm
-
2
 
± SEM, 
J, 
µA.cm
-
2
 
Mean, 
J, 
µA.cm
-
2
 
± SEM, 
J, 
µA.cm
-
2
 
Mean, 
J, 
µA.cm
-
2
 
± SEM, 
J, 
µA.cm
-
2
 
0 0 0 0 0 0 0 0 0 
40 0.422 0.144 0.224 0.080 0.609 0.079 0.414 0.047 
50 0.562 0.119 0.333 0.112 1.154 0.109 0.582 0.068 
60 0.730 0.184 0.382 0.131 1.331 0.147 0.611 0.074 
100 1.131 0.254 0.693 0.237 2.096 0.180 1.124 0.147 
200 2.428 0.535 1.282 0.451 5.271 0.350 2.551 0.316 
500 3.600 0.714 3.466 1.077 11.434 1.095 5.516 0.497 
1000 6.433 1.050 4.568 1.458 18.556 1.700 9.399 0.928 
2000 8.842 1.327 8.524 2.291 23.811 2.120 13.788 1.132 
3000 10.332 1.535 11.582 2.348 25.598 2.326 15.958 1.308 
5000 11.855 1.531 12.943 2.684 26.502 2.549 18.595 1.568 
8000 12.603 1.530 13.400 2.300 27.647 2.635 19.323 2.033 
10000 13.089 1.528 13.492 1.757 27.452 2.640 19.861 2.228 
15000 13.845 1.469 13.944 2.402 27.808 2.644 20.954 2.614 
Table 11-2 
The ᴅ-ser calibration data returned when MMA and Sty were compared over one and two 
applications for the general recipe PtC-{X-[600UPBSx5-GA1.0%]x2}x1/x2. 
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Electrod
e Design 
PtC-{MMA-
[600UPBSx5-
GA1%]x2}x2 
n = 8 
PtC-{MMA-
[600UPBSx2-
GA1%]x5}x2 
n = 4 
PtC-{MMA-
[600UPBSx5-
BSAGA1%]x2}x2 
n = 4 
PtC-{MMA-
[600UPBSx2-
BSAGA1%]x5}x2 
n = 4 
ᴅ-Serine, 
µM 
Mean, 
J, 
µA.cm
-
2
 
± SEM, 
J, 
µA.cm
-2
 
Mean, 
J, 
µA.cm
-
2
 
± SEM, 
J, 
µA.cm
-2
 
Mean, 
J, 
µA.cm
-
2
 
± SEM, 
J, 
µA.cm
-2
 
Mean, 
J, 
µA.cm
-
2
 
± SEM, 
J, 
µA.cm
-
2
 
0 0 0 0 0 0 0 0 0 
40 0.609 0.079 0.319 0.020 0.021 0.001 0.350 0.089 
50 1.154 0.109 0.406 0.024 0.022 0.002 0.417 0.091 
60 1.331 0.147 0.523 0.031 0.032 0.003 0.505 0.105 
100 2.096 0.180 0.817 0.054 0.042 0.004 0.818 0.173 
500 11.434 1.095 3.641 0.231 0.190 0.019 3.281 0.661 
1000 18.556 1.700 6.083 0.394 0.332 0.036 5.826 1.165 
5000 26.502 2.549 15.540 0.422 1.361 0.123 15.795 2.690 
10000 27.452 2.640 19.991 1.195 2.733 0.282 18.754 3.252 
15000 27.808 2.644 21.256 1.233 3.105 0.322 21.915 3.778 
Table 11-3 
The ᴅ-ser calibration data returned when MMA replaced Sty and a second application was 
incorporated into the four best designs from Section 5.4.4. 
Electrode 
Design 
PtC-{MMA-
[600UPBSx5-
GA1%]x2}x2 
n = 8 
PtC-{MMA-
[600UPBSx5-
GA1.0%]x2-
FAD0.08(5)}x2, n = 4 
PtC-{MMA-
[600UPBSx5-FAD0.08-
GA1.0%]x2}-x2, n = 4 
ᴅ-Serine, 
µM 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
0 0 0 0 0 0 0 
40 0.609 0.079 0.638 0.090 0.673 0.046 
50 1.154 0.109 1.073 0.081 0.908 0.076 
60 1.331 0.147 0.990 0.093 1.084 0.083 
100 2.096 0.180 1.684 0.150 1.692 0.108 
200 5.271 0.350 3.883 0.410 
  
500 11.434 1.095 6.565 1.082 6.305 0.410 
1000 18.556 1.700 10.347 1.479 11.892 0.634 
2000 23.811 2.120 17.353 1.402 
  
3000 25.598 2.326 22.058 1.808 
  
5000 26.502 2.549 25.190 1.960 25.768 1.488 
8000 27.647 2.635 27.735 1.882 
  
10000 27.452 2.640 28.971 1.914 28.151 1.449 
15000 27.808 2.644 29.817 1.833 27.962 1.617 
Table 11-4 
The ᴅ-ser calibration data returned when MMA replaced Sty and a second application was 
incorporated into the four best designs from Section 5.4.4. 
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Electrode 
Design 
PtC-{MMA-
[600UPBSx5-
GA1%]x2}x2 
DAY 0, n = 4 
PtC-{MMA-
[600UPBSx5-
GA1%]x2}x2 
DAY 1, n = 4 
PtC-{MMA-
[600UPBSx5-
GA1%]x2}x2 
DAY 4, n = 4 
[ᴅ-Serine], 
µM 
Mean, J, 
µA.cm
-2 
± SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
0 0 0 0 0 0 0 
40 1.224 0.158 0.895 0.142 0.393 0.087 
50 1.540 0.194 1.362 0.134 0.505 0.118 
60 2.162 0.163 1.338 0.288 0.653 0.154 
100 3.526 0.258 2.161 0.377 1.069 0.249 
500 13.650 1.648 6.656 1.231 7.455 0.901 
1000 20.724 2.744 12.243 2.226 9.445 1.908 
5000 30.996 2.652 25.088 2.635 17.563 2.381 
10000 31.778 2.648 27.149 2.598 19.991 1.437 
15000 32.053 2.564 27.983 2.433 20.836 1.440 
Electrode 
Design 
PtC-{MMA-
[600UPBSx5-
GA1%]x2}x2-MMA 
DAY 0, n = 4 
PtC-{MMA-
[600UPBSx5-
GA1%]x2}x2-MMA 
DAY 1, n = 4 
PtC-{MMA-
[600UPBSx5-
GA1%]x2}x2-MMA 
DAY 4, n = 4 
[ᴅ-Serine], 
µM 
Mean, J, 
µA.cm
-2 
± SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
0 0 0 0 0 0 0 
50 1.649 0.102 1.539 0.093 1.706 0.112 
100 2.995 0.103 2.889 0.193 3.317 0.132 
500 12.654 0.618 11.682 1.500 12.886 0.902 
1000 21.932 0.620 26.313 2.608 22.782 1.418 
5000 29.607 0.638 40.837 3.043 35.815 1.825 
10000 31.625 0.697 42.387 3.692 41.805 2.483 
15000 32.261 0.664 41.306 2.844 41.507 2.387 
Table 11-5 
The ᴅ-ser calibration data from for the general recipe PtC-{MMA-[600UPBSx5-GA1%]x2}x2 and PtC-
{MMA-[600UPBSx5-GA1%]x2}x2-MMA over 4 days. 
 Appendix 3 
338 
Electrode 
Design 
PtC 
n = 24 
Electrode 
Design 
PtC 
n = 8 
[H2O2], µM 
Mean, J, 
µA.cm
-2 
± SEM, J, 
µA.cm
-2
 
[AA], µM 
Mean, J, 
µA.cm
-2 
± SEM, J, 
µA.cm
-2
 
0 0 0 0 0 0 
1 0.168 0.016 200 94.334 6.620 
2 0.351 0.037 400 176.127 12.642 
5 0.942 0.065 600 267.090 11.766 
10 1.833 0.158 800 355.075 18.079 
20 3.421 0.318 1000 437.895 30.164 
50 8.352 0.702    
150 17.838 1.399    
200 32.751 2.984    
500 82.505 7.277    
1000 170.793 15.341    
Table 11-6 
Calibration responses obtained for H2O2 and AA on PtC. 
Polymerisation 
Method 
PPD 
n = 16 
PPDCV 
n = 4 
[AA], µM 
Mean, J, 
µA.cm
-2 
± SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2 
± SEM, J, 
µA.cm
-2
 
0 0 0 0 0 
200 0.156 0.013 0.042 0.018 
400 0.212 0.016 0.070 0.036 
600 0.235 0.019 0.096 0.053 
800 0.245 0.019 0.122 0.070 
1000 0.236 0.017 0.152 0.087 
Table 11-7 
Calibration responses obtained for AA on PtC-PPD-{MMA-[600UPBSx5-GA1%]x2}x2-MMA and PtC-
PPDCV-{MMA-[600UPBSx5-GA1%]x2}x2-MMA. 
Interference 
Layers 
Naf-PPD 
n = 24 
Naf-PPDCV 
n = 4 
[AA], µM 
Mean, J, 
µA.cm
-2 
± SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2 
± SEM, J, 
µA.cm
-2
 
0 0 0 0 0 
200 0.032 0.011 0.058 0.011 
400 0.019 0.014 0.083 0.015 
600 0.011 0.019 0.102 0.018 
800 0.001 0.025 0.115 0.020 
1000 -0.011 0.030 0.106 0.018 
Table 11-8 
Calibration responses obtained for AA on PtC-Naf-PPD-{MMA-[600UPBSx5-GA1%]x2}x2-MMA and 
PtC-Naf-PPDCV-{MMA-[600UPBSx5-GA1%]x2}x2-MMA. 
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Electrod
e Design 
No interferent 
rejection layer 
n = 16 
with Naf-PPD 
n = 52 
 with PPD 
n = 4 
with PPDCV 
n = 4 
ᴅ-Serine, 
µM 
Mean, 
J, 
µA.cm
-
2
 
± SEM, 
J, 
µA.cm
-2
 
Mean, 
J, 
µA.cm
-
2
 
± SEM, 
J, 
µA.cm
-2
 
Mean, 
J, 
µA.cm
-
2
 
± SEM, 
J, 
µA.cm
-2
 
Mean, 
J, 
µA.cm
-
2
 
± SEM, 
J, 
µA.cm
-
2
 
0 0 0 0 0 0 0 0 0 
1 0.062 0.006 0.018 0.002 0.047 0.008 0.043 0.002 
2 0.125 0.009 0.032 0.003 0.097 0.016 0.099 0.006 
5 0.233 0.013 0.052 0.004 0.217 0.037 0.221 0.020 
10 0.409 0.020 0.085 0.007 0.407 0.074 0.453 0.047 
20 0.707 0.040 0.154 0.015 0.728 0.130 1.049 0.133 
50 1.628 0.113 0.490 0.032 1.447 0.229 1.901 0.151 
100 3.126 0.247 1.040 0.071 2.775 0.451 4.191 0.463 
200 9.518 0.751 2.136 0.161 
  
  
500 12.955 0.889 5.232 0.335 12.223 2.005 15.494 1.123 
1000 21.422 1.429 9.275 0.582 21.515 3.439 25.408 1.580 
2000 30.605 1.908 14.439 0.845 
  
  
3000 31.960 1.855 16.935 0.969 
  
  
5000 32.091 1.669 19.267 1.063 34.411 4.045 37.293 1.541 
10000 33.812 1.520 21.750 1.140 39.643 5.848 38.955 1.473 
15000 33.584 1.465 22.745 1.163 39.135 5.374 39.333 1.383 
Table 11-9 
The ᴅ-ser calibration data returned when calibrations were performed to elucidate the effect upon 
sensitivity of the interferent rejection layers. 
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Calibration Cal 1, n = 8 Cal 2, n = 8 Cal 3, n = 8 
[ᴅ-Serine], 
µM 
Mean, J, 
µA.cm
-2 
± SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
0 0 0 0 0 0 0 
1 0.012 0.004 0.018 0.010 0.017 0.006 
2 0.025 0.008 0.031 0.012 0.022 0.006 
5 0.044 0.015 0.062 0.016 0.045 0.011 
10 0.075 0.025 0.073 0.019 0.072 0.020 
20 0.162 0.051 0.111 0.028 0.125 0.025 
50 0.282 0.092 0.225 0.068 0.212 0.043 
100 0.367 0.109 0.327 0.088 0.414 0.103 
200 0.459 0.133 0.484 0.086 0.422 0.082 
500 0.761 0.238 0.711 0.166 0.750 0.154 
1000 1.659 0.664 1.416 0.337 1.414 0.298 
2000 3.492 1.094 3.551 0.863 3.912 0.708 
3000 6.610 1.811 6.612 1.414 5.120 0.933 
5000 11.228 2.920 11.008 2.357 9.281 1.521 
8000 13.456 3.168 12.978 2.386 10.955 1.817 
10000 14.450 3.234 15.531 2.626 14.104 2.079 
15000 17.069 3.123 18.547 2.288 15.669 2.319 
Calibration Cal 4, n =8 Cal 5, n = 8 Cal 6, n = 8 
[ᴅ-Serine], 
µM 
Mean, J, 
µA.cm
-2 
± SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
0 0 0 0 0 0 0 
1 0.012 0.003 0.008 0.003 0.000 0.005 
2 0.015 0.003 0.016 0.004 -0.005 0.012 
5 0.027 0.004 0.028 0.006 0.025 0.006 
10 0.044 0.007 0.089 0.027 0.036 0.010 
20 0.087 0.017 0.118 0.026 0.056 0.009 
50 0.161 0.028 0.245 0.048 0.129 0.035 
100 0.231 0.044 0.309 0.058 0.158 0.038 
200 0.242 0.043 0.376 0.071 0.210 0.033 
500 0.400 0.068 0.669 0.107 0.431 0.085 
1000 1.406 0.317 0.940 0.175 0.820 0.174 
2000 2.670 0.555 2.140 0.430 1.833 0.377 
3000 3.788 0.595 4.935 0.839 4.157 0.812 
5000 6.323 1.084 7.651 1.408 6.586 1.262 
8000 8.267 1.454 9.039 1.686 7.859 1.450 
10000 10.941 1.955 10.595 2.026 9.667 1.896 
15000 12.516 1.899 12.467 2.228 10.919 2.196 
Table 11-10 
The ᴅ-ser calibration data from obtained when biosensors were calibrated 6 times over a 2 day 
period. 
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Calibration Day 0, n = 4 Day 1, n = 4 Day 3, n = 4 
[ᴅ-Serine], 
µM 
Mean, J, 
µA.cm
-2 
± SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
0 0 0 0 0 0 0 
1 0.026 0.014 0.015 0.003 0.014 0.001 
2 0.030 0.008 0.023 0.003 0.018 0.001 
5 0.052 0.003 0.053 0.011 0.029 0.004 
10 0.109 0.020 0.063 0.012 0.048 0.003 
20 0.177 0.003 0.088 0.013 0.111 0.008 
50 0.492 0.055 0.358 0.059 0.260 0.023 
100 0.950 0.122 0.783 0.111 0.506 0.055 
200 1.914 0.243 1.668 0.233 0.943 0.114 
500 4.967 0.316 4.189 0.632 2.171 0.321 
1000 8.641 1.112 7.279 1.174 5.006 0.908 
2000 13.534 1.405 12.396 1.954 7.482 1.115 
3000 15.481 1.997 14.130 1.987 9.897 1.526 
5000 17.399 1.745 17.000 2.284 12.716 1.743 
8000 18.238 1.548 18.092 2.309 15.710 2.017 
10000 18.675 1.348 18.749 2.248 16.129 1.996 
15000 18.702 1.510 19.728 2.151 18.141 2.401 
Calibration Day 7, n = 4 Day 21, n = 4 Day 28, n = 4 
[ᴅ-Serine], 
µM 
Mean, J, 
µA.cm
-2 
± SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
0 0 0 0 0 0 0 
1 -0.007 0.005 0.014 0.002 0.002 0.001 
2 0.002 0.008 0.010 0.001 0.009 0.001 
5 0.009 0.007 0.015 0.000 0.016 0.004 
10 0.017 0.008 0.037 0.004 0.039 0.011 
20 0.036 0.010 0.067 0.005 0.078 0.025 
50 0.283 0.040 0.158 0.014 0.157 0.023 
100 0.489 0.059 0.260 0.037 0.291 0.040 
200 0.999 0.132 0.679 0.020 0.578 0.061 
500 2.202 0.254 1.529 0.070 1.236 0.124 
1000 4.614 0.517 3.198 0.319 2.239 0.210 
2000 7.710 0.871 5.619 0.730 4.227 0.462 
3000 10.156 1.116 6.773 0.748 5.325 0.530 
5000 13.048 1.439 9.771 0.592 8.812 1.200 
8000 15.284 1.631 11.742 0.707 9.917 0.799 
10000 16.835 1.579 12.078 0.793 11.351 0.504 
15000 17.980 1.687 13.954 0.646 12.195 0.736 
Table 11-11 
The ᴅ-ser calibration data from obtained when biosensors were calibrated repeatedly over an 
extended period of time. 
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Calibration Day 0, n = 8 Day 21, n = 4 Day 28, n = 4 
[ᴅ-Serine], 
µM 
Mean, J, 
µA.cm
-2 
± SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
0 0 0 0 0 0 0 
1 0.026 0.014 0.015 0.003 0.014 0.001 
2 0.030 0.008 0.023 0.003 0.018 0.001 
5 0.052 0.003 0.053 0.011 0.029 0.004 
10 0.109 0.020 0.063 0.012 0.048 0.003 
20 0.177 0.003 0.088 0.013 0.111 0.008 
50 0.492 0.055 0.358 0.059 0.260 0.023 
100 0.950 0.122 0.783 0.111 0.506 0.055 
200 1.914 0.243 1.668 0.233 0.943 0.114 
500 4.967 0.316 4.189 0.632 2.171 0.321 
1000 8.641 1.112 7.279 1.174 5.006 0.908 
2000 13.534 1.405 12.396 1.954 7.482 1.115 
3000 15.481 1.997 14.130 1.987 9.897 1.526 
5000 17.399 1.745 17.000 2.284 12.716 1.743 
8000 18.238 1.548 18.092 2.309 15.710 2.017 
10000 18.675 1.348 18.749 2.248 16.129 1.996 
15000 18.702 1.510 19.728 2.151 18.141 2.401 
Table 11-12 
The ᴅ-ser calibration data from obtained when biosensors were calibrated once after an extended 
period of time in storage. 
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Calibration Day 0, n = 4 Day 1, n = 4 Day 3, n = 4 
[ᴅ-Serine], 
µM 
Mean, J, 
µA.cm
-2 
± SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
0 0 0 0 0 0 0 
1 0.021 0.012 0.004 0.001 0.014 0.013 
2 0.035 0.010 0.007 0.002 0.003 0.001 
5 0.043 0.012 0.016 0.004 0.005 0.003 
10 0.055 0.017 0.032 0.008 0.012 0.005 
20 0.101 0.068 0.067 0.012 0.013 0.004 
50 0.387 0.137 0.149 0.030 0.071 0.013 
100 0.837 0.254 0.305 0.057 0.213 0.049 
200 1.832 0.566 0.632 0.121 0.468 0.121 
500 4.652 1.207 1.548 0.326 1.090 0.189 
1000 8.464 2.439 2.829 0.612 1.933 0.387 
2000 13.532 3.922 5.350 1.266 4.623 0.829 
3000 16.471 4.892 7.356 1.725 5.329 0.652 
5000 18.220 5.472 9.799 2.548 7.074 1.237 
8000 21.559 6.284 12.001 3.039 8.903 1.921 
10000 20.846 5.940 12.591 3.195 10.879 2.056 
15000 21.765 6.117 14.509 3.765 12.770 2.272 
Calibration Day 7, n =4 Day 10, n = 4 Day 14, n = 4 
[ᴅ-Serine], 
µM 
Mean, J, 
µA.cm
-2 
± SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
0 0 0 0 0 0 0 
1 0.007 0.004 -0.006 0.001 -0.003 0.001 
2 0.009 0.003 -0.001 0.001 -0.008 0.002 
5 0.030 0.012 0.004 0.001 -0.010 0.003 
10 0.049 0.024 0.007 0.002 -0.005 0.004 
20 0.032 0.004 0.018 0.003 0.003 0.004 
50 0.048 0.007 0.049 0.007 0.028 0.007 
100 0.116 0.015 0.100 0.015 0.069 0.010 
200 0.241 0.030 0.197 0.030 0.172 0.024 
500 0.568 0.096 0.467 0.071 0.407 0.068 
1000 1.101 0.194 0.907 0.126 0.661 0.104 
2000 2.005 0.320 1.541 0.236 1.198 0.205 
3000 3.024 0.463 2.006 0.357 1.819 0.330 
5000 3.920 0.758 4.088 1.145 2.754 0.265 
8000 5.168 1.019 5.212 1.140 3.341 0.417 
10000 5.913 1.251 4.460 1.070 3.796 0.544 
15000 7.211 1.566 5.127 1.191 4.519 0.784 
Table 11-13 
The ᴅ-ser calibration data from obtained when biosensors were calibrated repeatedly, over a two 
week period, and were stored in BSA 1% between calibrations. 
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Calibration Day 0, n = 4 Day 1, n = 4 Day 3, n = 4 
[ᴅ-Serine], 
µM 
Mean, J, 
µA.cm
-2 
± SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
0 0 0 0 0 0 0 
1 0.009 0.019 0.005 0.002 0.000 0.001 
2 0.021 0.041 0.019 0.003 0.002 0.001 
5 0.037 0.042 0.028 0.005 0.011 0.003 
10 0.060 0.044 0.074 0.009 0.029 0.006 
20 0.110 0.037 0.118 0.017 0.062 0.011 
50 0.449 0.033 0.326 0.031 0.182 0.030 
100 1.084 0.059 0.689 0.058 0.325 0.052 
200 2.483 0.106 1.285 0.107 0.706 0.121 
500 6.240 0.463 2.861 0.233 1.714 0.304 
1000 11.263 0.493 5.529 0.455 3.553 0.402 
2000 17.131 1.243 8.700 0.578 5.612 0.880 
3000 20.445 1.710 11.442 0.513 7.490 1.285 
5000 24.188 2.133 14.075 0.365 10.449 1.482 
8000 27.342 1.914 16.215 0.463 12.212 1.766 
10000 28.271 1.990 17.869 0.581 13.762 1.455 
15000 28.731 2.037 18.808 0.823 15.252 1.563 
Calibration Day 7, n =4 Day 10, n = 4 Day 14, n = 4 
[ᴅ-Serine], 
µM 
Mean, J, 
µA.cm
-2 
± SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
0 0 0 0 0 0 0 
1 0.005 0.001 0.005 0.002 0.005 0.000 
2 0.001 0.002 0.006 0.002 0.008 0.003 
5 -0.003 0.017 0.007 0.001 0.015 0.008 
10 -0.002 0.017 0.026 0.007 0.030 0.015 
20 0.042 0.023 0.042 0.010 -0.006 0.028 
50 0.108 0.026 0.098 0.022 0.042 0.022 
100 0.237 0.044 0.184 0.038 0.133 0.027 
200 0.496 0.084 0.373 0.077 0.250 0.039 
500 1.209 0.200 0.801 0.148 0.585 0.101 
1000 2.238 0.382 1.697 0.372 1.108 0.208 
2000 5.035 0.459 3.384 0.804 2.226 0.486 
3000 5.648 0.542 4.007 0.862 3.587 0.833 
5000 7.727 1.129 5.221 0.976 4.369 1.220 
8000 10.164 1.377 7.604 1.362 5.931 1.194 
10000 10.362 1.296 7.159 1.153 6.637 1.327 
15000 11.120 1.005 7.869 1.182 7.509 1.354 
Table 11-14 
The ᴅ-ser calibration data from obtained when biosensors were calibrated repeatedly, over a two 
week period, and were stored in 10% BSA between calibrations. 
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Calibration Day 0, n = 4 Day 1, n = 4 Day 3, n = 4 
[ᴅ-Serine], 
µM 
Mean, J, 
µA.cm
-2 
± SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
0 0 0 0 0 0 0 
1 0.014 0.003 0.016 0.011 -0.003 0.001 
2 0.028 0.005 0.027 0.014 -0.001 0.004 
5 0.045 0.009 0.052 0.024 -0.016 0.006 
10 0.096 0.023 0.071 0.023 0.003 0.009 
20 0.186 0.040 0.135 0.040 0.008 0.009 
50 0.621 0.140 0.347 0.082 0.093 0.035 
100 1.244 0.291 0.658 0.142 0.236 0.064 
200 2.677 0.623 1.211 0.282 0.603 0.149 
500 6.062 1.401 2.850 0.662 1.487 0.401 
1000 11.646 2.855 5.865 1.035 3.443 1.353 
2000 18.152 3.924 10.329 1.704 5.164 1.581 
3000 21.303 4.199 13.536 2.608 6.785 1.684 
5000 23.091 4.296 16.984 3.552 8.896 2.461 
8000 24.309 4.379 19.638 3.930 10.818 2.729 
10000 24.999 4.307 20.162 3.927 12.035 2.928 
15000 25.632 4.332 21.635 4.086 13.274 3.304 
Calibration Day 7, n =4 Day 10, n = 4 Day 14, n = 4 
[ᴅ-Serine], 
µM 
Mean, J, 
µA.cm
-2 
± SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
0 0 0 0 0 0 0 
1 -0.002 0.002 -0.010 0.010 0.014 0.015 
2 -0.002 0.001 -0.007 0.010 0.019 0.029 
5 -0.001 0.003 0.027 0.028 0.021 0.034 
10 0.002 0.003 0.001 0.010 0.017 0.032 
20 0.019 0.007 -0.002 0.013 0.018 0.034 
50 0.056 0.015 0.017 0.011 0.021 0.033 
100 0.104 0.029 0.047 0.013 0.020 0.006 
200 0.258 0.059 0.112 0.025 0.062 0.005 
500 0.641 0.144 0.342 0.098 0.185 0.025 
1000 1.234 0.268 0.682 0.169 0.404 0.048 
2000 2.234 0.460 1.208 0.285 0.802 0.109 
3000 3.598 1.044 1.575 0.367 1.014 0.168 
5000 4.259 0.878 2.123 0.462 1.689 0.223 
8000 5.418 1.132 2.670 0.529 2.070 0.363 
10000 6.141 1.286 2.869 0.637 2.775 0.339 
15000 7.313 1.573 3.460 0.767 2.657 0.527 
Table 11-15 
The ᴅ-ser calibration data obtained when biosensors were calibrated repeatedly, over a two week 
period, and were stored in PEA 1% between calibrations. 
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Calibration Day 0, n = 4 Day 1, n = 4 Day 3, n = 4 
[ᴅ-Serine], 
µM 
Mean, J, 
µA.cm
-2 
± SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
0 0 0 0 0 0 0 
1 0.016 0.002 -0.003 0.002 -0.003 0.003 
2 0.038 0.006 0.012 0.009 -0.003 0.006 
5 0.069 0.010 0.022 0.010 0.004 0.013 
10 0.096 0.014 0.058 0.024 0.019 0.022 
20 0.177 0.013 0.077 0.021 0.047 0.023 
50 0.439 0.046 0.070 0.023 0.097 0.025 
100 0.629 0.063 0.136 0.033 0.092 0.028 
200 0.782 0.076 0.192 0.030 0.145 0.014 
500 1.293 0.109 0.160 0.023 0.251 0.014 
1000 2.383 0.211 0.958 0.123 0.580 0.064 
2000 5.832 0.531 2.596 0.204 1.240 0.102 
3000 10.516 0.800 4.356 0.389 2.846 0.385 
5000 18.541 1.750 9.459 0.772 6.415 1.947 
8000 21.506 2.315 9.971 1.076 6.261 0.841 
10000 26.265 2.689 12.683 0.807 8.840 1.168 
15000 29.297 2.783 14.390 1.080 10.918 1.370 
Calibration Day 7, n =4 Day 10, n = 4 Day 14, n = 4 
[ᴅ-Serine], 
µM 
Mean, J, 
µA.cm
-2 
± SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
0 0 0 0 0 0 0 
1 0.012 0.005 -0.003 0.002 -0.006 0.001 
2 0.007 0.002 0.002 0.012 -0.026 0.024 
5 0.007 0.001 0.003 0.012 -0.020 0.012 
10 0.011 0.002 0.005 0.011 -0.018 0.009 
20 0.023 0.002 0.004 0.013 -0.019 0.005 
50 0.031 0.008 0.010 0.016 -0.018 0.005 
100 0.038 0.009 0.003 0.017 -0.013 0.002 
200 0.043 0.008 0.004 0.016 -0.012 0.003 
500 0.084 0.009 0.010 0.005 0.006 0.012 
1000 0.146 0.025 0.043 0.006 0.028 0.014 
2000 0.230 0.042 0.157 0.031 0.076 0.016 
3000 0.568 0.101 0.301 0.063 0.127 0.005 
5000 1.063 0.197 0.592 0.126 0.246 0.045 
8000 1.439 0.247 0.839 0.174 0.291 0.043 
10000 2.299 0.412 1.284 0.296 0.458 0.068 
15000 3.272 0.566 1.928 0.511 0.719 0.090 
Table 11-16 
The ᴅ-ser calibration data obtained when biosensors were calibrated repeatedly, over a two week 
period, and were stored in PEA 10% between calibrations. 
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Cal Day 0, n = 4 Day 1, n = 4 Day 3, n = 4 Day 7, n = 4 Day 14, n = 4 
ᴅ-
Serine 
µM 
Mean, 
J, 
µA.cm-2 
± 
SEM, 
J, 
µA.cm-2 
Mean, 
J, 
µA.cm-2 
± 
SEM, 
J, 
µA.cm-2 
Mean, 
J, 
µA.cm-2 
± 
SEM, 
J, 
µA.cm-2 
Mean, 
J, 
µA.cm-2 
± 
SEM, 
J, 
µA.cm-2 
Mean, 
J, 
µA.cm-2 
± 
SEM, 
J, 
µA.cm-2 
0 0 0 0 0 0 0 0 0 0 0 
1 0.008 0.003 -0.003 0.002 0.004 0.004 0.001 0.002 0.002 0.001 
2 0.038 0.010 0.003 0.002 -0.001 0.001 -0.004 0.001 0.003 0.000 
5 0.072 0.011 0.015 0.009 0.005 0.001 0.025 0.011 0.006 0.001 
10 0.079 0.013 0.024 0.008 0.012 0.002 0.005 0.004 0.013 0.003 
20 0.026 0.026 0.022 0.007 0.045 0.018 0.011 0.003 0.026 0.006 
50 0.365 0.024 0.115 0.018 0.080 0.013 0.060 0.002 0.061 0.016 
100 0.802 0.035 0.291 0.032 0.168 0.017 0.144 0.027 0.111 0.030 
200 1.747 0.031 0.612 0.073 0.356 0.025 0.426 0.056 0.207 0.056 
500 4.429 0.144 1.526 0.123 0.854 0.065 0.883 0.123 0.317 0.092 
1000 7.919 0.167 3.390 0.519 1.615 0.131 1.510 0.217 0.744 0.192 
2000 10.854 0.553 4.630 0.296 2.817 0.180 2.403 0.348 1.233 0.311 
3000 12.132 0.677 5.515 0.558 4.618 0.604 3.998 0.471 1.590 0.339 
5000 13.524 0.890 6.049 0.815 5.704 0.966 3.511 0.252 2.285 0.341 
8000 14.229 0.958 7.160 0.965 6.415 0.939 4.275 0.156 2.673 0.298 
10000 14.298 0.865 7.734 0.914 6.530 0.967 4.497 0.193 2.545 0.294 
15000 14.140 0.813 8.481 0.959 6.581 1.056 5.252 0.222 2.889 0.288 
Table 11-17 
The ᴅ-ser calibration data obtained when biosensors were calibrated repeatedly, over a two week 
period, and were stored in brain tissue between calibrations. 
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Calibration 
pre pH 8.0 
n = 4 
pH 8.0 
n = 4 
pre pH 6.5 
n = 4 
pH 6.5 
n = 4 
ᴅ-Serine, 
µM 
Mean, 
J, 
µA.cm
-
2
 
± SEM, 
J, 
µA.cm
-
2
 
Mean, 
J, 
µA.cm
-
2
 
± SEM, 
J, 
µA.cm
-
2
 
Mean, 
J, 
µA.cm
-
2
 
± 
SEM, 
J, 
µA.cm
-
2
 
Mean, 
J, 
µA.cm
-
2
 
± 
SEM, 
J, 
µA.cm
-
2
 
0 0 0 0 0 0 0 0 0 
1 0.029 0.006 0.007 0.005 0.019 0.011 0.014 0.010 
2 0.051 0.008 0.023 0.010 0.017 0.004 0.016 0.010 
5 0.044 0.009 0.034 0.012 0.033 0.008 0.022 0.012 
10 0.066 0.013 0.044 0.014 0.059 0.012 0.028 0.012 
20 0.307 0.087 0.083 0.022 0.083 0.018 0.042 0.013 
40 0.474 0.097 0.129 0.034 0.304 0.077 0.039 0.015 
50 0.786 0.154 0.968 0.152 0.450 0.100 0.084 0.020 
60 1.082 0.199 1.068 0.161 0.469 0.109 0.088 0.019 
100 1.934 0.393 1.964 0.243 0.882 0.196 0.117 0.021 
200 3.927 0.867 4.651 0.802 1.447 0.282 0.200 0.025 
500 9.065 1.764 8.473 1.545 4.185 1.148 0.468 0.065 
1000 15.342 2.547 15.815 2.340 4.105 0.490 1.015 0.131 
2000 21.224 2.654 25.057 2.958 6.635 0.765 1.954 0.260 
3000 24.160 2.884 27.633 2.792 8.584 0.828 3.834 0.680 
5000 25.316 2.910 31.568 2.881 10.335 0.850 4.878 1.064 
8000 26.968 2.774 31.071 2.915 11.754 0.910 8.193 2.080 
10000 27.923 2.704 32.855 2.944 11.712 0.966 8.497 2.097 
15000 28.088 2.747 30.681 3.175 14.421 1.624 9.758 2.182 
Table 11-18 
The ᴅ-ser calibration data returned when calibrations were performed to elucidate the effect of pH 
changes on the sensitivity of the biosensor. 
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Calibration pre 37 ºC, n = 4 37 ºC, n = 4 post 37 ºC, n = 4 
ᴅ-Serine, µM 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
0 0 0 0 0 0 0 
1 0.014 0.007 0.031 0.003 0.019 0.015 
2 0.031 0.005 0.040 0.004 0.023 0.009 
5 0.056 0.007 0.068 0.014 0.031 0.008 
10 0.091 0.012 0.092 0.017 0.070 0.022 
20 0.141 0.022 0.168 0.009 0.060 0.021 
40 0.201 0.016 0.340 0.017 0.117 0.037 
50 0.253 0.041 0.432 0.030 0.143 0.038 
60 0.332 0.050 0.515 0.041 0.145 0.040 
100 0.531 0.058 0.930 0.150 0.313 0.061 
200 1.085 0.077 1.922 0.194 0.602 0.067 
500 2.574 0.187 5.046 0.592 1.429 0.118 
1000 5.842 0.412 7.074 0.718 3.785 0.354 
2000 9.094 0.804 10.549 0.958 4.940 0.409 
3000 10.682 1.240 12.660 1.134 6.063 0.400 
5000 13.764 2.223 15.364 1.691 8.082 0.467 
8000 15.471 2.771 16.280 1.873 8.998 0.439 
10000 17.709 3.759 17.672 2.084 9.150 0.499 
15000 17.923 4.192 18.319 2.362 9.878 0.453 
Table 11-19 
The ᴅ-ser calibration data for calibrations which were performed at room temperature and 37 ºC. 
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350 
Calibration pre ᴅ-alanine, n = 4 ᴅ-alanine, n = 4 post ᴅ-alanine, n = 4 
[substrate], 
µM 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
Mean, J, 
µA.cm
-2
 
± SEM, J, 
µA.cm
-2
 
0 0 0 0 0 0 0 
1 0.015 0.005 0.047 0.008 0.007 0.003 
2 0.024 0.006 0.079 0.020 0.013 0.003 
5 0.034 0.005 0.154 0.021 0.028 0.004 
10 0.040 0.007 0.164 0.019 0.050 0.007 
20 0.059 0.009 0.325 0.026 0.113 0.011 
40 0.107 0.019 0.599 0.068 0.249 0.032 
50 0.222 0.034 0.742 0.047 0.317 0.032 
60 0.294 0.042 0.912 0.048 0.333 0.029 
100 0.571 0.060 1.504 0.094 0.592 0.062 
200 1.152 0.125 2.862 0.207 1.132 0.106 
500 2.911 0.260 6.025 0.548 2.785 0.279 
1000 5.899 0.708 9.512 1.119 6.108 0.692 
2000 9.085 0.760 13.381 1.446 8.811 0.608 
3000 10.726 0.880 15.198 1.766 9.509 0.299 
5000 11.719 1.202 16.234 1.877 10.840 0.568 
8000 12.505 1.107 15.860 1.704 11.988 0.796 
10000 12.606 1.070 16.867 2.013 12.385 0.893 
15000 13.332 1.241 17.221 2.064 12.713 0.926 
Table 11-20 
The calibration data for a ᴅ-ala calibration, and a pre and post ᴅ-ser calibration. 
Substrate 
J, µA.cm
-2
, n = 8 Substrate 
Concentration, µM Mean ± SEM 
AA 0.048 0.028 500 
HVA 0.005 0.009 10 
ʟ-gluta -0.007 0.004 50 
ʟ-cys 0.004 0.007 50 
UA -0.009 0.001 50 
ʟ-trp -0.010 0.002 100 
DHAA -0.021 0.009 100 
ʟ-tyr -0.010 0.003 100 
DA -0.006 0.003 0.5 
5-HIAA 0.001 0.007 50 
DOPAC -0.008 0.005 20 
5-HT 0.001 0.006 0.01 
Overall 0.014 0.027 > 1000 
Table 11-21 
Calibration data for electroactive species found in the ECF.  
 
